chronic JJ I-NP O
normocytic JJ I-NP O
anemia NN I-NP O
felt VBD B-VP O
likely JJ O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
her PRP$ O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
Her NNP I-NP O
iron NN I-NP O
studies NNS I-NP O
were VBD B-VP O
rechecked VBN O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
and CC O O
her PRP$ O O
iron NN B-NP O
studies NNS I-NP O
were VBD B-VP O
also RB O O
normal JJ O O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Aranesp NNP B-NP B-m
through IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
and CC O O
she PRP O O
is VBZ O O
on IN B-VP O
Procrit NNP B-NP B-m
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
she PRP O O
will MD O O
continue VB O O
on IN B-VP O
that DT O O
with IN B-VP O
further JJ B-NP O
discussion NN I-NP O
with IN B-VP O
the DT B-NP O
GGVH NNP I-NP O
Renal NNP I-NP O
Clinic NNP I-NP O
after IN B-VP O
she PRP O O
is VBZ O O
discharged JJ O O
6 CD O O
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
, , O O
and CC O O
nutrition: VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
fluid RB O O
restricted VBN O O
to TO O O
2 CD O O
liters NNS B-NP O
of IN B-VP O
fluid JJ O O
per IN B-VP O
day NN B-NP O
p.o NN I-NP O
and CC O O
potassium NN B-NP B-m
and CC O O
magnesium NN B-NP B-m
were VBD B-VP O
repleted VBN O O
as IN B-VP B-f
as IN B-VP B-f
needed VBN O I-f
needed VBN O I-f
and CC O O
she PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
diet NN I-NP O
Prophylaxis NNP I-NP B-r
Prophylaxis NNP I-NP B-r
was VBD B-VP O
with IN B-VP O
Coumadin NNP B-NP B-m
and CC O O
Nexium NNP B-NP B-m
DISCHARGE NNP I-NP O
PLAN: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
services NNS I-NP O
for IN B-VP O
some DT B-NP O
home NN I-NP O
physical JJ B-NP O
therapy NN I-NP O
She PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
Dr NNP I-NP O
Bublitz NNP I-NP O
at IN B-VP O
MHS NNP B-NP O
and CC O O
also RB O O
with IN B-VP O
the DT B-NP O
SRRH NNP I-NP O
Cardiology NNP I-NP O
Clinic NNP I-NP O
and CC O O
Renal NNP B-NP O
Clinic NNP I-NP O
She PRP O O
should MD O O
have VB O O
her PRP$ O O
INR NNP B-NP O
checked VBD B-VP O
within IN B-VP O
4-5 JJ B-NP O
days NNS I-NP O
after IN B-VP O
discharge NN B-NP O
and CC O O
her PRP$ O O
Coumadin NNP B-NP B-m
restarted VBD B-VP O
when WRB O O
her PRP$ O O
INR NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
2.5 CD O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
2 CD O O
Amiodarone $ O B-m
200 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Folate NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Lantus NNP B-NP B-m
insulin NN I-NP I-m
12 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
nightly RB O B-f
6 CD O O
Ativan NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
7 CD O O
Metolazone NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
fluid JJ B-NP B-r
retention NN I-NP I-r
as IN B-VP O
directed VBN O O
by IN B-VP O
your PRP$ O O
physician JJ O O
8 CD O O
Multivitamin NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
p.o VB O B-mo
daily JJ O B-f
9 CD O O
Torsemide NNP B-NP B-m
Torsemide NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
at IN B-VP O
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m VBD B-VP B-f
10 CD O O
Vitamin NNP B-NP B-m
B12 NNP I-NP I-m
11 CD O O
Iron NNP B-NP B-m
12 CD O O
Procrit NNP B-NP B-m
40 CD O B-do
, , O I-do
000 CD O I-do
units NNS B-NP I-do
subcutaneously RB O B-mo
every DT B-NP B-f
other JJ I-NP I-f
week NN I-NP I-f
eScription NN I-NP O
document: VBZ O O
6-0072111 JJ B-NP O
RFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BURROW NNP I-NP O
, , O O
KENNETH NNP B-NP O
Attending: NNP I-NP O
NOVAKOVICH NNP I-NP O
, , O O
CURT NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1743355 CD O O
D: NNP B-NP O
1/16/06 CD O O
T: NNP B-NP O
2/8/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#815287 VBZ O O
265642788 CD O O
AYMC NNP B-NP O
78055007 CD O O
5390462 CD O O
6/4/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Pneumonia NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/4/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/10/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
EANS NNP I-NP O
, , O O
JUSTIN NNP B-NP O
244-78-04-0 JJ B-NP O
Chi NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
0/0/04 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
VANHYNING NNP I-NP O
, , O O
GLENN NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
TYLENOL NNP I-NP B-m
TYLENOL NNP I-NP B-m
( ( O I-m
( ( O I-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
ACETAMINOPHEN NNP I-NP I-m
ACETAMINOPHEN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
500 CD O B-do
500 CD O B-do
500 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
Q6H NNP I-NP B-f
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
PRN NNP I-NP I-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
, , O O
Headache NNP B-NP B-r
Headache NNP I-NP B-r
ATENOLOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
CALCIUM NNP I-NP B-m
CITRATE NNP I-NP I-m
950 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
GEMFIBROZIL NNP I-NP B-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HYDROCHLOROTHIAZIDE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NPH NNP I-NP B-m
INSULIN NNP I-NP I-m
HUMAN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
15 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
At IN B-VP B-f
10 CD O I-f
p.m NN B-NP I-f
( ( O I-f
bedtime NN B-NP I-f
) ) O I-f
LISINOPRIL VBZ O B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/28/04 CD O O
by IN B-VP O
WILBY NNP B-NP O
, , O O
BRYANT NNP B-NP O
BRYON NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
93677429 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/28/04 CD O O
by IN B-VP O
WASHMUTH NNP B-NP O
, , O O
SCOTTIE NNP B-NP O
CLEO NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
23327775 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
NIFEREX-150 NNP B-NP B-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/3/04 CD O O
by IN B-VP O
BEILER NNP B-NP O
, , O O
TOMMY NNP B-NP O
L NNP I-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LEVOFLOXACIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
46869053 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POLYSACCHARIDE NNP I-NP B-m
IRON NNP I-NP O
COMPLEX NNP I-NP O
&amp; NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Will NNP I-NP O
separate JJ B-NP O
doses NNS I-NP O
by IN B-VP O
2 CD O O
hours NNS B-NP O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/28/04 CD O O
by IN B-VP O
UREN NNP B-NP O
, , O O
FERMIN NNP B-NP O
JEWEL NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
POLYSACCHARIDE NNP I-NP B-m
IRON NNP I-NP I-m
COMPLEX NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
SIMETHICONE NNP B-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
VITAMIN NNP I-NP B-m
E NNP I-NP I-m
( ( O I-m
TOCOPHEROL-DL-ALPHA NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
200 CD O I-do
UNITS NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
7/21 CD O O
) ) O O
VITAMIN NNP B-NP B-m
B NNP I-NP I-m
COMPLEX NNP I-NP I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TRIAMCINOLONE NNP I-NP B-m
TRIAMCINOLONE NNP I-NP B-m
ACETONIDE NNP I-NP I-m
ACETONIDE NNP I-NP I-m
0.5% CD O I-m
0.5% CD O I-m
( ( O I-m
( ( O I-m
TRIAMCINOLONE NNP B-NP I-m
TRIAMCINOLONE NNP I-NP I-m
A NNP I-NP I-m
A NNP I-NP I-m
) ) O I-m
) ) O I-m
TOPICAL NNP B-NP B-mo
TOPICAL NNP I-NP B-mo
TP NNP I-NP I-mo
TP NNP I-NP I-mo
QID NNP I-NP B-f
QID NNP I-NP B-f
Instructions: NNP I-NP O
Please NNP I-NP O
apply VB O O
to TO O O
affected JJ B-NP O
area NN I-NP O
in IN B-VP O
right JJ B-NP O
axilla NN I-NP O
four CD O O
times NNS B-NP O
per IN B-VP O
day NN B-NP O
LEVOFLOXACIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Instructions: NNP I-NP O
Please NNP I-NP O
give VB O O
at IN B-VP O
least JJS O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
and CC O O
after IN B-VP O
any DT B-NP O
iron NN I-NP B-m
supplements NNS I-NP I-m
until IN B-VP B-du
November NNP B-NP I-du
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Alert NNP I-NP O
overridden: MD O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
3/3/04 CD O O
by IN B-VP O
GANAWAY NNP B-NP O
, , O O
BENNETT NNP B-NP O
S NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POLYSACCHARIDE NNP I-NP B-m
IRON NNP I-NP O
COMPLEX NNP I-NP O
&amp; NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Will NNP I-NP O
separate JJ B-NP O
doses NNS I-NP O
by IN B-VP O
2 CD O O
hours NNS B-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
2% CD O I-m
POWDER NNP B-NP I-m
TOPICAL NNP I-NP B-mo
TP NNP I-NP I-mo
BID NNP I-NP B-f
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
METFORMIN NNP I-NP B-m
XR NNP I-NP I-m
( ( O I-m
METFORMIN NNP B-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
2 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC NNP I-NP B-f
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
PROTONIX NNP B-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
NAS NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/day NN B-NP O
/ VB O O
Very RB O O
low JJ B-NP O
fat NN I-NP O
( ( O O
20gms/day CD O O
) ) O O
ACTIVITY: NNP B-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Devon NNP I-NP O
Filgo NNP I-NP O
11/10/04 CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Marvin NNP I-NP O
Brendle NNP I-NP O
10/8/04 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
HORSE NNP I-NP O
, , O O
tricor JJ B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
right JJ B-NP O
upper NN I-NP O
quadrant NN I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Pneumonia NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
+H NN B-NP O
pylori NN I-NP O
, , O O
s/p JJ B-NP O
rx NN I-NP O
( ( O O
Helicobacter NNP B-NP O
pylori NN I-NP O
) ) O O
guiac NN B-NP O
+ NN I-NP O
stools NNS I-NP O
( ( O O
lower JJR B-NP O
GI NNP I-NP O
bleeding VBG O O
) ) O O
diverticulosis NN B-NP O
( ( O O
diverticulosis NN B-NP O
) ) O O
polyposis NN B-NP O
( ( O O
colonic JJ B-NP O
polyp NN I-NP O
) ) O O
nephrolithiasis NN B-NP O
( ( O O
kidney VB O O
stone NN B-NP O
) ) O O
depression NN B-NP O
( ( O O
depression NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
hypertriglyceridemia NN B-NP O
( ( O O
elevated JJ B-NP O
triglycerides NNS I-NP O
) ) O O
OSA NNP B-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
pneumonia NN B-NP O
( ( O O
pneumonia NN B-NP O
) ) O O
contact NN B-NP O
dermatitis NN I-NP O
R NNP I-NP O
axilla NN I-NP O
( ( O O
contact JJ B-NP O
dermatitis NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Mr NNP I-NP O
Schoel NNP I-NP O
underwent VBD B-VP O
an DT B-NP O
upper JJ I-NP O
endoscopy NN I-NP O
on IN B-VP O
6/1 CD O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC/HPI: NNP I-NP O
56 CD O O
y.o NN B-NP O
man NN I-NP O
with IN B-VP O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
hypertryglyceridemia NN B-NP O
, , O O
depression NN B-NP O
comes VBZ O O
in IN B-VP O
with IN B-VP O
2-day JJ B-NP O
h/o NN I-NP O
increasing VBG O O
abdominal JJ B-NP O
girth NN I-NP O
, , O O
1-day JJ B-NP O
h/o NN I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
pleuritic JJ B-NP O
CP NNP I-NP O
7 CD O O
days NNS B-NP O
PTA NNP I-NP O
noticed VBD B-VP O
increase NN B-NP O
in IN B-VP O
nocturia NNS B-NP O
from IN B-VP O
2x CD O O
to TO O O
6x CD O O
2 CD O O
days NNS B-NP O
PTA NNP I-NP O
became VBD B-VP O
uncomfortable JJ O O
while IN B-VP O
sleeping VBG O O
, , O O
could MD O O
not RB O O
take VB O O
deep JJ B-NP O
breath NN I-NP O
without IN B-VP O
RUQ NNP B-NP O
abdominal JJ B-NP O
pain NN I-NP O
No NNP I-NP O
fever/chills NNS I-NP O
, , O O
no DT B-NP O
cough NN I-NP O
, , O O
mild JJ B-NP O
nausea NN I-NP O
, , O O
no DT B-NP O
vomiting NN I-NP O
, , O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
bowel NN B-NP O
habits NNS I-NP O
, , O O
no DT B-NP O
dysuria NN I-NP O
Arrived NNP I-NP O
in IN B-VP O
ED NNP B-NP O
10/21 CD O O
, , O O
given VBN O O
i.v NNS B-NP B-mo
Lasix NNP I-NP B-m
for IN B-VP O
presumed JJ B-NP B-r
CHF NNP I-NP I-r
PMH: NNP I-NP O
Per NNP I-NP O
problem NN I-NP O
list NN I-NP O
MEDS: NNP I-NP O
Not RB O O
compliant JJ B-NP O
Admission NNP I-NP O
- : O O
Nexium NN B-NP B-m
40 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
bid NN I-NP B-f
, , O O
HCTZ NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Lisinopril NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Tiazac NNP B-NP B-m
240 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Metformin NNP B-NP B-m
XR NNP I-NP I-m
2000 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
on IN B-VP O
admission NN B-NP O
Allergies: NNP I-NP O
Horse NNP I-NP O
( ( O O
unknown JJ O O
) ) O O
, , O O
TriCort NNP B-NP O
( ( O O
rash NN B-NP O
) ) O O
PE VBD B-VP O
6/6 CD O O
T NNP B-NP O
97.5 CD O O
HR NNP B-NP O
108 CD O O
BP NNP B-NP O
196/112 CD O O
RR NNP B-NP O
18 CD O O
SAT NNP B-NP O
96% CD O O
RA NNP B-NP O
AOX3 NNP I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
lungs NNS B-NP O
clear VBP O O
, , O O
RRR NNP B-NP O
no DT B-NP O
M/R/G NNP I-NP O
, , O O
abdom RB O O
en IN B-VP O
obese JJ O O
, , O O
distended VBD B-VP O
, , O O
w/o JJ B-NP O
peritoneal NN I-NP O
signs NNS I-NP O
, , O O
+bs NNP B-NP O
, , O O
no DT B-NP O
LE NNP I-NP O
edema VBZ O O
PE NNP B-NP O
10/25 CD O O
Tm NNP B-NP O
99.8 CD O O
HR NNP B-NP O
80-90 JJ B-NP O
BP NNP I-NP O
140-170/80-90 CD O O
RR NNP B-NP O
18 CD O O
- : O O
22 CD O O
SAT NNP B-NP O
97% CD O O
3L CD O O
92-94% JJ B-NP O
RA NNP I-NP O
AOX3 NNP I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
lungs NNS B-NP O
and CC O O
heart NN B-NP O
WNL NNP I-NP O
, , O O
abd RB O O
less JJR B-NP O
tender JJ I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
) ) O O
CV NNP B-NP O
Ischemia NNP I-NP O
Cardiac NNP I-NP O
enzymes VBZ O O
flat JJ B-NP O
x NNP I-NP O
3 CD O O
No NNP B-NP O
significant JJ B-NP O
EKG NNP I-NP O
changes NNS I-NP O
Pump NNP I-NP O
10/21 CD O O
BNP NNP B-NP O
64 CD O O
, , O O
no DT B-NP O
clinical JJ I-NP O
CHF NNP I-NP O
Hypertension NNP I-NP O
poorly RB O O
controlled VBD B-VP O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
missing VBG O O
home NN B-NP O
meds NNS I-NP O
w/bp VBP O O
up RB O O
to TO O O
170's/90's CD O O
Diltiazem NNP B-NP B-m
d/c'd NN I-NP O
in IN B-VP O
favor NN B-NP O
of IN B-VP O
Metoprolol NNP B-NP B-m
and CC O O
uptitrated VBD B-VP B-do
2 CD O O
) ) O O
Pulmonary NNP B-NP O
Ruled VBD B-VP O
out RP O O
PE NNP B-NP O
with IN B-VP O
D-dimer NNP B-NP O
( ( O O
&lt;200 NNP B-NP O
) ) O O
OSA NNP B-NP O
, , O O
likely JJ B-NP O
obesity NN I-NP O
hypoventilation NN I-NP O
Failed VBD B-VP O
2 CD O O
CPAP NNP B-NP O
trials NNS I-NP O
Had VBD B-VP O
fever VBN O O
to TO O O
101.5 CD O O
, , O O
desat NN B-NP O
on IN B-VP O
RA NNP B-NP O
, , O O
tachypneic NN B-NP O
, , O O
pan-cx JJ O O
, , O O
CXR NNP B-NP O
LLL NNP I-NP O
PNA NNP I-NP O
, , O O
Vanco/Levo/Flagyl NNP B-NP B-m
Vanco/Levo/Flagyl NNP I-NP B-m
begun VBN O O
, , O O
Vanco NNP B-NP B-m
d/c'd NN I-NP O
since IN B-VP O
unlikely JJ O O
nosocomial JJ O O
, , O O
Levo/Flagyl NNP B-NP B-m
changed VBD B-VP O
to TO O O
p.o VB O B-mo
3 CD O O
) ) O O
GI NNP B-NP O
10/21 CD O O
Abd NNP B-NP O
CT NNP I-NP O
- : O O
fatty NN B-NP O
liver NN I-NP O
, , O O
pancreas JJ B-NP O
ALT/AST: NNP I-NP O
133/98 CD O O
, , O O
others NNS B-NP O
WNL NNP I-NP O
, , O O
trending VBG O O
down RP O O
, , O O
near IN B-VP O
norma JJ B-NP O
TG NNP I-NP O
- : O O
2032 CD O O
Serological NNP B-NP O
liver NN I-NP O
dz NN I-NP O
w/u NN I-NP O
neg JJ B-NP O
Gemfibrozil NNP I-NP B-m
begun VBN O O
presumed JJ B-NP O
dx NN I-NP O
NASH NNP I-NP O
, , O O
EGD NNP B-NP O
- : O O
antral JJ B-NP O
erosions NNS I-NP O
, , O O
ASA/NSAIDs NNP B-NP B-m
ASA/NSAIDs NNP I-NP B-m
d/c'd NN I-NP O
for IN B-VP B-du
for IN B-VP B-du
6 CD O O
- : O O
8 CD O O
wks NN B-NP O
4 CD O O
)END: NN B-NP O
Metformin NNP I-NP B-m
, , O O
ISS NNP B-NP O
8/18 CD O O
15 CD O B-do
units NNS B-NP I-do
NPH NNP I-NP B-m
added VBD B-VP O
at IN B-VP B-f
bedtime NN B-NP I-f
am VBP O O
FSBG NNP B-NP O
120 CD O O
, , O O
will MD O O
continue VB O O
5 CD O O
)RENAL/FEN NNP B-NP O
Good NNP I-NP O
renal JJ B-NP O
function NN I-NP O
, , O O
pt NN B-NP O
on IN B-VP O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
Urine NNP I-NP O
cx NN I-NP O
likely RB O O
contaminant JJ O O
, , O O
6 CD O O
)NEURO/PSY JJ B-NP O
Pt NNP I-NP O
self-d/c'd NN I-NP O
Wellbutrin NNP I-NP B-m
Effexor NNP I-NP I-m
7d CD O B-du
PTA NNP B-NP O
Restart NNP I-NP O
as IN B-VP O
outpatient JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
return VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
if IN B-VP O
you PRP O O
feel VBP O O
fever RB O O
or CC O O
chills NNS B-NP O
dizziness NN I-NP O
, , O O
worsening VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
persistent JJ B-NP O
nausea/vomiting NN I-NP O
Please NNP I-NP O
go VB O O
to TO O O
all DT O O
follow VB O O
up RP O O
appointments NNS B-NP O
, , O O
including VBG O O
Dr NNP B-NP O
Gregorio NNP I-NP O
Fernald NNP I-NP O
( ( O O
Endocrinology NNP B-NP O
) ) O O
9/29 CD O O
2 CD O O
p.m NN B-NP O
in IN B-VP O
Stin NNP B-NP O
Hi NNP I-NP O
Wi NNP I-NP O
( ( O O
651 CD O O
) ) O O
510-9486 CD O O
and CC O O
with IN B-VP O
Dr NNP B-NP O
Antonia NNP I-NP O
Swarn NNP I-NP O
, , O O
your PRP$ O O
Primary NNP B-NP O
Care NNP I-NP O
Doctor NNP I-NP O
, , O O
on IN B-VP O
9/24/04 CD O O
at IN B-VP O
1:30 CD O O
p.m JJ B-NP O
Please NNP I-NP O
call VB O O
her PRP$ O O
office NN B-NP O
to TO O O
confirm VB O O
at IN B-VP O
( ( O O
190 CD O O
) ) O O
786-1186 JJ B-NP O
Please NNP I-NP O
take VB O O
all DT B-NP O
medications NNS I-NP O
as IN B-VP O
prescribed JJ B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Satisfactory NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
) ) O O
Complete JJ B-NP O
14-day JJ I-NP O
course NN I-NP O
of IN B-VP O
Levofloxacin NNP B-NP B-m
( ( O O
until IN B-VP O
4/18/04 CD O O
) ) O O
2 CD O O
) ) O O
Follow NNP B-NP O
up RP O O
with IN B-VP O
Endocrine NNP B-NP O
and CC O O
PCP NNP B-NP O
re VBP O O
diabetes NNS B-NP O
and CC O O
lipid JJ B-NP O
management NN I-NP O
3 CD O O
) ) O O
Follow NNP B-NP O
up RP O O
with IN B-VP O
PCP NNP B-NP O
for IN B-VP O
management NN B-NP O
of IN B-VP O
chronic JJ B-NP O
medical JJ I-NP O
problems NNS I-NP O
, , O O
including VBG O O
GERD NNP B-NP O
, , O O
gastric JJ B-NP O
erosions NNS I-NP O
, , O O
hypertension NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
4 CD O O
) ) O O
Follow NNP B-NP O
up RP O O
with IN B-VP O
outpatient JJ B-NP O
psychiatrist NN I-NP O
regarding VBG O O
reinitiation NN B-NP O
of IN B-VP O
medications NNS B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
DEMARIO NNP I-NP O
, , O O
ROSENDO NNP B-NP O
EUSEBIO NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
DN49 NNP B-NP O
) ) O O
0/0/04 CD O O
@ $ O O
10 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#815850 VBZ O O
437970544 CD O O
SAMC NNP B-NP O
86695057 CD O O
097799 CD O O
4/6/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/10/1998 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/24/1998 CD O O
ADMISSION NNP B-NP O
DIAGNOSIS: NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
BYPASS NNP I-NP O
GRAFT NNP I-NP O
IDENTIFICATION: NNP I-NP O
Mr NNP I-NP O
Wolfinbarger NNP I-NP O
is VBZ O O
a DT O O
55 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
, , O O
who WP O O
had VBD B-VP O
increased VBN O O
symptoms NNS B-NP O
of IN B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
fatigue NN B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
positive JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
on IN B-VP O
7/6/98 CD O O
BRIEF NNP B-NP O
HISTORY: NNP I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
Enreen VB O O
Dallout NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
, , O O
which WDT O O
demonstrated VBD B-VP O
a DT B-NP O
right JJ I-NP O
dominate NN I-NP O
system NN I-NP O
with IN B-VP O
diffuse NN B-NP O
30% CD O O
to TO O O
40% CD O O
lesions NNS B-NP O
of IN B-VP O
his PRP$ O O
left JJ O O
main JJ O O
, , O O
90% CD O O
lesion NN B-NP O
of IN B-VP O
his PRP$ O O
left JJ O O
anterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
, , O O
100% CD O O
lesion NN B-NP O
of IN B-VP O
his PRP$ O O
circumflex NN B-NP O
and CC O O
OM NNP B-NP O
1 CD O O
and CC O O
a DT O O
100% CD O O
lesion NN B-NP O
past IN B-VP O
his PRP$ O O
obtuse NN B-NP O
marginal JJ B-NP O
#2 NNP I-NP O
, , O O
60% CD O O
proximal JJ B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
lesion NN I-NP O
and CC O O
a DT O O
70% CD O O
posterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
lesion NN I-NP O
On IN B-VP O
7/6/98 CD O O
he PRP O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
demonstrated VBD B-VP O
good JJ B-NP O
LV NNP I-NP O
function NN I-NP O
He PRP O O
is VBZ O O
admitted VBN O O
for IN B-VP O
CABG NNP B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
His PRP$ O O
Past NNP B-NP O
Medical NNP I-NP O
History NNP I-NP O
includes VBZ O O
non-Hodgkin's JJ B-NP O
lymphoma NN I-NP O
, , O O
status NN B-NP O
bone NN I-NP O
marrow NN I-NP O
transplant NN I-NP O
and CC O O
chemotherapy NN B-NP O
in IN B-VP O
1992 CD O O
and CC O O
1993; CD O O
history NN B-NP O
of IN B-VP O
hypercholesterolemia NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
insulin NN B-NP O
dependent NN I-NP O
diabetes NNS I-NP O
, , O O
gastroesophageal JJ B-NP O
reflux NN I-NP O
disorder NN I-NP O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
ALLERGIES: NNP I-NP O
He PRP O O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
Benadryl NNP B-NP O
, , O O
it PRP O O
gives VBZ O O
him PRP O O
the DT B-NP O
jitters NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
His PRP$ O O
medications NNS B-NP O
on IN B-VP O
admission NN B-NP O
are VBP O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
200 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
Procardia NNP I-NP B-m
XL NNP I-NP I-m
90 CD O B-do
mg NN B-NP O
q.d NN I-NP B-f
, , O O
Lipitor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
aspirin RB O B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
humulin NNP I-NP I-m
humulin NNP I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
32 CD O B-do
units NNS B-NP I-do
each DT B-NP B-f
morning NN I-NP I-f
and CC O O
18 CD O B-do
units NNS B-NP I-do
each DT O B-f
evening VBG O O
subcutaneously RB O B-mo
subcutaneously RB O B-mo
, , O O
Valium NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Minipress NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
His PRP$ O O
physical JJ B-NP O
examination NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
no DT B-NP O
varicosities NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
His PRP$ O O
laboratories NNS B-NP O
on IN B-VP O
admission NN B-NP O
included VBD B-VP O
BUN NNP B-NP O
of IN B-VP O
40 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
1.7 CD O O
His PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
6.5 CD O O
and CC O O
hematocrit NN B-NP O
was VBD B-VP O
35.0 CD O O
EKG NNP B-NP O
showed VBD B-VP O
sinus JJ B-NP O
rhythm NN I-NP O
with IN B-VP O
first JJ B-NP O
degree NN I-NP O
AV NNP I-NP O
block NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
, , O O
no DT B-NP O
active JJ I-NP O
disease NN I-NP O
PROCEDURE: NNP I-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
11/11/98 CD O O
where WRB O O
he PRP O O
underwent VBD B-VP O
harvesting NN B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
radial JJ I-NP O
artery NN I-NP O
for IN B-VP O
graft NN B-NP O
and CC O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
x NNP B-NP O
three CD O O
with IN B-VP O
a DT B-NP O
left JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
, , O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
from IN B-VP O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
to TO O O
the DT B-NP O
aorta NN I-NP O
and CC O O
a DT B-NP O
radial JJ I-NP O
artery NN I-NP O
from IN B-VP O
the DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
obtuse NN I-NP O
marginal JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
His PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
fever NN B-NP O
to TO O O
101 CD O O
on IN B-VP O
two CD O O
occasions NNS B-NP O
, , O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
was VBD B-VP O
5 CD O O
and CC O O
6 CD O O
respectively RB O O
His PRP$ O O
cultures NNS B-NP O
were VBD B-VP O
negative JJ O O
, , O O
sputum NN B-NP O
, , O O
blood NN B-NP O
, , O O
line NN B-NP O
tip NN I-NP O
and CC O O
chest VB O O
x-ray NN B-NP O
were VBD B-VP O
negative JJ O O
He PRP O O
had VBD B-VP O
, , O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
5 CD O O
, , O O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
rapid JJ B-NP B-r
rapid JJ I-NP B-r
rapid JJ I-NP B-r
atrial JJ I-NP I-r
atrial JJ I-NP I-r
atrial JJ I-NP I-r
flutter NN I-NP I-r
flutter NN I-NP I-r
flutter NN I-NP I-r
and CC O O
was VBD B-VP O
chemically RB O O
converted VBN O O
to TO O O
sinus VB O O
rhythm NN B-NP O
with IN B-VP O
Corvert NNP B-NP B-m
and CC O O
has VBZ O O
remained VBN O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
on IN B-VP O
Lopressor NNP B-NP B-m
and CC O O
diltiazem NN B-NP B-m
for IN B-VP B-du
for IN B-VP B-du
24 CD O I-du
24 CD O I-du
hours NNS B-NP I-du
hours NNS I-NP I-du
He PRP O O
will MD O O
be VB O O
discharged VBN O O
today NN B-NP O
, , O O
postoperative JJ B-NP O
day NN I-NP O
6 CD O O
, , O O
to TO O O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Carmen NNP I-NP O
E NNP I-NP O
Okray NNP I-NP O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications NNS I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
his PRP$ O O
saphenous JJ B-NP O
vein NN I-NP O
harvest JJS B-NP O
site NN I-NP O
showed VBD B-VP O
some DT B-NP O
slight JJ I-NP O
erythema NN I-NP B-r
to TO O O
be VB O O
treated VBN O O
with IN B-VP O
antibiotics NNS B-NP B-m
by IN B-VP B-mo
mouth NN B-NP I-mo
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
He PRP O O
is VBZ O O
discharged VBN O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications: NN I-NP O
Axid NNP I-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Lipitor NNP B-NP B-m
20 CD O B-do
mg NN B-NP O
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
Humulin NNP I-NP I-m
Humulin NNP I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
32 CD O B-do
Units NNS B-NP I-do
every DT B-NP B-f
morning NN I-NP I-f
, , O O
18 CD O B-do
Units NNS B-NP I-do
every DT B-NP B-f
evening; NN I-NP I-f
Diltiazem NNP I-NP B-m
60 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
enteric RB O B-m
coated VBD B-VP I-m
aspirin JJ O I-m
125 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Valium NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
four CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
for IN B-VP B-du
7 CD O I-du
days NNS B-NP I-du
, , O O
Percocet NNP B-NP B-m
1 CD O B-do
to TO O I-do
2 CD O I-do
tablets NNS B-NP I-do
every DT O B-f
four CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
Dictated NNP I-NP O
By: NNP I-NP O
MARCEL NNP I-NP O
MAZZILLO NNP I-NP O
, , O O
P.A NNP B-NP O
Attending: NNP I-NP O
FLORENCIO NNP I-NP O
J NNP I-NP O
WETZEL NNP I-NP O
, , O O
M.D NNP B-NP O
YX4 NNP I-NP O
HA126/7839 NNP I-NP O
Batch: NNP I-NP O
10482 CD O O
Index NNP B-NP O
No NNP I-NP O
BJBOUO06I3 NNP I-NP O
D: NNP I-NP O
5/18/98 CD O O
T: NNP B-NP O
8/21/98 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#817866 VBZ O O
546608017 CD O O
OWH NNP B-NP O
85716261 CD O O
046188 CD O O
7/12/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/16/1994 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/7/1994 CD O O
PRINCIPLE NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
BRADYARRHYTHMIA NNP B-NP O
SECONDARY NNP I-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
SYNCOPE NNP B-NP O
PROCEDURES: NNP I-NP O
Pacemaker NNP I-NP O
insertion NN I-NP O
, , O O
4 CD O O
of IN B-VP O
October NNP B-NP O
IDENTIFICATION: NNP I-NP O
Sixty NNP I-NP O
year NN I-NP O
old JJ B-NP O
black JJ I-NP O
female NN I-NP O
who WP O O
has VBZ O O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
dizziness NN B-NP O
and CC O O
syncope VB O O
The DT B-NP O
source NN I-NP O
of IN B-VP O
history NN B-NP O
was VBD B-VP O
the DT B-NP O
patient NN I-NP O
, , O O
who WP O O
was VBD B-VP O
a DT B-NP O
moderate JJ I-NP O
historian NN I-NP O
and CC O O
the DT B-NP O
old JJ I-NP O
chart JJ I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
According VBG O O
to TO O O
the DT B-NP O
patient NN I-NP O
, , O O
she PRP O O
first RB O O
presented VBD B-VP O
to TO O O
the DT B-NP O
medical JJ I-NP O
system NN I-NP O
in IN B-VP O
1989 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
she PRP O O
was VBD B-VP O
walking VBG O O
at IN B-VP O
home NN B-NP O
and CC O O
became VBD B-VP O
dizzy JJ O O
She PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
Meeville NNP B-NP O
Valley NNP I-NP O
Health NNP I-NP O
in IN B-VP O
Rhode NNP B-NP O
Island NNP I-NP O
She PRP O O
was VBD B-VP O
told VBN O O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
heart NN I-NP O
attack NN I-NP O
and CC O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
monitor NN I-NP O
when WRB O O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
asystole NN B-NP O
on IN B-VP O
the DT B-NP O
monitor NN I-NP O
This DT O O
led VBD B-VP O
to TO O O
emergent VB O O
pacer NN B-NP O
insertion NN I-NP O
After IN B-VP O
pacer NN B-NP O
placement NN I-NP O
, , O O
the DT B-NP O
dizziness NN I-NP O
never RB O O
recurred VBN O O
until IN B-VP O
a DT B-NP O
few JJ I-NP O
months NNS I-NP O
ago IN B-VP O
This DT O O
led VBN O O
to TO O O
hospitalization NN B-NP O
on IN B-VP O
March NNP B-NP O
, , O O
1994 CD O O
at IN B-VP O
Xas*tu NNP B-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
pacer NN I-NP O
service NN I-NP O
who WP O O
interrogated VBD B-VP O
her PRP$ O O
pacer NN B-NP O
and CC O O
found VBD B-VP O
it PRP O O
functioning VBG O O
normally RB O O
However RB O O
, , O O
the DT B-NP O
pacer NN I-NP O
lead NN I-NP O
type NN I-NP O
( ( O O
MECHRONIC NNP B-NP O
4012 CD O O
) ) O O
is VBZ O O
felt VBN O O
to TO O O
have VB O O
a DT B-NP O
high JJ I-NP O
failure NN I-NP O
rate NN I-NP O
, , O O
necessitating VBG O O
a DT B-NP O
new JJ I-NP O
pacer NN I-NP O
insertion NN I-NP O
Unfortunately RB O O
, , O O
the DT B-NP O
patient NN I-NP O
left VBD B-VP O
AMA NNP B-NP O
before IN B-VP O
the DT B-NP O
procedure NN I-NP O
could MD O O
be VB O O
performed VBN O O
Today NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
got VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
and CC O O
preceded VBD B-VP O
to TO O O
the DT B-NP O
bathroom NN I-NP O
, , O O
where WRB O O
she PRP O O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
bowel NN I-NP O
movement NN I-NP O
without IN B-VP O
any DT B-NP O
symptoms NNS I-NP O
She PRP O O
got VBD B-VP O
up RB O O
from IN B-VP O
the DT B-NP O
toilet NN I-NP O
and CC O O
while IN B-VP O
walking VBG O O
back RB O O
to TO O O
bed NN B-NP O
became VBD B-VP O
dizzy RB O O
again RB O O
She PRP O O
subsequently RB O O
passed VBD B-VP O
out RP O O
for IN B-VP O
an DT B-NP O
undetermined JJ I-NP O
time NN I-NP O
After IN B-VP O
waking VBG O O
up RP O O
she PRP O O
knew VBD B-VP O
exactly RB O O
where WRB O O
she PRP O O
was VBD B-VP O
and CC O O
had VBD B-VP O
no DT B-NP O
post-ictal JJ I-NP O
symptoms NNS I-NP O
She PRP O O
fell VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
but CC O O
denies VBZ O O
any DT B-NP O
trauma NN I-NP O
She PRP O O
also RB O O
denied VBD B-VP O
urinary/fecal JJ B-NP O
incontinence NN I-NP O
during IN B-VP O
this DT B-NP O
episode NN I-NP O
She PRP O O
adamantly RB O O
denies VBZ O O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
significant JJ B-NP O
palpitations NNS I-NP O
She PRP O O
presented VBD B-VP O
today NN B-NP O
to TO O O
the DT B-NP O
ER NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
Medications NNS I-NP O
on IN B-VP O
admission NN B-NP O
- : O O
None NN B-NP O
No DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
None NNP I-NP O
HABITS: NNP I-NP O
No NNP I-NP O
tobacco NN I-NP O
, , O O
no DT B-NP O
alcohol NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Unemployed NNP I-NP O
, , O O
divorced VBD B-VP O
, , O O
mother NN B-NP O
of IN B-VP O
six CD O O
children NNS B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Positive NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
No NNP I-NP O
seizure NN I-NP O
disorder NN I-NP O
in IN B-VP O
the DT B-NP O
family NN I-NP O
and CC O O
her PRP$ O O
mother NN B-NP O
and CC O O
two CD O O
aunts NNS B-NP O
have VBP O O
pacemakers NNS B-NP O
inserted VBN O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Admission NNP I-NP O
- : O O
Morbidly RB O O
obese JJ B-NP O
black JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
without IN B-VP O
complaints NNS B-NP O
presently RB O O
T NNP B-NP O
98.3 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
lying VBG O O
down RB O O
120/80 CD O O
, , O O
sitting VBG O O
up RP O O
133/82 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
lying VBG O O
down RP O O
72 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
sitting VBG O O
up RP O O
80 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
is VBZ O O
16 CD O O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
is VBZ O O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
HEENT NNP I-NP O
- : O O
Anicteric JJ B-NP O
Clear JJ I-NP O
oropharynx NN I-NP O
Neck NNP I-NP O
is VBZ O O
supple JJ B-NP O
Lungs NNS I-NP O
are VBP O O
clear JJ B-NP O
Back NNP I-NP O
- : O O
Without IN B-VP O
spinal JJ O O
or CC O O
cvat JJ B-NP O
Cardiovascular NNP I-NP O
- : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
No NNP I-NP O
jugular NN I-NP O
venous JJ B-NP O
distention NN I-NP O
Normal NNP I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
Carotids NNP I-NP O
with IN B-VP O
normal JJ B-NP O
upstrokes NNS I-NP O
and CC O O
no DT B-NP O
bruits NNS I-NP O
Abdomen NNP I-NP O
- : O O
Positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
obese JJ O O
, , O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
no DT B-NP O
organomegaly NN I-NP O
Extremities NNP I-NP O
- : O O
No DT O O
pitting VBG O O
edema RB O O
2+ CD O O
radial JJ O O
and CC O O
DP NNP B-NP O
pulses VBZ O O
bilaterally RB O O
Neuro NNP B-NP O
- : O O
Alert NN B-NP O
and CC O O
oriented VBN O O
times NNS B-NP O
three CD O O
Cranial JJ B-NP O
nerves NNS I-NP O
III-XII NNP I-NP O
are VBP O O
tested VBN O O
and CC O O
are VBP O O
intact JJ B-NP O
Sensation NNP I-NP O
is VBZ O O
grossly RB O O
intact JJ B-NP O
Motor NNP I-NP O
strength NN I-NP O
- : O O
Normal JJ B-NP O
gait NN I-NP O
, , O O
not RB O O
tested VBN O O
Reflexes NNP B-NP O
are VBP O O
1-2+ JJ B-NP O
patella NN I-NP O
and CC O O
biceps NN B-NP O
reflexes NNS I-NP O
, , O O
symmetrically RB O O
LABORATORY NNP B-NP O
DATA: NNP I-NP O
K NNP I-NP O
3.9 CD O O
, , O O
mag FW O O
2.1 CD O O
, , O O
Hematocrit NNP B-NP O
38.9 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
is VBZ O O
negative JJ B-NP O
Costophrenic JJ I-NP O
angles NNS I-NP O
were VBD B-VP O
not RB O O
visualized VBN O O
well RB O O
secondary JJ O O
to TO O O
her PRP$ O O
large JJ B-NP O
habitus NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
72 CD O O
, , O O
first RB O O
degree JJ B-NP O
AV NNP I-NP O
block NN I-NP O
, , O O
PR NNP B-NP O
interval NN I-NP O
of IN B-VP O
0.30 CD O O
, , O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
unit NN I-NP O
Her NNP I-NP O
story NN I-NP O
was VBD B-VP O
most RBS O O
consistent JJ O O
with IN B-VP O
an DT B-NP O
arrhythmia NN I-NP O
induced VBD B-VP O
syncope NN B-NP O
Considering VBG O O
her PRP$ O O
history NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
she PRP O O
certainly RB O O
had VBD B-VP O
a DT B-NP O
symptomatic JJ I-NP O
bradycardic NN I-NP O
episode NN I-NP O
Because IN B-VP O
her PRP$ O O
current JJ B-NP O
pacemaker NN I-NP O
had VBD B-VP O
a DT O O
very RB O O
high JJ B-NP O
failure NN I-NP O
rate NN I-NP O
, , O O
we PRP O O
recommended VBD B-VP O
changing VBG O O
the DT B-NP O
pacemaker NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
agreed VBD B-VP O
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
monitor NN I-NP O
without IN B-VP O
any DT B-NP O
event NN I-NP O
over IN B-VP O
her PRP$ O O
hospital JJ B-NP O
stay NN I-NP O
As IN B-VP O
part NN B-NP O
of IN B-VP O
her PRP$ O O
prepacer NN B-NP O
work-up NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
venogram NN I-NP O
which WDT O O
showed VBD B-VP O
patent NN B-NP O
vessels NNS I-NP O
on IN B-VP O
that DT B-NP O
side NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
pacemaker NN I-NP O
insertedon VBZ O O
4 CD O O
of IN B-VP O
October NNP B-NP O
in IN B-VP O
the DT B-NP O
OR NNP I-NP O
without IN B-VP O
any DT B-NP O
complications NNS I-NP O
The DT B-NP O
reason NN I-NP O
it PRP O O
was VBD B-VP O
done VBN O O
in IN B-VP O
the DT B-NP O
OR NNP I-NP O
was VBD B-VP O
because IN B-VP O
of IN B-VP O
her PRP$ O O
large JJ B-NP O
size NN I-NP O
and CC O O
the DT B-NP O
strength NN I-NP O
of IN B-VP O
the DT B-NP O
table NN I-NP O
After IN B-VP O
pacer NN B-NP O
insertion NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
very RB O O
well RB O O
without IN B-VP O
any DT B-NP O
further JJ I-NP O
symptoms NNS I-NP O
of IN B-VP O
dizziness NN B-NP O
or CC O O
syncope NN B-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
DISPOSITION: NNP I-NP O
Discharge NNP I-NP O
medications NNS I-NP O
- : O O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
q8h NN I-NP B-f
for IN B-VP B-du
nine CD O O
doses NNS B-NP O
, , O O
Percocet NNP B-NP B-m
1-2 CD O B-do
p.o NN B-NP B-mo
q6h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
Follow-up NNP I-NP O
will MD O O
be VB O O
in IN B-VP O
the DT B-NP O
Pacemaker NNP I-NP O
Clinic NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
KASEY NNP I-NP O
NAVEED NNP I-NP O
, , O O
M.D NNP B-NP O
HE93 NNP I-NP O
Attending: NNP I-NP O
WELDON NNP I-NP O
S NNP I-NP O
HERSHFIELD NNP I-NP O
, , O O
M.D NNP B-NP O
VT22 NNP I-NP O
CY954/3795 NNP I-NP O
Batch: NNP I-NP O
014 CD O O
Index NNP B-NP O
No NNP I-NP O
EQSO6P28BC NNP I-NP O
D: NNP I-NP O
6/26/94 CD O O
T: NNP B-NP O
6/26/94 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#818404 VBZ O O
514414960 CD O O
OCMH NNP B-NP O
44300452 CD O O
439016 CD O O
7/26/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
, , O O
HIP NNP B-NP O
FRACTURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/5/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/14/2002 CD O O
ADMISSION NNP B-NP O
DIAGNOSIS: NNP I-NP O
LEFT NNP I-NP O
HIP NNP I-NP O
FRACTURE NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
FAT NNP B-NP O
EMBOLI NNP I-NP O
SYNDROME NNP I-NP O
2 CD O O
CONGESTIVE NNP B-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
3 CD O O
DECUBITUS NNP B-NP O
ULCERS NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Lumadue NNP I-NP O
is VBZ O O
a DT B-NP O
68-year-old JJ I-NP O
man NN I-NP O
who WP O O
came VBD B-VP O
in IN B-VP O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
hip NN B-NP O
pain NN I-NP O
after IN B-VP O
a DT B-NP O
mechanical JJ I-NP O
fall NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
hospitalized VBN O O
in IN B-VP O
3/0 CD O O
for IN B-VP O
ischemic JJ B-NP O
right NN I-NP O
toes NNS I-NP O
requiring VBG O O
debridement NN B-NP O
and CC O O
amputation NN B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
his PRP$ O O
hospital JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
a DT B-NP O
non-Q JJ I-NP B-r
wave NN I-NP O
MI NNP I-NP O
Cardiology NNP I-NP O
have VBP O O
recommended VBN O O
medical JJ B-NP O
management NN I-NP O
with IN B-VP O
Lopressor NNP B-NP B-m
at IN B-VP O
that DT B-NP O
time NN I-NP O
and CC O O
an DT B-NP O
echocardiogram NN I-NP O
revealed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
45% CD O O
Dobutamine NNP B-NP B-m
MIBI NNP I-NP O
revealed VBD B-VP O
a DT O O
severe JJ O O
fixed VBN O O
perfusion NN B-NP O
defect NN I-NP O
in IN B-VP O
the DT B-NP O
inferoposterior NN I-NP O
and CC O O
inferoseptal JJ O O
left VBD B-VP O
ventricle NN B-NP O
without IN B-VP O
any DT B-NP O
peri-infarct JJ I-NP O
ischemia NN I-NP O
Ejection NNP I-NP O
fraction NN I-NP O
by IN B-VP O
MIBI NNP B-NP O
imaging NN I-NP O
was VBD B-VP O
26% CD O O
in IN B-VP O
contrast NN B-NP O
to TO O O
the DT B-NP O
echo JJ I-NP O
results NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
ultimately RB O O
discharged VBN O O
on IN B-VP O
Lopressor NNP B-NP B-m
, , O O
however RB O O
, , O O
she PRP O O
stopped VBD B-VP O
taking VBG O O
the DT B-NP O
Lopressor NNP I-NP B-m
for IN B-VP O
unclear JJ B-NP O
reasons NNS I-NP O
For IN B-VP O
the DT B-NP O
few JJ I-NP O
months NNS I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
he PRP O O
developed VBD B-VP O
increasing VBG O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
with IN B-VP O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
and CC O O
increasing VBG O O
pedal JJ B-NP O
edema NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
nocturia NNS B-NP O
, , O O
however RB O O
, , O O
denied VBD B-VP O
any DT B-NP O
orthopnea NN I-NP O
, , O O
any DT B-NP O
chest JJS I-NP O
pain NN I-NP O
, , O O
fevers NNS B-NP O
, , O O
melena NN B-NP O
, , O O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
or CC O O
palpitations NNS B-NP O
A NNP I-NP O
few JJ B-NP O
days NNS I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
developed VBD B-VP O
a DT B-NP O
dry JJ I-NP O
cough NN I-NP O
and CC O O
some DT B-NP O
rhinorrhea NN I-NP O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
sustained VBD B-VP O
a DT B-NP O
mechanical JJ I-NP O
fall NN I-NP O
while IN B-VP O
trying VBG O O
to TO O O
retrieve VB O O
a DT B-NP O
newspaper NN I-NP O
He PRP O O
had VBD B-VP O
no DT O O
light-headedness JJ O O
, , O O
palpitations NNS B-NP O
, , O O
pain NN B-NP O
in IN B-VP O
his PRP$ O O
chest NN B-NP O
, , O O
nausea NN B-NP O
or CC O O
vomiting NN B-NP O
, , O O
sweating VBG O O
or CC O O
change NN B-NP O
in IN B-VP O
vision NN B-NP O
or CC O O
sensory NN B-NP O
symptoms NNS I-NP O
prior RB O O
to TO O O
or CC O O
after IN B-VP O
the DT B-NP O
fall NN I-NP O
The DT B-NP O
patient NN I-NP O
fell VBD B-VP O
onto IN B-VP O
his PRP$ O O
left JJ B-NP O
side NN I-NP O
and CC O O
immediately RB O O
developed VBD B-VP O
left-sided JJ B-NP O
leg NN I-NP O
and CC O O
hip NN B-NP O
pain NN I-NP O
for IN B-VP O
which WDT O O
she PRP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
at IN B-VP O
Fentstraub NNP B-NP O
Neycian's NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
cardiomyopathy NN B-NP O
( ( O O
ischemic JJ O O
) ) O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
amputation NN I-NP O
of IN B-VP O
right-sided JJ B-NP O
toes NNS I-NP O
, , O O
status NN B-NP O
post NN I-NP O
right RB O O
femoral JJ O O
to TO O O
PT NNP B-NP O
avascularization NN I-NP O
, , O O
diabetes VBZ O O
type JJ B-NP O
II NNP I-NP O
, , O O
status NN B-NP O
post NN I-NP O
CVA NNP I-NP O
, , O O
hypertension NN B-NP O
MEDICATIONS: NNP I-NP O
HCTZ NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Zestril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
glyburide RB O B-m
5 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
multivitamins NNS B-NP B-m
, , O O
cough JJ B-NP B-m
medicine NN I-NP I-m
p.r.n NN I-NP B-f
ALLERGIES: NNP I-NP O
Aminoglycosides NNP I-NP O
, , O O
unknown JJ B-NP O
reaction NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
smoking VBG O O
one CD O O
pack NN B-NP O
per IN B-VP O
day NN B-NP O
x40 CD O O
years NNS B-NP O
, , O O
quit RB O O
five CD O O
years NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
He PRP O O
has VBZ O O
one CD O O
drink NN B-NP O
of IN B-VP O
liquor NN B-NP O
per IN B-VP O
day NN B-NP O
, , O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
alone RB O O
in IN B-VP O
Targtine NNP B-NP O
Highway NNP I-NP O
, , O O
Birm NNP B-NP O
, , O O
Vermont NNP B-NP O
21711 CD O O
, , O O
and CC O O
is VBZ O O
in IN B-VP O
the DT B-NP O
insurance NN I-NP O
business NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
mother NN B-NP O
died VBD B-VP O
of IN B-VP O
cancer NN B-NP O
at IN B-VP O
74 CD O O
Father NNP B-NP O
died VBD B-VP O
at IN B-VP O
55 CD O O
of IN B-VP O
heart NN B-NP O
disease NN I-NP O
Mother NNP I-NP O
died VBD B-VP O
at IN B-VP O
50 CD O O
of IN B-VP O
a DT B-NP O
heart NN I-NP O
attack NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
VITAL NNP I-NP O
SIGNS: NNP I-NP O
Afebrile NNP I-NP O
, , O O
temperature NN B-NP O
97.3 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
106 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
162/77 CD O O
, , O O
oxygenation NN B-NP O
94% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
GENERAL: NNP I-NP O
He PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented JJ B-NP O
LUNGS: NNP I-NP O
Clear NNP I-NP O
HEART: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
PELVIS: NNP I-NP O
Stable NNP I-NP O
His PRP$ O O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
had VBD B-VP O
well-healed JJ B-NP O
scars NNS I-NP O
from IN B-VP O
donor JJ B-NP O
site NN I-NP O
for IN B-VP O
bypass NN B-NP O
grafting NN I-NP O
, , O O
strong JJ B-NP O
dopplerable JJ I-NP O
PT NNP I-NP O
and CC O O
DP NNP B-NP O
pulses VBZ O O
His PRP$ O O
left JJ B-NP O
leg NN I-NP O
was VBD B-VP O
externally RB O O
rotated JJ B-NP O
Sensation NNP I-NP O
was VBD B-VP O
intact JJ O O
to TO O O
light JJ B-NP O
touch JJ I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
135 CD O O
, , O O
potassium NN B-NP O
4.4 CD O O
, , O O
chloride RB O O
102 CD O O
, , O O
bicarb NN B-NP O
19 CD O O
, , O O
BUN NNP B-NP O
56 CD O O
, , O O
creatinine NN B-NP O
2.5 CD O O
White NNP B-NP O
count NN I-NP O
12 CD O O
, , O O
hematocrit NN B-NP O
33 CD O O
, , O O
platelets NNS B-NP O
388 CD O O
PTT NNP B-NP O
40.5 CD O O
, , O O
INR NNP B-NP O
1.2 CD O O
EKG NNP B-NP O
showed VBD B-VP O
sinus JJ B-NP O
tach NN I-NP O
at IN B-VP O
102 CD O O
, , O O
with IN B-VP O
occasional JJ B-NP O
PVCs NNP I-NP O
, , O O
normal JJ B-NP O
axis NN I-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia JJ B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
bilateral JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
X-rays NNS I-NP O
of IN B-VP O
his PRP$ O O
left JJ B-NP O
pelvis NN I-NP O
and CC O O
femur NN B-NP O
revealed VBD B-VP O
fracture NN B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
intertrochanter NN I-NP O
and CC O O
subtrochanteric JJ B-NP O
fracture NN I-NP O
with IN B-VP O
lesser JJR B-NP O
trochanteric JJ I-NP O
fracture NN I-NP O
intact JJ O O
by IN B-VP O
3 CD O O
cm NNS B-NP O
, , O O
less JJR O O
than IN B-VP O
five CD O O
degrees NNS B-NP O
angulation NN I-NP O
His PRP$ O O
femoral JJ B-NP O
head NN I-NP O
was VBD B-VP O
reduced VBN O O
IMPRESSION: NNP B-NP O
A NNP I-NP O
68-year-old JJ B-NP O
man NN I-NP O
with IN B-VP O
significant JJ B-NP O
cardiac JJ I-NP O
history NN I-NP O
and CC O O
vascular JJ B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
hip JJ B-NP O
fracture NN I-NP O
with IN B-VP O
mechanical JJ B-NP O
fall NN I-NP O
, , O O
with IN B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
noted VBD B-VP O
on IN B-VP O
chest JJS B-NP O
x-ray JJ I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Cardiovascular NNP B-NP O
- : O O
Initially RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
to TO O O
be VB O O
admitted VBN O O
to TO O O
the DT B-NP O
orthopedic JJ I-NP O
service NN I-NP O
with IN B-VP O
medicine NN B-NP O
consult NN I-NP O
for IN B-VP O
wrist NN B-NP O
stratification NN I-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
medicine NN I-NP O
service NN I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
and CC O O
management NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
troponin NN I-NP O
leak NN I-NP O
although IN B-VP O
CK NNP B-NP O
enzymes NNS I-NP O
remained VBD B-VP O
negative JJ O O
for IN B-VP O
ischemia NN B-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
MIBI NNP I-NP O
performed VBD B-VP O
which WDT O O
revealed VBD B-VP O
an DT B-NP O
unchanged JJ I-NP O
fixed JJ I-NP O
defect NN I-NP O
He PRP O O
remained VBD B-VP O
in IN B-VP O
sinus JJ B-NP O
tach NN I-NP O
with IN B-VP O
occasional JJ B-NP O
PVCs NNP I-NP O
and CC O O
runs NNS B-NP O
of IN B-VP O
nonsustained JJ B-NP O
ventricular JJ I-NP O
tachycardia NN I-NP O
lasting VBG O O
3-4 JJ B-NP O
beats NNS I-NP O
at IN B-VP O
a DT B-NP O
time NN I-NP O
throughout IN B-VP O
his PRP$ O O
admission NN B-NP O
Sinus NNP I-NP O
tach NN I-NP O
was VBD B-VP O
attributed VBN O O
pain NN B-NP O
and CC O O
discomfort NN B-NP O
, , O O
possibly RB O O
with IN B-VP O
element NN B-NP O
of IN B-VP O
hypoxia NN B-NP O
contributing NN I-NP O
as RB O O
well RB O O
A NNP B-NP O
troponin NN I-NP O
leak NN I-NP O
was VBD B-VP O
attributed VBN O O
to TO O O
strain VB O O
particularly RB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
tachycardia JJ B-NP B-r
tachycardia NN I-NP B-r
tachycardia NN I-NP B-r
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
beta NN B-NP B-m
blocker NN I-NP I-m
, , O O
Ace NNP B-NP B-m
inhibitor NN I-NP I-m
and CC O O
continued VBD B-VP O
on IN B-VP O
an DT B-NP O
aspirin NN I-NP B-m
He PRP O O
was VBD B-VP O
aggressively RB O O
diuresed VBN O O
with IN B-VP O
afterload NN B-NP O
reduction NN I-NP O
He PRP O O
was VBD B-VP O
titrated VBN O O
upward RB O O
as IN B-VP O
noted JJ O O
2 CD O O
Pulmonary NNP B-NP O
- : O O
The DT B-NP O
patient's NN I-NP O
crackles NNS I-NP O
persisted VBN O O
on IN B-VP O
lung NN B-NP O
exam NN I-NP O
after IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
, , O O
prompting VBG O O
performance NN B-NP O
of IN B-VP O
a DT B-NP O
chest NN I-NP O
CT NNP I-NP O
which WDT O O
revealed VBD B-VP O
an DT B-NP O
interstitial JJ I-NP O
pattern NN I-NP O
with IN B-VP O
peripheral JJ B-NP O
nodularity NN I-NP O
consistent NN I-NP O
with IN B-VP O
fat JJ B-NP O
emboli JJ I-NP O
syndrome NN I-NP O
, , O O
positive JJ B-NP O
component NN I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
aspiration NN B-NP O
pneumonia NN I-NP O
as RB O O
well RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
a DT B-NP O
regimen NN I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
for IN B-VP O
diuresis NN B-NP O
and CC O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
aspiration NN B-NP B-r
pneumonia NN I-NP I-r
as IN B-VP O
noted VBN O O
below IN B-VP O
His PRP$ O O
oxygen NN B-NP O
requirement NN I-NP O
diminished VBD B-VP O
over IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
and CC O O
he PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
two CD O B-do
liters NNS B-NP O
of IN B-VP O
nasal JJ B-NP B-mo
cannula NN I-NP I-mo
oxygen NN I-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
to TO O O
rehab VB O O
3 CD O O
Renal NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
developed VBD B-VP O
some DT B-NP O
renal JJ I-NP O
failure NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
diuresis NN B-NP O
, , O O
which WDT O O
improved VBD B-VP O
with IN B-VP O
hydration NN B-NP O
The DT B-NP O
patient NN I-NP O
subsequently RB O O
tolerated VBD B-VP O
further JJ B-NP O
diuresis NN I-NP O
with IN B-VP O
improvement NN B-NP O
in IN B-VP O
his PRP$ O O
creatinine NN B-NP O
and CC O O
it PRP O O
is VBZ O O
possible JJ O O
that IN B-VP O
renal JJ B-NP O
failure NN I-NP O
is VBZ O O
due JJ O O
to TO O O
fat VB O O
emboli JJ B-NP O
syndrome NN I-NP O
as IN B-VP O
well RB O O
and CC O O
should MD O O
improve VB O O
slowly RB O O
4 CD O O
ID NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
vancomycin NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
and CC O O
levofloxacin NN B-NP B-m
for IN B-VP O
presumed VBN O B-r
presumed JJ B-NP B-r
presumed JJ I-NP B-r
aspiration NN I-NP I-r
aspiration NN I-NP I-r
aspiration NN I-NP I-r
pneumonia NN I-NP I-r
pneumonia NN I-NP I-r
pneumonia NN I-NP I-r
, , O O
course NN B-NP O
completed VBD B-VP O
5/6/02 CD O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
afebrile IN B-VP O
His PRP$ O O
white JJ B-NP O
blood NN I-NP O
count NN I-NP O
on IN B-VP O
admission NN B-NP O
and CC O O
discharge NN B-NP O
was VBD B-VP O
12 CD O O
5 CD O O
Neurologically RB O O
- : O O
The DT B-NP O
patient NN I-NP O
apparently RB O O
had VBD B-VP O
baseline JJ B-NP O
mild JJ I-NP O
perfusion NN I-NP O
The DT O O
possibly RB O O
worsened VBN O O
due JJ O O
to TO O O
the DT B-NP O
fat JJ I-NP O
embolic JJ I-NP O
syndrome NN I-NP O
and CC O O
was VBD B-VP O
at IN B-VP O
baseline JJ B-NP O
prior NN I-NP O
to TO O O
discharge VB O O
per IN B-VP O
the DT B-NP O
patient's NN I-NP O
daughter NN I-NP O
6 CD O O
Heme NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Lovenox NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
subcu NN I-NP B-mo
b.i.d NN I-NP B-f
for IN B-VP O
prophylaxis NN B-NP B-r
against IN B-VP I-r
DVT NNP B-NP I-r
post-hip NN I-NP I-r
surgery NN I-NP I-r
to TO O O
continue VB O O
for IN B-VP B-du
six CD O O
months NNS B-NP O
minimal JJ O O
followed VBN O O
by IN B-VP O
orthopedic JJ B-NP O
surgery NN I-NP O
7 CD O O
GI NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
developed VBD B-VP O
some DT B-NP O
diarrhea NNS I-NP O
C NNP I-NP O
diff NN I-NP O
cultures NNS I-NP O
were VBD B-VP O
negative JJ O O
to TO O O
date NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
Nexium NNP B-NP B-m
prophylaxis NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
anticoagulation NN B-NP O
8 CD O O
Endocrine NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
oral JJ B-NP B-mo
hypoglycemics NNS I-NP B-m
prior RB O O
to TO O O
discharge VB O O
in IN B-VP O
addition NN B-NP O
to TO O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
Foley NNP I-NP O
and CC O O
a DT B-NP O
triple JJ I-NP O
lumen NNS I-NP O
catheter NN I-NP O
, , O O
both DT O O
of IN B-VP O
which WDT O O
were VBD B-VP O
removed VBN O O
on IN B-VP O
5/6/02 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
plastic NN B-NP O
surgery NN I-NP O
for IN B-VP O
his PRP$ O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
with IN B-VP O
ulcers NNS B-NP O
Recommended NNP I-NP O
dry NN I-NP O
sterile NN I-NP O
dressings NNS I-NP O
to TO O O
the DT B-NP O
right NN I-NP O
and CC O O
left VBD B-VP O
foot NN B-NP O
wound NN I-NP O
changed VBD B-VP O
q.d NN B-NP O
with IN B-VP O
DuoDerm NNP B-NP O
to TO O O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
leg NN I-NP O
wound NN I-NP O
to TO O O
be VB O O
changed VBN O O
q.3 JJ B-NP O
days NNS I-NP O
, , O O
with IN B-VP O
pressure NN B-NP O
sore NN I-NP O
prevention NN I-NP O
9 CD O O
FEN NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
standing VBG O O
20 CD O B-do
mEq NN B-NP I-do
of IN B-VP O
K-Dur NNP B-NP B-m
q.d NN I-NP B-f
It PRP O O
is VBZ O O
likely JJ O O
to TO O O
be VB O O
checked VBN O O
q.o.d JJ O O
to TO O O
monitor VB O O
for IN B-VP O
any DT B-NP O
further JJ I-NP O
requirements NNS I-NP O
particularly RB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
runs NNS B-NP O
of IN B-VP O
nonsustained JJ B-NP O
V-tach NNP I-NP O
as IN B-VP O
noted VBN O O
above IN B-VP O
10 CD O O
Ortho NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
followed VBN O O
daily JJ O O
by IN B-VP O
orthopedic JJ B-NP O
surgery NN I-NP O
and CC O O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
staples NNS B-NP O
on IN B-VP O
his PRP$ O O
left JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
to TO O O
be VB O O
discontinued VBN O O
per IN B-VP O
orthopedic NN B-NP O
surgery NN I-NP O
recommendations NNS I-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
11 CD O O
Disposition NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
stable JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
rehab VB O O
on IN B-VP O
8/18/02 CD O O
He PRP O O
was VBD B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
orthopedic JJ B-NP O
surgery NN I-NP O
, , O O
cardiology NN B-NP O
, , O O
and CC O O
pulmonary JJ B-NP O
medicine NN I-NP O
within IN B-VP O
the DT O O
next JJ O O
two CD O O
weeks NNS B-NP O
His PRP$ O O
labs NNS B-NP O
are VBP O O
to TO O O
be VB O O
drawn VBN O O
for IN B-VP O
a DT B-NP O
metabolic JJ I-NP O
panel NN I-NP O
, , O O
magnesium NN B-NP O
and CC O O
calcium NN B-NP O
q.o.d NN I-NP O
for IN B-VP O
as RB O O
long RB O O
as IN B-VP O
the DT B-NP O
primary JJ I-NP O
care NN I-NP O
physician JJ B-NP O
feels NNS I-NP O
it PRP O O
is VBZ O O
necessary JJ O O
with IN B-VP O
repletion NN B-NP O
of IN B-VP O
his PRP$ O O
electrolytes NNS B-NP O
as IN B-VP O
needed VBN O O
He PRP O O
is VBZ O O
to TO O O
have VB O O
physical JJ B-NP O
therapy NN I-NP O
performed VBD B-VP O
as IN B-VP O
needed VBN O O
His PRP$ O O
weightbearing NN B-NP O
status NN I-NP O
is VBZ O O
non-weightbearing VBG O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
and CC O O
weightbearing NN B-NP O
as RB O O
tolerated VBN O O
on IN B-VP O
his PRP$ O O
right NN B-NP O
lower JJR B-NP O
extremity NN I-NP O
per IN B-VP O
orthopedic JJ B-NP O
surgery NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
DISCHARGE NNP I-NP O
DIET: NNP I-NP O
ADA NNP I-NP O
diet JJ O O
, , O O
low JJ B-NP O
fat NN I-NP O
, , O O
low JJ B-NP O
cholesterol NN I-NP O
, , O O
low JJ B-NP O
salt NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric-coated NNP I-NP B-m
aspirin VBZ O I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
hold NN B-NP O
for IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
less JJR O O
than IN B-VP O
100 CD O O
or CC O O
heart NN B-NP O
rate NN I-NP O
less JJR O O
than IN B-VP O
55 CD O O
, , O O
lisinopril VBD B-VP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
hold NN B-NP O
for IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
less JJR O O
than IN B-VP O
100 CD O O
, , O O
Lasix NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lovenox NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
subcu NN I-NP B-mo
b.i.d NN I-NP B-f
x6 NNP I-NP B-du
months NNS I-NP O
, , O O
glipizide RB O B-m
2.5 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Silvadene NNP B-NP B-m
wet-to-dry JJ B-NP O
dressing NN I-NP O
, , O O
please VB O O
appy JJ B-NP O
dry JJ I-NP O
sterile NN I-NP O
dressing VBG O O
to TO O O
right VB O O
and CC O O
left JJ B-NP O
foot NN I-NP B-r
wound NN I-NP I-r
to TO O O
change VB O O
q.d RB O B-f
Apply NNP B-NP O
DuoDerm NNP I-NP B-m
to TO O O
left VB O O
lower JJR B-NP O
leg NN I-NP B-r
wound NN I-NP I-r
and CC O O
change NN B-NP O
q.3 NN I-NP B-f
days NNS I-NP I-f
, , O O
continue VBP O O
pressure NN B-NP O
care NN I-NP O
precautions NNS I-NP O
Dictated VBD B-VP O
By: NNP B-NP O
EVAN NNP I-NP O
HOBLIT NNP I-NP O
, , O O
M.D NNP B-NP O
XJ782 NNP I-NP O
Attending: NNP I-NP O
ENOCH NNP I-NP O
HADDAWAY NNP I-NP O
, , O O
M.D NNP B-NP O
FV88 NNP I-NP O
SJ564/025538 NNP I-NP O
Batch: NNP I-NP O
3727 CD O O
Index NNP B-NP O
No NNP I-NP O
WICEEC84U0 NNP I-NP O
D: NNP I-NP O
6/12/02 CD O O
T: NNP B-NP O
6/12/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#818884 VBZ O O
571742072 CD O O
MMC NNP B-NP O
97450845 CD O O
891607 CD O O
1/7/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/30/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/10/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
UMBAUGH NNP I-NP O
, , O O
ARRON NNP B-NP O
327-41-37-5 CD O O
none NN B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/23/01 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
MCQUILLEN NNP I-NP O
, , O O
GIOVANNI NNP B-NP O
ARCHIE NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ASA NNP I-NP B-m
( ( O I-m
ACETYLSALICYLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/23/01 CD O O
by IN B-VP O
DELAGOL NNP B-NP O
, , O O
WILTON NNP B-NP O
HUGO NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
29560859 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/26/01 CD O O
by IN B-VP O
MIRAMON NNP B-NP O
, , O O
LOREN NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
13666204 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
ATENOLOL NNP B-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
1/24 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
60 CD O O
MG NNP B-NP O
PO NNP I-NP B-mo
QD NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
1/24 CD O O
) ) O O
Instructions: NNP B-NP O
Take NNP I-NP O
60mg CD O B-do
per IN B-VP O
day NN B-NP O
for IN B-VP B-du
3 CD O I-du
days NNS B-NP I-du
and CC O O
then RB O O
change NN B-NP O
dose NN I-NP O
as IN B-VP O
per IN B-VP O
Dr NNP B-NP O
Paul NNP I-NP O
Ciesiolka NNP I-NP O
instructions NNS I-NP O
ZESTRIL NNP I-NP B-m
( ( O I-m
LISINOPRIL NNP B-NP I-m
) ) O I-m
7.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
1/24 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/26/01 CD O O
by IN B-VP O
ANGERER NNP B-NP O
, , O O
KENNITH NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
85723815 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/26/01 CD O O
by IN B-VP O
SHALA NNP B-NP O
, , O O
LEONARDO NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
68279429 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
COUMADIN NNP B-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
6 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/23/01 CD O O
by IN B-VP O
CAPAS NNP B-NP O
, , O O
FREDERIC NNP B-NP O
NEVILLE NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ZOCOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
88249805 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/26/01 CD O O
by IN B-VP O
SERUM NNP B-NP O
, , O O
ALAN NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ZOCOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
58803531 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/26/01 CD O O
by IN B-VP O
AGAN NNP B-NP O
, , O O
FRANCIS NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
ZOCOR NNP B-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/23/01 CD O O
by IN B-VP O
SLEIGH NNP B-NP O
, , O O
ROMEO NNP B-NP O
FABIAN NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ERYTHROMYCIN NNP B-NP B-m
TP NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
53201344 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
ERYTHROMYCIN NNP I-NP B-m
ERYTHROMYCIN NNP I-NP B-m
, , O O
TOPICAL NNP B-NP B-mo
OR NNP I-NP O
OPHTHALMIC NNP I-NP B-mo
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/23/01 CD O O
by IN B-VP O
LOFGREN NNP B-NP O
, , O O
RONNIE NNP B-NP O
ALEC NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
29560859 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/26/01 CD O O
by IN B-VP O
DAGNONE NNP B-NP O
, , O O
ROBIN NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
METFORMIN NNP B-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
1/24 CD O O
) ) O O
PRILOSEC NNP B-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/3/01 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
FUROSEMIDE NNP I-NP B-m
&amp; NNP I-NP O
OMEPRAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
indicated VBD B-VP O
VALACYCLOVIR NNP B-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q8H NNP I-NP B-f
X NNP I-NP B-du
7 CD O I-du
Days NNP B-NP I-du
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Drzewiecki NNP I-NP O
on IN B-VP O
wenesday NN B-NP O
at IN B-VP O
HAMH NNP B-NP O
10/24/01 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
chronic JJ B-NP O
Afib NNP I-NP O
G-E NNP I-NP O
Reflux NNP I-NP O
HTN NNP I-NP O
NIDDM NNP I-NP O
, , O O
DIET NNP B-NP O
CTRL NNP I-NP O
CHF NNP I-NP O
( ( O O
EF NNP B-NP O
65% CD O O
) ) O O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
s/p NN B-NP O
colectomy NN I-NP O
for IN B-VP O
diverticulitis NN B-NP O
( ( O O
S/P NNP B-NP O
colectomy NN I-NP O
) ) O O
s/p VBZ O O
ventral JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
( ( O O
S/P NNP B-NP O
hernia NNP I-NP O
repair NN I-NP O
) ) O O
s/p NN B-NP O
carpal JJ B-NP O
tunnel NN I-NP O
release NN I-NP O
( ( O O
S/P NNP B-NP O
carpal VBZ O O
tunnel RB O O
repair NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
75 CD O O
y.o NN B-NP O
admitted VBN O O
for IN B-VP O
cHF JJ B-NP O
exacerbation NN I-NP O
, , O O
incr JJ B-NP O
SOB NNP I-NP O
over IN B-VP O
past JJ B-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
orthopnea NN B-NP O
and CC O O
PND NNP B-NP O
JVP NNP I-NP O
7 CD O O
cm NN B-NP O
, , O O
minimal JJ B-NP O
pedal NN I-NP O
edema NN I-NP O
, , O O
L NNP B-NP O
sided VBD B-VP O
failure NN B-NP O
with IN B-VP O
diastolic JJ B-NP O
dysfunction NN I-NP O
IV NNP I-NP B-mo
lasix VBZ O B-m
40 CD O B-do
in IN B-VP O
ED NNP B-NP O
, , O O
pt NN B-NP O
diruesed VBN O O
well RB O O
and CC O O
decreased VBD B-VP O
SOB NNP B-NP B-r
Pt NNP I-NP O
also RB O O
with IN B-VP O
L NNP B-NP O
subcostal NN I-NP O
pain NN I-NP O
likely JJ B-NP O
musculoskeltal NN I-NP O
in IN B-VP O
orgin NN B-NP O
, , O O
chronic JJ B-NP O
No NNP I-NP O
ekg NN I-NP O
changes NNS I-NP O
, , O O
enzymes RB O O
flat JJ B-NP O
CXR NNP I-NP O
enlarged VBD B-VP O
heart NN B-NP O
with IN B-VP O
minimal JJ B-NP O
pulm NN I-NP O
engorgement NN I-NP O
, , O O
no DT B-NP O
pulm NN I-NP O
edema VBZ O O
Comparison NNP B-NP O
with IN B-VP O
old JJ B-NP O
CXR NNP I-NP O
shows VBZ O O
increase NN B-NP O
in IN B-VP O
size NN B-NP O
of IN B-VP O
heart--echo JJ O O
done VBN O O
and CC O O
shows VBZ O O
EF NNP B-NP O
55% CD O O
mod NN B-NP O
MR NNP I-NP O
and CC O O
severe JJ B-NP O
TR NNP I-NP O
, , O O
slight VBD B-VP O
worsening NN B-NP O
of IN B-VP O
MR/TR NNP B-NP O
from IN B-VP O
old JJ B-NP O
echo NN I-NP O
, , O O
still RB O O
increased VBD B-VP O
right RB O O
sided JJ B-NP O
pressures NNS I-NP O
as IN B-VP O
well RB O O
Plan NNP B-NP O
is VBZ O O
for IN B-VP O
pt NN B-NP O
to TO O O
go VB O O
home NN B-NP O
on IN B-VP O
60 CD O B-do
mg NNS B-NP I-do
lasix JJ B-NP B-m
qd NN I-NP B-f
and CC O O
see VB O O
Dr NNP B-NP O
boeshore VB O O
on IN B-VP O
wed NN B-NP O
as RB O O
well RB O O
as IN B-VP O
daily JJ B-NP O
weights NNS I-NP O
Back RP O O
lesions NNS B-NP O
vesicular NN I-NP O
and CC O O
c/w NN B-NP O
herpes NNS I-NP O
zoster RBR O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
please NN I-NP O
weigh VBD B-VP O
yourself PRP O O
every DT B-NP O
day NN I-NP O
If IN B-VP O
you PRP O O
gain VBP O O
more JJR O O
than IN B-VP O
2 CD O O
lbs NN B-NP O
, , O O
please VB O O
call VB O O
Dr NNP B-NP O
Mitchel NNP I-NP O
Your NNP I-NP O
baseline NN I-NP O
"dry" NN I-NP O
weight NN I-NP O
is VBZ O O
185 CD O O
Please NNP B-NP O
weigh JJ O O
yourself PRP O O
on IN B-VP O
scale NN B-NP O
as RB O O
soon RB O O
as IN B-VP O
you PRP O O
get VBP O O
home VBN O O
to TO O O
have VB O O
accurate JJ B-NP O
baseline NN I-NP O
wei NN I-NP O
gt NN I-NP O
and CC O O
compare VB O O
all DT B-NP O
values NNS I-NP O
to TO O O
first VB O O
weight NN B-NP O
at IN B-VP O
home NN B-NP O
You PRP O O
have VBP O O
herpes NNS B-NP O
zoster RBR O O
on IN B-VP O
your PRP$ O O
back NN B-NP O
Call NN I-NP O
Dr NNP I-NP O
Pradel NNP I-NP O
if IN B-VP O
you PRP O O
can't VBP O O
control VB O O
your PRP$ O O
pain NN B-NP B-r
with IN B-VP O
Tylenol NNP B-NP B-m
Please NNP I-NP O
page VB O O
Dr NNP B-NP O
Blouir NNP I-NP O
about IN B-VP O
your PRP$ O O
eye NN B-NP O
pain NN I-NP O
and CC O O
come NN B-NP O
to TO O O
the DT B-NP O
ED NNP I-NP O
if IN B-VP O
pain JJ B-NP O
worse JJR I-NP O
VNA:page NNP I-NP O
Dr NNP I-NP O
Cudd NNP I-NP O
when WRB O O
he/she NN B-NP O
sees VBZ O O
ms JJ B-NP O
Krzak NNP I-NP O
( ( O O
193 CD O O
) ) O O
484-0206 CD O O
DB NNP B-NP O
26096 CD O O
and CC O O
leave VB O O
call NN B-NP O
back RB O O
number NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ZEUNER NNP I-NP O
, , O O
PASQUALE NNP B-NP O
DEVIN NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
QK37 NNP B-NP O
) ) O O
6/3/01 CD O O
@ $ O O
01 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#824987 VBZ O O
184716522 CD O O
GH NNP B-NP O
05684560 CD O O
8163103 CD O O
5/2/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
ABDOMINAL NNP I-NP O
PAIN NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/0/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/16/2006 CD O O
ATTENDING: NNP B-NP O
DRISCOLL NNP I-NP O
, , O O
ELDEN NNP B-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
GMS NNP I-NP O
Katena NNP I-NP O
Highway NNP I-NP O
PRIMARY NNP I-NP O
CARE NNP I-NP O
PHYSICIAN: NNP I-NP O
Chet NNP I-NP O
Nerpio NNP I-NP O
, , O O
M.D NNP B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSES: NNP I-NP O
End-stage NNP I-NP O
renal JJ B-NP O
disease NN I-NP O
and CC O O
osteomyelitis JJ B-NP O
LIST NNP I-NP O
OF IN B-VP O
OTHER NNP B-NP O
PROBLEMS NNP I-NP O
AND NNP I-NP O
DIAGNOSES: NNP I-NP O
Insulin-dependent NNP I-NP O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
peripheral JJ B-NP O
neuropathy NN I-NP O
, , O O
left VBD B-VP O
Charcot NNP B-NP O
foot NN I-NP O
complicated VBN O O
by IN B-VP O
ulceration NN B-NP O
requiring VBG O O
partial JJ B-NP O
thickness NN I-NP O
debridement NN I-NP O
on IN B-VP O
7/28/06 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
new JJ B-NP O
Aircast NNP I-NP O
started VBD B-VP O
on IN B-VP O
6/23/06 CD O O
now RB O O
with IN B-VP O
a DT B-NP O
cast NN I-NP O
applied VBN O O
to TO O O
the DT B-NP O
left JJ I-NP O
foot NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
spinal JJ B-NP O
stenosis NN I-NP O
, , O O
anemia NN B-NP O
of IN B-VP O
chronic JJ B-NP O
disease NN I-NP O
, , O O
thrombocytopenia NN B-NP O
, , O O
and CC O O
ascus VB O O
1/5 CD O O
and CC O O
4/27 CD O O
BRIEF NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
58-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
baseline JJ B-NP O
creatinine NN I-NP O
3.8 CD O O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
and CC O O
anemia NN B-NP O
, , O O
who WP O O
present VBP O O
with IN B-VP O
two CD O O
weeks NNS B-NP O
of IN B-VP O
diffuse NN B-NP O
abdominal JJ B-NP O
pain NN I-NP O
that WDT O O
acutely RB O O
worsened VBD B-VP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
with IN B-VP O
associated JJ B-NP O
nausea NN I-NP O
, , O O
nonbloody NN B-NP O
emesis NN I-NP O
, , O O
and CC O O
chills VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
febrile JJ O O
with IN B-VP O
leukocytosis NN B-NP O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
seen VBN O O
previously RB O O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
on IN B-VP O
3/30/06 CD O O
at IN B-VP O
which WDT O O
time NN B-NP O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP O
UTI NNP I-NP O
She PRP O O
was VBD B-VP O
sent VBN O O
home NN B-NP O
with IN B-VP O
a DT B-NP O
seven-day JJ I-NP B-du
course NN I-NP I-du
of IN B-VP O
ciprofloxacin NN B-NP B-m
and CC O O
oxycodone NN B-NP B-m
for IN B-VP O
pain NN B-NP B-r
pain VBP O B-r
The DT B-NP O
ciprofloxacin NN I-NP B-m
was VBD B-VP O
renally RB O O
dosed VBN O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
that IN B-VP O
she PRP O O
stopped VBD B-VP O
taking VBG O O
oxycodone NN B-NP B-m
and CC O O
ciprofloxacin NN B-NP B-m
After IN B-VP O
developing VBG O O
constipation NN B-NP O
, , O O
it PRP O O
is VBZ O O
unclear JJ O O
if IN B-VP O
she PRP O O
completed VBD B-VP O
her PRP O O
full JJ B-NP O
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
She PRP O O
currently RB O O
present VBP O O
with IN B-VP O
complaints NNS B-NP O
of IN B-VP O
diarrhea NN B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
having VBG O O
taken VBN O O
laxative JJ O O
at IN B-VP O
home NN B-NP O
No NNP I-NP O
melena NN I-NP O
or CC O O
hematochezia VB O O
The DT B-NP O
pain NN I-NP O
is VBZ O O
not RB O O
related VBN O O
to TO O O
food NN B-NP O
, , O O
urination NN B-NP O
, , O O
or CC O O
defecation NN B-NP O
She PRP O O
has VBZ O O
poor JJ B-NP O
p.o NNS I-NP O
intake VBP O O
, , O O
denies VBZ O O
any DT B-NP O
sick JJ I-NP O
contacts NNS I-NP O
at IN B-VP O
home NN B-NP O
No NNP I-NP O
recent JJ B-NP O
travel NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Positive NNP I-NP O
for IN B-VP O
blood NN B-NP O
sugars NNS I-NP O
ranging VBG O O
from IN B-VP O
180-190 CD O O
, , O O
although IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
blood NN I-NP O
sugar NN I-NP O
of IN B-VP O
499 CD O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
She PRP O O
has VBZ O O
fatigue VBN O O
but CC O O
no DT B-NP O
myalgias NN I-NP O
, , O O
no DT B-NP O
cough NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
no DT B-NP O
dysuria NN I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
given VBN O O
ampicillin RB O B-m
2 CD O B-do
g NN B-NP I-do
IV NNP I-NP B-mo
, , O O
gentamicin VBD B-VP B-m
80 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
, , O O
Flagyl NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
and CC O O
8 CD O B-do
units NNS B-NP I-do
of IN B-VP O
insulin NN B-NP B-m
ALLERGIES: NNP I-NP O
Medication NNP I-NP O
reaction NN I-NP O
, , O O
she PRP O O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
lisinopril VB O O
with IN B-VP O
reaction NN B-NP O
of IN B-VP O
elevated JJ B-NP O
creatinine NN I-NP O
at IN B-VP O
a DT B-NP O
low JJ I-NP O
dose NN I-NP O
To TO O O
levofloxacin VB O O
, , O O
she PRP O O
has VBZ O O
reflux NN B-NP O
and CC O O
celecoxib NN B-NP O
gives VBZ O O
her PRP$ O O
dizziness NN B-NP O
and CC O O
elevated JJ B-NP O
creatinine NN I-NP O
BRIEF NNP I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
101 CD O O
, , O O
pulse NN B-NP O
of IN B-VP O
106 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
172/71 CD O O
, , O O
oxygen JJR B-NP O
saturation NN I-NP O
of IN B-VP O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
, , O O
in IN B-VP O
mild JJ B-NP O
distress NN I-NP O
Her PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Her NNP B-NP O
heart NN I-NP O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT O O
2/6 CD O O
early JJ B-NP O
systolic JJ I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
sternal JJ B-NP O
border NN I-NP O
She PRP O O
was VBD B-VP O
obese JJ O O
, , O O
but CC O O
had VBD B-VP O
a DT B-NP O
nontender NN I-NP O
, , O O
nondistended VBD B-VP O
abdomen NNS B-NP O
with IN B-VP O
normal JJ B-NP O
abdominal JJ I-NP O
bowel NN I-NP O
sounds VBZ O O
She PRP O O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
, , O O
and CC O O
her PRP$ O O
left JJ B-NP O
foot NN I-NP O
was VBD B-VP O
in IN B-VP O
a DT B-NP O
cast NN I-NP O
PERTINENT NNP I-NP O
LABORATORY NNP I-NP O
TESTS NNP I-NP O
AND NNP I-NP O
RESULTS: NNP I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
127 CD O O
, , O O
corrected VBN O O
to TO O O
131 CD O O
with IN B-VP O
her PRP$ O O
glucose NN B-NP O
, , O O
potassium NN B-NP O
of IN B-VP O
4.9 CD O O
, , O O
bicarbonate NN B-NP O
of IN B-VP O
27 CD O O
, , O O
BUN NNP B-NP O
95 CD O O
, , O O
creatinine NN B-NP O
4.5 CD O O
, , O O
glucose VBD B-VP O
329 CD O O
LFTs NNP B-NP O
were VBD B-VP O
normal JJ O O
, , O O
amylase JJ O O
19 CD O O
, , O O
lipase NN B-NP O
8 CD O O
, , O O
negative JJ B-NP O
keto NN I-NP O
acids NNS I-NP O
in IN B-VP O
the DT B-NP O
serum NN I-NP O
and CC O O
urine JJ B-NP O
Her NNP I-NP O
white JJ B-NP O
blood NN I-NP O
count NN I-NP O
was VBD B-VP O
26.8 CD O O
, , O O
INR NNP B-NP O
was VBD B-VP O
1.4 CD O O
, , O O
PTT NNP B-NP O
was VBD B-VP O
36.6 CD O O
She PRP O O
had VBD B-VP O
a DT B-NP O
dirty JJ I-NP O
urinalysis NN I-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
abdominal JJ I-NP O
CT NN I-NP O
that WDT O O
showed VBD B-VP O
a DT B-NP O
non-incarcerated JJ I-NP O
hernia NN I-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
colitis NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
debridement NN I-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
foot NN I-NP O
on IN B-VP O
3/11/06 CD O O
She PRP O O
also RB O O
had VBD B-VP O
hemodialysis NN B-NP O
initiated VBN O O
on IN B-VP O
1/10/06 CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
1 CD O O
Infectious NNP B-NP O
disease: VBD B-VP O
The DT B-NP O
patient's NN I-NP O
left VBD B-VP O
foot NN B-NP O
was VBD B-VP O
encasted VBN O O
by IN B-VP O
orthopedics NNS B-NP O
surgery NN I-NP O
on IN B-VP O
6/1/06 CD O O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
underlying JJ B-NP O
infection NN I-NP O
Her NNP I-NP O
wound NN I-NP O
cultures VBZ O O
grew VBD B-VP O
MRSA NNP B-NP O
with IN B-VP O
probes NNS B-NP O
to TO O O
the DT B-NP O
bone NN I-NP O
X-rays NNS I-NP O
were VBD B-VP O
unrevealing JJ O O
and CC O O
MRI NNP B-NP O
showed VBD B-VP O
severe JJ B-NP O
osteomyelitis NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
ESR NNP I-NP O
of IN B-VP O
109 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
thus RB O O
put VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
, , O O
vancomycin NN B-NP B-m
, , O O
and CC O O
Flagyl NNP B-NP B-m
Blood NNP I-NP O
cultures NNS I-NP O
from IN B-VP O
7/14/06 CD O O
additionally RB O O
grew VBD B-VP O
gram-positive JJ B-NP O
cocci NN I-NP O
in IN B-VP O
clusters NNS B-NP O
which WDT O O
eventually RB O O
yielded VBD B-VP O
MRSA NNP B-NP O
However RB O O
, , O O
surveillance NN B-NP O
cultures NNS I-NP O
with IN B-VP O
treatment NN B-NP O
on IN B-VP O
levofloxacin NN B-NP B-m
, , O O
vancomycin NN B-NP B-m
, , O O
and CC O O
Flagyl NNP B-NP B-m
were VBD B-VP O
negative JJ O O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
debridement NN B-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
foot NN I-NP O
on IN B-VP O
3/11/06 CD O O
In IN B-VP O
the DT B-NP O
OR NNP I-NP O
, , O O
the DT B-NP O
bone NN I-NP O
looked VBD B-VP O
necrotic JJ O O
and CC O O
infected VBD B-VP O
The DT B-NP O
bone NN I-NP O
was VBD B-VP O
sent VBN O O
to TO O O
pathology NN B-NP O
and CC O O
microbiology NN B-NP O
, , O O
the DT B-NP O
results NNS I-NP O
of IN B-VP O
which WDT O O
are VBP O O
pending VBG O O
Given NNP B-NP O
the DT B-NP O
appearance NN I-NP O
of IN B-VP O
her PRP$ O O
bone NN B-NP O
during IN B-VP O
debridement NN B-NP O
, , O O
it PRP O O
is VBZ O O
presumed VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
will MD O O
need VB O O
eight CD O B-du
weeks NNS B-NP I-du
of IN B-VP O
vancomycin NN B-NP B-m
Because IN B-VP O
she PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
clear JJ I-NP O
source NN I-NP O
of IN B-VP O
fevers NNS B-NP O
after IN B-VP O
it PRP O O
was VBD B-VP O
found VBN O O
that IN B-VP O
she PRP O O
had VBD B-VP O
osteomyelitis NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
discontinued VBN O O
off RP O O
Flagyl NNP B-NP B-m
and CC O O
levofloxacin VB O B-m
on IN B-VP O
5/22/06 CD O O
2 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
abdominal JJ B-NP O
pain NN I-NP O
with IN B-VP O
gastric JJ O O
emptying VBG O O
study NN B-NP O
on IN B-VP O
7/14/06 CD O O
showing VBG O O
0% CD O O
clearance NN B-NP O
at IN B-VP O
90 CD O O
minutes NNS B-NP O
consistent JJ O O
with IN B-VP O
severe JJ B-NP O
gastroparesis NN I-NP O
versus NN I-NP O
obstruction NN I-NP O
Radiology NNP I-NP O
did VBD B-VP O
not RB O O
feel VB O O
that IN B-VP O
an DT B-NP O
upper JJ I-NP O
GI NNP I-NP O
series NN I-NP O
would MD O O
give VB O O
further JJ B-NP O
information NN I-NP O
regarding VBG O O
obstruction NN B-NP O
and CC O O
it PRP O O
was VBD B-VP O
judged VBN O O
to TO O O
be VB O O
unlikely JJ O O
given VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
has VBZ O O
bowel VBN O O
movements NNS B-NP O
and CC O O
rare JJ B-NP O
emesis NN I-NP O
Later NNP I-NP O
on IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
put VBN O O
on IN B-VP O
erythromycin NN B-NP B-m
with IN B-VP O
a DT B-NP O
decrease NN I-NP O
in IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
and CC O O
vomiting VBG O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
bowel NN B-NP O
ischemia NN I-NP O
on IN B-VP O
MRA NNP B-NP O
Later NNP I-NP O
, , O O
erythromycin NN B-NP B-m
was VBD B-VP O
changed VBN O O
to TO O O
Reglan VB O B-m
on IN B-VP O
8/6/06 CD O O
per IN B-VP O
renal JJ B-NP O
request NN I-NP O
during IN B-VP O
hemodialysis NN B-NP O
There EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
pancreatis NN B-NP O
or CC O O
liver NN B-NP O
disease NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
kept VBN O O
on IN B-VP O
Compazine NNP B-NP B-m
for IN B-VP O
nausea NN B-NP B-r
3 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
, , O O
on IN B-VP O
admission NN B-NP O
, , O O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
concern NN I-NP O
for IN B-VP O
prerenal JJ B-NP O
azotemia NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
nausea NN B-NP O
and CC O O
vomiting NN B-NP O
and CC O O
diarrhea VB O O
She PRP O O
had VBD B-VP O
a DT B-NP O
fractional JJ I-NP O
excretion NN I-NP O
of IN B-VP O
sodium NN B-NP O
which WDT O O
was VBD B-VP O
0.3% CD O O
, , O O
but CC O O
it PRP O O
was VBD B-VP O
difficult JJ O O
to TO O O
interpret VB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
Lasix NNP I-NP B-m
and CC O O
Cozaar NNP B-NP B-m
were VBD B-VP O
held VBN O O
However RB O O
, , O O
the DT B-NP O
creatinine NN I-NP O
continued VBD B-VP O
to TO O O
worsen VB O O
reaching VBG O O
6.1 CD O O
on IN B-VP O
10/14/06 CD O O
Renal NNP B-NP O
was VBD B-VP O
consulted VBN O O
regarding VBG O O
the DT B-NP O
need NN I-NP O
for IN B-VP O
dialysis NN B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
matured VBN O O
AV NNP B-NP O
fistula NN I-NP O
graft NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
thus RB O O
started VBN O O
on IN B-VP O
hemodialysis NN B-NP O
on IN B-VP O
1/10/06 CD O O
4 CD O O
Hematology: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
INR NNP I-NP O
which WDT O O
was VBD B-VP O
elevated VBN O O
Hematocrit NNP B-NP O
was VBD B-VP O
also RB O O
decreased VBN O O
to TO O O
25.5 CD O O
from IN B-VP O
34 CD O O
She PRP O O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
and CC O O
did VBD B-VP O
have VB O O
any DT B-NP O
schistocyte NN I-NP O
Her NNP I-NP O
LDH NNP I-NP O
was VBD B-VP O
also RB O O
normal JJ O O
with IN B-VP O
her PRP$ O O
haptoglobin NN B-NP O
high JJ O O
It PRP O O
was VBD B-VP O
judged VBN O O
from IN B-VP O
her PRP$ O O
iron NN B-NP O
studies NNS I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
iron JJ B-NP B-r
deficient NN I-NP I-r
She PRP O O
was VBD B-VP O
put VBN O O
on IN B-VP O
iron NN B-NP B-m
supplementation NN I-NP O
She PRP O O
also RB O O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
renal JJ B-NP O
component NN I-NP O
to TO O O
her PRP$ O B-r
her PRP$ O B-r
anemia NN B-NP I-r
anemia NN I-NP I-r
and CC O O
she PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
darbepoetin NN B-NP B-m
initially RB O O
and CC O O
changed VBD B-VP O
to TO O O
erythropoietin VB O B-m
later RB O O
during IN B-VP O
dialysis NN B-NP O
by IN B-VP O
renal JJ O O
5 CD O O
Cardiovascular: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
a DT B-NP O
statin NN I-NP B-m
, , O O
and CC O O
calcium NN B-NP B-m
channel NN I-NP I-m
blocker NN I-NP I-m
She PRP O O
started VBD B-VP O
prophylactic JJ B-NP O
beta-blocker NN I-NP B-m
during IN B-VP B-du
her PRP$ O I-du
hospital JJ B-NP I-du
course NN I-NP I-du
as RB O O
well RB O O
6 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
hemoglobin VBN O O
A1c NNP B-NP O
of IN B-VP O
7.8 CD O O
She PRP O O
was VBD B-VP O
transitioned VBN O O
to TO O O
NPH NNP B-NP B-m
and CC O O
Aspart NNP B-NP B-m
during IN B-VP B-du
her PRP$ O I-du
hospital NN B-NP I-du
stay NN I-NP I-du
She PRP O O
had VBD B-VP O
intermittent JJ B-NP O
problems NNS I-NP O
with IN B-VP O
hypoglycemia NN B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
being VBG O O
NPO NNP B-NP O
pending VBG O O
operations NNS B-NP O
and CC O O
procedures; NN B-NP O
however RB O O
, , O O
her PRP O O
insulin VBP O B-m
regimen NNS B-NP O
was VBD B-VP O
titrated VBN O O
to TO O O
good JJ B-NP O
glycemic JJ I-NP O
response NN I-NP O
7 CD O O
Prophylaxis: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
kept VBN O O
on IN B-VP O
heparin NN B-NP B-m
and CC O O
Nexium NNP B-NP B-m
8 CD O O
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
, , O O
and CC O O
nutrition: IN B-VP O
Her NNP B-NP O
IV NNP I-NP O
fluids NNS I-NP O
were VBD B-VP O
stopped VBN O O
as IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
oliguric JJ O O
and CC O O
anuric JJ O O
initially RB O O
before IN B-VP O
hemodialysis NN B-NP O
Later NNP I-NP O
on IN B-VP O
, , O O
she PRP O O
was VBD B-VP O
also RB O O
put VBN O O
on IN B-VP O
1500 CD O O
mL NN B-NP O
fluid NN I-NP O
restriction NN I-NP O
Later NNP I-NP O
on IN B-VP O
during IN B-VP O
dialysis NN B-NP O
, , O O
her PRP O O
volume NN B-NP O
status NN I-NP O
resolved VBD B-VP O
euvolemia RB O O
She PRP O O
was VBD B-VP O
kept VBN O O
on IN B-VP O
a DT B-NP O
low JJ I-NP O
fat NN I-NP O
and CC O O
low JJ B-NP O
cholesterol NN I-NP O
diabetic JJ O O
diet VBZ O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Tylenol NNP B-NP B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4 NN I-NP B-f
p.r.n NN I-NP I-f
headache NN I-NP B-r
2 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
4 CD O O
Heparin NNP B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subq VBD B-VP B-mo
t.i.d JJ O B-f
5 CD O O
Dilaudid NNP B-NP B-m
0.4-0.8 JJ B-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.4 NN I-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
6 CD O O
Insulin NNP B-NP B-m
NPH NNP I-NP I-m
human JJ O I-m
20 CD O B-do
units NNS B-NP I-do
subq VBD B-VP B-mo
b.i.d RB O B-f
7 CD O O
Lactulose JJ O B-m
30 CD O B-do
mL NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
p.r.n NN I-NP I-f
constipation NN I-NP B-r
8 CD O O
Reglan NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.c VBD B-VP B-f
9 CD O O
Reglan NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s VBD B-VP B-f
10 CD O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d VBD B-VP B-f
11 CD O O
Senna NNP B-NP B-m
tablets NNS I-NP I-m
two CD O B-do
tabs NNS B-NP I-do
p.o VBP O B-mo
b.i.d RB O B-f
12 CD O O
Norvasc NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
13 CD O O
Compazine NNP B-NP B-m
5-10 JJ B-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
nausea NN I-NP B-r
14 CD O O
Nephrocaps NNP B-NP B-m
one CD O B-do
tab NN B-NP I-do
p.o VBD B-VP B-mo
daily RB O B-f
15 CD O O
Insulin NNP B-NP B-m
Aspart NNP I-NP I-m
sliding VBG O B-do
scale JJ B-NP I-do
subq NN I-NP B-mo
a.c VBZ O B-f
16 CD O O
Insulin NNP B-NP B-m
Aspart NNP I-NP I-m
4 CD O B-do
units NNS B-NP I-do
subq VBD B-VP B-mo
q.a.c RB O B-f
17 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
18 CD O O
Protonix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
19 CD O O
Vancomycin NNP B-NP B-m
1 CD O B-do
g NN B-NP I-do
IV NNP I-NP B-mo
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
week NN I-NP I-f
These DT B-NP O
doses NNS I-NP O
are VBP O O
all DT O O
to TO O O
be VB O O
given VBN O O
during IN B-VP O
hemodialysis NN B-NP O
20 CD O O
Ergocalciferol NNP B-NP B-m
50 CD O B-do
, , O I-do
000 CD O I-do
units NNS B-NP I-do
p.o RB O B-mo
q VBP O B-f
week NN B-NP I-f
for IN B-VP B-du
six CD O I-du
weeks NNS B-NP I-du
eScription NN I-NP O
document: IN B-VP O
3-9828070 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
NADOLNY NNP I-NP O
, , O O
SANG NNP B-NP O
Attending: NNP I-NP O
UNSWORTH NNP I-NP O
, , O O
OTTO NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6989547 CD O O
D: NNP B-NP O
2/5/06 CD O O
T: NNP B-NP O
2/5/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#827931 VBZ O O
757633121 CD O O
SHR NNP B-NP O
39434670 CD O O
081816 CD O O
0/5/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
UROSEPSIS NNP I-NP O
, , O O
MYOCARDIAL NNP B-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/5/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/29/2001 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
BKA NNP B-NP O
2 CD O O
E NNP B-NP O
COLI NNP I-NP O
UROSEPSIS NNP I-NP O
3 CD O O
NON-Q-WAVE NNP B-NP O
MI NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
MORBID NNP B-NP O
OBESITY NNP I-NP O
2 CD O O
PULMONARY NNP B-NP O
EDEMA NNP I-NP O
3 CD O O
PULMONARY NNP B-NP O
HYPERTENSION NNP I-NP O
4 CD O O
RULE NNP B-NP O
OUT NNP I-NP O
PE NNP I-NP O
5 CD O O
OBSTRUCTIVE NNP B-NP O
SLEEP NNP I-NP O
APNEA NNP I-NP O
6 CD O O
ACUTE NNP B-NP O
RENAL NNP I-NP O
FAILURE NNP I-NP O
This DT O O
is VBZ O O
the DT B-NP O
third JJ I-NP O
Daughters NNP I-NP O
Wyckwe NNP I-NP O
Hospital NNP I-NP O
hospitalization NN I-NP O
for IN B-VP O
this DT O O
46-year-old JJ O O
morbidly RB O O
obese JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus RB O O
complicated VBN O O
by IN B-VP O
BKA NNP B-NP O
on IN B-VP O
two CD O O
prior JJ B-NP O
occasions NNS I-NP O
, , O O
admitted VBN O O
to TO O O
the DT B-NP O
MICU NNP I-NP O
with IN B-VP O
BKA NNP B-NP O
, , O O
urosepsis NN B-NP O
, , O O
and CC O O
a DT B-NP O
non-Q-wave JJ I-NP O
MI NNP I-NP O
On IN B-VP O
presentation NN B-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
confused VBN O O
and CC O O
therefore RB O O
proved VBD B-VP O
to TO O O
be VB O O
a DT O O
difficult JJ O O
historian JJ O O
, , O O
but CC O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
four CD O O
days NNS B-NP O
of IN B-VP O
epigastric JJ B-NP O
pain NN I-NP O
with IN B-VP O
radiation NN B-NP O
under IN B-VP O
her PRP$ O O
right JJ B-NP O
breast NN I-NP O
She PRP O O
also RB O O
complained VBD B-VP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
for IN B-VP O
4-5 JJ B-NP O
days NNS I-NP O
associated VBN O O
with IN B-VP O
nausea NN B-NP O
, , O O
but CC O O
denied VBD B-VP O
vomiting NN B-NP O
, , O O
diarrhea NN B-NP O
, , O O
constipation NN B-NP O
, , O O
hematochezia NN B-NP O
, , O O
or CC O O
melena NN B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
some DT B-NP O
dysuria NN I-NP O
for IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
period NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
subjective JJ B-NP O
fevers NNS I-NP O
, , O O
but CC O O
denied VBD B-VP O
cough NN B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
any DT B-NP O
prior JJ I-NP O
history NN I-NP O
of IN B-VP O
heart NN B-NP O
disease NN I-NP O
or CC O O
chest JJS B-NP O
pain NN I-NP O
On IN B-VP O
presentation NN B-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
her PRP$ O O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
189/92 CD O O
, , O O
pulse JJ B-NP O
rate NN I-NP O
of IN B-VP O
120 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
, , O O
and CC O O
an DT B-NP O
O2 NNP I-NP O
sat NN I-NP O
of IN B-VP O
90% CD O O
She PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
finger NN I-NP O
stick JJ B-NP O
blood NN I-NP O
glucose NN I-NP O
of IN B-VP O
354 CD O O
, , O O
a DT B-NP O
positive JJ I-NP O
urinalysis NN I-NP O
, , O O
and CC O O
an DT B-NP O
EKG NNP I-NP O
that WDT O O
was VBD B-VP O
concerning VBG O O
for IN B-VP O
ischemia NN B-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
IV NNP B-NP B-mo
insulin NN I-NP B-m
, , O O
given VBN O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
x NNP I-NP B-du
three CD O I-du
, , O O
4 CD O B-do
mg NN B-NP I-do
of IN B-VP O
morphine NN B-NP B-m
, , O O
5 CD O B-do
mg NN B-NP I-do
of IN B-VP O
Lopressor NNP B-NP B-m
, , O O
and CC O O
started VBD B-VP O
on IN B-VP O
a DT B-NP O
heparin NN I-NP B-m
drip NN I-NP I-m
and CC O O
IV NNP B-NP B-mo
antibiotics NNS I-NP B-m
, , O O
and CC O O
admitted VBD B-VP O
to TO O O
the DT B-NP O
MICU NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Insulin-dependent JJ B-NP B-r
diabetes NNS I-NP I-r
mellitus NNS I-NP I-r
, , O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
BKA NNP B-NP O
in IN B-VP O
March NNP B-NP O
1992 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
E NNP B-NP O
coli JJ B-NP O
sepsis NN I-NP O
of IN B-VP O
unclear JJ B-NP O
source NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
BKA NNP B-NP O
in IN B-VP O
March NNP B-NP O
2001 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
MS NNP B-NP B-m
Contin NNP I-NP I-m
withdrawal VBD B-VP O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Iron NNP B-NP O
deficiency NN I-NP O
anemia RB O O
4 CD O O
Fibroids NNS B-NP O
5 CD O O
Status NNP B-NP O
post NN I-NP O
C-section NNP I-NP O
complicated VBN O O
by IN B-VP O
wound JJ B-NP O
infection NN I-NP O
and CC O O
dehiscence NN B-NP O
6 CD O O
Sciatica NNP B-NP O
and CC O O
low JJ O O
back RB O O
pain NN B-NP O
secondary JJ O O
to TO O O
disc VB O O
herniation NN B-NP O
MEDICATIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
provide VB O O
the DT B-NP O
dose NN I-NP O
of IN B-VP O
her PRP$ O O
medications NNS B-NP O
, , O O
but CC O O
her PRP$ O O
medication NN B-NP O
list NN I-NP O
on IN B-VP O
admission NN B-NP O
included VBD B-VP O
insulin NN B-NP B-m
, , O O
amitriptyline NN B-NP B-m
, , O O
Flexeril NNP B-NP B-m
, , O O
Valium NNP B-NP B-m
, , O O
Prozac NNP B-NP B-m
, , O O
and CC O O
albuterol NN B-NP B-m
and CC O O
Atrovent NNP B-NP B-m
inhalers NNS I-NP I-m
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
provide VB O O
significant JJ B-NP O
details NNS I-NP O
of IN B-VP O
her PRP$ O O
family NN B-NP O
history NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
positive JJ B-NP O
tobacco NN I-NP O
use NN I-NP O
, , O O
approximately RB O O
one CD O O
cigarette NN B-NP O
per IN B-VP O
day NN B-NP O
She PRP O O
was VBD B-VP O
unable JJ O O
to TO O O
say VB O O
for IN B-VP O
how WRB O O
many JJ B-NP O
years NNS I-NP O
Positive NNP I-NP O
ethanol NN I-NP B-m
use NN I-NP O
, , O O
approximately RB O O
one CD O B-f
drink NN B-NP O
per IN B-VP O
week NN B-NP O
She PRP O O
denied VBD B-VP O
IV NNP B-NP O
drug NN I-NP O
use NN I-NP O
or CC O O
other JJ B-NP O
illicit JJ I-NP O
drug NN I-NP O
use NN I-NP O
She PRP O O
is VBZ O O
married JJ O O
and CC O O
has VBZ O O
three CD O O
children NNS B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
As IN B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
HPI NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
on IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
MICU: NNP I-NP O
Temperature NNP I-NP O
103.7 CD O O
, , O O
pulse RB O O
110 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
125/55 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
34 CD O O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
95% CD O O
on IN B-VP O
2 CD O O
L NNP B-NP O
In IN B-VP O
general JJ O O
, , O O
she PRP O O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
African JJ I-NP O
American JJ I-NP O
female NN I-NP O
who WP O O
was VBD B-VP O
confused VBN O O
, , O O
but CC O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x NN I-NP O
two CD O O
HEENT: NNP B-NP O
Pupils NNPS I-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Extraocular JJ I-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Oropharynx NNP I-NP O
was VBD B-VP O
dry JJ O O
and CC O O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
fruity NN I-NP O
odor NN I-NP O
LUNGS: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
NECK: NNP B-NP O
Supple NNP I-NP O
CARDIOVASCULAR: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
, , O O
or CC O O
gallops NNS B-NP O
, , O O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
ABDOMEN: NNP I-NP O
Obese NNP I-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ O O
, , O O
nondistended VBD B-VP O
, , O O
positive JJ B-NP O
tenderness NN I-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
quadrant NN B-NP O
, , O O
with IN B-VP O
no DT B-NP O
guarding NN I-NP O
or CC O O
rebound VB O O
EXTREMITIES: NNP B-NP O
2+ CD O O
distal NN B-NP O
pulses NNS I-NP O
, , O O
1+ CD O O
edema NN B-NP O
RECTAL NNP I-NP O
EXAM: NNP I-NP O
Guaiac NNP I-NP O
negative JJ O O
, , O O
with IN B-VP O
normal JJ B-NP O
tone NN I-NP O
per IN B-VP O
ED NNP B-NP O
physician NN I-NP O
LABS: NNP I-NP O
Sodium NNP I-NP O
139 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
chloride RB O O
105 CD O O
, , O O
bicarb NN B-NP O
19 CD O O
, , O O
BUN NNP B-NP O
37 CD O O
, , O O
creatinine NN B-NP O
2.1 CD O O
( ( O O
increased VBN O O
from IN B-VP O
her PRP$ O O
baseline NN B-NP O
of IN B-VP O
1.4 CD O O
) ) O O
, , O O
glucose JJ O O
379 CD O O
, , O O
calcium NN B-NP O
8.1 CD O O
, , O O
magnesium NN B-NP O
2.1 CD O O
, , O O
phosphorus NN B-NP O
3 CD O O
, , O O
ALT NNP B-NP O
33 CD O O
, , O O
AST NNP B-NP O
56 CD O O
, , O O
alk VBP O O
phos JJ O O
119 CD O O
, , O O
T NNP B-NP O
bili VBD B-VP O
1.0 CD O O
, , O O
amylase NN B-NP O
13 CD O O
, , O O
lipase NN B-NP O
3 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
14.7 CD O O
, , O O
with IN B-VP O
85% CD O O
polys NNS B-NP O
, , O O
9 CD O O
bands NNS B-NP O
, , O O
and CC O O
4 CD O O
lymphocytes NNS B-NP O
, , O O
hematocrit NN B-NP O
34.1 CD O O
, , O O
platelets NNS B-NP O
122 CD O O
, , O O
PT NNP B-NP O
14.2 CD O O
, , O O
PTT NNP B-NP O
29.1 CD O O
, , O O
INR NNP B-NP O
1.3 CD O O
, , O O
ABG NNP B-NP O
T NNP I-NP O
at IN B-VP O
7.4 CD O O
, , O O
PCO2 NNP B-NP O
32 CD O O
, , O O
PO2 NNP B-NP O
82 CD O O
, , O O
O2 NNP B-NP O
saturation NN I-NP O
96% CD O O
, , O O
CK NNP B-NP O
12-35 CD O O
, , O O
MB NNP B-NP O
1.5 CD O O
, , O O
troponin NN B-NP O
1.52 CD O O
, , O O
beta NN B-NP O
hydroxybutyrate NN I-NP O
.7 NNP I-NP O
Positive NNP I-NP O
ACE NNP I-NP O
test NN I-NP O
Urine NN I-NP O
and CC O O
serum NN B-NP O
toxicology NN I-NP O
screens NNS I-NP O
negative JJ B-NP O
Urinalysis NNP I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
pH NN I-NP O
of IN B-VP O
5.5 CD O O
, , O O
specific JJ B-NP O
gravity NN I-NP O
of IN B-VP O
1.02 CD O O
, , O O
3+ CD O O
protein NN B-NP O
, , O O
3+ CD O O
glucose NN B-NP O
, , O O
1+ CD O O
ketones NNS B-NP O
, , O O
3+ CD O O
bloods NNS B-NP O
, , O O
positive JJ B-NP O
leuk NN I-NP O
esterase NN I-NP O
and CC O O
nitrites NNS B-NP O
, , O O
45-50 JJ B-NP O
white JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
3-4 JJ B-NP O
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
3+ CD O O
bacteria NNS B-NP O
, , O O
and CC O O
1+ CD O O
squamous JJ B-NP O
epithelium NN I-NP O
Urine NNP I-NP O
beta-hCG NN I-NP O
was VBD B-VP O
negative JJ O O
The DT B-NP O
chest JJS I-NP O
x-ray JJ I-NP O
showed JJ I-NP O
cephalization NN I-NP O
and CC O O
interstitial JJ B-NP O
edema NN I-NP O
Her NNP I-NP O
initial JJ B-NP O
EKG NNP I-NP O
showed VBD B-VP O
.5-1 JJ B-NP O
mm NN I-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
leads NNS B-NP O
1 CD O O
and CC O O
aVL RB O O
, , O O
1 CD O O
mm NN B-NP O
ST NNP I-NP O
elevations NNS I-NP O
in IN B-VP O
leads NNS B-NP O
V1 NNP I-NP O
and CC O O
V2 NNP B-NP O
, , O O
flattened VBD B-VP O
T NNP B-NP O
waves NNS I-NP O
in IN B-VP O
leads NNS B-NP O
1 CD O O
, , O O
aVL NN B-NP O
, , O O
V2 NNP B-NP O
, , O O
and CC O O
V3 NNP B-NP O
SUMMARY: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
42-year-old JJ O O
morbidly RB O O
obese JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus RB O O
complicated VBN O O
by IN B-VP O
BKA NNP B-NP O
on IN B-VP O
two CD O O
prior JJ B-NP O
occasions NNS I-NP O
, , O O
who WP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
MICU NNP I-NP O
with IN B-VP O
a DT B-NP O
BKA NNP I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
urosepsis NN B-NP O
and CC O O
a DT B-NP O
non-Q-wave JJ I-NP O
MI NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Her NNP I-NP O
hospital NN I-NP O
course NN I-NP O
by IN B-VP O
systems NNS B-NP O
is VBZ O O
as IN B-VP O
follows: JJ O O
1 CD O O
ENDOCRINE: NNP B-NP O
As IN B-VP O
noted VBN O O
above IN B-VP O
, , O O
the DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
BKA NNP B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
urosepsis NN B-NP O
and CC O O
a DT B-NP O
non-Q-wave JJ I-NP B-r
MI NNP I-NP I-r
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
an DT B-NP O
insulin NN I-NP B-m
drip NN I-NP I-m
and CC O O
hydrated VBN O O
with IN B-VP O
intravenous JJ B-NP B-mo
fluids NNS I-NP O
, , O O
with IN B-VP O
improvement NN B-NP O
She PRP O O
was VBD B-VP O
eventually RB O O
transitioned VBN O O
to TO O O
NPH NNP B-NP B-m
with IN B-VP O
insulin NN B-NP O
sliding VBG O B-do
scale JJ B-NP I-do
coverage NN I-NP O
Despite IN B-VP O
escalating VBG O O
her PRP$ O O
dose NN B-NP O
of IN B-VP O
NPH NNP B-NP B-m
up RB O O
to TO O O
65 CD O B-do
U NNP B-NP I-do
subcu NN I-NP B-mo
b.i.d NN I-NP B-f
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
she PRP O O
continued VBD B-VP O
to TO O O
have VB O O
elevated VBN O B-r
elevated JJ B-NP B-r
blood NN I-NP I-r
blood NN I-NP I-r
sugars NNS I-NP I-r
sugars VBZ O I-r
&gt;200 JJ O O
and CC O O
required JJ B-NP O
coverage NN I-NP O
with IN B-VP O
insulin NN B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
This DT B-NP O
issue NN I-NP O
will MD O O
need VB O O
to TO O O
be VB O O
addressed VBN O O
as IN B-VP O
an DT O O
outpatient JJ O O
2 CD O O
PULMONARY: NNP B-NP O
Posthydration NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increasing VBG O O
respiratory JJ B-NP O
rates NNS I-NP O
and CC O O
O2 NNP B-NP O
requirements NNS I-NP O
and CC O O
rales NNS B-NP O
on IN B-VP O
exam NN B-NP O
As IN B-VP O
her PRP$ O O
creatinine NN B-NP O
had VBD B-VP O
improved VBN O O
concurrent NN B-NP O
with IN B-VP O
hydration NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
gently RB O O
diuresed VBN O O
An DT B-NP O
echocardiogram NN I-NP O
was VBD B-VP O
obtained VBN O O
to TO O O
assess VB O O
her PRP$ O O
left JJ B-NP O
ventricular JJ I-NP O
function NN I-NP O
in IN B-VP O
the DT B-NP O
context NN I-NP O
of IN B-VP O
her PRP$ O O
non-Q-wave JJ B-NP O
MI NNP I-NP O
, , O O
which WDT O O
was VBD B-VP O
notable JJ O O
for IN B-VP O
normal JJ O O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
, , O O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
50% CD O O
, , O O
hypokinesis NN B-NP O
of IN B-VP O
the DT B-NP O
inferior JJ I-NP O
septum NN I-NP O
, , O O
a DT B-NP O
right JJ I-NP O
ventricle NN I-NP O
that WDT O O
was VBD B-VP O
mildly RB O O
enlarged VBN O O
, , O O
with IN B-VP O
mildly RB O O
decreased VBN O O
systolic JJ B-NP O
function NN I-NP O
, , O O
normal JJ B-NP O
aortic JJ I-NP O
valve NN I-NP O
, , O O
mild JJ B-NP O
TR NNP I-NP O
, , O O
and CC O O
mild JJ B-NP O
MR NNP I-NP O
, , O O
and CC O O
a DT B-NP O
pulmonary JJ I-NP O
artery NN I-NP O
pressure NN I-NP O
of IN B-VP O
39 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
plus CC O O
right JJ B-NP O
atrial JJ I-NP O
pressure NN I-NP O
consistent JJ O O
with IN B-VP O
pulmonary JJ B-NP O
hypertension NN I-NP O
and CC O O
no DT B-NP O
pericardial JJ I-NP O
effusion NN I-NP O
With IN B-VP O
her PRP$ O O
body NN B-NP O
habitus NN I-NP O
putting VBG O O
her PRP$ O O
at IN B-VP O
risk NN B-NP O
for IN B-VP O
DVT NNP B-NP O
and CC O O
PE NNP B-NP O
, , O O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
showed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
pulmonary JJ B-NP O
hypertension NN I-NP O
raised VBD B-VP O
the DT B-NP O
concern NN I-NP O
for IN B-VP O
PE NNP B-NP O
being VBG O O
responsible JJ O O
for IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
of IN B-VP O
tachypnea NN B-NP O
and CC O O
tachycardia VB O O
A NNP B-NP O
spiral JJ B-NP O
CT NNP I-NP O
was VBD B-VP O
obtained VBN O O
that IN B-VP O
was VBD B-VP O
nondiagnostic JJ O O
secondary JJ O O
to TO O O
her PRP$ O O
body NN B-NP O
habitus VBZ O O
A NNP B-NP O
VQ NNP I-NP O
scan NN I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
which WDT O O
was VBD B-VP O
read VBN O O
as IN B-VP O
low JJ B-NP O
probability NN I-NP O
for IN B-VP O
PE NNP B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
also RB O O
had VBD B-VP O
negative JJ B-NP O
LENIs NNP I-NP O
These DT B-NP O
studies NNS I-NP O
taken VBN O O
together RB O O
alleviated VBD B-VP O
the DT B-NP O
concern NN I-NP O
of IN B-VP O
PE NNP B-NP O
or CC O O
DVT NNP B-NP O
in IN B-VP O
her PRP$ O O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
likely RB O O
had VBD B-VP O
obstructive JJ B-NP O
sleep JJ I-NP O
apnea NN I-NP O
secondary JJ O O
to TO O O
her PRP$ O O
body NN B-NP O
habitus NN I-NP O
She PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
CPAP NNP B-NP O
during IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
stay; NN I-NP O
however RB O O
, , O O
the DT B-NP O
patient NN I-NP O
informed VBD B-VP O
the DT B-NP O
treating NN I-NP O
team NN I-NP O
that IN B-VP O
she PRP O O
would MD O O
not RB O O
be VB O O
using VBG O O
a DT B-NP O
CPAP NNP I-NP O
machine NN I-NP O
once RB O O
she PRP O O
returned VBD B-VP O
home RB O O
secondary JJ O O
to TO O O
the DT B-NP O
inconvenience NN I-NP O
and CC O O
discomfort NN B-NP O
3 CD O O
ID: NNP B-NP O
On IN B-VP O
admission NN B-NP O
to TO O O
MICU NNP B-NP O
, , O O
given VBN O O
her PRP$ O O
positive JJ B-NP O
urinalysis NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
cefotaxime NN B-NP B-m
for IN B-VP O
gram JJ B-NP B-r
negative JJ I-NP I-r
coverage NN I-NP I-r
Both DT O O
her PRP$ O O
blood NN B-NP O
cultures NNS I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
grew VBD B-VP O
out RP O O
E NNP B-NP O
coli NNS I-NP O
which WDT O O
were VBD B-VP O
sensitive JJ O O
to TO O O
cefotaxime VB O B-m
and CC O O
gentamycin VB O B-m
As IN B-VP O
she PRP O O
initially RB O O
continued VBD B-VP O
to TO O O
be VB O O
febrile JJ O O
and CC O O
continued VBN O O
to TO O O
have VB O O
positive JJ B-NP O
blood NN I-NP O
cultures NNS I-NP O
, , O O
one CD O B-do
dose NN B-NP O
of IN B-VP O
gentamycin NN B-NP B-m
was VBD B-VP O
given VBN O O
for IN B-VP O
synergy NN B-NP B-r
Subsequently NNP I-NP O
, , O O
she PRP O O
improved VBD B-VP O
She PRP O O
remains VBZ O O
on IN B-VP O
IV NNP B-NP B-mo
cefotaxime NN I-NP B-m
for IN B-VP B-du
the DT B-NP I-du
7-day JJ I-NP I-du
period NN I-NP I-du
that IN B-VP O
she PRP O O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
On IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
switched VBN O O
to TO O O
p.o VB O B-mo
levofloxacin NN B-NP B-m
and CC O O
will MD O O
take VB O O
7 CD O B-du
7 CD O B-du
days NNS B-NP I-du
days NNS I-NP I-du
of IN B-VP O
p.o JJ B-NP B-mo
levofloxacin NN I-NP B-m
to TO O O
complete VB O O
a DT B-NP O
total JJ I-NP O
14-day JJ I-NP B-du
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
for IN B-VP O
urosepsis JJ B-NP B-r
urosepsis NN I-NP B-r
4 CD O O
CARDIOVASCULAR: NNP B-NP O
Patient NNP I-NP O
ruled VBD B-VP O
in IN B-VP O
for IN B-VP O
a DT B-NP O
non-Q-wave JJ I-NP O
MI NNP I-NP O
by IN B-VP O
EKG NNP B-NP O
and CC O O
enzymes VBZ O O
Her NNP B-NP O
peak NN I-NP O
CK NNP I-NP O
was VBD B-VP O
1200 CD O O
, , O O
with IN B-VP O
a DT B-NP O
troponin NN I-NP O
of IN B-VP O
1.52 CD O O
She PRP O O
was VBD B-VP O
initially RB O O
placed VBN O O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
heparin NN B-NP B-m
, , O O
and CC O O
a DT B-NP O
beta NN I-NP B-m
blocker NN I-NP I-m
Once IN B-VP O
her PRP$ O O
creatinine NN B-NP O
normalized VBN O O
, , O O
an DT B-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
was VBD B-VP O
also RB O O
added JJ B-NP O
Heparin NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
once RB O O
the DT B-NP O
concern NN I-NP O
for IN B-VP O
PE NNP B-NP B-r
was VBD B-VP O
alleviated VBN O O
Her NNP B-NP O
beta NN I-NP B-m
blocker NN I-NP I-m
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
were VBD B-VP O
titrated VBN O B-do
titrated VBN O B-do
up RP O I-do
up RB O I-do
for IN B-VP O
a DT B-NP O
goal NN I-NP O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
&lt;140 NN B-NP O
and CC O O
a DT B-NP O
pulse NN I-NP O
of IN B-VP O
&lt;70 NNP B-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
7 CD O O
, , O O
where WRB O O
she PRP O O
remained VBD B-VP O
stable JJ O O
Another DT B-NP O
guanosine NN I-NP O
MIBI NNP I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
as IN B-VP O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
that IN B-VP O
she PRP O O
would MD O O
be VB O O
unable JJ O O
to TO O O
exercise VB O O
, , O O
given VBN O O
her PRP$ O O
chronic JJ O O
low JJ O O
back RB O O
pain NN B-NP O
and CC O O
sciatica VB O O
A NNP B-NP O
planar NN I-NP O
study NN I-NP O
was VBD B-VP O
done VBN O O
secondary JJ O O
to TO O O
her PRP$ O O
body NN B-NP O
habitus NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
moderate JJ I-NP O
sized JJ I-NP O
area NN I-NP O
of IN B-VP O
prior JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
throughout IN B-VP O
the DT B-NP O
mid NN I-NP O
LAD NNP I-NP O
coronary JJ B-NP O
territory NN I-NP O
, , O O
with IN B-VP O
moderate JJ B-NP O
residual JJ I-NP O
peri-infarct NN I-NP O
ischemia NN I-NP O
The DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
did VBD B-VP O
not RB O O
feel VB O O
that IN B-VP O
the DT B-NP O
degree NN I-NP O
of IN B-VP O
this DT B-NP O
lesion NN I-NP O
warranted VBD B-VP O
catheterization NN B-NP O
, , O O
given VBN O O
the DT B-NP O
sizable JJ I-NP O
risk NN I-NP O
of IN B-VP O
catheterization NN B-NP O
in IN B-VP O
her PRP$ O O
5 CD O O
RENAL: NNP B-NP O
On IN B-VP O
presentation NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
2.1 CD O O
, , O O
up RB O O
from IN B-VP O
her PRP$ O O
baseline NN B-NP O
of IN B-VP O
1.4 CD O O
She PRP O O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
secondary JJ B-NP O
dehydration NN I-NP O
, , O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
diabetic JJ B-NP O
ketoacidosis NN I-NP O
She PRP O O
was VBD B-VP O
rehydrated VBN O O
and CC O O
concurrent JJ O O
with IN B-VP O
this DT O O
her PRP$ O O
creatinine NN B-NP O
returned VBD B-VP O
to TO O O
her PRP$ O O
baseline NN B-NP O
and CC O O
remained VBD B-VP O
stable JJ O O
thereafter RB O O
6 CD O O
GI: NNP B-NP O
On IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
MICU NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
GI NNP B-NP B-r
prophylaxis NN I-NP O
with IN B-VP O
Carafate NNP B-NP B-m
Carafate NNP I-NP B-m
Once NNP I-NP O
she PRP O O
was VBD B-VP O
tolerating VBG O O
p.o.'s NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
an DT B-NP O
ADA NNP I-NP O
diet NN I-NP O
and CC O O
her PRP$ O O
Carafate NNP B-NP O
was VBD B-VP O
discontinued VBN O O
prior RB O O
to TO O O
discharge VB O O
Once RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
diarrhea; NN B-NP O
however RB O O
, , O O
the DT B-NP O
nurses NNS I-NP O
did VBD B-VP O
not RB O O
witness JJ O O
and CC O O
were VBD B-VP O
unable JJ O O
to TO O O
obtain VB O O
a DT B-NP O
stool NN I-NP O
sample NN I-NP O
to TO O O
check VB O O
for IN B-VP O
C NNP B-NP O
diff NN I-NP O
toxin NN I-NP O
Patient NNP I-NP O
was VBD B-VP O
treated VBN O O
symptomatically RB O O
with IN B-VP O
Imodium NNP B-NP B-m
p.r.n NN I-NP B-f
diarrhea NN I-NP B-r
Prior NNP I-NP O
to TO O O
discharge VB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
counseled VBN O O
by IN B-VP O
the DT B-NP O
Nutrition NNP I-NP O
Service NNP I-NP O
regarding VBG O O
an DT B-NP O
appropriate JJ I-NP O
diabetic NN I-NP O
and CC O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
diet JJ O O
7 CD O O
PAIN: NNP B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
several JJ B-NP O
pain NN I-NP B-m
medicines NNS I-NP I-m
, , O O
including VBG O O
amitriptyline JJ B-NP B-m
amitriptyline NN I-NP B-m
, , O O
Flexeril NNP B-NP B-m
Flexeril NNP I-NP B-m
, , O O
and CC O O
Valium NNP B-NP B-m
Valium NNP I-NP B-m
for IN B-VP O
reported VBD B-VP O
history NN B-NP O
of IN B-VP O
sciatica NN B-NP B-r
sciatica NN I-NP B-r
sciatica NN I-NP B-r
and CC O O
low JJ B-NP B-r
low JJ I-NP B-r
low NN I-NP B-r
back RB O I-r
back RB O I-r
back RB O I-r
pain NN B-NP I-r
pain NN I-NP I-r
pain NN I-NP I-r
On IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
, , O O
these DT B-NP B-m
medications NNS I-NP O
were VBD B-VP O
discontinued VBN O O
and CC O O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Neurontin NNP B-NP B-m
for IN B-VP O
likely JJ B-NP B-r
diabetic JJ I-NP I-r
neuropathy JJ I-NP I-r
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric NNP I-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
Humulin NNP I-NP I-m
insulin NN I-NP I-m
65 CD O B-do
U NNP B-NP I-do
subcu NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
human JJ B-NP B-m
human JJ I-NP B-m
human JJ I-NP B-m
human JJ I-NP B-m
human JJ I-NP B-m
insulin NN I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
sliding VBG O B-do
scale: NN B-NP I-do
for IN B-VP O
blood NN B-NP B-r
sugars NNS I-NP I-r
151-200 JJ O O
give JJ O O
4 CD O B-do
U NNP B-NP I-do
, , O O
for IN B-VP O
blood NN B-NP B-r
sugars NNS I-NP I-r
201-250 JJ O O
give JJ O O
6 CD O B-do
U NNP B-NP I-do
, , O O
for IN B-VP O
blood NN B-NP B-r
sugars NNS I-NP I-r
251-300 JJ O O
give JJ O O
8 CD O B-do
U NNP B-NP O
, , O O
for IN B-VP O
blood NN B-NP B-r
sugars NNS I-NP I-r
301-350 JJ O O
give JJ O O
10 CD O B-do
U NNP B-NP I-do
, , O O
Imodium NNP B-NP B-m
2 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
6 CD O I-f
hrs NN B-NP I-f
p.r.n NN I-NP O
diarrhea NN I-NP B-r
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
nitroglycerin RB O B-m
1/150 CD O I-m
one CD O B-do
tab NN B-NP I-do
sublingual JJ B-NP B-mo
q NN I-NP B-f
5 CD O I-f
min NN B-NP I-f
x VBD B-VP I-f
3 CD O I-f
p.r.n JJ B-NP I-f
chest NN I-NP B-r
pain NN I-NP I-r
, , O O
multivitamin VB O B-m
one CD O B-do
tab NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
simvastatin VBD B-VP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
600 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
levofloxacin VBZ O B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
x $ O B-du
5 CD O I-du
days NNS B-NP I-du
, , O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
400 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d JJ B-NP B-f
CONDITION NNP I-NP O
UPON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
DISPOSITION: NNP I-NP O
Prior NNP I-NP O
to TO O O
discharge VB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
physical JJ I-NP O
therapist NN I-NP O
, , O O
who WP O O
noted VBD B-VP O
her PRP O O
to TO O O
walk VB O O
around IN B-VP O
the DT B-NP O
hospital NN I-NP O
Eldsche NNP I-NP O
St NNP I-NP O
, , O O
Lake NNP B-NP O
Corp NNP I-NP O
Ver NNP I-NP O
, , O O
Alaska NNP B-NP O
29176 CD O O
without IN B-VP O
significant JJ B-NP O
problems NNS I-NP O
They PRP O O
felt VBD B-VP O
that IN B-VP O
she PRP O O
would MD O O
be VB O O
safe JJ O O
to TO O O
discharge VB O O
to TO O O
home NN B-NP O
and CC O O
did VBD B-VP O
not RB O O
need VB O O
home NN B-NP O
PT NNP I-NP O
, , O O
but CC O O
agreed VBD B-VP O
that IN B-VP O
she PRP O O
would MD O O
benefit VB O O
from IN B-VP O
cardiac JJ B-NP O
rehab NN I-NP O
, , O O
for IN B-VP O
which WDT O O
she PRP O O
was VBD B-VP O
referred VBN O O
Patient NNP B-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
9 CD O O
, , O O
with IN B-VP O
VNA NNP B-NP O
, , O O
who WP O O
will MD O O
monitor VB O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
, , O O
pulse NN B-NP O
, , O O
and CC O O
blood NN B-NP O
sugar NN I-NP O
, , O O
and CC O O
contact VB O O
her PRP$ O O
PCP NNP B-NP O
with IN B-VP O
any DT B-NP O
concerns NNS I-NP O
or CC O O
questions NNS B-NP O
She PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
PCP NNP B-NP O
, , O O
Dr NNP B-NP O
Carmine NNP I-NP O
Guillebeau NNP I-NP O
, , O O
at IN B-VP O
WNDH NNP B-NP O
in IN B-VP O
one CD O O
week's NN B-NP O
time NN I-NP O
, , O O
and CC O O
she PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Sammie NNP I-NP O
Derobertis NNP I-NP O
of IN B-VP O
cardiology NN B-NP O
at IN B-VP O
Gons NNP B-NP O
Landgilesnyton NNP I-NP O
Dralvail NNP I-NP O
in IN B-VP O
May NNP B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
DAMIAN NNP I-NP O
TABISOLA NNP I-NP O
, , O O
M.D NNP B-NP O
D NNP I-NP O
Attending: NNP I-NP O
BRODERICK NNP I-NP O
TURPEN NNP I-NP O
, , O O
M.D NNP B-NP O
IJ11 NNP I-NP O
WE511/247457 NNP I-NP O
Batch: NNP I-NP O
33669 CD O O
Index NNP B-NP O
No NNP I-NP O
MKYNKN6RWB NNP I-NP O
D: NNP I-NP O
10/9/01 CD O O
T: NNP B-NP O
10/9/01 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#828964 VBZ O O
037061753 CD O O
NCPUMC NNP B-NP O
63134887 CD O O
477589 CD O O
0/24/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/16/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/19/1995 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
HYPERLIPIDEMIA NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Legions NNP I-NP O
is VBZ O O
a DT O O
54 CD O O
year NN B-NP O
old JJ B-NP O
professor NN I-NP O
at IN B-VP O
A NNP B-NP O
No NNP I-NP O
Sa NNP I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
( ( O O
5 CD O O
vessel NN B-NP O
bypass NN I-NP O
) ) O O
8 CD O O
years NNS B-NP O
ago RB O O
who WP O O
presents VBZ O O
with IN B-VP O
recurrent JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
times NNS I-NP O
one CD O O
day NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
Phlukester NNP B-NP O
Hospital NNP I-NP O
after IN B-VP O
developing VBG O O
the DT B-NP O
acute NN I-NP O
onset NN I-NP O
of IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
while IN B-VP O
driving VBG O O
his PRP$ O O
automobile NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
under IN B-VP O
no DT B-NP O
extraordinary JJ I-NP O
circumstances NNS I-NP O
( ( O O
e.g JJ B-NP O
emotional JJ I-NP O
stress NN I-NP O
, , O O
exertional JJ B-NP O
stress NN I-NP O
) ) O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
he PRP O O
developed VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
Since IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
his PRP$ O O
five CD O O
vessel NN B-NP O
CABG NNP I-NP O
in IN B-VP O
1987 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
experienced VBN O O
no DT O O
intercurrent JJ O O
angina VBZ O O
The DT B-NP O
patient's NN I-NP O
coronary JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
a DT B-NP O
positive JJ I-NP O
family NN I-NP O
history NN I-NP O
and CC O O
a DT B-NP O
previous JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
hyperlipidemia NN B-NP O
However RB O O
the DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
have VB O O
hypertension NN B-NP O
, , O O
diabetes NNS B-NP O
and CC O O
he PRP O O
is VBZ O O
not RB O O
a DT B-NP O
tobacco NN I-NP O
smoker NN I-NP O
As IN B-VP O
mentioned VBN O O
, , O O
the DT B-NP O
patient's NN I-NP O
chest NN I-NP O
pain NN I-NP O
was VBD B-VP O
substernal JJ O O
and CC O O
radiated VBD B-VP O
to TO O O
the DT B-NP O
upper JJ I-NP O
epigastrium NN I-NP O
He PRP O O
experienced VBD B-VP O
an DT B-NP O
element NN I-NP O
of IN B-VP O
burning VBG O O
with IN B-VP O
exertion NN B-NP O
Prior NNP I-NP O
to TO O O
this DT B-NP O
episode NN I-NP O
of IN B-VP O
recurrent NN B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
had VBN O O
multiple JJ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
tests NNS I-NP O
which WDT O O
were VBD B-VP O
read VBN O O
as IN B-VP O
normal JJ O O
He PRP O O
graded VBD B-VP O
the DT B-NP O
chest JJS I-NP O
pain NN I-NP O
at IN B-VP O
8/10 CD O O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
G NNP B-NP O
urgent NN I-NP O
care NN I-NP O
where WRB O O
his PRP$ O B-r
pain NN B-NP I-r
was VBD B-VP O
not RB O O
relieved VBN O O
with IN B-VP O
four CD O B-do
sublingual JJ O B-mo
nitroglycerin RB O B-m
An DT B-NP O
EKG NNP I-NP O
demonstrated VBD B-VP O
lateral JJ B-NP O
ST NNP I-NP O
wave NN I-NP O
depressions NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
Skaggssin NNP B-NP O
Hospital NNP I-NP O
where WRB O O
IV NNP B-NP B-mo
TNG NNP I-NP B-m
, , O O
morphine NN B-NP B-m
and CC O O
Nifedipine NNP B-NP B-m
were VBD B-VP O
given VBN O O
The DT B-NP O
patient's NN I-NP O
pain NN I-NP O
decreased VBD B-VP O
to TO O O
a DT B-NP O
level NN I-NP O
of IN B-VP O
4/10 CD O O
Despite IN B-VP O
these DT B-NP O
maneuvers NNS I-NP O
, , O O
the DT B-NP B-r
patient's NN I-NP I-r
pain NN I-NP I-r
continued VBD B-VP O
through IN B-VP O
the DT B-NP O
night NN I-NP O
and CC O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
In IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
he PRP O O
received VBD B-VP O
additional JJ B-NP O
morphine NN I-NP B-m
and CC O O
IV NNP B-NP B-mo
Heparin NNP I-NP B-m
was VBD B-VP O
begun VBN O O
Subsequently RB O O
the DT B-NP O
patient NN I-NP O
became VBD B-VP O
pain-free JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
Ck NNP B-NP O
Health NNP I-NP O
Of IN B-VP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hyperlipidemia NNP I-NP O
Bilateral NNP I-NP O
anterior NN I-NP O
and CC O O
lateral JJ B-NP O
thigh JJ I-NP O
achiness NN I-NP O
with IN B-VP O
exertion NN B-NP O
times NNS I-NP O
six CD O O
months NNS B-NP O
( ( O O
workup NN B-NP O
in IN B-VP O
progress NN B-NP O
) ) O O
MEDICATIONS: NN B-NP O
On IN B-VP O
presentation NN B-NP O
to TO O O
Menjack NNP B-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
Lovastatin NNP B-NP B-m
Lovastatin NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
q.m NN I-NP I-f
, , O O
20 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
p.m NN I-NP I-f
and CC O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
one CD O B-do
tablet NN B-NP I-do
q NN I-NP B-f
day NN I-NP I-f
MEDICATIONS NNP I-NP O
ON NNP I-NP O
TRANSFER NNP I-NP O
FROM NNP I-NP O
A,XO NNP I-NP O
COMMUNITY NNP I-NP O
HOSPITAL NNP I-NP O
IV NNP I-NP B-mo
nitroglycerin NN I-NP B-m
, , O O
IV NNP B-NP B-mo
heparin NN I-NP B-m
, , O O
Nifedipine NNP B-NP B-m
SL NNP I-NP B-mo
, , O O
morphine NN B-NP B-m
as RB O O
well RB O O
as IN B-VP O
aspirin NN B-NP B-m
and CC O O
Lovastatin NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
father NN I-NP O
developed VBD B-VP O
angina RB O O
secondary JJ O O
to TO O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
at IN B-VP O
age NN B-NP O
54 CD O O
and CC O O
died VBD B-VP O
at IN B-VP O
age NN B-NP O
75 CD O O
from IN B-VP O
an DT B-NP O
MI NNP I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
He PRP O O
works VBZ O O
as IN B-VP O
a DT B-NP O
professor NN I-NP O
at IN B-VP O
Rieglemoinesro NNP B-NP O
A NNP I-NP O
Shing NNP I-NP O
and CC O O
restores VBZ O O
buildings NNS B-NP O
in IN B-VP O
his PRP$ O O
free JJ B-NP O
time NN I-NP O
HABITS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
tobacco NN B-NP O
use NN I-NP O
He PRP O O
is VBZ O O
an DT B-NP O
occasional JJ I-NP O
alcohol NN I-NP O
drinker NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
Mr NNP B-NP O
Latimer NNP I-NP O
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
middle-aged JJ I-NP O
man NN I-NP O
, , O O
mildly RB O O
anxious JJ O O
but CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
on IN B-VP O
transfer: JJ B-NP O
temperature NN I-NP O
98.6 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
78 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
110/78 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
22 CD O O
with IN B-VP O
oxygen JJ B-NP O
saturation NN I-NP O
of IN B-VP O
99% CD O O
on IN B-VP O
4 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
HEENT: NNP I-NP O
unremarkable JJ B-NP O
Neck: NNP I-NP O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
( ( O O
JVP NNP B-NP O
less JJR O O
than IN B-VP O
6 CD O O
cm NN B-NP O
) ) O O
, , O O
carotids NNS B-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
with IN B-VP O
no DT B-NP O
bruits NNS I-NP O
or CC O O
delayed VBN O O
upstroke JJ B-NP O
Lungs: NNP I-NP O
clear JJ O O
with IN B-VP O
good JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
bilaterally RB O O
Coronary: NNP B-NP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
good JJ B-NP O
heart NN I-NP O
sounds NNS I-NP O
and CC O O
a DT B-NP O
clear JJ I-NP O
Sl NNP I-NP O
and CC O O
S2 NNP B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
rubs NN I-NP O
, , O O
murmurs NNS B-NP O
or CC O O
gallops NNS B-NP O
appreciated VBD B-VP O
There EX O O
was VBD B-VP O
no DT B-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
The DT B-NP O
point NN I-NP O
of IN B-VP O
maximum JJ B-NP O
impulse NN I-NP O
was VBD B-VP O
not RB O O
displaced VBN O O
The DT B-NP O
patient's NN I-NP O
spine NN I-NP O
was VBD B-VP O
not RB O O
tender NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
costovertebral JJ B-NP O
angle NN I-NP O
tenderness NN I-NP O
Abdomen NNP I-NP O
had VBD B-VP O
good JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
and CC O O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP O
to TO O O
palpation VB O O
No DT B-NP O
masses NNS I-NP O
were VBD B-VP O
palpated VBN O O
Groin NNP B-NP O
demonstrated VBD B-VP O
decreased JJ B-NP O
femoral JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
with IN B-VP O
a DT B-NP O
faint NN I-NP O
left VBD B-VP O
femoral JJ B-NP O
bruit NN I-NP O
Rectal: NNP I-NP O
normal JJ B-NP O
rectal JJ I-NP O
tone NN I-NP O
with IN B-VP O
an DT B-NP O
anodular JJ I-NP O
prostate NN I-NP O
Stool NNP I-NP O
was VBD B-VP O
soft JJ O O
, , O O
brown JJ O O
and CC O O
guaiac JJ B-NP O
negative JJ I-NP O
Extremities NNS I-NP O
demonstrated VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema VB O O
The DT B-NP O
patient's NN I-NP O
pulses VBZ O O
at IN B-VP O
the DT B-NP O
dorsalis NN I-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibialis NNS I-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
Neurologic NNP B-NP O
examination NN I-NP O
was VBD B-VP O
nonfocal JJ B-NP O
Electrolytes NNS I-NP O
on IN B-VP O
presentation NN B-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
His PRP$ O O
LFTs NNP B-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
slight JJ I-NP O
increase NN I-NP O
in IN B-VP O
his PRP$ O O
LDH NNP B-NP O
to TO O O
252 CD O O
The DT B-NP O
patient's NN I-NP O
first RB O O
CK NNP B-NP O
on IN B-VP O
presentation NN B-NP O
was VBD B-VP O
2300 CD O O
with IN B-VP O
a DT B-NP O
quantitative JJ I-NP O
MB NNP I-NP O
of IN B-VP O
10.2 CD O O
ng/ml NNS B-NP O
Cholesterol NNP I-NP O
was VBD B-VP O
79 CD O O
Albumin NNP B-NP O
2.8 CD O O
Protime NNP B-NP O
12.4 CD O O
, , O O
INR NNP B-NP O
1.1 CD O O
PTT NNP B-NP O
40.7 CD O O
, , O O
consistent NN B-NP O
with IN B-VP O
heparin JJ B-NP B-m
therapy NN I-NP O
CBC NNP I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
normal JJ I-NP O
white JJ I-NP O
count NN I-NP O
, , O O
hematocrit NN B-NP O
and CC O O
platelet NN B-NP O
count NN I-NP O
Urine NNP I-NP O
had VBD B-VP O
a DT B-NP O
specific JJ I-NP O
gravity NN I-NP O
of IN B-VP O
1.021 CD O O
, , O O
pH NN B-NP O
5 CD O O
, , O O
negative JJ B-NP O
dipstick NN I-NP O
evaluation NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
demonstrated VBD B-VP O
clear JJ B-NP O
lung NN I-NP O
parenchyma NN I-NP O
and CC O O
no DT B-NP O
bony NN I-NP O
abnormalities VBZ O O
EKG NNP B-NP O
on IN B-VP O
admission NN B-NP O
to TO O O
Raldmance NNP B-NP O
Mountbay NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
73 CD O O
with IN B-VP O
normal JJ B-NP O
intervals NNS I-NP O
and CC O O
an DT B-NP O
axis NN I-NP O
of IN B-VP O
0 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
Q NNP B-NP O
waves NNS I-NP O
in IN B-VP O
leads NNS B-NP O
3 CD O O
and CC O O
F NNP B-NP O
and CC O O
biphasic JJ B-NP O
T NNP I-NP O
waves NNS I-NP O
in IN B-VP O
leads NNS B-NP O
V4 NNP I-NP O
through IN B-VP O
V6 NNP B-NP O
There EX O O
was VBD B-VP O
minimal JJ B-NP O
change NN I-NP O
in IN B-VP O
these DT B-NP O
abnormalities NNS I-NP O
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
pain NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
EKGs NNP B-NP O
taken VBN O O
at IN B-VP O
Townileahli NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
during IN B-VP O
the DT B-NP O
patient's JJ I-NP O
initial JJ I-NP O
admission NN I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
T NNP B-NP O
wave VBP O O
depressions NNS B-NP O
in IN B-VP O
leads NNS B-NP O
V4 NNP I-NP O
through IN B-VP O
V6 NNP B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
on IN B-VP O
IV NNP B-NP B-mo
heparin NN I-NP B-m
and CC O O
nitroglycerine NN B-NP B-m
as RB O O
well RB O O
as IN B-VP O
continuation NN B-NP O
of IN B-VP O
his PRP$ O O
aspirin NN B-NP B-m
and CC O O
Lovastatin NNP B-NP B-m
The DT B-NP B-r
patient's NN I-NP I-r
pain NN I-NP I-r
was VBD B-VP O
treated VBN O O
with IN B-VP O
morphine NN B-NP B-m
sulfate NN I-NP I-m
His PRP$ O O
CKs NNP B-NP O
were VBD B-VP O
followed VBN O O
serially RB O O
every DT O O
8 CD O O
hours NNS B-NP O
and CC O O
achieved VBD B-VP O
a DT B-NP O
peak JJ I-NP O
CK NNP I-NP O
of IN B-VP O
2790 CD O O
on IN B-VP O
2/15/95 CD O O
at IN B-VP O
12 CD O O
a.m NN B-NP O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
of IN B-VP O
188.8 CD O O
ng/ml JJ B-NP O
Thereafter NNP I-NP O
the DT B-NP O
patient's NN I-NP O
CKs NNP I-NP O
rapidly RB O O
declined VBD B-VP O
On IN B-VP O
3/26/94 CD O O
, , O O
the DT B-NP O
patient's NN I-NP O
CK NNP I-NP O
was VBD B-VP O
317 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
of IN B-VP O
3.5 CD O O
ng/ml NNS B-NP O
After IN B-VP O
24 CD O O
hours NNS B-NP O
pain-free JJ O O
in IN B-VP O
the DT B-NP O
Cardiac NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Step-Down NNP I-NP O
floor NN I-NP O
His PRP$ O O
IV NNP B-NP B-mo
nitroglycerin NN I-NP B-m
and CC O O
IV NNP B-NP B-mo
heparin NN I-NP B-m
were VBD B-VP O
discontinued VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
pain-free JJ B-NP O
Echocardiogram NNP I-NP O
performed VBD B-VP O
on IN B-VP O
2/15/95 CD O O
demonstrated JJ B-NP O
inferior NN I-NP O
and CC O O
posterior JJ B-NP O
hypokinesis NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
approximately RB O O
46% CD O O
On IN B-VP O
3/21/95 CD O O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
testing VBG O O
with IN B-VP O
a DT B-NP O
submax NN I-NP O
modified VBN O O
Bruce NNP B-NP O
protocol VBZ O O
The DT B-NP O
patient NN I-NP O
exercised VBD B-VP O
9 CD O O
minutes NNS B-NP O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
complete VB O O
the DT B-NP O
study NN I-NP O
without IN B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
or CC O O
chest NN B-NP O
pain NN I-NP O
He PRP O O
achieved VBD B-VP O
a DT B-NP O
maximum JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
108 CD O O
and CC O O
a DT B-NP O
maximum JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
160/80 CD O O
EKG NNP B-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
unifocal JJ B-NP O
PVCs NNP I-NP O
and CC O O
up RB O O
to TO O O
2 CD O O
mm NNS B-NP O
ST NNP I-NP B-r
depression NN I-NP I-r
in IN B-VP O
leads NNS B-NP O
V2 NNP I-NP O
through IN B-VP O
V4 NNP B-NP O
which WDT O O
persisted VBD B-VP O
up RB O O
to TO O O
15 CD O O
minutes NNS B-NP O
into IN B-VP O
recovery NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
one CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
and CC O O
these DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
resolved VBD B-VP O
The DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
was VBD B-VP O
interpreted VBN O O
as IN B-VP O
strongly RB O O
positive JJ O O
for IN B-VP O
ischemic JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
On IN B-VP O
3/28/95 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
submax NN I-NP O
MIBI NNP I-NP O
to TO O O
assess VB O O
coronary JJ B-NP O
perfusion NN I-NP O
of IN B-VP O
the DT B-NP O
heart NN I-NP O
Similarly NNP I-NP O
, , O O
the DT B-NP O
exercise NN I-NP O
component NN I-NP O
of IN B-VP O
this DT B-NP O
examination NN I-NP O
demonstrated VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
consistent VBP O O
with IN B-VP O
ischemic JJ B-NP O
coronary JJ I-NP O
flow NN I-NP O
Nuclear NNP I-NP O
imaging NN I-NP O
demonstrated VBD B-VP O
a DT B-NP O
fixed JJ I-NP O
apical JJ I-NP O
lateral JJ I-NP O
defect NN I-NP O
in IN B-VP O
the DT B-NP O
patient's JJ I-NP O
heart NN I-NP O
consistent NN I-NP O
with IN B-VP O
a DT O O
healed VBN O O
or CC O O
healing VBG O O
transmural JJ B-NP O
infarct NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemic JJ B-NP O
reperfusion NN I-NP O
defects VBZ O O
The DT B-NP O
results NNS I-NP O
of IN B-VP O
these DT B-NP O
tests NNS I-NP O
were VBD B-VP O
discussed VBN O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
his PRP$ O O
wife NN B-NP O
in IN B-VP O
conjunction NN B-NP O
with IN B-VP O
the DT O O
treating VBG O O
medical JJ B-NP O
team NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Settecase NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
offered VBN O O
the DT B-NP O
opportunity NN I-NP O
for IN B-VP O
coronary JJ B-NP O
catheterization NN I-NP O
to TO O O
evaluate VB O O
his PRP$ O O
anatomy NN B-NP O
, , O O
but CC O O
he PRP O O
declined VBD B-VP O
at IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
It PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
be VB O O
maximally RB O O
medically RB O O
managed VBN O O
and CC O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
close JJ B-NP O
followup NNS I-NP O
under IN B-VP O
Dr NNP B-NP O
Cockburn NNP I-NP O
and CC O O
Dr NNP B-NP O
Stenkamp NNP I-NP O
The DT B-NP O
patient's NN I-NP O
cardiac JJ B-NP B-m
medications NNS I-NP I-m
were VBD B-VP O
appropriately RB O O
adjusted VBN O O
while IN B-VP O
an DT B-NP O
inpatient NN I-NP O
to TO O O
achieve VB O O
maximum JJ B-NP O
cardiac JJ I-NP O
benefit NN I-NP O
On IN B-VP O
presentation NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
also RB O O
complained VBD B-VP O
of IN B-VP O
progressive JJ B-NP O
anterior NN I-NP O
and CC O O
lateral JJ B-NP O
thigh NN I-NP O
pain NN I-NP O
This DT B-NP O
pain NN I-NP O
was VBD B-VP O
brought VBN O O
on IN B-VP O
by IN B-VP O
exertion NN B-NP O
and CC O O
had VBD B-VP O
increasingly RB O O
limited VBN O O
his PRP$ O O
ability NN B-NP O
to TO O O
walk VB O O
over IN B-VP O
the DT O O
last JJ O O
six CD O O
months NNS B-NP O
whereas IN B-VP O
he PRP O O
had VBD B-VP O
been VBN O O
able JJ O O
to TO O O
walk VB O O
four CD O O
to TO O O
five CD O O
miles NNS B-NP O
a DT B-NP O
day NN I-NP O
in IN B-VP O
recent JJ B-NP O
months NNS I-NP O
He PRP O O
had VBD B-VP O
been VBN O O
able JJ O O
to TO O O
walk VB O O
only RB O O
approximately RB O O
one-quarter JJ B-NP O
mile NN I-NP O
before IN B-VP O
developing VBG O O
pain NN B-NP O
in IN B-VP O
his PRP$ O O
anterior JJ B-NP O
thighs NNS I-NP O
as RB O O
well RB O O
whereas IN B-VP O
he PRP O O
had VBD B-VP O
been VBN O O
able JJ O O
to TO O O
climb VB O O
several JJ B-NP O
flights NNS I-NP O
of IN B-VP O
stairs NNS B-NP O
a DT B-NP O
few JJ I-NP O
months NNS I-NP O
ago IN B-VP O
He PRP O O
now RB O O
was VBD B-VP O
able JJ O O
to TO O O
walk VB O O
only RB O O
half PDT O O
a DT B-NP O
flight NN I-NP O
to TO O O
a DT B-NP O
flight NN I-NP O
of IN B-VP O
stairs NNS B-NP O
at IN B-VP O
a DT B-NP O
time NN I-NP O
before IN B-VP O
having VBG O O
to TO O O
rest VB O O
Six CD O O
months NNS B-NP O
ago RB O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
achieved VBN O O
a DT O O
25 CD O O
pound NN B-NP O
weight VBD B-VP O
loss NN B-NP O
but CC O O
, , O O
by IN B-VP O
his PRP$ O O
report NN B-NP O
, , O O
because IN B-VP O
of IN B-VP O
his PRP$ O O
inability NN B-NP O
to TO O O
exercise VB O O
effectively RB O O
, , O O
he PRP O O
had VBD B-VP O
regained VBN O O
15 CD O O
pounds NNS B-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
experience VB O O
this DT B-NP O
same JJ I-NP O
anterior JJ I-NP O
thigh NN I-NP O
pain NN I-NP O
while IN B-VP O
riding VBG O O
a DT B-NP O
bicycle NN I-NP O
or CC O O
swimming NN B-NP O
As IN B-VP O
an DT B-NP O
inpatient NN I-NP O
, , O O
Mr NNP B-NP O
Woollen NNP I-NP O
underwent VBD B-VP O
a DT B-NP O
non-invasive JJ I-NP O
vascular NN I-NP O
study NN I-NP O
of IN B-VP O
the DT O O
femoral JJ O O
and CC O O
popliteal JJ B-NP O
arteries NNS I-NP O
These DT O O
demonstrated VBD B-VP O
no DT B-NP O
significant JJ I-NP O
arterial JJ I-NP O
occlusions NNS I-NP O
as IN B-VP O
assessed VBN O O
by IN B-VP O
pressure NN B-NP O
manometry NN I-NP O
The DT B-NP O
possibility NN I-NP O
of IN B-VP O
myositis NN B-NP O
or CC O O
neuromuscular JJ B-NP O
compromise NN I-NP O
was VBD B-VP O
entertained VBN O O
and CC O O
these DT O O
are VBP O O
to TO O O
be VB O O
followed VBN O O
up RP O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
complained VBD B-VP O
of IN B-VP O
symptoms NNS B-NP O
consistent JJ O O
with IN B-VP O
an DT B-NP O
upper JJ I-NP O
respiratory NN I-NP O
viral JJ B-NP O
infection NN I-NP O
which WDT O O
he PRP O O
had VBD B-VP O
been VBN O O
experiencing VBG O O
over IN B-VP O
the DT O O
past JJ O O
two CD O O
weeks NNS B-NP O
While IN B-VP O
an DT B-NP O
inpatient NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
number NN I-NP O
of IN B-VP O
febrile JJ B-NP O
episodes NNS I-NP O
, , O O
achieving VBG O O
a DT B-NP O
maximum JJ I-NP O
temperature NN I-NP B-r
temperature NN I-NP B-r
of IN B-VP O
101.4 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
symptomatically RB O O
with IN B-VP O
Tylenol NNP B-NP B-m
and CC O O
started VBD B-VP O
on IN B-VP O
Biaxin NNP B-NP B-m
500 CD O B-do
mg NN B-NP O
po NN I-NP B-mo
bid NN I-NP B-f
He PRP O O
received VBD B-VP O
a DT O O
five CD O B-du
day NN B-NP I-du
course NN I-NP I-du
of IN B-VP O
oral JJ B-NP B-mo
Biaxin NNP I-NP B-m
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
his PRP$ O O
fever NN B-NP B-r
and CC O O
decrease NN B-NP O
in IN B-VP O
his PRP$ O O
symptomatology NN B-NP O
The DT B-NP O
patient NN I-NP O
never RB O O
complained VBD B-VP O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
diaphoresis NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
or CC O O
recurrent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
as IN B-VP O
an DT B-NP O
inpatient NN I-NP O
However RB O O
physical JJ B-NP O
examination NN I-NP O
demonstrated VBD B-VP O
rales NNS B-NP O
4 CD O O
to TO O O
5 CD O O
cm NNS B-NP O
above IN B-VP O
the DT B-NP O
bases NNS I-NP O
bilaterally RB O O
The DT B-NP O
extremities NNS I-NP O
remained VBD B-VP O
free JJ O O
of IN B-VP O
edema NN B-NP O
and CC O O
the DT B-NP O
patient's NN I-NP O
jugular NN I-NP O
venous JJ B-NP O
pressure NN I-NP O
never RB O O
exceeded VBD B-VP O
6 CD O O
cm NN B-NP O
A DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
on IN B-VP O
0/26/95 CD O O
demonstrated JJ B-NP O
evidence NN I-NP O
of IN B-VP O
early JJ B-NP B-r
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
daily JJ B-NP B-f
doses NNS I-NP O
of IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
his PRP$ O O
rales NNS B-NP O
By IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
continued JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
the DT B-NP O
patient's NN I-NP O
Lasix NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
Cholestyramine NNP B-NP B-m
one CD O B-do
packet NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
hs VBD B-VP I-f
3 CD O O
Lovastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
hs VBD B-VP I-f
4 CD O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
tid VBD B-VP B-f
5 CD O O
Sublingual NNP B-NP B-mo
nitroglycerin RB O B-m
1/150 CD O I-m
tablets NNS B-NP I-m
to TO O O
be VB O O
taken VBN O O
prn NN B-NP B-f
with IN B-VP O
chest NN B-NP B-r
pain NN I-NP I-r
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
being VBG O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
followup NN B-NP O
in IN B-VP O
MERH NNP B-NP O
under IN B-VP O
Drs NNP B-NP O
Dwayne NNP I-NP O
Ariel NNP I-NP O
Bremme NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
call VB O O
CMH NNP B-NP O
Urgent NNP I-NP O
Care NNP I-NP O
if IN B-VP O
his PRP$ O O
chest NN B-NP B-r
pain NN I-NP O
recurs NNS I-NP O
and CC O O
does VBZ O O
not RB O O
resolve VB O O
with IN B-VP O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
Dictated NNP I-NP O
By: NNP I-NP O
ROLANDO NNP I-NP O
YAFAI NNP I-NP O
, , O O
M.D NNP B-NP O
BE79 NNP I-NP O
Attending: NNP I-NP O
HOMER NNP I-NP O
PRESTWICH NNP I-NP O
, , O O
M.D NNP B-NP O
VN7 NNP I-NP O
XP500/6846 NNP I-NP O
Batch: NNP I-NP O
173 CD O O
Index NNP B-NP O
No NNP I-NP O
JEAJT21F84 NNP I-NP O
D: NNP I-NP O
3/16/95 CD O O
T: NNP B-NP O
3/16/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#831462 VBZ O O
305748131 CD O O
STRH NNP B-NP O
02609711 CD O O
3036987 CD O O
4/16/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
abdominal JJ B-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
, , O O
6cm CD O O
suprarenal JJ B-NP O
abdominal JJ I-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/24/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/12/2005 CD O O
ATTENDING: NNP B-NP O
LUIGI NNP I-NP O
ILLAS NNP I-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
This DT B-NP O
patient NN I-NP O
received VBD B-VP O
care NN B-NP O
at IN B-VP O
the DT B-NP O
Vascular NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Abdominal NNP I-NP O
aortic JJ B-NP O
aneurysm NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
open JJ B-NP O
abdominal JJ I-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
( ( O O
AAA NNP B-NP O
) ) O O
repair NN B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
71-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
morbid NN B-NP O
obesity NN I-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
, , O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
x VBZ O O
4 CD O O
in IN B-VP O
2001 CD O O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
vague JJ B-NP O
abdominal JJ I-NP O
pain NN I-NP O
and CC O O
was VBD B-VP O
found VBN O O
by IN B-VP O
CT NNP B-NP O
scan JJ O O
to TO O O
have VB O O
a DT B-NP O
6-cm JJ I-NP O
infrarenal JJ I-NP O
AAA NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
prepared JJ O O
for IN B-VP O
a DT B-NP O
repair NN I-NP O
in IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
that IN B-VP O
upon IN B-VP O
review NN B-NP O
of IN B-VP O
the DT B-NP O
aneurysm NN I-NP O
extended VBD B-VP O
up RB O O
to TO O O
include VB O O
of IN B-VP O
the DT B-NP O
origin NN I-NP O
of IN B-VP O
at IN B-VP O
least JJS O O
to TO O O
the DT B-NP O
left JJ I-NP O
renal JJ I-NP O
artery NN I-NP O
and CC O O
this DT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
a DT B-NP O
suprarenal JJ I-NP O
abdominal JJ I-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
requiring VBG O O
a DT B-NP O
retroperitoneal NN I-NP O
approach NN I-NP O
He PRP O O
presents VBZ O O
now RB O O
for IN B-VP O
surgery NN B-NP O
ALLERGIES: NNP I-NP O
Penicillin NNP I-NP O
leading VBG O O
to TO O O
a DT B-NP O
rash NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
CAD NNP I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
x VBZ O O
4 CD O O
in IN B-VP O
2001 CD O O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
gout NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
morbid NN B-NP O
obesity NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
silent NN I-NP O
MI NNP I-NP O
in IN B-VP O
1980 CD O O
and CC O O
1985 CD O O
, , O O
Meniere's NNP B-NP O
syndrome NN I-NP O
in IN B-VP O
left JJ B-NP O
ear NN I-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
leading VBG O O
to TO O O
BiPAP NNP B-NP O
use NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
CABG NNP I-NP O
x VBZ O O
4 CD O O
in IN B-VP O
2001 CD O O
, , O O
status NN B-NP O
post NN I-NP O
laparoscopic NN I-NP O
cholecystectomy NN I-NP O
, , O O
2004 CD O O
, , O O
and CC O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
knee NN B-NP O
arthroscopy RB O O
PREVIOUS NNP B-NP O
STUDIES: NNP I-NP O
PFTs NNP I-NP O
showing VBG O O
an DT B-NP O
FVC NNP I-NP O
of IN B-VP O
3.44 CD O O
( ( O O
80% CD O O
predicted VBN O O
) ) O O
, , O O
FEV1 NNP B-NP O
of IN B-VP O
2.40 CD O O
( ( O O
83% CD O O
predicted VBN O O
) ) O O
, , O O
and CC O O
an DT B-NP O
FEV1/FVC NNP I-NP O
of IN B-VP O
70 CD O O
( ( O O
104% CD O O
predicted VBN O O
) ) O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
negative JJ I-NP O
stress NN I-NP O
test NN I-NP O
on IN B-VP O
9/6/01 CD O O
and CC O O
9/12/01 CD O O
and CC O O
a DT B-NP O
MIBI NNP I-NP O
, , O O
9/12/01 CD O O
showing VBG O O
concentric JJ B-NP O
LVH NNP I-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
approximately RB O O
48% CD O O
, , O O
wall NN B-NP O
motion NN I-NP O
abnormalities NNS I-NP O
of IN B-VP O
the DT B-NP O
septum NN I-NP O
consistent NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
surgery NN I-NP O
, , O O
no DT B-NP O
perfusion NN I-NP O
abnormalities NNS I-NP O
and CC O O
minimal JJ B-NP O
reversible JJ I-NP O
ischemia NN I-NP O
at IN B-VP O
the DT B-NP O
base NN I-NP O
of IN B-VP O
the DT B-NP O
lateral JJ I-NP O
wall NN I-NP O
with IN B-VP O
the DT B-NP O
volume NN I-NP O
affected VBD B-VP O
being VBG O O
small JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
71-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
morbid NN B-NP O
obesity NN I-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
, , O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
x NNP I-NP O
4 CD O O
, , O O
presenting VBG O O
with IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
found VBN O O
by IN B-VP O
CT NNP B-NP O
scan JJ O O
to TO O O
have VB O O
6-cm JJ B-NP O
infrarenal JJ I-NP O
abdominal JJ I-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
6/28/05 CD O O
where WRB O O
he PRP O O
underwent VBD B-VP O
an DT B-NP O
uncomplicated JJ I-NP O
open JJ I-NP O
repair NN I-NP O
of IN B-VP O
his PRP$ O O
abdominal JJ B-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
through IN B-VP O
a DT B-NP O
retroperitoneal NN I-NP O
flank NN I-NP O
approach VBP O O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
He PRP O O
left VBD B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
with IN B-VP O
an DT O O
epidural JJ O O
, , O O
Foley NNP B-NP O
, , O O
and CC O O
nasogastric JJ B-NP O
tube NN I-NP O
to TO O O
low VB O O
wall DT B-NP O
suction NN I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
overnight RB O O
to TO O O
the DT B-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
for IN B-VP O
a DT B-NP O
close JJ I-NP O
monitoring NN I-NP O
of IN B-VP O
blood NN B-NP O
pressure NN I-NP O
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
overnight VBD B-VP O
remained VBN O O
good JJ O O
and CC O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
set NN I-NP O
of IN B-VP O
enzymes NNS B-NP O
on IN B-VP O
postop JJ B-NP O
#0 NN I-NP O
with IN B-VP O
a DT B-NP O
CK NNP I-NP O
of IN B-VP O
146 CD O O
, , O O
MB NNP B-NP O
of IN B-VP O
1.7 CD O O
, , O O
and CC O O
troponin RB O O
less JJR O O
than IN B-VP O
assay VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
up RP O O
to TO O O
the DT B-NP O
surgical JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
intubated VBD B-VP O
He PRP O O
received VBD B-VP O
7800 CD O B-do
units NNS B-NP I-do
of IN B-VP O
crystalloid NN B-NP B-m
, , O O
6 CD O B-do
units NNS B-NP I-do
of IN B-VP O
cell NN B-NP B-m
saver NN I-NP I-m
, , O O
and CC O O
2 CD O B-do
units NNS B-NP O
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
intraoperatively RB O O
, , O O
put VBD B-VP O
out RP O O
1200 CD O O
cc NN B-NP O
of IN B-VP O
urine NN B-NP O
, , O O
175 CD O O
cc NN B-NP O
out IN B-VP O
of IN B-VP O
the DT B-NP O
nasogastric JJ I-NP O
tube NN I-NP O
, , O O
with IN B-VP O
an DT B-NP O
EBL NNP I-NP O
of IN B-VP O
2400 CD O O
cc NN B-NP O
He PRP O O
was VBD B-VP O
weaned VBN O O
from IN B-VP O
the DT B-NP O
ventilator NN I-NP O
without IN B-VP O
difficulty NN B-NP O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
and CC O O
was VBD B-VP O
extubated VBN O O
by IN B-VP O
the DT B-NP O
evening NN I-NP O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#1 VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
He PRP O O
was VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
and CC O O
to TO O O
chair VB O O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#2 IN B-VP O
with IN B-VP O
nursing NN B-NP O
assistance NN I-NP O
Diet NNP I-NP O
was VBD B-VP O
advanced VBN O O
as IN B-VP O
tolerated VBN O O
to TO O O
a DT B-NP O
low JJ I-NP O
fat NN I-NP O
, , O O
low JJ B-NP O
cholesterol NN I-NP O
diet VBZ O O
The DT B-NP O
patient NN I-NP O
initially RB O O
started VBD B-VP O
on IN B-VP O
his PRP$ O O
home NN B-NP O
Celebrex NNP I-NP B-m
and CC O O
other JJ B-NP B-m
medications NNS I-NP O
The DT B-NP O
epidural NN I-NP O
was VBD B-VP O
capped VBN O O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
1/29/05 CD O O
It PRP O O
was VBD B-VP O
removed VBN O O
on IN B-VP O
7/3/05 CD O O
and CC O O
this DT O O
is VBZ O O
fully RB O O
discontinued VBN O O
as RB O O
well RB O O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
7/3/05 CD O O
The DT B-NP O
patient's NN I-NP O
nasogastric JJ B-NP O
tube NN I-NP O
had VBD B-VP O
been VBN O O
removed VBN O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
postop JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
as RB O O
well RB O O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
do VB O O
well RB O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
He PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
subcutaneous JJ B-NP B-mo
heparin NN I-NP B-m
for IN B-VP O
anticoagulation NN B-NP B-r
anticoagulation NN I-NP B-r
He PRP O O
was VBD B-VP O
Hep-Lock'd NNP B-NP B-m
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#3 VBD B-VP O
as IN B-VP O
he PRP O O
was VBD B-VP O
taking VBG O O
good JJ B-NP O
p.o NN I-NP O
orally RB O O
He PRP O O
was VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
to TO O O
chair VB O O
multiple JJ B-NP O
times NNS I-NP O
during IN B-VP O
the DT B-NP O
day NN I-NP O
Physical NNP I-NP O
Therapy NNP I-NP O
saw VBD B-VP O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
postop JJ B-NP O
days NNS I-NP O
# # O O
4 CD O O
to TO O O
#5 VB O O
and CC O O
worked VB O O
with IN B-VP O
some DT O O
on IN B-VP O
his PRP$ O O
mobility NN B-NP O
He PRP O O
, , O O
at IN B-VP O
home NN B-NP O
, , O O
gets VBZ O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
to TO O O
a DT B-NP O
wheelchair NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
back RB O O
to TO O O
his PRP$ O O
preoperative JJ B-NP O
functional JJ I-NP O
status NN I-NP O
with IN B-VP O
a DT B-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-VP O
fatigue NN B-NP O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
#7 NNP I-NP O
and CC O O
#8 VB O O
The DT B-NP O
patient NN I-NP O
continues VBZ O O
to TO O O
work VB O O
with IN B-VP O
Physical JJ B-NP O
Therapy NN I-NP O
and CC O O
to TO O O
get VB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
with IN B-VP O
nursing JJ B-NP O
staff NN I-NP O
on IN B-VP O
a DT B-NP O
regular JJ I-NP O
basis NN I-NP O
multiple NN I-NP O
times NNS I-NP O
per IN B-VP O
day NN B-NP O
Incision NNP I-NP O
site NN I-NP O
remained VBD B-VP O
clean JJ O O
, , O O
dry JJ O O
, , O O
and CC O O
intact JJ O O
On IN B-VP O
postop JJ B-NP O
days NNS I-NP O
#1 VBP O O
to TO O O
#2 VB O O
secondary JJ O O
to TO O O
his PRP$ O O
large JJ B-NP O
amount NN I-NP O
of IN B-VP O
edema NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
large JJ B-NP O
amount NN I-NP O
of IN B-VP O
drainage NN B-NP O
from IN B-VP O
his PRP$ O O
incision NN B-NP O
site NN I-NP O
on IN B-VP O
the DT B-NP O
flank NN I-NP O
However RB O O
, , O O
this DT O O
slowed VBD B-VP O
down RB O O
and CC O O
the DT B-NP O
incision NN I-NP O
site NN I-NP O
remained VBD B-VP O
clean JJ O O
, , O O
dry JJ O O
, , O O
and CC O O
intact JJ O O
with IN B-VP O
the DT B-NP O
erythema NN I-NP O
The DT B-NP O
patient NN I-NP O
continues VBZ O O
to TO O O
do VB O O
well RB O O
By IN B-VP O
postop JJ B-NP O
days NNS I-NP O
#7 VBP O O
to TO O O
#8 VB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
deemed VBN O O
stable JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
rehabilitation NN B-NP O
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Mevers NNP I-NP O
in IN B-VP O
clinic NN B-NP O
for IN B-VP O
staple JJ B-NP O
removal NN I-NP O
in IN B-VP O
seven CD O O
days NNS B-NP O
DISCHARGE NNP I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
with IN B-VP O
Services NNP B-NP O
eScription NN I-NP O
document: VBZ O O
4-3465349 JJ B-NP O
ISSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MARCONE NNP I-NP O
, , O O
BRYCE NNP B-NP O
Attending: NNP I-NP O
KRIESER NNP I-NP O
, , O O
ODIS NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
2526615 CD O O
D: NNP B-NP O
8/23/05 CD O O
T: NNP B-NP O
8/23/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#832352 VBZ O O
521245034 CD O O
NTMC NNP B-NP O
23821513 CD O O
387709 CD O O
5/28/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/20/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/6/1992 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Chief NNP I-NP O
complaint NN I-NP O
is VBZ O O
coronary JJ B-NP O
artery JJ I-NP O
disease NN I-NP O
Patient NNP I-NP O
is VBZ O O
a DT O O
71 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
angina NN B-NP O
, , O O
and CC O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
who WP O O
presents VBZ O O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
Patient NNP B-NP O
reports NNS I-NP O
angina VBD B-VP O
since IN B-VP O
9/29 CD O O
described NNS B-NP O
as IN B-VP O
chest JJ B-NP O
fullness NN I-NP O
Patient NNP I-NP O
denies VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
chest JJ B-NP O
pressure NN I-NP O
, , O O
or CC O O
syncope VB O O
Patient JJ B-NP O
notes NNS I-NP O
dyspnea VBP O O
on IN B-VP O
exertion NN B-NP O
while IN B-VP O
in IN B-VP O
Hills NNP B-NP O
Sagtyre NNP I-NP O
Gillflat NNP I-NP O
Drive NNP I-NP O
, , O O
Field NNP B-NP O
Ville NNP I-NP O
, , O O
Pennsylvania NNP B-NP O
63310 CD O O
nine CD O O
months NNS B-NP O
ago RB O O
Exercise NNP B-NP O
tolerance NN I-NP O
tests NNS I-NP O
were VBD B-VP O
performed VBN O O
which WDT O O
revealed VBD B-VP O
five CD O O
minutes NNS B-NP O
of IN B-VP O
exertion NN B-NP O
, , O O
however RB O O
, , O O
was VBD B-VP O
stopped VBN O O
prior RB O O
to TO O O
ST NNP B-NP O
segment NN I-NP O
changes NNS I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
in IN B-VP O
9/29 CD O O
revealed VBD B-VP O
a DT O O
30% CD O O
left NN B-NP O
main JJ O O
, , O O
40% CD O O
left VBD B-VP O
anterior JJ B-NP O
descending NN I-NP O
, , O O
50% CD O O
circumflex NN B-NP O
, , O O
100% CD O O
mid NN B-NP O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
, , O O
and CC O O
a DT O O
90% CD O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
lesion NN I-NP O
Angioplasty NNP I-NP O
was VBD B-VP O
attempted VBN O O
of IN B-VP O
the DT B-NP O
proximal JJ I-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
lesion NN I-NP O
A DT B-NP O
dissection NN I-NP O
resulted VBD B-VP O
and CC O O
total JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
proximal JJ I-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
without IN B-VP O
EKG NNP B-NP O
changes NNS I-NP O
or CC O O
chest JJS B-NP O
pain NN I-NP O
Cardiac NNP I-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
a DT B-NP O
family NN I-NP O
history NN I-NP O
, , O O
no DT B-NP O
tobacco NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
and CC O O
hypercholesterolemia NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
adult NN B-NP O
onset NN I-NP O
diabetes NNS I-NP O
, , O O
diet JJ O O
controlled VBN O O
, , O O
and CC O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP O
gout NN I-NP O
with IN B-VP O
no DT B-NP O
history NN I-NP O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
tonsillectomy NN B-NP O
and CC O O
adenoidectomy NN B-NP O
and CC O O
appendectomy NN B-NP O
as IN B-VP O
a DT B-NP O
child NN I-NP O
CURRENT NNP I-NP O
MEDICATIONS: NNP I-NP O
Levatol NNP I-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Procardia NNP B-NP B-m
XL NNP I-NP I-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Colchicine NNP B-NP B-m
0.6 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Pepcid NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
, , O O
and CC O O
Aspirin NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
ALLERGIES: NNP I-NP O
Patient NNP I-NP O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
Penicillin NNP B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Grossly NNP I-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Service NNP I-NP O
and CC O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
6/13/92 CD O O
where WRB O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
three-vessel JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
Patient NNP B-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
post-operatively JJ B-NP O
Patient's NNP I-NP O
post-operative JJ B-NP O
course NN I-NP O
from IN B-VP O
this DT B-NP O
point NN I-NP O
on IN B-VP O
was VBD B-VP O
uncomplicated JJ B-NP O
Patient NNP I-NP O
was VBD B-VP O
successfully RB O O
extubated VBN O O
on IN B-VP O
post-operative JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
and CC O O
was VBD B-VP O
diuresed VBN O O
back RB O O
to TO O O
pre-operative JJ B-NP O
weight NN I-NP O
through IN B-VP O
the DT B-NP O
subsequent JJ I-NP O
post-operative JJ I-NP O
days NNS I-NP O
Patient NNP I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
perioperatively RB O O
Patient NNP B-NP O
continues VBZ O O
to TO O O
do VB O O
very RB O O
well RB O O
and CC O O
plan NN B-NP O
is VBZ O O
to TO O O
discharge VB O O
the DT B-NP O
patient NN I-NP O
home NN I-NP O
on IN B-VP O
post-operative JJ B-NP O
day NN I-NP O
number NN I-NP O
seven CD O O
from IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
DISPOSITION: NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Pepcid NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Procardia NNP B-NP B-m
XL NNP I-NP I-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Levatol NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Colchicine NNP B-NP B-m
, , O O
and CC O O
Ciprofloxacin NNP B-NP B-m
Patient NNP I-NP O
is VBZ O O
instructed VBN O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Citrin NNP I-NP O
in IN B-VP O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Clinic NNP I-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Good NNP I-NP O
DB165/7998 NNP I-NP O
CARLOS NNP I-NP O
E NNP I-NP O
GOLDING NNP I-NP O
, , O O
M.D NNP B-NP O
DF5 NNP I-NP O
D: NNP I-NP O
1/8/92 CD O O
Batch: NNP B-NP O
5828 CD O O
Report: NNP B-NP O
L1905D3 NNP I-NP O
T: NNP I-NP O
7/19/92 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
ARCHIE NNP I-NP O
SIROKA NNP I-NP O
, , O O
M.D NNP B-NP O
QG06 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#844334 VBZ O O
410601949 CD O O
TH NNP B-NP O
39177106 CD O O
275150 CD O O
8/22/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/22/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/1/2001 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Raffo NNP I-NP O
is VBZ O O
a DT B-NP O
59-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
small JJ B-NP O
non-ST JJ I-NP O
elevation NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
2000 CD O O
and CC O O
also RB O O
status NN B-NP O
post NN I-NP O
cardiac JJ B-NP O
catheterization NN I-NP O
with IN B-VP O
2 CD O O
vessel NN B-NP O
disease NN I-NP O
, , O O
small JJ O O
left VBD B-VP O
PICA NNP B-NP O
cerebrovascular JJ B-NP O
accident NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
an DT B-NP O
echocardiogram NN I-NP O
in IN B-VP O
March NNP B-NP O
revealing VBG O O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
30% CD O O
Also RB O O
diabetes VBZ O O
mellitus NNS B-NP O
type JJ B-NP O
II NNP I-NP O
complicated VBN O O
by IN B-VP O
retinopathy NN B-NP O
, , O O
nephropathy JJ O O
and CC O O
question NN B-NP O
neuropathy JJ B-NP O
History NNP I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
as RB O O
well RB O O
who WP O O
presented VBD B-VP O
to TO O O
Dr NNP B-NP O
Bouie NNP I-NP O
clinic NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2001 CD O O
with IN B-VP O
progressive JJ O O
increasing VBG O O
dyspnea NN B-NP O
, , O O
increasing VBG O O
abdominal JJ B-NP O
girth NN I-NP O
and CC O O
weight JJ B-NP O
gain NN I-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
months NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Diabetes NNP I-NP O
mellitus VBD B-VP O
x JJ O O
20 CD O O
years NNS B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
with IN B-VP O
the DT B-NP O
last JJ I-NP O
creatinine NN I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
3.5 CD O O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
30% CD O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
2000 CD O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
, , O O
March NNP B-NP O
2000 CD O O
question NN B-NP O
f FW O O
silent JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
x VBD B-VP O
2 CD O O
, , O O
history NN B-NP O
of IN B-VP O
hyperlipidemia NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Aspirin NNP I-NP B-m
daily RB O B-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Zaroxolyn NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
toprol NN B-NP B-m
XL NNP I-NP I-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
insulin NN B-NP B-m
insulin NN I-NP B-m
70/30 CD O B-do
70/30 CD O I-m
65/45 CD O B-do
, , O O
Actos NNP B-NP B-m
45 CD O B-do
q NN B-NP B-f
p.m NN I-NP I-f
, , O O
Avapro NNP B-NP B-m
300 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
p.r.n NN I-NP B-f
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
Temperature NNP I-NP O
98.1 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
116/70 CD O O
, , O O
pulse RB O O
88 CD O O
, , O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
of IN B-VP O
18 CD O O
The DT B-NP O
patient NN I-NP O
appeared VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Jugular NNP I-NP O
venous JJ B-NP O
pressure NN I-NP O
approximately RB O O
13 CD O O
cm JJ B-NP O
water NN I-NP O
LUNGS: NNP I-NP O
Faint NNP I-NP O
bibasilar JJ B-NP O
rales NNS I-NP O
CARDIAC: NNP I-NP O
Tachycardia NNP I-NP O
, , O O
regular JJ B-NP O
rhythm NN I-NP O
without IN B-VP O
murmurs NNS B-NP O
ABDOMEN: NNP I-NP O
Positive NNP I-NP O
, , O O
normal JJ B-NP O
active JJ I-NP O
bowel NN I-NP O
sounds VBZ O O
Obese JJ O O
, , O O
distended VBD B-VP O
and CC O O
nontender JJ B-NP O
EXTREMITIES: NNP I-NP O
2 CD O O
plus CC O O
dorsalis JJ B-NP O
pedis NN I-NP O
pulse NN I-NP O
, , O O
2-3 JJ O O
plus CC O O
edema JJ O O
bilaterally RB O O
to TO O O
the DT B-NP O
knees NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
given VBN O O
notes NNS B-NP O
of IN B-VP O
thyroid JJ B-NP O
dysfunction NN I-NP O
, , O O
his PRP$ O O
history NN B-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
fluid NN B-NP O
overload NN I-NP O
His PRP$ O O
jugular JJ B-NP O
venous JJ I-NP O
pressure NN I-NP O
was VBD B-VP O
elevated VBN O O
and CC O O
he PRP O O
had VBD B-VP O
3plus CD O O
pitting VBG O O
edema NN B-NP O
to TO O O
the DT B-NP O
knees NNS I-NP O
without IN B-VP O
significant JJ B-NP O
rales NNS I-NP O
on IN B-VP O
chest NN B-NP O
exam NN I-NP O
He PRP O O
was VBD B-VP O
aggressively RB O O
diuresed VBN O O
with IN B-VP O
doses NNS B-NP O
of IN B-VP O
Lasix NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
IV NNP I-NP B-mo
as RB O O
well RB O O
as IN B-VP O
Zaroxolyn NNP B-NP B-m
Weight NNP I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
135 CD O O
kilograms NNS B-NP O
and CC O O
on IN B-VP O
discharge NN B-NP O
he PRP O O
was VBD B-VP O
down RB O O
to TO O O
132 CD O O
kilograms NNS B-NP O
A NNP I-NP O
repeat NN I-NP O
echocardiogram NN I-NP O
at IN B-VP O
Ethool NNP B-NP O
Hospital NNP I-NP O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
30-35 JJ O O
, , O O
left VBD B-VP O
ventricular JJ B-NP O
dimensions NNS I-NP O
of IN B-VP O
47 CD O O
mm NNS B-NP O
, , O O
1 CD O O
plus CC O O
mitral JJ B-NP O
regurgitation NN I-NP O
and CC O O
global JJ B-NP O
hypokinesis NN I-NP O
as RB O O
well RB O O
as IN B-VP O
moderate JJ B-NP O
right NN I-NP O
ventricular NN I-NP O
dysfunction NN I-NP O
Abdominal NNP I-NP O
ultrasound NN I-NP O
showed VBD B-VP O
no DT B-NP O
ascites NNS I-NP O
despite IN B-VP O
extremely RB O O
distended VBN O O
abdomen NNS B-NP O
and CC O O
right JJ B-NP O
renal JJ I-NP O
cyst NN I-NP O
x VBD B-VP O
2 CD O O
Follow NNP B-NP O
up RB O O
abdominal JJ B-NP O
CT NNP I-NP O
also RB O O
showed VBD B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
mass NN I-NP O
or CC O O
ascites NNS B-NP O
and CC O O
his PRP$ O O
distended JJ B-NP O
abdomen NN I-NP O
was VBD B-VP O
likely JJ O O
due JJ O O
to TO O O
adipose VB O O
tissue NN B-NP O
Diuresis NNP I-NP O
was VBD B-VP O
limited VBN O O
by IN B-VP O
acute NN B-NP O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
oliguria JJ B-NP O
Diuresis NNP I-NP O
was VBD B-VP O
held VBN O O
from IN B-VP O
March NNP B-NP O
, , O O
2001 CD O O
Right NNP B-NP O
heart NN I-NP O
catheterization NN I-NP O
on IN B-VP O
February NNP B-NP O
, , O O
2001 CD O O
showed VBD B-VP O
mildly RB O O
elevated VBN O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
and CC O O
moderately RB O O
elevated VBD B-VP O
right JJ B-NP O
ventricular NN I-NP O
pressures NNS I-NP O
Dopamine NNP I-NP B-m
Dopamine NNP I-NP B-m
was VBD B-VP O
started VBN O O
on IN B-VP O
November NNP B-NP O
, , O O
2001 CD O O
to TO O O
aid VB O O
with IN B-VP O
renal JJ B-NP B-r
perfusion NN I-NP I-r
and CC O O
diuresis NN B-NP O
and CC O O
he PRP O O
was VBD B-VP O
then RB O O
weaned VBN O O
off IN B-VP O
of IN B-VP O
that DT O O
on IN B-VP O
August NNP B-NP O
, , O O
2001 CD O O
His PRP$ O O
Lasix NNP B-NP B-m
was VBD B-VP O
stopped VBN O O
on IN B-VP O
August NNP B-NP O
, , O O
2001 CD O O
and CC O O
he PRP O O
auto-diuresed VBD B-VP O
until IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
with IN B-VP O
stable JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
He PRP O O
remained VBD B-VP O
stable JJ O O
with IN B-VP O
no DT B-NP O
dyspnea NN I-NP O
at IN B-VP O
rest NN B-NP O
and CC O O
is VBZ O O
symptom JJ O O
free JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
2 CD O O
Renal: NNP B-NP O
His PRP$ O O
basic JJ B-NP O
chronic JJ I-NP O
renal JJ I-NP O
insufficiency NN I-NP O
is VBZ O O
likely JJ O O
secondary JJ O O
to TO O O
poor JJ B-NP O
diabetic JJ I-NP O
control NN I-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
2.5 CD O O
on IN B-VP O
March NNP B-NP O
, , O O
2001 CD O O
, , O O
3.3 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
Acute NNP I-NP O
renal JJ B-NP O
failure NN I-NP O
with IN B-VP O
increasing VBG O O
creatinine NN B-NP O
of IN B-VP O
6 CD O O
after IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
with IN B-VP O
a DT B-NP O
mean NN I-NP O
of IN B-VP O
0.8 CD O O
percent JJ B-NP O
Renal NNP I-NP O
function NN I-NP O
improved VBD B-VP O
with IN B-VP O
creatinine NN B-NP O
of IN B-VP O
4.1 CD O O
on IN B-VP O
August NNP B-NP O
, , O O
2001 CD O O
with IN B-VP O
autodiuresis NN B-NP O
The DT B-NP O
renal JJ I-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
to TO O O
comment VB O O
on IN B-VP O
the DT B-NP O
nature NN I-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
renal JJ I-NP O
insufficiency NN I-NP O
and CC O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
as RB O O
well RB O O
as IN B-VP O
to TO O O
assist VB O O
in IN B-VP O
the DT B-NP O
use NN I-NP O
of IN B-VP O
vasodilators NNS B-NP O
3 CD O O
Endocrine: NNP B-NP O
He PRP O O
has VBZ O O
a DT O O
long JJ O O
standing VBG O O
history NN B-NP O
of IN B-VP O
type NN B-NP O
II NNP I-NP O
diabetes VBZ O O
complicated VBN O O
by IN B-VP O
retinopathy NN B-NP O
and CC O O
neuropathy JJ O O
and CC O O
nephropathy JJ O O
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
his PRP$ O O
outpatient JJ B-NP O
endocrine JJ I-NP O
regimen NNS I-NP O
during IN B-VP O
his PRP$ O O
stay NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
He PRP O O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Marro NNP I-NP O
on IN B-VP O
June NNP B-NP O
, , O O
2001 CD O O
at IN B-VP O
3:30 CD O O
p.m NN B-NP O
, , O O
with IN B-VP O
Dr NNP B-NP O
Loatman NNP I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
2002 CD O O
at IN B-VP O
3:30 CD O O
p.m NN B-NP O
, , O O
Dr NNP B-NP O
Carcano NNP I-NP O
March NNP I-NP O
, , O O
2001 CD O O
at IN B-VP O
10:00 CD O O
a.m JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Aspirin NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Zocor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
insulin NN B-NP B-m
70/30 CD O I-m
65 CD O B-do
units NNS B-NP I-do
q RB O B-f
a.m RB O I-f
, , O O
insulin VBZ O B-m
70/30 CD O I-m
45 CD O B-do
units NNS B-NP I-do
q RB O B-f
p.m RB O I-f
, , O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Levaquin NNP B-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
for IN B-VP O
a DT B-NP O
duration NN I-NP O
of IN B-VP O
7 CD O B-du
days NNS B-NP I-du
, , O O
Actos NNP B-NP B-m
45 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
p.m JJ B-NP I-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BENJAMIN NNP I-NP O
DOUYON NNP I-NP O
, , O O
M.D NNP B-NP O
RB65 NNP I-NP O
Attending: NNP I-NP O
RUDOLF NNP I-NP O
D NNP I-NP O
FEDERKEIL NNP I-NP O
, , O O
M.D NNP B-NP O
ZS91 NNP I-NP O
SY386/598343 NNP I-NP O
Batch: NNP I-NP O
63384 CD O O
Index NNP B-NP O
No NNP I-NP O
E1SALZWZJ5 NNP I-NP O
D: NNP I-NP O
0/12/02 CD O O
T: NNP B-NP O
0/12/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#852130 VBZ O O
844726908 CD O O
IHC NNP B-NP O
54526162 CD O O
6224708 CD O O
2/15/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
ATRIAL NNP I-NP O
FIBRILLATION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/3/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/26/2006 CD O O
ATTENDING: NNP B-NP O
PAWELEK NNP I-NP O
, , O O
BENTON NNP B-NP O
FREDERIC NNP I-NP O
MD NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
CHF NNP B-NP O
, , O O
EF NNP B-NP O
of IN B-VP O
15% CD O O
status NN B-NP O
post NN I-NP O
AVR NNP I-NP O
, , O O
history NN B-NP O
of IN B-VP O
NSTEMI NNP B-NP O
initially RB O O
presenting VBG O O
to TO O O
outside JJ B-NP O
hospital NN I-NP O
on IN B-VP O
0/9/06 CD O O
with IN B-VP O
chief JJ B-NP O
complaint NN I-NP O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
found VBN O O
to TO O O
be VB O O
volume NN B-NP O
overloaded VBN O O
with IN B-VP O
a DT B-NP O
clinical JJ I-NP O
exam NN I-NP O
and CC O O
laboratory NN B-NP O
findings NNS I-NP O
consistent JJ O O
with IN B-VP O
heart NN B-NP O
failure NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
BNP NNP I-NP O
of IN B-VP O
747 CD O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
troponin NN I-NP O
I PRP O O
of IN B-VP O
0.43 CD O O
A NNP B-NP O
repeat NN I-NP O
echo NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
revealed VBD B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
15% CD O O
, , O O
down RB O O
from IN B-VP O
a DT B-NP O
previous JJ I-NP O
EF NNP I-NP O
of IN B-VP O
25 CD O O
to TO O O
35% CD O O
with IN B-VP O
a DT B-NP O
functional JJ I-NP O
aortic JJ I-NP O
valve NN I-NP O
, , O O
moderate-to-severe JJ B-NP O
mitral JJ I-NP O
insufficiency NN I-NP O
A NNP I-NP O
persantine NN I-NP O
MIBI NNP I-NP O
demonstrated VBD B-VP O
left VBD B-VP O
ventricular JJ B-NP O
enlargement NN I-NP O
and CC O O
three-vessel JJ B-NP O
disease NN I-NP O
with IN B-VP O
ischemia NN B-NP O
in IN B-VP O
the DT B-NP O
mid JJ I-NP O
distal JJ I-NP O
LAD NNP I-NP O
and CC O O
left VBD B-VP O
circ JJ B-NP O
territory NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
fixed JJ I-NP O
inferior JJ I-NP O
wall NN I-NP O
defect NN I-NP O
consistent NN I-NP O
with IN B-VP O
a DT B-NP O
right JJ I-NP B-r
coronary JJ I-NP I-r
artery NN I-NP I-r
infarct IN B-VP I-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
diuresed VBN O O
, , O O
started VBN O O
on IN B-VP O
Carvedilol NNP B-NP B-m
and CC O O
improved VBN O O
Troponins NNP B-NP O
trended VBD B-VP O
down RP O O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
have VB O O
frequent JJ B-NP O
runs NNS I-NP O
of IN B-VP O
ectopy NN B-NP O
and CC O O
SVT NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
heparin NN I-NP B-m
drip NN I-NP B-mo
and CC O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
Acbroadl NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
catheterization NN B-NP O
and CC O O
possible JJ B-NP O
percutaneous JJ I-NP O
intervention NN I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
to TO O O
be VB O O
feeling VBG O O
much JJ O O
better JJR O O
, , O O
denied VBD B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
chest JJS O O
pain VBP O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
progressive JJ B-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
months NNS I-NP O
, , O O
inability NN B-NP O
to TO O O
lay VB O O
flat JJ O O
, , O O
positive JJ B-NP O
orthopnea NN I-NP O
and CC O O
PND NNP B-NP O
, , O O
reports VBZ O O
ability NN B-NP O
to TO O O
climb VB O O
two CD O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
, , O O
also RB O O
reports VBZ O O
occasional JJ B-NP O
palpitations NNS I-NP O
No DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
constipation NN B-NP O
, , O O
diarrhea NN B-NP O
, , O O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
or CC O O
pedal NN B-NP O
edema VBP O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
poor JJ B-NP O
compliance NN I-NP O
with IN B-VP O
diabetes NNS B-NP O
management NN I-NP O
, , O O
denies VBZ O O
dietary JJ B-NP O
indiscretion NN I-NP O
, , O O
reports VBZ O O
medical JJ B-NP O
compliance NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Includes NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
in IN B-VP O
1994 CD O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
CHF NNP B-NP O
, , O O
cardiomyopathy NN B-NP O
, , O O
non-ST-wave JJ B-NP O
MI NNP I-NP O
, , O O
status NN B-NP O
post NN I-NP O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
with IN B-VP O
St NNP B-NP O
Jude's NNP I-NP O
valve NN I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
diabetes VBZ O O
, , O O
anxiety NN B-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Include NNP I-NP O
aspirin VBZ O B-m
81 CD O B-do
, , O O
lisinopril VBD B-VP B-m
20 CD O B-do
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
, , O O
verapamil FW O B-m
240 CD O B-do
sustained JJ B-NP O
release NN I-NP O
, , O O
gemfibrozil VBP O B-m
600 CD O B-do
b.i.d NN B-NP B-f
, , O O
nystatin RB O B-m
500 CD O B-do
b.i.d NN B-NP B-f
, , O O
Paxil NNP B-NP B-m
20 CD O B-do
daily RB O B-f
, , O O
glipizide JJ O B-m
10 CD O B-do
daily RB O B-f
, , O O
Coumadin NNP B-NP B-m
4 CD O B-do
prior RB O B-du
to TO O I-du
admission NN B-NP I-du
to TO O I-du
outside JJ B-NP I-du
hospital NN I-NP I-du
, , O O
Carvedilol NNP B-NP B-m
6.25 CD O B-do
daily RB O B-f
, , O O
heparin JJ B-NP B-m
drip NN I-NP B-mo
and CC O O
spironolactone NN B-NP B-m
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
currently RB O O
uses VBZ O O
tobacco NN B-NP O
No NNP I-NP O
alcohol NN I-NP O
use VB O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
retired VBN O O
, , O O
lives VBZ O O
with IN B-VP O
wife NN B-NP O
in IN B-VP O
Lin NNP B-NP O
Con NNP I-NP O
, , O O
teaches VBZ O O
graduate NN B-NP O
courses NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
however RB O O
, , O O
there EX O O
is VBZ O O
hypertension NN B-NP O
and CC O O
cerebrovascular JJ B-NP O
disease NN I-NP O
in IN B-VP O
his PRP$ O O
family NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile RB O O
, , O O
heart NN B-NP O
rate NN I-NP O
58 CD O O
, , O O
BP NNP B-NP O
124/60 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
, , O O
saturating VBG O O
98% CD O O
on IN B-VP O
2 CD O O
L NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
, , O O
lying VBG O O
flat JJ O O
, , O O
speaking VBG O O
in IN B-VP O
full JJ B-NP O
sentences NNS I-NP O
Mucous JJ B-NP O
membranes NNS I-NP O
moist NN I-NP O
, , O O
oropharynx JJ B-NP O
clear JJ I-NP O
JVP NNP I-NP O
12 CD O O
with IN B-VP O
bibasilar JJ B-NP O
crackles NNS I-NP O
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right NN B-NP O
and CC O O
expiratory NN B-NP O
wheeze NN I-NP O
with IN B-VP O
long JJ O O
, , O O
pronounced JJ B-NP O
expiratory NN I-NP O
phase NN I-NP O
Heart NNP I-NP O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
prosthetic JJ B-NP O
S2 NNP I-NP O
No NNP I-NP O
murmurs NN I-NP O
, , O O
gallops NNS B-NP O
or CC O O
rubs NNS B-NP O
appreciated VBN O O
Abdomen NNP B-NP O
soft JJ O O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBD B-VP O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities NNS B-NP O
are VBP O O
without IN B-VP O
edema JJ B-NP O
DP NNP I-NP O
intact JJ B-NP O
Feet NNP I-NP O
are VBP O O
cool JJ O O
but CC O O
well RB O O
perfused JJ B-NP O
Skin NNP I-NP O
warm NN I-NP O
, , O O
dry JJ O O
and CC O O
intact JJ O O
, , O O
no DT B-NP O
rashes NNS I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Labs NNP I-NP O
notable JJ O O
for IN B-VP O
creatinine NN B-NP O
of IN B-VP O
1 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
39.5 CD O O
, , O O
platelets NNS B-NP O
of IN B-VP O
113 CD O O
, , O O
cholesterol NN B-NP O
157 CD O O
, , O O
triglycerides NNS B-NP O
76 CD O O
, , O O
HDL NNP B-NP O
32 CD O O
, , O O
LDL NNP B-NP O
110 CD O O
, , O O
hemoglobin NN B-NP O
A1c NNP I-NP O
6.3 CD O O
, , O O
TSH NNP B-NP O
1.9 CD O O
EKG NNP B-NP O
, , O O
sinus NN B-NP O
rhythm NN I-NP O
, , O O
left VBD B-VP O
bundle JJ B-NP O
branch NN I-NP O
block NN I-NP O
with IN B-VP O
multiple JJ B-NP O
PVCs NNP I-NP O
, , O O
a DT B-NP O
widened JJ I-NP O
QRS NNP I-NP O
of IN B-VP O
duration NN B-NP O
of IN B-VP O
190 CD O O
milliseconds NNS B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
, , O O
cardiomegaly JJ B-NP O
consistent NN I-NP O
with IN B-VP O
mild JJ B-NP O
interstitial JJ I-NP O
edema NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
and CC O O
NSTEMI NNP B-NP O
, , O O
CHF NNP B-NP O
with IN B-VP O
a DT B-NP O
known JJ I-NP O
EF NNP I-NP O
of IN B-VP O
15% CD O O
, , O O
status NN B-NP O
post NN I-NP O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
, , O O
presenting VBG O O
through IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
likely RB O O
secondary JJ O O
to TO O O
ischemia VB O O
1 CD O O
Cardiovascular: NNP B-NP O
Ischemia: NNP I-NP O
No NNP I-NP O
evidence NN I-NP O
of IN B-VP O
ongoing VBG O O
ischemia NN B-NP O
on IN B-VP O
admission NN B-NP O
Elevated VBN O O
troponin NN B-NP O
at IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
trended VBD B-VP O
down RB O O
possibly RB O O
secondary JJ O O
to TO O O
NSTEMI NNP B-NP O
prior RB O O
to TO O O
admission VB O O
versus JJ B-NP O
demand NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
beta-blocker NN B-NP B-m
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP O
, , O O
which WDT O O
were VBD B-VP O
titrated VBN O O
to TO O O
effect NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
statin NN I-NP B-m
and CC O O
continued VBN O O
on IN B-VP O
Niaspan NNP B-NP B-m
, , O O
left VBD B-VP O
heart NN B-NP O
cath NN I-NP O
revealed VBD B-VP O
occluded VBN O O
graft NN B-NP O
and CC O O
2+ CD O O
aortic JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
100% CD O O
LAD NNP B-NP O
stenosis NN I-NP O
, , O O
70% CD O O
diagonal JJ O O
1 CD O O
, , O O
90% CD O O
circumflex NN B-NP O
, , O O
45% CD O O
RCA NNP B-NP O
and CC O O
100% CD O O
effused VBD B-VP O
LIMA NNP B-NP O
graft NN I-NP O
to TO O O
circumflex VB O O
and CC O O
a DT O O
100% CD O O
effused JJ B-NP O
SVG NNP I-NP O
graft NN I-NP O
to TO O O
LAD VB O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
now RB O O
status NN B-NP O
post NN I-NP O
stenting VBG O O
the DT B-NP O
OM NNP I-NP O
V1 NNP I-NP O
and CC O O
LAD NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
remained VBN O O
asymptomatic JJ O O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
has VBZ O O
improved VBN O O
Pump: NNP B-NP O
EF NNP I-NP O
15% CD O O
on IN B-VP O
repeat NN B-NP O
echo NN I-NP O
with IN B-VP O
severe JJ B-NP B-r
MR NNP I-NP I-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
spironolactone NN B-NP B-m
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
be VB O O
diuresed VBN O O
initially RB O O
and CC O O
is VBZ O O
now RB O O
euvolemic JJ O O
He PRP O O
will MD O O
need VB O O
a DT B-NP O
repeat NN I-NP O
echo NN I-NP O
in IN B-VP O
three CD O O
months NNS B-NP O
to TO O O
evaluate VB O O
his PRP$ O O
ejection NN B-NP O
fraction NN I-NP O
and CC O O
determine VB O O
the DT B-NP O
utility NN I-NP O
of IN B-VP O
an DT B-NP O
AICD NNP I-NP O
placement NN I-NP O
Rhythm: NNP I-NP O
We PRP O O
held VBD B-VP O
verapamil RB O B-m
secondary JJ O O
to TO O O
double VB O O
AV NNP B-NP O
nodal FW O O
blockade NN B-NP O
However RB O O
, , O O
with IN B-VP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
widened JJ B-NP O
QRS NNP I-NP O
and CC O O
multiple JJ B-NP O
PVCs NNP I-NP O
and CC O O
SVT NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
EP NNP B-NP O
to TO O O
assess VB O O
the DT B-NP O
utility NN I-NP O
of IN B-VP O
AICD NNP B-NP O
2 CD O O
Respiratory: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT B-NP O
acute JJ I-NP O
issues NNS I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath NN B-NP O
has VBZ O O
improved VBN O O
Continues NNS B-NP O
to TO O O
complain VB O O
of IN B-VP O
residual JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
while IN B-VP O
lying VBG O O
flat JJ O O
on IN B-VP O
his PRP$ O O
left JJ B-NP O
side NN I-NP O
3 CD O O
Renal: NNP B-NP O
Creatinine NNP I-NP O
has VBZ O O
been VBN O O
stable JJ O O
at IN B-VP O
baseline NN B-NP O
We PRP O O
will MD O O
closely RB O O
follow VB O O
status NN B-NP O
post NN I-NP O
chat WP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
pretreated VBN O O
with IN B-VP O
bicarbonate NN B-NP B-m
and CC O O
Mucomyst NNP B-NP B-m
Creatinine NNP I-NP O
remained VBD B-VP O
stable JJ O O
4 CD O O
GI: NNP B-NP O
LFTs NNP I-NP O
are VBP O O
mildly RB O O
increased VBN O O
likely RB O O
secondary JJ O O
to TO O O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
5 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
was VBD B-VP O
39 CD O O
on IN B-VP O
admission NN B-NP O
It PRP O O
trended VBD B-VP O
down RB O O
status NN B-NP O
post NN I-NP O
cath NN I-NP O
likely RB O O
secondary JJ O O
to TO O O
blood VB O O
loss NN B-NP O
given VBN O O
the DT B-NP O
long JJ I-NP O
case NN I-NP O
and CC O O
hemodilution; NN B-NP O
however RB O O
, , O O
hematocrit NN B-NP O
fell VBD B-VP O
to TO O O
38 CD O O
concerning VBG O O
for IN B-VP O
retroperitoneal NN B-NP O
bleed VBN O O
Despite IN B-VP O
patient JJ O O
remaining VBG O O
hemodynamically RB O O
stable JJ O O
and CC O O
groin VB O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
hematoma NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
CT NNP I-NP O
scan NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
negative JJ O O
His PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
stabilized VBN O O
He PRP O O
was VBD B-VP O
not RB O O
transfused VBN O O
, , O O
as IN B-VP O
he PRP O O
was VBD B-VP O
asymptomatic JJ O O
and CC O O
recently RB O O
revascularized VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
guaiac JJ O O
positive JJ O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
gross JJ B-NP O
bleeding NN I-NP O
, , O O
thus RB O O
will MD O O
need VB O O
outpatient JJ O O
follow-up JJ O O
and CC O O
colonoscopy VBZ O O
The DT B-NP O
patient NN I-NP O
continues VBZ O O
his PRP$ O O
heparin-bridged JJ B-NP B-m
Coumadin NNP I-NP I-m
with IN B-VP O
a DT B-NP O
goal NN I-NP O
of IN B-VP O
INR NNP B-NP O
2 CD O O
to TO O O
3 CD O O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
suffers NNS I-NP O
from IN B-VP O
long-term JJ B-NP O
thrombocytopenia NN I-NP O
His PRP$ O O
platelet NN B-NP O
count NN I-NP O
was VBD B-VP O
113 CD O O
on IN B-VP O
admission NN B-NP O
Review NNP I-NP O
of IN B-VP O
records NNS B-NP O
revealed VBN O O
thrombocytopenia NN B-NP O
on IN B-VP O
previous JJ B-NP O
admission NN I-NP O
to TO O O
Norpid NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
on IN B-VP O
presentation NN B-NP O
to TO O O
outside VB O O
hospital NN B-NP O
prior RB O O
to TO O O
heparinization NN B-NP O
, , O O
thus RB O O
low JJ B-NP O
suspicion NN I-NP O
for IN B-VP O
HIT NNP B-NP O
The DT B-NP O
patient's JJ I-NP O
platelet NN I-NP O
level NN I-NP O
remained VBD B-VP O
stable JJ O O
He PRP O O
should MD O O
consider VB O O
outpatient JJ B-NP O
evaluation NN I-NP O
by IN B-VP O
Hematology NNP B-NP O
6 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-r
on IN B-VP O
oral JJ B-NP B-mo
hypoglycemics NNS I-NP B-m
, , O O
which WDT O O
were VBD B-VP O
discontinued VBN O O
on IN B-VP O
admission NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
controlled VBN O O
with IN B-VP O
regular JJ B-NP B-m
insulin NN I-NP I-m
and CC O O
placed VBD B-VP O
back RP O O
on IN B-VP O
his PRP$ O O
oral JJ B-NP B-mo
hypoglycemics NNS I-NP B-m
prior RB O O
to TO O O
discontinuing VBG O O
A1c NNP B-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
7 CD O O
ID: NNP B-NP O
No NNP I-NP O
acute NN I-NP O
issues NNS I-NP O
8 CD O O
Psych: NNP B-NP O
History NNP I-NP O
of IN B-VP O
anxiety NN B-NP B-r
anxiety NN I-NP B-r
, , O O
on IN B-VP O
Paxil NNP B-NP B-m
and CC O O
Ativan NNP B-NP B-m
9 CD O O
FEN: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
diet NN I-NP O
10 CD O O
Prophylaxis: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
encouraged VBN O O
to TO O O
stop VB O O
smoking NN B-NP B-r
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP O
nicotine JJ I-NP B-m
patch NN I-NP I-m
during IN B-VP B-du
his PRP$ O I-du
hospital NN B-NP I-du
stay NN I-NP I-du
, , O O
which WDT O O
he PRP O O
tolerated VBD B-VP O
well RB O O
He PRP O O
will MD O O
be VB O O
discharged VBN O O
with IN B-VP O
a DT B-NP O
prescription NN I-NP O
for IN B-VP O
the DT B-NP O
nicotine JJ I-NP B-m
patch NN I-NP I-m
as IN B-VP O
well RB O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
PCP NNP B-NP O
and CC O O
Cardiology NNP B-NP O
as RB O O
well RB O O
as IN B-VP O
EP NNP B-NP O
Patient NNP I-NP O
encouraged VBD B-VP O
to TO O O
check VB O O
his PRP$ O O
daily JJ B-NP O
weights NNS I-NP O
and CC O O
report VB O O
a DT B-NP O
weight JJ I-NP O
increase NN I-NP O
of IN B-VP O
more JJR O O
than IN B-VP O
2 CD O O
pounds NNS B-NP O
daily JJ O O
or CC O O
3 CD O O
pounds NNS B-NP O
a DT B-NP O
week NN I-NP O
to TO O O
his PRP$ O O
PCP NNP B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
also RB O O
follow VB O O
up RP O O
with IN B-VP O
INR NNP B-NP O
checks NNS I-NP O
as IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
DISCHARGE NNP I-NP O
APPOINTMENTS: NNP I-NP O
With IN B-VP O
his PRP$ O O
PCP NNP B-NP O
, , O O
Dr NNP B-NP O
Qin NNP I-NP O
, , O O
telephone NN B-NP O
044-133-1576 CD O O
, , O O
on IN B-VP O
0/16/06 CD O O
at IN B-VP O
1:45 CD O O
, , O O
Cardiology NNP B-NP O
with IN B-VP O
Dr NNP B-NP O
Mccoyle NNP I-NP O
at IN B-VP O
372-301-7202 NNP B-NP O
on IN B-VP O
11/21/06 CD O O
at IN B-VP O
3:15 CD O O
and CC O O
with IN B-VP O
Electrophysiology NNP B-NP O
, , O O
Dr NNP B-NP O
Kunich NNP I-NP O
on IN B-VP O
11/10/06 CD O O
at IN B-VP O
10:20 CD O O
The DT B-NP O
patient NN I-NP O
should MD O O
arrange VB O O
to TO O O
have VB O O
his PRP$ O O
INR NNP B-NP O
drawn NN I-NP O
on IN B-VP O
6/21/06 CD O O
and CC O O
follow-up JJ B-NP O
INRs NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
seven CD O O
days NNS B-NP O
INRs NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
his PRP$ O O
PCP NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
p.o JJ O B-mo
daily RB O B-f
2 CD O O
Lisinopril NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Nicotine NNP B-NP B-m
patch NN I-NP I-m
14 CD O B-do
mg NN B-NP I-do
per IN B-VP B-f
day NN B-NP I-f
topical JJ O B-mo
4 CD O O
Spironolactone NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Paxil NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
6 CD O O
Atorvastatin NNP B-NP B-m
80 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
7 CD O O
Niaspan NNP B-NP B-m
0.5 CD O B-do
gm NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
8 CD O O
Carvedilol NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
9 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
10 CD O O
Gemfibrozil NNP B-NP B-m
900 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
11 CD O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
night NN B-NP I-f
eScription NN I-NP O
document: VBD B-VP O
1-7905999 CD O O
CSSten NNP B-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SPELMAN NNP I-NP O
, , O O
TERENCE NNP B-NP O
Attending: NNP I-NP O
MELVILLE NNP I-NP O
, , O O
GARRETT NNP B-NP O
WALLY NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7214166 CD O O
D: NNP B-NP O
7/0/06 CD O O
T: NNP B-NP O
7/0/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#854980 VBZ O O
466605453 CD O O
FLMC NNP B-NP O
88455449 CD O O
4128807 CD O O
8/14/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
WEAKNESS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/2/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/14/2006 CD O O
ATTENDING: NNP B-NP O
HAJDUK NNP I-NP O
, , O O
COLUMBUS NNP B-NP O
MD NNP I-NP O
DATE NNP I-NP O
AND NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
DEATH: NNP I-NP O
10/18/06 CD O O
at IN B-VP O
2:20 CD O O
p.m NN B-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
0/5/06 CD O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
weakness NN B-NP O
and CC O O
confusion NN B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
was VBD B-VP O
a DT B-NP O
70-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
CHF NNP B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
that WDT O O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
0/5/06 CD O O
for IN B-VP O
weakness NN B-NP O
and CC O O
confusion NN B-NP O
She PRP O O
had VBD B-VP O
been VBN O O
recently RB O O
hospitalized VBN O O
on IN B-VP O
8/1/06 CD O O
through IN B-VP O
9/11/06 CD O O
and CC O O
5/6/06 CD O O
through IN B-VP O
5/24/06 CD O O
for IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
requiring VBG O O
aggressive JJ B-NP O
diuresis NN I-NP O
Her NNP I-NP O
weight NN I-NP O
on IN B-VP O
discharge NN B-NP O
on IN B-VP O
5/24/06 CD O O
was VBD B-VP O
85 CD O O
kg NN B-NP O
She PRP O O
did VBD B-VP O
well RB O O
initially RB O O
at IN B-VP O
home NN B-NP O
after IN B-VP O
discharge NN B-NP O
, , O O
but CC O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
had VBD B-VP O
increasing VBG O O
somnolence NN B-NP O
and CC O O
confusion NN B-NP O
with IN B-VP O
global JJ B-NP O
weakness NN I-NP O
causing VBG O O
the DT B-NP O
patient NN I-NP O
to TO O O
fall VB O O
without IN B-VP O
head NN B-NP O
trauma NN I-NP O
or CC O O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
decreased VBN O O
p.o NNS B-NP O
intake NN I-NP O
and CC O O
was VBD B-VP O
febrile VBN O O
to TO O O
99.5 CD O O
On IN B-VP O
admission NN B-NP O
, , O O
her PRP$ O O
weight NN B-NP O
was VBD B-VP O
83.9 CD O O
kg NN B-NP O
She PRP O O
was VBD B-VP O
hypotensive JJ O O
with IN B-VP O
blood NN B-NP O
pressures NNS I-NP O
of IN B-VP O
100/50 CD O O
Her NNP B-NP O
JVP NNP I-NP O
was VBD B-VP O
elevated VBN O O
to TO O O
15 CD O O
and CC O O
3+ CD O O
pitting NN B-NP O
edema NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
BNP NNP I-NP O
of IN B-VP O
2321 CD O O
and CC O O
a DT B-NP O
white JJ I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
18.9 CD O O
Assessment: NNP B-NP O
An DT B-NP O
assessment NN I-NP O
on IN B-VP O
admission NN B-NP O
suggested VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
possibly RB O O
had VBD B-VP O
hypoperfusion NN B-NP O
secondary JJ O O
to TO O O
over IN B-VP O
diuresis NN B-NP O
or CC O O
worsening VBG O O
heart NN B-NP O
failure NN I-NP O
secondary JJ O O
to TO O O
a DT B-NP O
cardiac JJ I-NP O
event NN I-NP O
with IN B-VP O
a DT B-NP O
note NN I-NP O
of IN B-VP O
having VBG O O
a DT B-NP O
troponin NN I-NP O
of IN B-VP O
2.61 CD O O
Hospital NNP B-NP O
Course: NNP I-NP O
Her NNP I-NP O
hospital NN I-NP O
course NN I-NP O
after IN B-VP O
admission NN B-NP O
on IN B-VP O
0/5/06 CD O O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
worsening VBG O B-r
cardiac JJ B-NP I-r
function NN I-NP I-r
with IN B-VP O
minimal JJ B-NP O
improvement NN I-NP O
on IN B-VP O
milrinone NN B-NP B-m
and CC O O
decreasing VBG O O
urine JJ B-NP O
output NN I-NP O
despite IN B-VP O
diuretics NNS B-NP B-m
and CC O O
also RB O O
gross JJ B-NP O
gastrointestinal JJ I-NP O
bleeding NN I-NP O
with IN B-VP O
melanotic JJ B-NP O
stool NN I-NP O
while IN B-VP O
she PRP O O
was VBD B-VP O
on IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
there EX O O
was VBD B-VP O
concern NN B-NP O
for IN B-VP O
sepsis NN B-NP B-r
sepsis NN I-NP B-r
sepsis NN I-NP B-r
sepsis VBD B-VP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
antibiotics NNS B-NP B-m
with IN B-VP O
levofloxacin NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
, , O O
and CC O O
vancomycin IN B-VP B-m
She PRP O O
required VBD B-VP O
a DT B-NP O
transfer NN I-NP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
on IN B-VP O
9/15/06 CD O O
for IN B-VP O
further JJ B-NP O
medical JJ I-NP O
therapy NN I-NP O
for IN B-VP O
poor JJ B-NP O
cardiac JJ I-NP O
output NN I-NP O
, , O O
a DT B-NP O
possible JJ I-NP O
need NN I-NP O
for IN B-VP O
CVVH NNP B-NP O
, , O O
given VBN O O
volume NN B-NP O
overload NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
renal JJ B-NP O
failure NN I-NP O
, , O O
and CC O O
work-up NN B-NP O
of IN B-VP O
GIB NNP B-NP O
Her NNP I-NP O
code NN I-NP O
status NN I-NP O
was VBD B-VP O
DNR/DNI NNP B-NP O
during IN B-VP O
her PRP$ O O
admission NN B-NP O
into IN B-VP O
the DT B-NP O
CCU NNP I-NP O
on IN B-VP O
9/23/06 CD O O
The DT B-NP O
patient NN I-NP O
reversed VBD B-VP O
her PRP$ O O
status NN B-NP O
to TO O O
DNR NNP B-NP O
, , O O
but CC O O
allowed VBD B-VP O
for IN B-VP O
elective JJ B-NP O
intubation NN I-NP O
on IN B-VP O
9/15/06 CD O O
, , O O
given VBN O O
her PRP$ O O
increasing VBG O O
GI NNP B-NP O
bleed NN I-NP O
and CC O O
the DT O O
worsening VBG O O
renal JJ B-NP O
failure NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
electively RB O O
intubated VBN O O
on IN B-VP O
5/27/06 CD O O
without IN B-VP O
any DT B-NP O
complications NNS I-NP O
For IN B-VP O
her PRP$ O O
GI NNP B-NP O
bleed NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
EGD NNP I-NP O
and CC O O
colonoscopy NN B-NP O
, , O O
which WDT O O
found VBD B-VP O
a DT O O
gross JJ O O
large JJ O O
ascending VBG O O
colorectal JJ B-NP O
mass NN I-NP O
with IN B-VP O
ulcerations NNS B-NP O
, , O O
which WDT O O
likely RB O O
contributed VBD B-VP O
to TO O O
her PRP$ O O
gross JJ B-NP O
GI NNP I-NP O
bleed VBD B-VP O
Given NNP B-NP O
the DT B-NP O
patient's NN I-NP O
wishes VBZ O O
to TO O O
be VB O O
DNR/DNI NNP B-NP O
and CC O O
given VBN O O
her PRP$ O O
new JJ B-NP O
finding NN I-NP O
for IN B-VP O
a DT B-NP O
large JJ I-NP O
mass NN I-NP O
in IN B-VP O
the DT B-NP O
ascending NN I-NP O
colon NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
code NN I-NP O
status NN I-NP O
was VBD B-VP O
changed VBN O O
to TO O O
comfort VB O O
measures NNS B-NP O
only RB O O
on IN B-VP O
1/17/06 CD O O
In IN B-VP O
addition NN B-NP O
, , O O
her PRP$ O O
colorectal JJ B-NP O
mass NN I-NP O
pathology NN I-NP O
returned VBD B-VP O
showing VBG O O
poorly RB O O
differentiated VBN O O
tumor NN B-NP O
with IN B-VP O
lymphoma JJ B-NP O
versus NN I-NP O
adenocarcinoma NN I-NP O
being VBG O O
most RBS O O
likely RB O O
as IN B-VP O
the DT B-NP O
diagnosis NN I-NP O
For IN B-VP O
the DT B-NP O
above JJ I-NP O
reason NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
made VBN O O
CMO NNP B-NP O
Being NNP I-NP O
CMO NNP I-NP O
status NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
removed VBN O O
of IN B-VP O
all DT B-NP O
pressors NNS I-NP B-m
and CC O O
antibiotics NNS B-NP B-m
in IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
1/17/06 CD O O
She PRP O O
was VBD B-VP O
made VBN O O
comfortable JJ O O
sedated VBN O O
on IN B-VP O
fentanyl NN B-NP B-m
and CC O O
Versed VBD B-VP B-m
She PRP O O
was VBD B-VP O
then RB O O
extubated VBN O O
for IN B-VP O
comfort NN B-NP O
with IN B-VP O
family NN B-NP O
present NN I-NP O
She PRP O O
had VBD B-VP O
agonal JJ B-NP O
breathing NN I-NP O
with IN B-VP O
episodes NNS B-NP O
of IN B-VP O
apnea NN B-NP O
and CC O O
was VBD B-VP O
given VBN O O
additional JJ B-NP O
sedation NN I-NP B-m
for IN B-VP O
comfort NN B-NP B-r
The DT B-NP O
patient NN I-NP O
drew VBD B-VP O
her PRP$ O O
last JJ B-NP O
breath NN I-NP O
at IN B-VP O
2:20 CD O O
p.m NN B-NP O
Her NNP I-NP O
family NN I-NP O
was VBD B-VP O
present JJ O O
at IN B-VP O
bedside IN B-VP O
The DT B-NP O
attending NN I-NP O
was VBD B-VP O
aware JJ O O
On IN B-VP O
assessment NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
spontaneous JJ I-NP O
breathing NN I-NP O
, , O O
no DT B-NP O
corneal NN I-NP O
reflex NN I-NP O
, , O O
and CC O O
no DT O O
peripheral JJ O O
pulses VBZ O O
The DT B-NP O
patient's JJ I-NP O
eyes NNS I-NP O
were VBD B-VP O
dilated VBN O O
and CC O O
no DT B-NP O
heart NN I-NP O
sounds VBZ O O
or CC O O
breath VB O O
sounds NNS B-NP O
were VBD B-VP O
appreciated VBN O O
Given NNP B-NP O
the DT B-NP O
CMO NNP I-NP O
status NN I-NP O
, , O O
no DT B-NP O
CPR NNP I-NP O
was VBD B-VP O
undertaken VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
pronounced VBN O O
dead JJ O O
at IN B-VP O
2:20 CD O O
p.m NN B-NP O
on IN B-VP O
1/17/06 CD O O
Family NNP B-NP O
declined VBD B-VP O
autopsy JJ B-NP O
eScription NN I-NP O
document: VBZ O O
3-8774785 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BOYDSTUN NNP I-NP O
, , O O
JOHNNY NNP B-NP O
Attending: NNP I-NP O
PETITJEAN NNP I-NP O
, , O O
SIMON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3563977 CD O O
D: NNP B-NP O
10/18/06 CD O O
T: NNP B-NP O
10/18/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#858069 VBZ O O
094697245 CD O O
CLH NNP B-NP O
57134396 CD O O
4156892 CD O O
5/9/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
chf NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/12/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/17/2007 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SHAULL NNP I-NP O
, , O O
DARIN NNP B-NP O
086-88-68-2 CD O O
Ton- NNP B-NP O
Ph NNP I-NP O
Aga NNP I-NP O
Van NNP I-NP O
Ux NNP I-NP O
Ny NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
3/22/07 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
HEINIGER NNP I-NP O
, , O O
DARRON NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/30/07 CD O O
by IN B-VP O
LAUB NNP B-NP O
, , O O
STERLING NN B-NP O
B NNP I-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
853955570 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/10/07 CD O O
by IN B-VP O
KRABBE NNP B-NP O
, , O O
TERRY NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
808894579 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ATENOLOL NNP I-NP B-m
37.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
CAPTOPRIL NNP I-NP B-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/12/07 CD O O
by IN B-VP O
CUCCHIARA NNP B-NP O
, , O O
JERROLD NNP B-NP O
T NNP I-NP O
CURTIS NNP I-NP O
REYNALDO NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
545368405 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CAPTOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CAPTOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
CELEXA NNP I-NP B-m
( ( O I-m
CITALOPRAM NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
EPLERENONE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/12/07 CD O O
by IN B-VP O
HOEGERL NNP B-NP O
, , O O
ISAAC NNP B-NP O
E NNP I-NP O
EDGAR NNP I-NP O
CHESTER NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
545368405 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
EPLERENONE NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
FOLATE NNP I-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting NNP I-NP O
AT NNP I-NP O
5:00 CD O O
PM NNP B-NP O
( ( O O
0/19 CD O O
) ) O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/30/07 CD O O
by IN B-VP O
GOODWINE NNP B-NP O
, , O O
BUFORD NNP B-NP O
H NNP I-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LASIX NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
145213873 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
TAMSULOSIN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Genital JJ B-NP O
ache NN I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
NEURONTIN NNP I-NP B-m
( ( O I-m
GABAPENTIN NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
LORAZEPAM NNP I-NP B-m
0.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Anxiety NNP I-NP B-r
LOVASTATIN NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Give VBP O O
with IN B-VP O
meals NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/30/07 CD O O
by IN B-VP O
PERAULT NNP B-NP O
, , O O
SHELBY NNP B-NP O
H NNP I-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
853955570 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LOVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/10/07 CD O O
by IN B-VP O
KATSUDA NNP B-NP O
, , O O
CLINTON NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
808894579 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LOVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/14/07 CD O O
by IN B-VP O
OGIAMIEN NNP B-NP O
, , O O
JACINTO NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LOVASTATIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
657865834 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
SIMVASTATIN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
leg JJ B-NP O
pain NN I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
med VBD B-VP O
Previous NNP B-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/14/07 CD O O
by IN B-VP O
TUROMSHA NNP B-NP O
, , O O
IRA NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
LOVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Number NNP I-NP B-du
Number NNP I-NP B-du
of IN B-VP I-du
of IN B-VP I-du
Doses NNP B-NP I-du
Doses NNP I-NP I-du
Required NNP I-NP I-du
Required NNP I-NP I-du
( ( O I-du
( ( O I-du
approximate VB O I-du
approximate NN B-NP I-du
): NNP I-NP I-du
): VBD B-VP I-du
7 CD O I-du
7 CD O I-du
OMEPRAZOLE NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
TEMAZEPAM NNP I-NP B-m
15-30 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
PRN NNP I-NP I-f
Insomnia NNP I-NP B-r
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/14/07 CD O O
by IN B-VP O
VANSTEENBURG NNP B-NP O
, , O O
TREVOR NNP B-NP O
B NNP I-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LOVASTATIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
657865834 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
LOVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
COSOPT NNP I-NP B-m
( ( O I-m
TIMOLOL/DORZOLAMIDE NNP B-NP I-m
) ) O I-m
1 CD O B-do
DROP NNP B-NP I-do
OU NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/14/07 CD O O
by IN B-VP O
LUTHY NNP B-NP O
, , O O
LANNY NNP B-NP O
D NNP I-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COSOPT NNP B-NP B-m
OU NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
517414331 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
TAMSULOSIN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Genital JJ B-NP O
ache NN I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ O O
, , O O
home NN B-NP O
med VBD B-VP O
COUMADIN NNP B-NP B-m
COUMADIN NNP I-NP B-m
( ( O I-m
( ( O I-m
WARFARIN NNP B-NP I-m
WARFARIN NNP I-NP I-m
SODIUM NNP I-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Instructions: NNP B-NP O
Please NNP I-NP O
take VB O O
1mg CD O B-do
every DT B-NP B-f
day NN I-NP I-f
except IN B-VP I-f
for IN B-VP I-f
monday NN B-NP I-f
when WRB O O
you PRP O O
take VBP O O
2mg CD O O
, , O O
unless IN B-VP O
your PRP$ O O
coumadin NN B-NP O
clinic NN I-NP O
at IN B-VP O
the DT B-NP O
AWMH NNP I-NP O
tells VBZ O O
you PRP O O
otherwise RB O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
10/30/07 CD O O
by IN B-VP O
ANGELILLO NNP B-NP O
, , O O
ORVILLE NNP B-NP O
R NNP I-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LOVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
TRAVATAN NNP I-NP B-m
1 CD O B-do
DROP NNP B-NP I-do
OU NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Instructions: NNP I-NP O
OU NNP I-NP O
thanks NNS I-NP O
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction NN I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Vonfelden NNP I-NP O
8/21 CD O O
@ NNP B-NP O
10 CD O O
, , O O
Dr NNP B-NP O
Odien NNP I-NP O
, , O O
please VB O O
call VB O O
724-105-6354 JJ O O
for IN B-VP O
earlier RBR O O
appointment NN B-NP O
if IN B-VP O
able JJ O O
4/23 CD O O
@ JJ O O
3:40 CD O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
2/21/07 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
7 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
SUH NNP B-NP O
coumadin NN I-NP O
clinic NN I-NP O
ALLERGY: NNP I-NP O
PREDNISONE NNP I-NP O
, , O O
Penicillins NNP B-NP O
, , O O
TAMSULOSIN NNP B-NP O
, , O O
SIMVASTATIN NNP B-NP O
, , O O
SPIRONOLACTONE NNP B-NP O
, , O O
Fam NNP B-NP O
Hx NNP I-NP O
malignant JJ B-NP O
hyperthermia NN I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chf NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chf VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
kidney NNP I-NP O
stone NN I-NP O
cardiomyopathy-ef25% JJ B-NP O
degenerative JJ I-NP O
arthritis NN I-NP O
blurred VBD B-VP O
vision NN B-NP O
sleep NN I-NP O
apnea NN I-NP O
arrhythmias IN B-VP O
prior JJ B-NP O
MI NNP I-NP O
spinal JJ B-NP O
stenosis NN I-NP O
( ( O O
spinal JJ B-NP O
stenosis NN I-NP O
) ) O O
barrett's NN B-NP O
esophagus NN I-NP O
( ( O O
barrett's JJ B-NP O
esophagus NN I-NP O
) ) O O
peripheral NN B-NP O
neuropathy NN I-NP O
( ( O O
peripheral JJ B-NP O
neuropathy NN I-NP O
) ) O O
glaucoma NN B-NP O
( ( O O
glaucoma NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
RHC/LHC NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
PCP: NNP I-NP O
Wickell NNP I-NP O
, , O O
Hyman NNP B-NP O
CARDS: NNP I-NP O
Shannon NNP I-NP O
Marlon NNP I-NP O
Sefcik NNP I-NP O
CC:SOB NNP I-NP O
HPI:78M NNP I-NP O
w/ VBD B-VP O
CAD NNP B-NP O
S/ NNP I-NP O
P NNP I-NP O
stents NNS I-NP O
( ( O O
Cypher NNP B-NP O
to TO O O
LM NNP B-NP O
and CC O O
LAD NNP B-NP O
in IN B-VP O
8/15 CD O O
) ) O O
, , O O
ischemic JJ B-NP O
CM NNP I-NP O
with IN B-VP O
EF NNP B-NP O
15-20% JJ O O
, , O O
S/P NNP B-NP O
AV NNP I-NP O
node POS O O
ablation NN B-NP O
1/29 CD O O
w/ NN B-NP O
BiV NNP I-NP O
pacer NN I-NP O
, , O O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
MGUS NNP B-NP O
, , O O
hx NN B-NP O
of IN B-VP O
syncope NN B-NP O
due JJ O O
to TO O O
orthostasis/dehydration VB O O
presenting VBG O O
w JJ B-NP O
SOB NNP I-NP O
Usually NNP I-NP O
does VBZ O O
30 CD O O
mins NNS B-NP O
on IN B-VP O
bike NN B-NP O
, , O O
now RB O O
having VBG O O
dyspnea NN B-NP O
with IN B-VP O
20 CD O O
mins NNS B-NP O
, , O O
stopping VBG O O
after IN B-VP O
1 CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
, , O O
used VBD B-VP O
to TO O O
do VB O O
2 CD O O
flights NNS B-NP O
Sx NNP I-NP O
progressively RB O O
worsening VBG O O
over IN B-VP O
past JJ B-NP O
1-2 JJ I-NP O
mos NN I-NP O
Weight NNP I-NP O
195 CD O O
lbs NN B-NP O
, , O O
got VBD B-VP O
extra JJ B-NP O
lasix NN I-NP B-m
, , O O
now RB O O
190 CD O O
lb NN B-NP O
( ( O O
he PRP O O
says VBZ O O
baseline NN B-NP O
) ) O O
, , O O
but CC O O
has VBZ O O
not RB O O
noticed VBN O O
difference NN B-NP O
in IN B-VP O
sx JJ B-NP O
+CP NN I-NP O
1 CD O O
week NN B-NP O
ago RB O O
while IN B-VP O
on IN B-VP O
treadmill NN B-NP O
, , O O
stopped VBD B-VP O
with IN B-VP O
resting VBG O O
+dizzy NN B-NP O
and CC O O
lightheadedness NN B-NP O
( ( O O
chronic JJ O O
) ) O O
, , O O
no DT B-NP O
orthopena NN I-NP O
, , O O
PND NNP B-NP O
, , O O
no DT B-NP O
edema.No JJ I-NP O
change NN I-NP O
in IN B-VP O
diet JJ B-NP O
Taking NNP I-NP O
meds NNS I-NP O
*** VBP O O
PMHx:ischemic NNP B-NP O
CM NNP I-NP O
, , O O
EF NNP B-NP O
15%-20% CD O O
( ( O O
dry JJ B-NP O
wt NN I-NP O
per IN B-VP O
D/C NNP B-NP O
summary JJ O O
185.2 CD O O
lb NN B-NP O
) ) O O
, , O O
hx JJ B-NP O
Afib NNP I-NP O
and CC O O
VT NNP B-NP O
, , O O
S/P NNP B-NP O
ICD NNP I-NP O
4/12 CD O O
, , O O
BiV NNP B-NP O
3/22 CD O O
, , O O
AV NNP B-NP O
node POS O O
ablation NN B-NP O
7/26 CD O O
, , O O
CAD NNP B-NP O
S/P NNP I-NP O
IMI NNP I-NP O
1982 CD O O
stents NNS B-NP O
to TO O O
LM NNP B-NP O
and CC O O
LAD NNP B-NP O
8/15 CD O O
as IN B-VP O
not RB O O
candidate VB O O
for IN B-VP O
CABG NNP B-NP O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
, , O O
DJD NNP B-NP O
, , O O
Barrett's NNP B-NP O
esophagus NN I-NP O
, , O O
Glaucoma NNP B-NP O
, , O O
Graves NNP B-NP O
disease NN I-NP O
, , O O
Diverticulitis NNP B-NP O
, , O O
Hypothyroidism NNP B-NP O
, , O O
secondary JJ O O
to TO O O
amiodarone VB O B-m
toxicity NN B-NP O
, , O O
Peripheral NNP B-NP O
neuropathy NN I-NP O
, , O O
restless NN B-NP O
legs NNS I-NP O
, , O O
Spinal JJ B-NP O
stenosis NN I-NP O
ALL:Prednisone-&gt;soreness NNP I-NP O
, , O O
PCN-&gt;flushing NNP B-NP O
, , O O
Tamsulosin-&gt;genital NNP B-NP O
ache NN I-NP O
, , O O
zocor-&gt;leg JJ B-NP O
pain NN I-NP O
, , O O
spironolactone-&gt;gynecomastia JJ B-NP O
Exam: NNP I-NP O
95.7 CD O O
85 CD O O
98/70 CD O O
absent JJ B-NP O
overshoot NN I-NP O
on IN B-VP O
valsalva NN B-NP O
GEN: NNP I-NP O
well-appearing NN I-NP O
CV: NNP I-NP O
distant NN I-NP O
HS NNP I-NP O
, , O O
non-palpable JJ B-NP O
PMI NNP I-NP O
, , O O
diminished VBD B-VP O
carotid NN B-NP O
pulses VBZ O O
no DT B-NP O
bruits NNS I-NP O
, , O O
JVP NNP B-NP O
8 CD O O
cm NN B-NP O
LUNGS: NNP I-NP O
CTAB NNP I-NP O
Abd: NNP I-NP O
benign NN I-NP O
, , O O
non-pulsatile JJ B-NP O
liver NN I-NP O
Ext: NNP I-NP O
cool NN I-NP O
, , O O
2+PT CD O O
B/L NNP B-NP O
, , O O
no DT B-NP O
edema NN I-NP O
Neuro: NNP I-NP O
no DT B-NP O
facial JJ I-NP O
droop NN I-NP O
, , O O
non-focal JJ B-NP O
*** NNP I-NP O
EKG: NNP I-NP O
CXR:neg NNP I-NP O
Stress NNP I-NP O
Echo NNP I-NP O
9/24/06: CD O O
66% CD O O
MPHR NNP B-NP O
, , O O
RPP NNP B-NP O
12000 CD O O
BPM NNP B-NP O
, , O O
stopped VBD B-VP O
for IN B-VP O
fatigue NN B-NP O
, , O O
dyspnea NN B-NP O
LV NNP I-NP O
enlarged VBD B-VP O
EF NNP B-NP O
15-20% JJ B-NP O
+RWMA NNP I-NP O
, , O O
mid NN B-NP O
and CC O O
distal JJ B-NP O
ant NN I-NP O
wall NN I-NP O
, , O O
mid NN B-NP O
and CC O O
distal JJ B-NP O
ant NN I-NP O
septum NN I-NP O
, , O O
inf JJ B-NP O
septum NN I-NP O
, , O O
entire JJ B-NP O
apex NN I-NP O
, , O O
and CC O O
post NN B-NP O
wall NN I-NP O
AK NNP I-NP O
All NNP I-NP O
other JJ B-NP O
walls NNS I-NP O
HK VBP O O
At IN B-VP O
stress: NN B-NP O
LV NNP I-NP O
not RB O O
dilated VBD B-VP O
akinetic JJ B-NP O
segments NNS I-NP O
remained VBD B-VP O
so RB O O
EF NNP B-NP O
up RB O O
to TO O O
25% CD O O
ETT NNP B-NP O
9/24/06: CD O O
STANDARD NNP B-NP O
BRUCE NNP I-NP O
, , O O
stopped VBD B-VP O
for IN B-VP O
DYSPNEA NNP B-NP O
&amp; NNP I-NP O
FATIGUE NNP I-NP O
, , O O
3'16" CD O O
, , O O
57.74% CD O O
MPHR NNP B-NP O
, , O O
RPP NNP B-NP O
8200 CD O O
, , O O
no DT B-NP O
ectopy NN I-NP O
Cath NNP I-NP O
3/29 CD O O
Right NNP B-NP O
Dominant NNP I-NP O
, , O O
LM NNP B-NP O
ostial JJ O O
70% CD O O
lesion NN B-NP O
, , O O
prox VBP O O
LAD NNP B-NP O
70% CD O O
lesion NN B-NP O
( ( O O
both DT O O
got VBD B-VP O
Cyphers NNP B-NP O
) ) O O
, , O O
no DT B-NP O
RAS NNP I-NP O
RCA NNP I-NP O
not RB O O
evaluated VBD B-VP O
Cath NNP B-NP O
10/16 CD O O
RCA NNP B-NP O
evaluated VBD B-VP O
( ( O O
Mid NNP B-NP O
) ) O O
, , O O
80% CD O O
lesion NN B-NP O
RCA NNP I-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
60% CD O O
lesion NN B-NP O
Elevated NNP I-NP O
RH NNP I-NP O
pressures VBZ O O
PFTs NNP B-NP O
0/30/92: CD O O
FEV1 NNP B-NP O
101% CD O O
ADENOSINE NNP B-NP O
MIBI NNP I-NP O
1/11/07: CD O O
1 CD O O
Abnormal NNP B-NP O
and CC O O
consistent JJ O O
with IN B-VP O
a DT B-NP O
large JJ I-NP O
region NN I-NP O
of IN B-VP O
myocardial JJ B-NP O
scar NN I-NP O
in IN B-VP O
the DT B-NP O
distribution NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
and CC O O
a DT B-NP O
posterolateral/OM JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
without IN B-VP O
residual JJ B-NP O
adenosine NN I-NP O
induced VBN O O
perfusion NN B-NP O
defect JJ B-NP O
Test NNP I-NP O
sensitivity NN I-NP O
for IN B-VP O
detecting VBG O O
ischemia NN B-NP O
is VBZ O O
reduced VBN O O
in IN B-VP O
this DT B-NP O
patient NN I-NP O
due JJ O O
to TO O O
lack VB O O
of IN B-VP O
a DT O O
separate JJ O O
normally RB O O
perfused JJ B-NP O
myocardium NN I-NP O
to TO O O
compare VB O O
to TO O O
2 CD O O
Severe NNP B-NP O
global JJ B-NP O
LV NNP I-NP O
systolic JJ B-NP O
dysfunction NN I-NP O
3 CD O O
Results NNP B-NP O
essentially RB O O
unchanged JJ O O
from IN B-VP O
March NNP B-NP O
, , O O
2005 CD O O
CATH NNP B-NP O
10/26/07: CD O O
LHC: NNP B-NP O
R NNP I-NP O
dom NN I-NP O
, , O O
No NNP B-NP O
LM NNP I-NP O
or CC O O
LAD NNP B-NP O
lesions NNS I-NP O
Cx NNP I-NP O
with IN B-VP O
discrete JJ O O
calcified VBD B-VP O
80% CD O O
lesion NN B-NP O
, , O O
RCA NNP B-NP O
with IN B-VP O
porx NN B-NP O
diffuse NN I-NP O
calcified VBD B-VP O
80%lesion CD O O
, , O O
RT NNP B-NP O
LV-BR NNP I-NP O
prox NN I-NP O
tubular NN I-NP O
70% CD O O
lesion NN B-NP O
, , O O
no DT B-NP O
change NN I-NP O
since IN B-VP O
2005 CD O O
RHC: NNP B-NP O
RA NNP I-NP O
7/8 CD O O
, , O O
6 CD O O
RV NNP B-NP O
27/5 CD O O
, , O O
6 CD O O
PA NNP B-NP O
26/13 CD O O
, , O O
19 CD O O
PCWP NNP B-NP O
16 CD O O
, , O O
CO/CI NNP B-NP O
3.6/1.8 CD O O
TTE: NNP B-NP O
5/16/07: CD O O
EF NNP B-NP O
15-20% JJ O O
with IN B-VP O
global JJ B-NP O
HK NNP I-NP O
and CC O O
ant/apical/inf/post/mid JJ B-NP O
sept NN I-NP O
AK NNP I-NP O
Severe NNP I-NP O
decr NN I-NP O
RV NNP I-NP O
fxn NN I-NP O
, , O O
severe JJ B-NP O
LAE NNP I-NP O
, , O O
Mild NNP B-NP O
AR NNP I-NP O
, , O O
Tr NNP B-NP O
TR/PR NNP I-NP O
, , O O
Mod NNP B-NP O
MR NNP I-NP O
, , O O
no DT B-NP O
change NN I-NP O
from IN B-VP O
prior JJ B-NP O
*** NNP I-NP O
Hospital NNP I-NP O
Course:78M NNP I-NP O
with IN B-VP O
significant JJ B-NP O
CAD NNP I-NP O
, , O O
iCM JJ B-NP O
EF NNP I-NP O
15-20% CD O O
, , O O
presenting VBG O O
with IN B-VP O
SOB NNP B-NP O
Suspected NNP I-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
1 CD O O
CV: NNP B-NP O
Ischemia- NNP I-NP O
Checked NNP I-NP O
troponin NN I-NP O
( ( O O
neg JJ O O
) ) O O
for IN B-VP O
hx NN B-NP O
of IN B-VP O
CP NNP B-NP O
1 CD O O
week NN B-NP O
ago RB O O
Cont NNP B-NP O
ASA/Plavix NNP I-NP B-m
, , O O
BB NNP B-NP B-m
Some DT B-NP O
concern NN I-NP O
for IN B-VP O
ischemia NN B-NP O
causing VBG O O
his PRP$ O O
worsening NN B-NP O
symptoms NNS I-NP O
so RB O O
Adenosine NNP B-NP O
MIBI NNP I-NP O
on IN B-VP O
1/8 CD O O
w/o JJ B-NP O
focal JJ I-NP O
defects NNS I-NP O
, , O O
but CC O O
no DT B-NP O
good JJ I-NP O
area NN I-NP O
to TO O O
compare VB O O
it PRP O O
to TO O O
LHC NNP B-NP O
w/o VB O O
new JJ B-NP O
disease NN I-NP O
, , O O
no DT B-NP O
interventions NNS I-NP O
TSH NNP I-NP O
nl RB O O
Pump: NNP B-NP O
Possibly NNP I-NP O
slightly RB O O
volume NN B-NP O
up RP O O
RHC NNP B-NP O
with IN B-VP O
wedge NN B-NP O
of IN B-VP O
16 CD O O
Changed NNP B-NP O
Lasix NNP I-NP B-m
to TO O O
60 CD O B-do
bid NN B-NP B-f
Cont NNP I-NP O
Dig/nitrate/BB NNP I-NP B-m
, , O O
ACEi NNP B-NP B-m
Checked NNP I-NP O
echo NN I-NP O
, , O O
no DT B-NP O
change NN I-NP O
Rhythym: NNP I-NP O
Tele NNP I-NP O
Lyte NNP I-NP B-m
replete VB O O
prn RB O B-f
2 CD O O
PULM: NNP B-NP O
no DT B-NP O
COPD NNP I-NP O
by IN B-VP O
PFTs NNP B-NP O
1992.No CD O O
asthma NN B-NP O
or CC O O
PNA NNP B-NP O
3 CD O O
Renal: NNP B-NP O
CRI NNP I-NP O
( ( O O
1.4-1.8 JJ O O
) ) O O
1.6 CD O O
on IN B-VP O
admit NN B-NP O
, , O O
follow VBP O O
Stable JJ O O
, , O O
got VBD B-VP O
mucomyst JJ B-NP B-m
pre NN I-NP O
cath NN I-NP O
, , O O
no DT B-NP O
bump NN I-NP O
in IN B-VP O
Cr NNP B-NP O
1.4 CD O O
on IN B-VP O
discharge NN B-NP O
4 CD O O
GI: NNP B-NP O
Barrett's NNP I-NP B-r
, , O O
on IN B-VP O
a DT B-NP O
PPI NNP I-NP B-m
5 CD O O
NEURO: NNP B-NP O
neuropathy JJ B-NP B-r
neuropathy NN I-NP B-r
, , O O
neurontin NN B-NP B-m
, , O O
celexa VBP O B-m
6 CD O O
Optho: NNP B-NP O
glaucoma NN I-NP O
, , O O
on IN B-VP O
eye NN B-NP B-m
drops NNS I-NP I-m
7 CD O O
FEN: NNP B-NP O
CV NNP I-NP O
, , O O
NAS NNP B-NP O
, , O O
2L CD O O
fluid NN B-NP O
restrict NN I-NP O
diet JJ O O
8 CD O O
HEME: NNP B-NP O
Held NNP I-NP O
coumadin NN I-NP B-m
for IN B-VP O
cath NN B-NP O
, , O O
then RB O O
restarted VBD B-VP O
it PRP O O
with IN B-VP O
2mg CD O B-do
on IN B-VP O
8/1 CD O O
, , O O
1mg CD O O
on IN B-VP O
6/10 CD O O
, , O O
INR NNP B-NP O
of IN B-VP O
1.7 CD O O
on IN B-VP O
d/c JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
stop VB O O
taking VBG O O
your PRP$ O O
Imdur NNP B-NP B-m
Please NNP I-NP O
measure NN I-NP O
daily JJ B-NP O
weights NNS I-NP O
and CC O O
call VB O O
your PRP$ O O
MD NNP B-NP O
if IN B-VP O
your PRP$ O O
weight NN B-NP O
increases NNS I-NP O
by IN B-VP O
more JJR O O
than IN B-VP O
5lbs CD O O
in IN B-VP O
one CD O O
week NN B-NP O
or CC O O
by IN B-VP O
more JJR O O
than IN B-VP O
2-3 CD O O
lbs NN B-NP O
in IN B-VP O
one CD O O
day NN B-NP O
Please NNP I-NP O
continue VB O O
your PRP$ O O
coumadin NN B-NP B-m
and CC O O
take VB O O
it PRP O O
as IN B-VP O
previously RB O O
Check NNP B-NP O
your PRP$ O O
INR NNP B-NP O
on IN B-VP O
monday JJ B-NP O
Please NNP I-NP O
take VB O O
Lasix NNP B-NP B-m
60 CD O B-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
Otherwise NNP I-NP O
resume VBZ O O
all DT O O
of IN B-VP O
your PRP$ O O
home NN B-NP O
medications NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Please NNP I-NP O
follow VB O O
up RP O O
volume NN B-NP O
status NN I-NP O
INR NNP I-NP O
was VBD B-VP O
1.7 CD O O
on IN B-VP O
d/c NN B-NP O
Will NNP I-NP O
check VB O O
INR NNP B-NP O
on IN B-VP O
2/21/07 CD O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GIPSON NNP I-NP O
, , O O
KOREY NNP B-NP O
I PRP O O
, , O O
M.D NNP B-NP O
( ( O O
DH589 NNP B-NP O
) ) O O
3/22/07 CD O O
@ $ O O
11:28 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#868962 VBZ O O
417047334 CD O O
BH NNP B-NP O
46210361 CD O O
1866712 CD O O
1/20/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Hypertensive NNP I-NP O
urgency NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/7/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/22/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
HU NNP I-NP O
, , O O
BRADLY NNP B-NP O
340-67-65-6 CD O O
Na NNP B-NP O
Lu NNP I-NP O
Sno NNP I-NP O
, , O O
Colorado NNP B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/7/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CANUPP NNP I-NP O
, , O O
WILFORD NNP B-NP O
STANTON NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LASIX NNP I-NP B-m
LASIX NNP I-NP B-m
LASIX NNP I-NP B-m
LASIX NNP I-NP B-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
FUROSEMIDE NNP I-NP I-m
FUROSEMIDE NNP I-NP I-m
FUROSEMIDE NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
QAM; NNP I-NP B-f
120 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
PO NNP I-NP B-mo
PO NNP I-NP B-mo
160 CD O B-do
MG NNP B-NP I-do
QAM NNP I-NP B-f
120 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/7/05 CD O O
by IN B-VP O
KULOW NNP B-NP O
, , O O
LUPE NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
49689673 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
MVI NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVITAMINS NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
AMBIEN NNP B-NP B-m
( ( O I-m
ZOLPIDEM NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
DEPAKOTE NNP B-NP B-m
ER NNP I-NP I-m
( ( O I-m
DIVALPROEX NNP B-NP I-m
SODIUM NNP I-NP I-m
ER NNP I-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
5/13 CD O O
) ) O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Primary NNP I-NP O
cardiologist NN I-NP O
Please NNP I-NP O
make VB O O
an DT B-NP O
appt NN I-NP O
for IN B-VP O
the DT B-NP O
next JJ I-NP O
1-2 JJ I-NP O
weeks NNS I-NP O
, , O O
Primary NNP B-NP O
care NN I-NP O
doctor NN I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CAD NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Hypertensive NNP B-NP O
urgency NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
obesity NN I-NP O
tobacco NN I-NP O
OSA NNP I-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
h/o NN B-NP O
asthma/bronchitis NN I-NP O
( ( O O
H/O NNP B-NP O
asthmatic JJ B-NP O
bronchitis NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Cardiac NNP B-NP O
catherization NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Chest NNP I-NP O
pain NN I-NP O
HPI: NNP I-NP O
54M CD O O
w/ NN B-NP O
hx NN I-NP O
chf NN I-NP O
ef NN I-NP O
45% CD O O
, , O O
dm NN B-NP O
, , O O
htn NN B-NP O
, , O O
osa NN B-NP O
, , O O
was VBD B-VP O
admitted VBN O O
to TO O O
FH NNP B-NP O
w/ NN I-NP O
c/o NN I-NP O
cp NN I-NP O
Found NNP I-NP O
to TO O O
have VB O O
BP NNP B-NP O
190-200 JJ B-NP O
w/ NN I-NP O
troponin NN I-NP O
elevated VBD B-VP O
to TO O O
6.o CD O O
No NNP B-NP O
ekg NN I-NP O
changes NNS I-NP O
Pt NNP I-NP O
sent VBD B-VP O
to TO O O
SR NNP B-NP O
for IN B-VP O
cath NN B-NP O
Cath NNP I-NP O
revealed VBD B-VP O
100% CD O O
RCA NNP B-NP O
lesion NN I-NP O
but CC O O
well RB O O
collateralized JJ O O
and CC O O
no DT B-NP O
other JJ I-NP O
CAD--&gt;no NNP I-NP O
intervention NN I-NP O
R NNP I-NP O
heart NN I-NP O
cath NN I-NP O
w/ NN I-NP O
elev NN I-NP O
filling NN I-NP O
pressures NNS I-NP O
Pt NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
free JJ O O
since IN B-VP O
ECH NNP B-NP O
admission NN I-NP O
PMH: NNP I-NP O
as IN B-VP O
above IN B-VP O
meds: NN B-NP O
toprol NN I-NP B-m
lisinopril NN I-NP I-m
, , O O
norvasc RB O B-m
, , O O
asa NN B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
depakote VB O B-m
PE: NNP B-NP O
BP NNP I-NP O
145/90 CD O O
, , O O
HR NNP B-NP O
68 CD O O
JVP NNP B-NP O
9 CD O O
, , O O
lungs NNS B-NP O
clear VBP O O
, , O O
heart NN B-NP O
normal JJ B-NP O
labs: JJ I-NP O
cr NN I-NP O
1.5 CD O O
( ( O O
baseline NN B-NP O
) ) O O
, , O O
hct $ O O
55 CD O O
, , O O
k VBD B-VP O
3.3 CD O O
EKG: NNP B-NP O
nsr NN I-NP O
at IN B-VP O
68 CD O O
w/ NNS B-NP O
old JJ B-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
inf JJ B-NP O
leads NNS I-NP O
and CC O O
TWIs NNP B-NP O
in IN B-VP O
v3-v6 JJ B-NP O
CXR: NNP I-NP O
nl NN I-NP O
************************************************** NNP I-NP O
A/P: NNP I-NP O
54M CD O O
w/ NN B-NP O
hx NN I-NP O
chf NN I-NP O
admitted VBD B-VP O
w/ JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
elev JJ B-NP O
troponin NN I-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
elev NN B-NP O
BP NNP I-NP O
likely JJ B-NP O
demand NN I-NP O
2/2 CD O O
hypertensive JJ B-NP O
emergency NN I-NP O
1 CD O O
)CV: NN B-NP O
Presented NNP I-NP O
w/ NN I-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
troponin JJ B-NP O
elevation NN I-NP O
Non-sig NNP I-NP O
CAD NNP I-NP O
discovered VBD B-VP O
at IN B-VP O
cath NN B-NP O
However RB O O
, , O O
elev VBP O O
filling VBG O O
pressures NNS B-NP O
on IN B-VP O
right JJ B-NP O
heart NN I-NP O
cath NN I-NP O
Keys NNP I-NP O
to TO O O
management NN B-NP O
are VBP O O
aggressive JJ B-NP O
BP NNP I-NP O
control NN I-NP O
with IN B-VP O
meds NNS B-NP O
, , O O
low JJ B-NP O
salt NN I-NP O
diet NN I-NP O
, , O O
weight JJ B-NP O
loss NN I-NP O
cont NN I-NP O
asa NN I-NP B-m
, , O O
statin JJ B-NP B-m
Cont NNP I-NP O
lasix NN I-NP B-m
lasix VBD B-VP B-m
160 CD O B-do
in IN B-VP O
AM NNP B-NP B-f
, , O O
120 CD O B-do
in IN B-VP O
PM NNP B-NP B-f
for IN B-VP O
volume NN B-NP B-r
volume NN I-NP B-r
control NN I-NP I-r
control NN I-NP I-r
Troponin NNP I-NP O
trended VBD B-VP O
down RB O O
and CC O O
pt JJ O O
remained VBD B-VP O
asymptomatic JJ O O
in IN B-VP O
house NN B-NP O
Monitored VBD B-VP O
on IN B-VP O
tele--&gt;no JJ B-NP O
events NNS I-NP O
2 CD O O
)Renal: NNP B-NP O
Cr NNP I-NP O
1.5 CD O O
, , O O
remained VBD B-VP O
stable JJ O O
at IN B-VP O
baseline NN B-NP O
Gave NNP I-NP O
mucomyst NN I-NP B-m
3 CD O O
)Endo: NNP B-NP O
DM NNP I-NP O
on IN B-VP O
diet JJ B-NP O
control NN I-NP O
Hba1c NNP I-NP O
pending VBG O O
RISS NNP B-NP B-m
in IN B-VP O
house NN B-NP O
4 CD O O
)pulm: NN B-NP O
hx NN I-NP O
osa NN I-NP O
on IN B-VP O
cpap NN B-NP B-m
Likely JJ O O
contributing VBG O O
to TO O O
pulm VB O O
htn VB O O
given VBN O O
hct PRP O O
55 CD O O
Cont NNP B-NP O
cpap NN I-NP B-m
and CC O O
encourage VB O O
weight JJ B-NP O
loss NN I-NP O
No NNP I-NP O
SOB NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
be VB O O
sure JJ O O
to TO O O
continue VB O O
your PRP$ O B-m
medications NNS B-NP I-m
as IN B-VP O
prescribed JJ B-NP O
Continue NNP I-NP O
to TO O O
monitor VB O O
your PRP$ O O
BP NNP B-NP O
Cutting VBG O O
out RP O O
salt NN B-NP O
, , O O
losing VBG O O
weight NN B-NP O
, , O O
and CC O O
taking VBG O O
your PRP$ O O
meds NNS B-NP O
will MD O O
help VB O O
lower VB O O
your PRP$ O O
BP NNP B-NP O
If IN B-VP O
you PRP O O
re-experience VBP O O
chest JJ B-NP O
pain NN I-NP O
or CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
call VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
return NN B-NP O
to TO O O
the DT B-NP O
hospital NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SEDER NNP I-NP O
, , O O
FIDEL NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
XR068 NNP B-NP O
) ) O O
7/7/05 CD O O
@ $ O O
10:24 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#869853 VBZ O O
194458735 CD O O
RMC NNP B-NP O
86089618 CD O O
904118 CD O O
3/19/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
?MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/19/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/16/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
ACUTE NNP B-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mrs NNP I-NP O
Trudell NNP I-NP O
is VBZ O O
a DT O O
69 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
an DT B-NP O
inferoposterior JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
March NNP B-NP O
1996 CD O O
She PRP O O
had VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
an DT O O
80% CD O O
mid NN B-NP O
left VBD B-VP O
anterior JJ O O
descending VBG O O
artery NN B-NP O
lesion NN I-NP O
, , O O
and CC O O
80% CD O O
left VBD B-VP O
circumflex JJ B-NP O
lesion NN I-NP O
before IN B-VP O
OM1 NNP B-NP O
, , O O
50% CD O O
proximal JJ B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
lesion NN I-NP O
, , O O
and CC O O
an DT O O
80% CD O O
posterior NN B-NP O
left VBD B-VP O
ventricular JJ B-NP O
branch NN I-NP O
lesion NN I-NP O
She PRP O O
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
have VB O O
inferior JJ O O
and CC O O
anterolateral JJ B-NP O
HK NNP I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
52% CD O O
The DT B-NP O
patient NN I-NP O
expressed VBD B-VP O
her PRP$ O O
desire NN B-NP O
to TO O O
be VB O O
managed VBN O O
conservatively RB O O
, , O O
and CC O O
was VBD B-VP O
medically RB O O
managed VBN O O
for IN B-VP O
the DT B-NP O
following JJ I-NP O
year NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
sub-max JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
prior RB O O
to TO O O
discharge VB O O
and CC O O
one CD O O
month NN B-NP O
later RB O O
had VBD B-VP O
a DT B-NP O
full JJ I-NP O
BRUCE NNP I-NP O
protocol NN I-NP O
going VBG O O
six CD O O
minutes NNS B-NP O
with IN B-VP O
less JJR O O
than IN B-VP O
1 CD O O
mm JJ B-NP O
ST NNP I-NP O
segment NN I-NP O
depressions NNS I-NP O
in IN B-VP O
several JJ O O
leads VBZ O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
for IN B-VP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
without IN B-VP O
symptoms NNS B-NP O
until IN B-VP O
1:00 CD O O
a.m NNS B-NP O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
when WRB O O
she PRP O O
woke VBD B-VP O
from IN B-VP O
sleep NN B-NP O
with IN B-VP O
substernal JJ B-NP B-r
chest NN I-NP I-r
pain NN I-NP I-r
She PRP O O
took VBD B-VP O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
with IN B-VP O
relief NN B-NP O
after IN B-VP O
half NN B-NP O
and CC O O
hour NN B-NP O
but CC O O
at IN B-VP O
3:00 CD O O
a.m IN B-VP O
the DT B-NP O
pain NN I-NP O
recurred VBD B-VP O
with IN B-VP O
nausea NN B-NP O
The DT B-NP O
patient NN I-NP O
took VBD B-VP O
two CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
the DT B-NP O
pain NN I-NP B-r
by IN B-VP O
4:00 CD O O
a.m NN B-NP O
She PRP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
free JJ O O
of IN B-VP O
pain NN B-NP O
and CC O O
electrocardiogram NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
showed VBD B-VP O
changes NNS B-NP O
consistent JJ O O
with IN B-VP O
anterior JJ O O
ischemia VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
unstable JJ B-NP O
angina NN I-NP O
for IN B-VP O
evaluation NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Remarkable NNP I-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Include NNP I-NP O
simvastatin VBD B-VP B-m
10 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
, , O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
, , O O
enalapril VBZ O B-m
5 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
aspirin RB O B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
She PRP O O
had VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Revealed VBD B-VP O
a DT B-NP O
pulse NN I-NP O
of IN B-VP O
62 CD O O
, , O O
regular JJ O O
and CC O O
blood NN B-NP O
pressure NN I-NP O
160/80 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
12 CD O O
, , O O
oxygen JJR B-NP O
saturation NN I-NP O
of IN B-VP O
99% CD O O
on IN B-VP O
three CD O O
liters NNS B-NP O
nasal VBP O O
cannula NN B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
jugular JJ B-NP O
venous JJ I-NP O
distention NN I-NP O
, , O O
carotids NNS B-NP O
2+ CD O O
bilaterally RB O O
, , O O
no DT B-NP O
bruits NNS I-NP O
Chest NNP I-NP O
is VBZ O O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Heart NNP B-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
and CC O O
an DT B-NP O
S4 NNP I-NP O
was VBD B-VP O
present JJ B-NP O
Abdomen NNP I-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBN O O
with IN B-VP O
normal JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
present JJ B-NP O
Extremities NNS I-NP O
were VBD B-VP O
without IN B-VP O
edema JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
admission NN B-NP O
the DT B-NP O
patient's JJ I-NP O
initial JJ I-NP O
CK NNP I-NP O
was VBD B-VP O
111 CD O O
Her NNP B-NP O
second JJ B-NP O
CK NNP I-NP O
was VBD B-VP O
452 CD O O
, , O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
of IN B-VP O
45.1 CD O O
, , O O
third JJ B-NP O
CK NNP I-NP O
was VBD B-VP O
550 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
of IN B-VP O
47.9 CD O O
, , O O
and CC O O
a DT B-NP O
fourth JJ I-NP O
CK NNP I-NP O
of IN B-VP O
439 CD O O
with IN B-VP O
MB NNP B-NP O
fraction NN I-NP O
of IN B-VP O
33.5 CD O O
, , O O
fifth JJ B-NP O
CK NNP I-NP O
of IN B-VP O
261 CD O O
, , O O
with IN B-VP O
MB NNP B-NP O
fraction NN I-NP O
of IN B-VP O
14.9 CD O O
, , O O
and CC O O
a DT B-NP O
sixth JJ I-NP O
CK NNP I-NP O
of IN B-VP O
156 CD O O
SMA NNP B-NP O
seven CD O O
was VBD B-VP O
normal JJ B-NP O
Troponin NNP I-NP O
I PRP O O
was VBD B-VP O
0.0 CD O O
on IN B-VP O
admission NN B-NP O
White NNP I-NP O
blood NN I-NP O
count NN I-NP O
of IN B-VP O
11 CD O O
, , O O
hematocrit NN B-NP O
39.7 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
was VBD B-VP O
unremarkable JJ O O
for IN B-VP O
any DT B-NP O
infiltrate NN I-NP O
or CC O O
any DT B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
evidence NN I-NP O
Electrocardiogram NNP I-NP O
revealed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
75 CD O O
, , O O
axis RB O O
0 CD O O
, , O O
2 CD O O
to TO O O
3 CD O O
ST NNP B-NP O
segment NN I-NP O
elevation NN I-NP O
in IN B-VP O
V1 NNP B-NP O
through IN B-VP O
V3 NNP B-NP O
, , O O
1 CD O O
mm NN B-NP O
elevation NN I-NP O
in IN B-VP O
V4 NNP B-NP O
, , O O
less JJR O O
than IN B-VP O
1 CD O O
mm JJ B-NP O
ST NNP I-NP O
segment NN I-NP O
depressions NNS I-NP O
in IN B-VP O
1 CD O O
, , O O
AVL NNP B-NP O
, , O O
and CC O O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
These DT B-NP O
changes NNS I-NP O
were VBD B-VP O
new JJ O O
compared VBN O O
to TO O O
a DT B-NP O
previous JJ I-NP O
electrocardiogram NN I-NP O
from IN B-VP O
March NNP B-NP O
1996 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
CCU NNP B-NP O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
she PRP O O
was VBD B-VP O
pain JJ O O
free JJ O O
and CC O O
her PRP$ O O
electrocardiogram NN B-NP O
abnormalities NNS I-NP O
had VBD B-VP O
resolved VBN O O
Her NNP B-NP O
heart NN I-NP O
rate NN I-NP O
and CC O O
blood NN B-NP O
pressure NN I-NP O
were VBD B-VP O
controlled VBN O O
with IN B-VP O
intravenous JJ B-NP B-mo
medications NNS I-NP B-m
and CC O O
she PRP O O
was VBD B-VP O
managed VBN O O
medically RB O O
until IN B-VP B-du
hospital JJ B-NP I-du
day NN I-NP I-du
three CD O I-du
when WRB O O
she PRP O O
was VBD B-VP O
taken VBN O O
of IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
laboratory NN I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
revealed VBD B-VP O
a DT O O
90% CD O O
plus CC O O
left VBD B-VP O
anterior JJ O O
descending VBG O O
artery JJ B-NP O
lesion NN I-NP O
distal NN I-NP O
to TO O O
D1 NNP B-NP O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
thrombus NN B-NP O
, , O O
60% CD O O
proximal NN B-NP O
left VBD B-VP O
circumflex JJ B-NP O
lesion NN I-NP O
with IN B-VP O
diffuse NN B-NP O
disease NN I-NP O
in IN B-VP O
the DT B-NP O
OM1 NNP I-NP O
, , O O
a DT O O
40% CD O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
lesion NN I-NP O
, , O O
left VBD B-VP O
ventriculogram NN B-NP O
revealed VBN O O
anterior JJ O O
lateral JJ O O
apical JJ O O
and CC O O
septal JJ B-NP O
HK NNP I-NP O
and CC O O
AK NNP B-NP O
The DT B-NP O
patient NN I-NP O
returned VBD B-VP O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
laboratory NN I-NP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
for IN B-VP O
PTCA NNP B-NP O
and CC O O
stenting NN B-NP O
of IN B-VP O
her PRP$ O O
left JJ O O
anterior JJ O O
descending VBG O O
artery NN B-NP B-r
lesion NN I-NP I-r
followed VBN O O
by IN B-VP O
ReoPro NNP B-NP B-m
infusion NN I-NP B-mo
From IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
admission NN B-NP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
throughout IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay VB O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
have VB O O
recurrence NN B-NP O
of IN B-VP O
her PRP$ O O
chest JJS B-NP O
pain NN I-NP O
Cardiac NNP I-NP O
enzymes RB O O
returned VBD B-VP O
to TO O O
baseline VB O O
Electrocardiogram NNP B-NP O
revealed VBD B-VP O
ST NNP B-NP O
segments NNS I-NP O
also RB O O
returned VBD B-VP O
to TO O O
baseline VB O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Include NNP I-NP O
aspirin VBZ O B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
simvastatin VBD B-VP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Ticlid NNP B-NP B-m
250 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
for IN B-VP B-du
11 CD O I-du
days NNS B-NP I-du
, , O O
Atenolol NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
enalapril VBZ O B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
The DT B-NP O
patient NN I-NP O
is VBZ O O
instructed VBN O O
to TO O O
resume VB O O
a DT B-NP O
low JJ I-NP O
fat NN I-NP O
, , O O
low JJ B-NP O
cholesterol NN I-NP O
diet JJ B-NP O
Activity NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW-UP: NNP B-NP O
With IN B-VP O
Dr NNP B-NP O
Kroell NNP I-NP O
on IN B-VP O
10/10/97 CD O O
at IN B-VP O
3:50 CD O O
p.m NN B-NP O
and CC O O
will MD O O
also RB O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Brendlinger NNP I-NP O
in IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
November NNP B-NP O
or CC O O
beginning NN B-NP O
of IN B-VP O
May NNP B-NP O
, , O O
to TO O O
be VB O O
arranged VBN O O
Dictated NNP B-NP O
By: NNP I-NP O
ABE NNP I-NP O
HENSLER NNP I-NP O
, , O O
M.D NNP B-NP O
MM88 NNP I-NP O
Attending: NNP I-NP O
RUSTY NNP I-NP O
D NNP I-NP O
SUELLENTROP NNP I-NP O
, , O O
M.D NNP B-NP O
NY6 NNP I-NP O
WD474/8780 NNP I-NP O
Batch: NNP I-NP O
89907 CD O O
Index NNP B-NP O
No NNP I-NP O
WOCER31071 NNP I-NP O
D: NNP I-NP O
11/4/97 CD O O
T: NNP B-NP O
0/29/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#874479 VBZ O O
792982757 CD O O
LPH NNP B-NP O
16192386 CD O O
268126 CD O O
7/0/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/6/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/21/1992 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT O O
46 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
asthma NN B-NP O
, , O O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
an DT B-NP O
asthma NN I-NP O
exacerbation NN I-NP O
She PRP O O
had VBD B-VP O
asthma VBN O O
since IN B-VP O
childhood NN B-NP O
, , O O
never RB O O
intubated VBN O O
, , O O
never RB O O
previously RB O O
treated VBN O O
with IN B-VP O
steroids NNS B-NP O
She PRP O O
felt VBD B-VP O
upper JJ B-NP O
respiratory NN I-NP O
symptoms NNS I-NP O
5 CD O O
days NNS B-NP O
before IN B-VP O
admission NN B-NP O
She PRP O O
had VBD B-VP O
dyspnea NN B-NP O
2 CD O O
days NNS B-NP O
before IN B-VP O
admission NN B-NP O
In IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
peak JJ I-NP O
flow NN I-NP O
of IN B-VP O
300 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
92% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
steroids NNS B-NP B-m
, , O O
Solu-Medrol NNP B-NP B-m
and CC O O
then RB O O
prednisone VB O B-m
60 CD O B-do
milligrams NNS B-NP O
orally RB O B-mo
, , O O
beta JJ B-NP B-m
agonist NN I-NP I-m
, , O O
nebulizer NN B-NP B-m
and CC O O
ampicillin NN B-NP B-m
She PRP O O
had VBD B-VP O
continuation NN B-NP O
of IN B-VP O
oral JJ B-NP B-mo
theophylline NN I-NP B-m
as IN B-VP O
she PRP O O
had VBD B-VP O
been VBN O O
using VBG O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
Her NNP I-NP O
lung NN I-NP O
examination NN I-NP O
showed VBD B-VP O
wheezes NNS B-NP O
bilaterally RB O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
asthma NN B-NP O
, , O O
degenerative JJ B-NP O
joint NN I-NP O
disease NN I-NP O
, , O O
lower JJR O O
back RB O O
pain NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
burn VBP O O
injury NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
were VBD B-VP O
Theo-Dur NNP B-NP B-m
200 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth NN B-NP O
3 CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
prednisone NN B-NP B-m
60 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth JJ O I-mo
each DT B-NP B-f
day NN I-NP I-f
, , O O
Albuterol NNP B-NP B-m
nebulizer NN I-NP I-m
, , O O
ampicillin VBZ O B-m
500 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
3 CD O B-f
times NNS B-NP O
a DT B-NP O
day NN I-NP O
and CC O O
Bronkosol NNP B-NP B-m
ALLERGIES NNP I-NP O
included VBD B-VP O
sulfa JJ B-NP O
drugs NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Temperature NNP I-NP O
was VBD B-VP O
97.8 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
84 CD O O
to TO O O
90 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
110 CD O O
to TO O O
132/70 CD O O
to TO O O
84 CD O O
Of IN B-VP O
note NN B-NP O
on IN B-VP O
the DT B-NP O
physical JJ I-NP O
examination NN I-NP O
her PRP$ O O
lungs NNS B-NP O
had VBD B-VP O
bilateral JJ B-NP O
wheezes NNS I-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
41.6 CD O O
, , O O
white JJ B-NP O
count NN I-NP O
9.66 CD O O
, , O O
platelets NNS B-NP O
199 CD O O
, , O O
000 CD O O
SMA-7 NN B-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
theophylline JJ B-NP B-m
level NN I-NP O
was VBD B-VP O
subtherapeutic JJ B-NP O
Sputum NNP I-NP O
gram NN I-NP O
stain NN I-NP O
showed VBD B-VP O
many JJ O O
gram RB O O
positive JJ B-NP O
cocci NN I-NP O
in IN B-VP O
clusters NNS B-NP O
and CC O O
pairs NNS B-NP O
with IN B-VP O
a DT B-NP O
few JJ I-NP O
polys NN I-NP O
, , O O
and CC O O
grew VBD B-VP O
Hemophilus NNP B-NP O
and CC O O
a DT B-NP O
peri-influenza NN I-NP O
that WDT O O
was VBD B-VP O
sensitive JJ O O
to TO O O
ciprofloxacin VB O O
and CC O O
Keflex NNP B-NP O
, , O O
but CC O O
resistant VBP O O
to TO O O
ampicillin VB O O
Chest NNP B-NP O
x-ray NN I-NP O
was VBD B-VP O
negative JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
slowly RB O O
improved VBN O O
with IN B-VP O
decreased JJ B-NP O
wheezing NN I-NP O
in IN B-VP O
her PRP$ O O
breath NN B-NP O
sounds VBZ O O
, , O O
increased VBD B-VP O
peak NN B-NP O
flow NN I-NP O
from IN B-VP O
300 CD O O
, , O O
went VBD B-VP O
down RB O O
to TO O O
270 CD O O
, , O O
back RB O O
up IN B-VP O
to TO O O
300 CD O O
with IN B-VP O
less JJR B-NP O
dyspnea NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
and CC O O
she PRP O O
was VBD B-VP O
given VBN O O
an DT B-NP O
echocardiogram NN I-NP O
to TO O O
look VB O O
for IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
etiology NN I-NP O
of IN B-VP O
bilateral JJ B-NP O
pedal NN I-NP O
edema NN I-NP O
that IN B-VP O
she PRP O O
was VBD B-VP O
having VBG O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
3 CD O O
of IN B-VP O
May NNP B-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
were VBD B-VP O
all DT O O
her PRP$ O O
usual JJ B-NP O
medications NNS I-NP O
, , O O
plus CC O O
Keflex NNP B-NP B-m
500 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
4 CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
prednisone NN B-NP B-m
50 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth JJ O O
each DT B-NP B-f
day NN I-NP I-f
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
to TO O O
FOLLOW-UP NNP B-NP O
with IN B-VP O
Dr NNP B-NP O
Joaquin NNP I-NP O
A NNP I-NP O
Reginal NNP I-NP O
at IN B-VP O
Ren NNP B-NP O
Bern NNP I-NP O
A NNP I-NP O
, , O O
Maryland NNP B-NP O
51916 CD O O
, , O O
S NNP B-NP O
, , O O
who WP O O
can MD O O
follow VB O O
her PRP$ O O
pulmonary JJ B-NP O
status NN I-NP O
FK608/6405 NNP I-NP O
RUSTY NNP I-NP O
H NNP I-NP O
HUGGARD NNP I-NP O
, , O O
M.D NNP B-NP O
TM1 NNP I-NP O
D: NNP I-NP O
9/29/92 CD O O
Batch: NNP B-NP O
1843 CD O O
Report: NNP B-NP O
L0931O73 NNP I-NP O
T: NNP I-NP O
1/0/92 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
ANTWAN NNP I-NP O
S NNP I-NP O
MCKEAGUE NNP I-NP O
, , O O
M.D NNP B-NP O
cc: VBZ O O
1 CD O O
DWAIN NNP B-NP O
YANDELL NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#881168 VBZ O O
147798665 CD O O
SPCMC NNP B-NP O
89807948 CD O O
3321390 CD O O
7/6/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/10/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/10/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MAZINGO NNP I-NP O
, , O O
THOMAS NNP B-NP O
281-40-01-4 CD O O
Awood NNP B-NP O
Raburg NNP I-NP O
West NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/14/04 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
COWDEN NNP I-NP O
, , O O
PRESTON NNP B-NP O
CRISTOBAL NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
No NNP I-NP O
defib NN I-NP O
/ VBZ O O
No DT B-NP O
intubation NN I-NP O
/ VBZ O O
DISPOSITION: NNP B-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Headache NNP I-NP B-r
ALBUTEROL NNP I-NP B-m
NEBULIZER NNP I-NP I-m
2.5 CD O B-do
MG NNP B-NP I-do
NEB NNP I-NP B-mo
Q2H NNP I-NP B-f
PRN NNP I-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
0/29 CD O O
) ) O O
Instructions: NNP B-NP O
Please NNP I-NP O
take VB O O
twice RB O O
a DT B-NP O
day NN I-NP O
until IN B-VP O
you PRP O O
see VBP O O
Dr NNP B-NP O
Dimino NNP I-NP O
in IN B-VP O
clinic JJ B-NP O
INSULIN NNP I-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
110 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
INSULIN NNP I-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
30 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
NTG NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
NITROGLYCERIN NNP B-NP I-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP B-f
X NNP I-NP I-f
3 CD O I-f
PRN NNP B-NP I-f
Chest NNP I-NP B-r
Pain NNP I-NP I-r
VERAPAMIL NNP I-NP B-m
SUSTAINED NNP I-NP I-m
RELEAS NNP I-NP I-m
240 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
FLOVENT NNP B-NP B-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE NNP I-NP I-m
) ) O I-m
220 CD O B-do
MCG NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
DIOVAN NNP I-NP B-m
( ( O I-m
VALSARTAN NNP B-NP I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
VIOXX NNP B-NP B-m
( ( O I-m
ROFECOXIB NNP B-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
DUONEB NNP I-NP B-m
( ( O I-m
ALBUTEROL NNP B-NP I-m
AND NNP I-NP I-m
IPRATROPIUM NNP I-NP I-m
NEBULIZER NNP I-NP I-m
) ) O I-m
3/0.5 CD O B-do
MG NNP B-NP I-do
INH NNP I-NP B-mo
Q6H NNP I-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
NAS NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/day NN B-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Robby NNP I-NP O
Stancey NNP I-NP O
7/3/04 CD O O
, , O O
ALLERGY: NNP B-NP O
Ace NNP I-NP O
inhibitors NNS I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
DM NNP I-NP O
HTN NNP I-NP O
OBESITY NNP I-NP O
CHF NNP I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
restrictive NN B-NP O
lung NN I-NP O
disease NN I-NP O
( ( O O
restrictive JJ B-NP O
pulmonary JJ I-NP O
disease NN I-NP O
) ) O O
asthma NN B-NP O
( ( O O
asthma NN B-NP O
) ) O O
retinopathy NN B-NP O
( ( O O
retinopathy JJ O O
) ) O O
s/p NN B-NP O
cataract NN I-NP O
surgery NN I-NP O
( ( O O
S/P NNP B-NP O
cataract VB O O
extraction NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
SOB NNP I-NP O
x VBD B-VP O
1 CD O O
week NN B-NP O
HPI: NNP I-NP O
63 CD O O
yoF NN B-NP O
w/ NN I-NP O
hx NN I-NP O
of IN B-VP O
resistant JJ B-NP O
DM NNP I-NP O
( ( O O
familial JJ B-NP O
syndrome NN I-NP O
assoc NN I-NP O
w/ JJ B-NP O
acanthosis NN I-NP O
nigricans NNS I-NP O
) ) O O
, , O O
morbid JJ B-NP O
obesity NN I-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
NSTEMI NNP B-NP O
in IN B-VP O
1/10 CD O O
followed VBN O O
by IN B-VP O
CAGB NNP B-NP O
x NNP I-NP O
4 CD O O
in IN B-VP O
1997 CD O O
, , O O
HTN NNP B-NP O
, , O O
who WP O O
presents VBZ O O
w/ VBP O O
1 CD O O
wk NN B-NP O
of IN B-VP O
SOB NNP B-NP O
Multiple NNP I-NP O
admissions NNS I-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
for IN B-VP O
breathing VBG O O
issues NNS B-NP O
usually RB O O
2/2 CD O O
either CC O O
asthma NN B-NP O
or CC O O
CHF NNP B-NP O
Now RB O O
has VBZ O O
had VBN O O
increasing VBG O O
dyspnea NN B-NP O
over IN B-VP O
one CD O O
week NN B-NP O
She PRP O O
does VBZ O O
not RB O O
feel VB O O
her PRP$ O O
usual JJ B-NP O
wheezing NN I-NP O
Denies NNP I-NP O
dietary JJ B-NP O
indiscretion NN I-NP O
or CC O O
med VBN O O
non-compliance JJ B-NP O
Appears NNP I-NP O
to TO O O
hav VB O O
e JJ B-NP O
fluid NN I-NP B-r
overload NN I-NP I-r
on IN B-VP O
CXR NNP B-NP O
and CC O O
clinical JJ B-NP O
exam NN I-NP O
Got VBD B-VP O
80 CD O B-do
IV NNP B-NP B-mo
lasix NN I-NP B-m
in IN B-VP O
ED NNP B-NP O
--&gt; NNP I-NP O
put VBD B-VP O
out RP O O
1200 CD O O
cc NN B-NP O
PE NNP I-NP O
notable JJ O O
for IN B-VP O
RR NNP B-NP O
22 CD O O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
98% CD O O
on IN B-VP O
2L CD O O
, , O O
bibasilar JJ B-NP O
crackles NNS I-NP O
, , O O
decreased VBD B-VP O
bs NN B-NP O
throughout IN B-VP O
, , O O
scattered VBD B-VP O
wheezes NNS B-NP O
, , O O
JVP NNP B-NP O
? . B-VP O
8 CD O O
, , O O
nl JJ B-NP O
heart NN I-NP O
exam NN I-NP O
LABS/STUDIES NNP I-NP O
notable JJ O O
for IN B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
negative JJ B-NP O
x3 NNP I-NP O
, , O O
BNP NNP B-NP O
marginally RB O O
elev VBZ O O
at IN B-VP O
191 CD O O
, , O O
glucose RB O O
286 CD O O
, , O O
otherwise RB O O
cbc NN B-NP O
and CC O O
chem NN B-NP O
7 CD O O
wnl NN B-NP O
, , O O
A1c NNP B-NP O
elev VBP O O
at IN B-VP O
10.3 CD O O
, , O O
TSH NNP B-NP O
3.847 CD O O
, , O O
elev FW O O
PTT NNP B-NP O
at IN B-VP O
64.9 CD O O
of IN B-VP O
uncertain JJ B-NP O
significance NN I-NP O
************HOSPITAL NNP I-NP O
COURSE*************** NNP I-NP O
*CV: NNP I-NP O
Ischemia- NNP I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
, , O O
cont NN B-NP O
ASA NNP I-NP B-m
, , O O
statin NN B-NP B-m
, , O O
ccb NN B-NP B-m
, , O O
no DT B-NP O
b-block NN I-NP O
as IN B-VP O
has VBZ O O
asthma VBN O O
and CC O O
low-prob JJ O O
for IN B-VP O
ischemia JJ B-NP O
Pump- NNP I-NP O
appears VBZ O O
to TO O O
be VB O O
overloaded VBN O O
BNP NNP B-NP O
somewhat RB O O
elev VBZ O O
at IN B-VP O
191 CD O O
, , O O
diuresed VBD B-VP O
2L CD O O
w/ NN B-NP O
significant JJ B-NP O
subjective JJ I-NP O
improvement NN I-NP O
R&amp;R- NNP I-NP O
on IN B-VP O
tele NN B-NP O
while IN B-VP O
being VBG O O
ruled VBN O O
out RP O O
, , O O
no DT B-NP O
events NNS I-NP O
*PULM: VBP O O
Sx NNP B-NP O
could MD O O
also RB O O
be VB O O
2/2 CD O O
asthma JJ B-NP B-r
Put NNP I-NP O
on IN B-VP O
duonebs NN B-NP B-m
qid NN I-NP B-f
w/ NN I-NP O
q2hr NN I-NP B-f
albuterol NN I-NP B-m
o/n NN I-NP O
As IN B-VP O
better JJR B-NP O
w/ NN I-NP O
diuresis NN I-NP O
, , O O
will MD O O
not RB O O
give VB O O
prednisone NN B-NP O
( ( O O
trying VBG O O
to TO O O
avoid VB O O
as IN B-VP O
BS NNP B-NP O
are VBP O O
very RB O O
difficult JJ O O
to TO O O
control VB O O
on IN B-VP O
steroids NNS B-NP O
) ) O O
*ENDO: VBP O O
hx NN B-NP O
of IN B-VP O
very RB O O
resistant JJ B-NP O
DM NNP I-NP O
Will NNP I-NP O
put VBD B-VP O
on IN B-VP O
home NN B-NP O
insulin NN I-NP B-m
regimen NNS I-NP I-m
and CC O O
RISS NNP B-NP B-m
Will NNP I-NP O
check VB O O
TSH NNP B-NP O
in IN B-VP O
case NN B-NP O
this DT O O
is VBZ O O
contributing VBG O O
to TO O O
tiredness VB O O
and CC O O
weight VB O O
-- : O O
nl NN B-NP O
at IN B-VP O
3.847 CD O O
Will NNP B-NP O
check VB O O
A1c NNP B-NP O
to TO O O
see VB O O
how WRB O O
BS NNP B-NP O
control NN I-NP O
has VBZ O O
been VBN O O
-- : O O
elev NN B-NP O
at IN B-VP O
10.3 CD O O
*FEN: NN B-NP O
On IN B-VP O
cardiac JJ O O
, , O O
low-salt JJ O O
, , O O
ADA NNP B-NP O
1800 CD O O
diet JJ O O
Checking VBG O O
lytes NNS B-NP O
and CC O O
repleting VBG O O
prn NN B-NP O
*HEME: NN I-NP O
had VBD B-VP O
newly RB O O
elev VBN O O
PTT NNP B-NP O
x $ O O
3 CD O O
readings NNS B-NP O
here RB O O
( ( O O
all DT O O
in IN B-VP O
low JJ O O
60's CD O O
) ) O O
, , O O
new JJ O O
since IN B-VP O
last JJ B-NP O
admission NN I-NP O
Uncertain NNP I-NP O
significance NN I-NP O
After IN B-VP O
discussion NN B-NP O
w/ NN I-NP O
PCP/attending NNP I-NP O
, , O O
given VBN O O
pt's VBP O O
overall JJ B-NP O
feelings NNS I-NP O
about IN B-VP O
aggressiveness NN B-NP O
of IN B-VP O
care NN B-NP O
will MD O O
not RB O O
work VB O O
up RP O O
for IN B-VP O
now RB O O
*PPX: NNP B-NP O
Put NNP I-NP O
on IN B-VP O
heparin NN B-NP B-m
5000 CD O B-do
sc NN B-NP B-mo
tid NN I-NP B-f
for IN B-VP O
DVT NNP B-NP B-r
ppx NN I-NP I-r
Put VBD B-VP O
on IN B-VP O
PPI NNP B-NP B-m
as IN B-VP O
has VBZ O O
hx NN B-NP O
of IN B-VP O
? . B-VP O
GERD NNP B-NP O
*CODE: NNP I-NP O
DNR/DNI NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
you PRP O O
have VBP O O
fever VBN O O
, , O O
chills NNS B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
chest JJS B-NP O
pain NN I-NP O
If IN B-VP O
you PRP O O
cannot VBP O O
reach VB O O
your PRP$ O O
doctor NN B-NP O
, , O O
go VB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
You PRP O O
will MD O O
need VB O O
to TO O O
call VB O O
Dr NNP B-NP O
Shim NNP I-NP O
office NN I-NP O
to TO O O
make VB O O
an DT B-NP O
appointment NN I-NP O
for IN B-VP O
Friday NNP B-NP O
6/8/04 CD O O
Until IN B-VP I-du
you PRP O I-du
see VBP O I-du
Dr NNP B-NP I-du
Nicoll NNP I-NP O
, , O O
please VB O O
take VB O O
your PRP$ O O
lasix NN B-NP B-m
pills NNS I-NP O
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
( ( O I-f
in IN B-VP I-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O I-f
at IN B-VP I-f
night NN B-NP I-f
) ) O I-f
Dr NNP B-NP O
Kuchto NNP I-NP O
will MD O O
decide VB O O
on IN B-VP O
Friday NNP B-NP O
whether IN B-VP O
to TO O O
continue VB O O
you PRP O O
on IN B-VP O
twice RB O O
a DT B-NP O
day NN I-NP O
pills VBZ O O
or CC O O
only RB O O
once RB O O
a DT B-NP O
day NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Pt NNP I-NP O
is VBZ O O
f/u VBN O O
with IN B-VP O
Dr NNP B-NP O
Ross NNP I-NP O
Ogston NNP I-NP O
on IN B-VP O
Friday NNP B-NP O
6/8/04 CD O O
He PRP O O
will MD O O
decide VB O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
whether IN B-VP O
pt NN B-NP O
is VBZ O O
to TO O O
continue VB O O
to TO O O
take VB O O
lasix JJ B-NP B-m
lasix JJ I-NP B-m
bid NN I-NP B-f
or CC O O
on IN B-VP O
her PRP$ O O
usual JJ O O
80 CD O O
qd NN B-NP B-f
schedule NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MUFFETT NNP I-NP O
, , O O
JULIO NNP B-NP O
FLORENCIO NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
BA76 NNP B-NP O
) ) O O
7/14/04 CD O O
@ $ O O
01:53 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#882171 VBZ O O
924386513 CD O O
OH NNP B-NP O
76816742 CD O O
262594 CD O O
6/27/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/27/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/0/1995 CD O O
DISCHARGE NNP B-NP O
DIAGNOSES: NNP I-NP O
( ( O O
1 CD O O
) ) O O
GASTRIC NNP B-NP O
REFLUX NNP I-NP O
DISEASE NNP I-NP O
( ( O O
2 CD O O
) ) O O
HYPERTENSION NNP B-NP O
, , O O
15 CD O O
YEARS NNP B-NP O
( ( O O
3 CD O O
) ) O O
ADULT NNP B-NP O
ONSET NNP I-NP O
DIABETES NNP I-NP O
MELLITUS NNP I-NP O
, , O O
NON-INSULIN NNP B-NP O
DEPENDENT NNP I-NP O
, , O O
1 CD O O
- : O O
2 CD O O
YEARS NNS B-NP O
( ( O O
4 CD O O
) ) O O
HYPERCHOLESTEROLEMIA NNP B-NP O
, , O O
TREATED NNP B-NP O
FOR NNP I-NP O
4 CD O O
YEARS NNP B-NP O
( ( O O
5 CD O O
) ) O O
HISTORY NN B-NP O
OF NNP I-NP O
MYOCARDITIS NNP I-NP O
( ( O O
6 CD O O
) ) O O
STATUS NNP B-NP O
POST NNP I-NP O
TOTAL NNP I-NP O
ABDOMINAL NNP I-NP O
HYSTERECTOMY/BILATERAL NNP I-NP O
SALPINGO-OOPHORECTOMY NNP I-NP O
IN NNP I-NP O
1975 CD O O
WITHOUT NNP B-NP O
ESTROGEN NNP I-NP O
REPLACEMENT NNP I-NP O
( ( O O
7 CD O O
) ) O O
HISTORY NN B-NP O
OF NNP I-NP O
DEPRESSION NNP I-NP O
( ( O O
8 CD O O
) ) O O
MULTIPLE NNP B-NP O
FOOD NNP I-NP O
AND NNP I-NP O
ENVIRONMENTAL NNP I-NP O
ALLERGIES NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
57 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
with IN B-VP O
complaint NN B-NP O
of IN B-VP O
substernal JJ B-NP B-r
chest NN I-NP I-r
pain NN I-NP I-r
relieved VBN O O
by IN B-VP O
two CD O B-do
sublingual JJ B-NP B-mo
nitroglycerins NNS I-NP B-m
Cardiac NNP I-NP O
risk NN I-NP O
factors NNS I-NP O
are VBP O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
mellitus NNS B-NP O
, , O O
tobacco NN B-NP O
use NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
and CC O O
early RB O O
menopause NN B-NP O
with IN B-VP O
no DT B-NP O
estrogen NN I-NP O
replacement NN I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
0/24/95 CD O O
with IN B-VP O
complaint NN B-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
at IN B-VP O
rest NN B-NP O
without IN B-VP O
associated VBN O O
symptoms NNS B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
complaint NN I-NP O
of IN B-VP O
decreased JJ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
, , O O
exertional JJ B-NP O
symptoms NNS I-NP O
No DT B-NP O
PND NNP I-NP O
, , O O
edema NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
or CC O O
diaphoresis NN B-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
The DT B-NP O
complaint NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
was VBD B-VP O
3 CD O O
out IN B-VP O
of IN B-VP O
10 CD O O
chest JJS B-NP O
pressure NN I-NP O
which WDT O O
spontaneously RB O O
resolved VBD B-VP O
It PRP O O
recurred VBD B-VP O
intermittently RB O O
without IN B-VP O
associated VBN O O
symptoms NNS B-NP O
, , O O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
She PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
by IN B-VP O
enzymes NNS B-NP O
and CC O O
EKG NNP B-NP O
CKs NNP I-NP O
were VBD B-VP O
156 CD O O
, , O O
135 CD O O
, , O O
and CC O O
108 CD O O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
aspirin NN B-NP B-m
, , O O
beta NN B-NP B-m
blockers NNS I-NP I-m
, , O O
and CC O O
nitroglycerin RB O B-m
The DT B-NP O
concern NN I-NP O
was VBD B-VP O
for IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
unequal JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
in IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
complaint NN B-NP O
of IN B-VP O
back RB O O
pain NN B-NP O
A NNP I-NP O
GEE NNP I-NP O
was VBD B-VP O
done VBN O O
to TO O O
rule VB O O
out RP O O
aortic JJ B-NP O
dissection NN I-NP O
On IN B-VP O
GEE NNP B-NP O
there EX O O
were VBD B-VP O
no DT B-NP O
valvular JJ I-NP O
abnormalities NNS I-NP O
or CC O O
evidence NN B-NP O
for IN B-VP O
dissection NN B-NP O
and CC O O
no DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
ETT NNP I-NP O
was VBD B-VP O
done VBN O O
on IN B-VP O
3/26/95 CD O O
The DT B-NP O
patient NN I-NP O
exercised VBD B-VP O
for IN B-VP O
4 CD O O
minutes NNS B-NP O
13 CD O O
seconds NNS B-NP O
on IN B-VP O
a DT B-NP O
standard JJ I-NP O
Bruce NNP I-NP O
protocol NN I-NP O
She PRP O O
was VBD B-VP O
stopped VBN O O
secondary JJ O O
to TO O O
leg VB O O
fatigue NN B-NP O
and CC O O
dyspnea NN B-NP O
with IN B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
84 CD O O
- : O O
113 CD O O
with IN B-VP O
a DT B-NP O
target NN I-NP O
of IN B-VP O
138 CD O O
Blood NNP B-NP O
pressure NN I-NP O
was VBD B-VP O
136/80 CD O O
and CC O O
elevated VBD B-VP O
to TO O O
164/90 CD O O
There EX O O
were VBD B-VP O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
and CC O O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
ischemia NN B-NP O
on IN B-VP O
this DT B-NP O
study NN I-NP O
despite IN B-VP O
limited JJ B-NP O
effort NN I-NP O
On IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
admission NN B-NP O
on IN B-VP O
11/8/95 CD O O
she PRP O O
again RB O O
had VBD B-VP O
the DT B-NP O
acute JJ I-NP O
onset NN I-NP O
of IN B-VP O
sharp JJ O O
, , O O
burning NN B-NP O
, , O O
mid-epigastric JJ B-NP O
versus NN I-NP O
sternal JJ B-NP O
pain NN I-NP O
without IN B-VP O
radiation NN B-NP O
and CC O O
with IN B-VP O
associated JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
diaphoresis NN B-NP O
, , O O
nausea NN B-NP O
, , O O
and CC O O
an DT B-NP O
acid JJ I-NP O
taste NN I-NP O
She PRP O O
took VBD B-VP O
two CD O B-do
sublingual JJ B-NP B-mo
nitroglycerins NNS I-NP B-m
with IN B-VP O
relief NN B-NP O
of IN B-VP O
symptoms NNS B-NP B-r
The DT B-NP O
pain NN I-NP O
lasted VBD B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
15 CD O O
minutes NNS B-NP O
She PRP O O
has VBZ O O
been VBN O O
pain-free JJ O O
since IN B-VP O
arrival NN B-NP O
to TO O O
the DT B-NP O
hospital NN I-NP O
MEDICATIONS: NNP I-NP O
Glucotrol NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Cardizem NNP B-NP B-m
CD NNP I-NP I-m
, , O O
Benadryl NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Provastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Hydrochlorothiazide NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Trazadone NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
, , O O
aspirin RB O B-m
1 CD O B-do
q.d NN B-NP B-f
, , O O
Lopressor NNP B-NP B-m
75 CD O B-do
mg NN B-NP O
q.d NN I-NP B-f
, , O O
nitroglycerin JJ B-NP B-m
sublingual JJ I-NP B-mo
p.r.n NN I-NP B-f
, , O O
Ambien NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
is VBZ O O
a DT B-NP O
receptionist NN I-NP O
She PRP O O
has VBZ O O
three CD O O
children NNS B-NP O
She PRP O O
has VBZ O O
never RB O O
married VBN O O
She PRP O O
lives VBZ O O
alone RB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
132/96 CD O O
, , O O
pulse RB O O
95 CD O O
She PRP O O
was VBD B-VP O
on IN B-VP O
one CD O B-do
liter NN B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
, , O O
saturation NN B-NP O
of IN B-VP O
97% CD O O
Respiratory NNP B-NP O
rate NN I-NP O
was VBD B-VP O
20 CD O O
HEENT: NNP B-NP O
Normal NNP I-NP O
No NNP I-NP O
JVD NNP I-NP O
Lungs NNP I-NP O
were VBD B-VP O
clear JJ B-NP O
Heart: NNP I-NP O
PMI NNP I-NP O
was VBD B-VP O
nondisplaced VBN O O
Normal NNP B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
No NNP I-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
No NNP I-NP O
murmurs NN I-NP O
, , O O
gallops NNS B-NP O
, , O O
or CC O O
rubs VB O O
Abdomen: NNP B-NP O
Soft NNP I-NP O
but CC O O
obese JJ B-NP O
Nontender NNP I-NP O
, , O O
nondistended VBD B-VP O
No DT B-NP O
hepatojugular JJ I-NP O
reflux NN I-NP O
No NNP I-NP O
abdominal JJ O O
bruits VBZ O O
No DT B-NP O
pulsatile NN I-NP O
masses VBZ O O
Extremities: NNP B-NP O
Without NNP I-NP O
edema NN I-NP O
, , O O
cords NNS B-NP O
, , O O
or CC O O
femoral JJ B-NP O
bruits NNS I-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
potassium NN B-NP O
of IN B-VP O
3.7 CD O O
, , O O
magnesium NN B-NP O
1.9 CD O O
Hematocrit NNP B-NP O
36 CD O O
, , O O
WBC NNP B-NP O
11.5 CD O O
CK NNP B-NP O
first RB O O
set VBD B-VP O
was VBD B-VP O
118 CD O O
Triponin NNP B-NP O
was VBD B-VP O
0.0 CD O O
EKG NNP B-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
occasional JJ B-NP O
PVCs NNP I-NP O
Intervals NNP I-NP O
and CC O O
axis NN B-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
slight JJ I-NP O
upper JJ I-NP O
concavity NN I-NP O
and CC O O
ST-T NNP B-NP O
segment NN I-NP O
in IN B-VP O
V2 NNP B-NP O
and CC O O
V3 NNP B-NP O
when WRB O O
compared VBN O O
to TO O O
old JJ O O
although IN B-VP O
this DT O O
could MD O O
be VB O O
consistent JJ O O
with IN B-VP O
J NNP B-NP O
point NN I-NP O
elevation NN I-NP O
and CC O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT O O
0.5 CD O O
mm NN B-NP O
segment NN I-NP O
elevation NN I-NP O
in IN B-VP O
V2 NNP B-NP O
The DT B-NP O
EKG NNP I-NP O
was VBD B-VP O
without IN B-VP O
change NN B-NP O
from IN B-VP O
previous JJ B-NP O
admission NN I-NP O
IMPRESSION: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
57 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
presenting VBG O O
with IN B-VP O
complaint NN B-NP O
of IN B-VP O
substernal JJ O O
, , O O
midepigastric JJ B-NP O
pain NN I-NP O
, , O O
burning VBG O O
Although IN B-VP O
she PRP O O
had VBD B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
, , O O
her PRP$ O O
pain NN B-NP O
is VBZ O O
of IN B-VP O
an DT B-NP O
atypical JJ I-NP O
quality NN I-NP O
and CC O O
sounds VBZ O O
more RBR O O
consistent JJ O O
with IN B-VP O
a DT B-NP O
gastrointestinal JJ I-NP O
source NN I-NP O
The DT B-NP O
GEE NNP I-NP O
was VBD B-VP O
a DT B-NP O
suboptimal JJ I-NP O
study NN I-NP O
and CC O O
it PRP O O
was VBD B-VP O
deemed VBN O O
more RBR O O
appropriate JJ O O
on IN B-VP O
admission NN B-NP O
to TO O O
both DT O O
rule VB O O
the DT B-NP O
patient NN I-NP O
out RP O O
but CC O O
consider VB O O
a DT B-NP O
pharmacologic NN I-NP O
stress NN I-NP O
test NN I-NP O
before IN B-VP O
cathing VBG O O
this DT B-NP O
patient JJ I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Since IN B-VP O
the DT B-NP O
patient's NN I-NP O
symptoms NNS I-NP O
did VBD B-VP O
sound VB O O
more RBR O O
gastrointestinal JJ O O
, , O O
she PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Axid NNP B-NP B-m
for IN B-VP O
possibility NN B-NP O
of IN B-VP O
gastroesophageal JJ B-NP B-r
gastroesophageal JJ I-NP B-r
reflux NN I-NP I-r
reflux NN I-NP I-r
disease NN I-NP I-r
disease NN I-NP I-r
, , O O
as RB O O
well RB O O
as IN B-VP O
provided VBN O O
with IN B-VP O
Maalox NNP B-NP B-m
and CC O O
told VBD B-VP O
to TO O O
keep VB O O
the DT B-NP O
head NN I-NP O
of IN B-VP O
the DT B-NP O
bed NN I-NP O
elevated VBD B-VP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Glucotrol NNP B-NP B-m
for IN B-VP O
diabetes NNS B-NP B-r
mellitus NNS I-NP I-r
and CC O O
was VBD B-VP O
instructed VBN O O
on IN B-VP O
risk NN B-NP O
factor NN I-NP O
modifications NNS I-NP O
, , O O
including VBG O O
diabetes NNS B-NP O
mellitus RBR O O
control NN B-NP O
, , O O
controlling VBG O O
cholesterol NN B-NP O
and CC O O
hypertension NN B-NP O
She PRP O O
is VBZ O O
currently RB O O
a DT B-NP O
non-smoker NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
following VBG O O
admission NN B-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
by IN B-VP O
enzyme JJ B-NP O
sets NNS I-NP O
respectively RB O O
A DT B-NP O
set NN I-NP O
was VBD B-VP O
118; CD O O
B NNP B-NP O
set NN I-NP O
was VBD B-VP O
105; CD O O
C NNP B-NP O
set NN I-NP O
was VBD B-VP O
105; CD O O
D NNP B-NP O
set NN I-NP O
was VBD B-VP O
100 CD O O
EKGs NNP B-NP O
were VBD B-VP O
without IN B-VP O
change NN B-NP O
As NNP I-NP O
well RB O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
remained VBN O O
symptom-free JJ O O
during IN B-VP O
the DT B-NP O
hospital JJ I-NP O
course NN I-NP O
and CC O O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
Dobutamine NNP I-NP B-m
MIBI NNP I-NP O
for IN B-VP O
8/10/95 CD O O
The DT B-NP O
patient NN I-NP O
on IN B-VP B-m
Dobutamine NNP B-NP O
MIBI NNP I-NP O
study NN I-NP O
showed VBD B-VP O
heart NN B-NP O
rate NN I-NP O
going VBG O O
up IN B-VP O
from IN B-VP O
70 CD O O
to TO O O
101 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
170/80 CD O O
went VBD B-VP O
up RB O O
to TO O O
230/90 CD O O
There EX O O
were VBD B-VP O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
and CC O O
no DT B-NP O
chest JJ I-NP O
pressure NN I-NP O
MIBI NNP I-NP O
images NNS I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
fixed JJ I-NP O
mild NN I-NP O
reduced VBD B-VP O
uptake JJ O O
in IN B-VP O
the DT B-NP O
inferior JJ I-NP O
wall NN I-NP O
consistent NN I-NP O
with IN B-VP O
but CC O O
not RB O O
diagnostic JJ O O
for IN B-VP O
myocardial JJ B-NP O
injury NN I-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
reversible JJ I-NP O
perfusion NN I-NP O
abnormalities NNS I-NP O
detected VBN O O
As IN B-VP O
such JJ O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
a DT B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
medication NN B-NP O
regimen NNS I-NP O
DISPOSITION: NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Ecasa NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Glucotrol NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Hydrochlorothiazide NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Trazadone NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Provastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
FOLLOW-UP: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Jonker NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
for IN B-VP O
further JJ B-NP O
workup NN I-NP O
and CC O O
management NN B-NP O
of IN B-VP O
gastroesophageal NN B-NP O
reflux NN I-NP O
disease NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
following VBG O O
her PRP$ O O
for IN B-VP O
her PRP$ O O
cardiac JJ B-NP O
disease NN I-NP O
via IN B-VP O
the DT B-NP O
risk NN I-NP O
factor NN I-NP O
modification NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MAC NNP I-NP O
MCKAMIE NNP I-NP O
, , O O
M.D NNP B-NP O
PD90 NNP I-NP O
Attending: NNP I-NP O
RAY NNP I-NP O
B NNP I-NP O
DUNWOODY NNP I-NP O
, , O O
M.D NNP B-NP O
BR50 NNP I-NP O
AO808/6489 NNP I-NP O
Batch: NNP I-NP O
61330 CD O O
Index NNP B-NP O
No NNP I-NP O
LEUDJZ88U9 NNP I-NP O
D: NNP I-NP O
3/7/96 CD O O
T: NNP B-NP O
2/18/96 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#883682 VBZ O O
454737049 CD O O
VDMH NNP B-NP O
87336835 CD O O
8702431 CD O O
4/29/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
PREGNANCY NNP I-NP O
, , O O
6 CD O O
WEEKS NNP B-NP O
DIABETIC NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/0/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/28/2007 CD O O
ATTENDING: NNP B-NP O
OBEY NNP I-NP O
, , O O
LAWRENCE NNP B-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Obstetrics/Maternal NNP I-NP O
Fetal NNP I-NP O
Medicine NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
Pre-gestational NNP B-NP O
diabetes NNS I-NP O
2 CD O O
History NNP B-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
3 CD O O
Recurrent NNP B-NP O
SABs NNP I-NP O
4 CD O O
Hepatitis NNP B-NP O
B NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
36-year-old JJ I-NP O
G16 NNP I-NP O
, , O O
P0-0-15-0 NNP B-NP O
, , O O
who WP O O
presented VBD B-VP O
at IN B-VP O
6 CD O O
and CC O O
4/7 CD O O
weeks NNS B-NP O
by IN B-VP O
LMP NNP B-NP O
consistent NN I-NP O
with IN B-VP O
ultrasound NN B-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
as IN B-VP O
a DT B-NP O
transfer NN I-NP O
from IN B-VP O
the DT B-NP O
High-Risk NNP I-NP O
Obstetric NNP I-NP O
Clinic NNP I-NP O
, , O O
admitted VBD B-VP O
to TO O O
the DT B-NP O
Fuller NNP I-NP O
Antepartum NNP I-NP O
Service NNP I-NP O
for IN B-VP O
diabetic JJ B-NP O
control NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
presented VBN O O
to TO O O
the DT B-NP O
Special JJ I-NP O
OB NNP I-NP O
Clinic NNP I-NP O
as IN B-VP O
a DT B-NP O
new JJ I-NP O
patient NN I-NP O
for IN B-VP O
prenatal JJ B-NP O
care NN I-NP O
Review NNP I-NP O
of IN B-VP O
her PRP$ O O
medical JJ B-NP O
problems NNS I-NP O
revealed VBD B-VP O
that IN B-VP O
the DT B-NP O
recent JJ I-NP O
glucose NN I-NP O
control NN I-NP O
had VBD B-VP O
been VBN O O
suboptimal JJ O O
In IN B-VP O
view NN B-NP O
of IN B-VP O
this DT O O
and CC O O
in IN B-VP O
view NN B-NP O
of IN B-VP O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
multiple JJ B-NP O
other JJ I-NP O
issues NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
diabetic JJ B-NP B-r
control NN I-NP I-r
, , O O
adjustment NN B-NP O
of IN B-VP O
her PRP$ O O
insulin NN B-NP B-m
regimen NNS I-NP I-m
and CC O O
evaluation NN B-NP O
regarding VBG O O
the DT B-NP O
other JJ I-NP O
medical JJ I-NP O
problems NNS I-NP O
History NNP I-NP O
of IN B-VP O
present JJ O O
pregnancy: IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
last JJ I-NP O
menstrual JJ I-NP O
period NN I-NP O
in IN B-VP O
the DT B-NP O
second JJ I-NP O
week NN I-NP O
of IN B-VP O
March NNP B-NP O
Ultrasound NNP I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
11/2/07 CD O O
, , O O
revealed VBD B-VP O
a DT B-NP O
6.6-week JJ I-NP O
intrauterine JJ I-NP O
pregnancy NN I-NP O
with IN B-VP O
a DT B-NP O
fetal JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
110 CD O O
The DT O O
estimated VBN O O
date NN B-NP O
of IN B-VP O
confinement NN B-NP O
is VBZ O O
4/22/07 CD O O
Prenatal JJ O O
screening VBG O O
labs NNS B-NP O
were VBD B-VP O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
blood VBN O O
group NN B-NP O
O NNP I-NP O
+ve NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
ST NNP B-NP O
elevation NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
in IN B-VP O
2000 CD O O
The DT B-NP O
infarct NN I-NP O
was VBD B-VP O
a DT B-NP O
presumed JJ I-NP O
embolism NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
the DT B-NP O
left NN I-NP O
circumflex JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
The DT B-NP O
complete JJ I-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
mid-to-distal JJ I-NP O
left NN I-NP O
anterior JJ O O
descending VBG O O
artery NN B-NP O
, , O O
which WDT O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
thrombosis VB O B-r
, , O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
TPA NNP B-NP B-m
and CC O O
angioplasty VB O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
catheterization NN I-NP O
in IN B-VP O
March NNP B-NP O
2000 CD O O
The DT B-NP O
last JJ I-NP O
echocardiogram NN I-NP O
revealed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
45% CD O O
in IN B-VP O
2002; CD O O
however RB O O
, , O O
the DT B-NP O
patient NN I-NP O
never RB O O
had VBD B-VP O
a DT B-NP O
repeat NN I-NP O
echo NN I-NP O
since IN B-VP O
that DT B-NP O
time NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
that IN B-VP O
she PRP O O
was VBD B-VP O
able JJ O O
to TO O O
climb VB O O
four CD O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
to TO O O
her PRP$ O O
apartment NN B-NP O
, , O O
haveing VBG O O
to TO O O
pause VB O O
after IN B-VP O
two CD O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
to TO O O
catch VB O O
her PRP$ O O
breath NN B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
mellitus NNS I-NP O
, , O O
diagnosed VBN O O
in IN B-VP O
2000 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
medical JJ I-NP O
admission NN I-NP O
in IN B-VP O
2006 CD O O
for IN B-VP O
hypoglycemia NN B-NP O
when WRB O O
she PRP O O
incidentally RB O O
injected VBD B-VP O
Humalog NNP B-NP B-m
instead RB O O
of IN B-VP O
Lantus NNP B-NP B-m
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
a DT B-NP O
Humalog NNP I-NP B-m
7 CD O B-do
units NNS B-NP I-do
b.i.d NN I-NP B-f
and CC O O
Lantus NNP B-NP B-m
12 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP O
evening NN I-NP O
Her NNP I-NP O
fasting NN I-NP O
sugars NNS I-NP O
were VBD B-VP O
in IN B-VP O
the DT O O
150s CD O O
before IN B-VP O
admission NN B-NP O
and CC O O
her PRP$ O O
blood NN B-NP O
sugar NN I-NP O
measurements NNS I-NP O
were VBD B-VP O
over RB O O
200 CD O O
in IN B-VP O
the DT B-NP O
evening NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
fasting NN I-NP O
sugar NN I-NP O
was VBD B-VP O
123 CD O O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hepatitis NN B-NP O
B NNP I-NP O
, , O O
diagnosed VBN O O
in IN B-VP O
2005 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP B-r
positive JJ I-NP I-r
E NN I-NP I-r
antigen NN I-NP I-r
in IN B-VP O
2005 CD O O
She PRP O O
had VBD B-VP O
previously RB O O
been VBN O O
on IN B-VP O
Epivir NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
but CC O O
this DT O O
was VBD B-VP O
stopped VBN O O
prior RB O O
to TO O O
the DT B-NP O
current JJ I-NP O
pregnancy NN I-NP O
PAST NNP I-NP O
OB/GYN NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP O
fibroid JJ I-NP O
uterus NN I-NP O
, , O O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
recurrent NN B-NP O
miscarriages NNS I-NP O
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
the DT B-NP O
fibroid JJ I-NP O
uterus NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
report VB O O
pelvic NN B-NP O
pain NN I-NP O
in IN B-VP O
the DT B-NP O
outpatient NN I-NP O
setting VBG O O
Ultrasound NNP B-NP O
had VBD B-VP O
shown VBN O O
an DT B-NP O
8-10 JJ I-NP O
cm NN I-NP O
dominant JJ O O
posterior JJ O O
fibroid VBP O O
The DT B-NP O
patient NN I-NP O
occasionally RB O O
takes VBZ O O
oxycodone NN B-NP B-m
for IN B-VP O
fibroid JJ B-NP B-r
pain NN I-NP I-r
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
recurrent NN I-NP O
miscarriages NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
fifteen JJ B-NP O
SABs NNP I-NP O
in IN B-VP O
the DT O O
past JJ O O
with IN B-VP O
over IN B-VP O
10 CD O O
dilatation NN B-NP O
and CC O O
evacuations NNS B-NP O
, , O O
including VBG O O
one CD O O
molar JJ B-NP O
pregnancy NN I-NP O
with IN B-VP O
subsequent JJ B-NP O
choriocarcinoma NN I-NP O
All DT B-NP O
losses NNS I-NP O
were VBD B-VP O
in IN B-VP O
the DT B-NP O
first JJ I-NP O
trimester NN I-NP O
, , O O
less JJR O O
than IN B-VP O
12 CD O O
weeks' JJ B-NP O
gestation NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
evaluated VBN O O
previously RB O O
for IN B-VP O
a DT B-NP O
thrombophilia NN I-NP O
workup NN I-NP O
, , O O
but CC O O
this DT O O
had VBD B-VP O
been VBN O O
negative JJ B-NP O
multiple JJ I-NP O
times NNS I-NP O
aside RB O O
from IN B-VP O
a DT B-NP O
MTHFR NNP I-NP O
gene NN I-NP O
mutation NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
noted VBN O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
and CC O O
it PRP O O
is VBZ O O
unclear JJ O O
whether IN B-VP O
this DT O O
has VBZ O O
been VBN O O
addressed VBN O O
previously RB O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
previously RB O O
been VBN O O
told VBN O O
by IN B-VP O
a DT B-NP O
reproductive JJ I-NP O
endocrinologist NN I-NP O
, , O O
that IN B-VP O
she PRP O O
should MD O O
consider VB O O
adoption NN B-NP O
or CC O O
a DT B-NP O
gestational JJ I-NP O
carrier NN I-NP O
Chromosomes NNS I-NP O
on IN B-VP O
several JJ B-NP O
pathology NN I-NP O
specimens NNS I-NP O
from IN B-VP O
the DT B-NP O
previous JJ I-NP O
abortions NNS I-NP O
showed VBD B-VP O
aneuploidy IN B-VP O
The DT B-NP O
patient NN I-NP O
currently RB O O
denies VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
sexually RB O O
transmitted VBN O O
infections NNS B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cervical JJ B-NP O
dysplasia NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CIN NNP B-NP O
I PRP O O
and CC O O
CIN NNP B-NP O
II NNP I-NP O
in IN B-VP O
1990 CD O O
and CC O O
1992 CD O O
She PRP O O
underwent VBD B-VP O
a DT B-NP O
LEEP NNP I-NP O
in IN B-VP O
1992 CD O O
, , O O
which WDT O O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
HSIL NNP B-NP O
All NNP I-NP O
subsequent VBD B-VP O
Pap NNP B-NP O
smears NNS I-NP O
were VBD B-VP O
either RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Last JJ B-NP O
Pap NNP I-NP O
smear VBD B-VP O
done VBN O O
in IN B-VP O
February NNP B-NP O
2006 CD O O
at IN B-VP O
Rexmo NNP B-NP O
Sha NNP I-NP O
Hospital NNP I-NP O
Of IN B-VP O
was VBD B-VP O
insufficient NN B-NP O
for IN B-VP O
analysis NN B-NP O
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
choriocarcinoma NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
molar JJ I-NP O
pregnancy NN I-NP O
, , O O
which WDT O O
then RB O O
developed VBD B-VP O
into IN B-VP O
a DT B-NP O
subsequent JJ I-NP O
choriocarcinoma NN I-NP B-r
choriocarcinoma NN I-NP B-r
choriocarcinoma NN I-NP B-r
For IN B-VP O
this DT O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
methotrexate NN B-NP B-m
, , O O
actinomycin JJ B-NP B-m
D NNP I-NP I-m
and CC O O
Cytoxan NNP B-NP B-m
, , O O
then RB O O
VP-16 NNP B-NP B-m
, , O O
cisplatin NN B-NP B-m
and CC O O
bleomycin NN B-NP B-m
with IN B-VP O
presumed JJ B-NP O
cure NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Dilatation NNP I-NP O
and CC O O
evacuation NN B-NP O
x10 NN I-NP O
, , O O
hysteroscopy NN B-NP O
for IN B-VP O
infertility NN B-NP O
workup NN I-NP O
, , O O
and CC O O
LEEP NNP B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Humalog NNP I-NP B-m
Insulin NNP I-NP I-m
7 CD O B-do
units NNS B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Lantus NNP B-NP B-m
12 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
evening NN I-NP I-f
, , O O
aspirin VBZ O B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
stopped VBD B-VP O
prior RB O O
to TO O O
pregnancy NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
lamivudine/Epivir NN B-NP B-m
use NN I-NP O
, , O O
150 CD O B-do
daily RB O B-f
stopped VBD B-VP O
prior RB O O
to TO O O
current JJ B-NP O
pregnancy NN I-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Former NNP I-NP O
smoker NN I-NP O
, , O O
given VBN O O
up RP O O
smoking VBG O O
in IN B-VP O
2000 CD O O
after IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarct NN I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
alcohol NN B-NP O
abuse NN I-NP O
or CC O O
IV NNP B-NP O
drug NN I-NP O
use VBP O O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
in IN B-VP O
Doreska NNP B-NP O
Dr NNP I-NP O
, , O O
Nah NNP B-NP O
Min NNP I-NP O
Knox NNP I-NP O
with IN B-VP O
her PRP$ O O
boyfriend NN B-NP O
, , O O
unemployed JJ B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
GYN NNP B-NP O
malignancies NNS I-NP O
, , O O
history NN B-NP O
of IN B-VP O
maternal JJ B-NP O
diabetes NNS I-NP O
, , O O
longstanding VBG O O
Father NNP B-NP O
with IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
in IN B-VP O
his PRP$ O O
50s CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
the DT B-NP O
primary JJ I-NP O
purpose NN I-NP O
of IN B-VP O
diabetic JJ B-NP O
control NN I-NP O
1 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
reported VBN O O
poor JJ B-NP O
diabetic JJ I-NP O
control NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
Therefore NN I-NP O
, , O O
her PRP$ O O
regimen NN B-NP O
was VBD B-VP O
continued VBN O O
, , O O
with IN B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
a DT O O
sliding VBG O B-do
scale NN B-NP I-do
, , O O
in IN B-VP O
order NN B-NP O
to TO O O
determine VB O O
the DT B-NP O
additional JJ I-NP O
insulin NN I-NP B-m
needs NNS I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
Over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
the DT B-NP O
admission NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
Lantus NNP I-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
20 CD O B-do
units NNS B-NP I-do
at IN B-VP B-f
nighttime NN B-NP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
using VBG O O
8 CD O B-do
units NNS B-NP I-do
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
of IN B-VP O
insulin NN B-NP B-m
lispro NN I-NP O
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
a DT O O
lispro JJ O B-m
sliding VBG O B-do
scale NN B-NP I-do
With IN B-VP O
this DT B-NP O
regimen NNS I-NP O
, , O O
the DT B-NP O
fingerstick JJ I-NP O
glucose NN I-NP O
control NN I-NP O
improved VBN O O
, , O O
and CC O O
the DT B-NP O
fasting NN I-NP O
blood NN I-NP O
sugar NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
90 CD O O
On IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
blood NN B-NP O
sugars NNS I-NP O
in IN B-VP O
the DT B-NP O
range NN I-NP O
from IN B-VP O
93 CD O O
to TO O O
139 CD O O
An DT B-NP O
HbA1c NNP I-NP O
was VBD B-VP O
sent VBN O O
, , O O
which WDT O O
was VBD B-VP O
6.7 CD O O
, , O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
Nutrition NN I-NP O
consult NN I-NP O
She PRP O O
will MD O O
be VB O O
followed VBN O O
in IN B-VP O
the DT B-NP O
High-Risk NNP I-NP O
Obstetric NNP I-NP O
and CC O O
Diabetic NNP B-NP O
Clinic NNP I-NP O
by IN B-VP O
Dr NNP B-NP O
Borguez NNP I-NP O
2 CD O O
Cardiology NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP O O
aspirin NN B-NP B-m
, , O O
given VBN O O
her PRP$ O O
history NN B-NP O
of IN B-VP O
myocardial JJ B-NP B-r
infarct NN I-NP I-r
at IN B-VP O
a DT O O
very RB O O
early JJ B-NP O
age NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
an DT B-NP O
echocardiogram NN I-NP O
was VBD B-VP O
obtained VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
admission NN B-NP O
This DT O O
revealed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
50% CD O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
large JJ I-NP O
left NN I-NP O
ventricular JJ B-NP O
thrombosis NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
presumed VBN O O
to TO O O
be VB O O
a DT B-NP O
longstanding JJ I-NP O
Cardiology NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
the DT B-NP O
impression NN I-NP O
was VBD B-VP O
that IN B-VP O
the DT B-NP O
thrombosis NN I-NP O
was VBD B-VP O
likely RB O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
ventricular JJ I-NP O
hypokinesia NN I-NP O
related VBN O O
to TO O O
the DT B-NP O
previous JJ I-NP O
infarct NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
hypercoagulable JJ B-NP O
state NN I-NP O
Therefore NNP I-NP O
, , O O
their PRP$ O O
recommendation NN B-NP O
was VBD B-VP O
to TO O O
start VB O O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
Lovenox NNP B-NP B-m
for IN B-VP B-du
the DT B-NP O
duration NN I-NP O
of IN B-VP O
this DT B-NP O
pregnancy NN I-NP O
, , O O
which WDT O O
adjusted VBD B-VP O
for IN B-VP O
her PRP$ O O
weight NN B-NP O
was VBD B-VP O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
90 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
followed VBN O O
by IN B-VP O
a DT B-NP O
transition NN I-NP O
to TO O O
Coumadin NNP B-NP B-m
postpartum NN I-NP O
, , O O
to TO O O
be VB O O
continued VBN O O
for IN B-VP B-du
likely JJ O I-du
long-term JJ O I-du
, , O I-du
possibly RB O I-du
lifelong JJ B-NP I-du
duration NN I-NP I-du
The DT B-NP O
Cardiology NNP I-NP O
Consult NNP I-NP O
Team NNP I-NP O
noted VBD B-VP O
that IN B-VP O
the DT B-NP O
MTHFR NNP I-NP O
mutation NN I-NP O
had VBD B-VP O
not RB O O
resulted VBN O O
in IN B-VP O
elevated JJ B-NP O
homocysteine NN I-NP O
levels NNS I-NP O
in IN B-VP O
the DT O O
past JJ O O
However RB O O
, , O O
they PRP O O
did VBD B-VP O
agree VB O O
that IN B-VP O
folate JJ B-NP B-m
supplementation NN I-NP I-m
at IN B-VP O
high JJ B-NP B-do
doses NNS I-NP I-do
was VBD B-VP O
indicated VBN O O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
continued VBN O O
on IN B-VP O
Lovenox NNP B-NP B-m
90 CD O B-do
mg JJ O I-do
daily RB O B-f
subcutaneously RB O B-mo
, , O O
and CC O O
aspirin RB O B-m
81 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
She PRP O O
will MD O O
have VB O O
Cardiology NNP B-NP O
followup NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Jasper NNP I-NP O
Erps NNP I-NP O
on IN B-VP O
11/27/07 CD O O
During IN B-VP O
the DT B-NP O
entire JJ I-NP O
admission NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
, , O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
, , O O
with IN B-VP O
no DT B-NP O
complaints NNS I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
palpitations NNS B-NP O
3 CD O O
Hepatitis NNP B-NP O
B NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
liver VBN O O
function NN B-NP O
tests NNS I-NP O
and CC O O
a DT B-NP O
hepatitis NN I-NP O
panel NN I-NP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
given VBN O O
her PRP$ O O
history NN B-NP O
of IN B-VP O
active JJ B-NP O
disease NN I-NP O
diagnosed VBN O O
in IN B-VP O
2005 CD O O
, , O O
with IN B-VP O
a DT B-NP O
positive JJ I-NP O
hepatitis NN I-NP O
E NNP I-NP O
antigen NN I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
not RB O O
been VBN O O
on IN B-VP O
Epivir NNP B-NP B-m
, , O O
which WDT O O
had VBD B-VP O
been VBN O O
stopped VBN O O
prior RB O O
to TO O O
this DT B-NP O
current JJ I-NP O
pregnancy NN I-NP O
Liver NNP I-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
checked VBN O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
and CC O O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
serologies NNS B-NP O
were VBD B-VP O
checked VBN O O
and CC O O
the DT B-NP O
hepatitis NN I-NP O
E NNP I-NP O
antigen NN I-NP O
and CC O O
the DT B-NP O
E NNP I-NP O
antibody NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Hepatitis NNP I-NP O
B NNP I-NP O
surface NN I-NP O
antigen NN I-NP O
and CC O O
hepatitis NN B-NP O
B NNP I-NP O
core NN I-NP O
antigen NN I-NP O
were VBD B-VP O
reactive JJ O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
, , O O
a DT B-NP O
hepatitis NN I-NP O
B NNP I-NP O
viral JJ B-NP O
load NN I-NP O
was VBD B-VP O
pending VBG O O
Given VBN O O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
hepatitis NN B-NP O
B NNP I-NP O
, , O O
an DT B-NP O
outpatient JJ I-NP O
appointment NN I-NP O
was VBD B-VP O
being VBG O O
arranged VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
with IN B-VP O
Dr NNP B-NP O
Lavy NNP I-NP O
, , O O
from IN B-VP O
the DT B-NP O
Division NNP I-NP O
of IN B-VP O
Gastroenterology NNP B-NP O
at IN B-VP O
the DT B-NP O
Sasspan NNP I-NP O
Hospital NNP I-NP O
It PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
should MD O O
not RB O O
take VB O O
any DT B-NP O
lamivudine NN I-NP B-m
until IN B-VP B-du
Gastroenterology NNP B-NP O
followup NN I-NP O
During IN B-VP O
the DT B-NP O
entire JJ I-NP O
hospital NN I-NP O
stay NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
GI NNP I-NP O
complaints NNS I-NP O
, , O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
, , O O
and CC O O
having VBG O O
normal JJ B-NP O
regular JJ I-NP O
bowel NN I-NP O
movements NNS I-NP O
4 CD O O
history NN B-NP O
of IN B-VP O
fibroids NNS B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
again RB O O
to TO O O
have VB O O
an DT B-NP O
8-cm JJ I-NP O
fibroid NN I-NP O
on IN B-VP O
her PRP$ O O
ultrasound JJ O O
scan JJ O O
She PRP O O
required VBD B-VP O
rare JJ B-NP O
intermittent JJ I-NP B-do
doses NNS I-NP I-do
of IN B-VP O
oxycodone NN B-NP B-m
as IN B-VP O
required VBN O O
for IN B-VP O
pain NN B-NP B-r
, , O O
which WDT O O
was VBD B-VP O
presumed VBN O O
to TO O O
be VB O O
related VBN O O
to TO O O
her PRP$ O O
fibroid JJ O O
uterus JJ O O
5 CD O O
Prenatal NNP B-NP O
care NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
her PRP$ O O
first JJ B-NP O
trimester NN I-NP O
labs NN I-NP O
sent VBD B-VP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
GC NNP I-NP O
and CC O O
chlamydia VB O O
testing VBG O O
were VBD B-VP O
negative JJ B-NP O
Urine JJ I-NP O
culture NN I-NP O
was VBD B-VP O
negative JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
O NNP B-NP O
+ve NNP I-NP O
Given NNP I-NP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
MTHFR NNP B-NP O
mutation NN I-NP O
and CC O O
the DT B-NP O
recurrent NN I-NP O
SABs NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
prenatal NN B-NP B-m
vitamins NNS I-NP I-m
, , O O
as RB O O
well RB O O
as IN B-VP O
high-dose JJ B-NP B-do
folic JJ I-NP B-m
acid NN I-NP I-m
, , O O
B12 NNP B-NP B-m
and CC O O
B6 NNP B-NP B-m
In IN B-VP O
view NN B-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
diabetic JJ I-NP O
history NN I-NP O
, , O O
and CC O O
a DT O O
transiently RB O O
elevated VBN O O
creatinine NN B-NP O
to TO O O
1.2 CD O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
2 CD O O
, , O O
which WDT O O
went VBD B-VP O
back RB O O
to TO O O
0.7 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
24-hour JJ I-NP O
urine JJ I-NP O
collection NN I-NP O
sent VBD B-VP O
, , O O
this DT O O
returned VBD B-VP O
negative JJ O O
at IN B-VP O
92 CD O O
mg NNS B-NP O
per IN B-VP O
24 CD O O
hours NNS B-NP O
It PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
Ophthalmology NNP I-NP O
retinal JJ B-NP O
exam NN I-NP O
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
health NN I-NP O
center NN I-NP O
this DT B-NP O
year NN I-NP O
For IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
this DT B-NP O
pregnancy NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
will MD O O
require VB O O
ultrasounds NNS B-NP O
at IN B-VP O
11 CD O O
and CC O O
17 CD O O
weeks NNS B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
fetal JJ I-NP O
echo NN I-NP O
, , O O
and CC O O
the DT B-NP O
recommended JJ I-NP O
testing NN I-NP O
for IN B-VP O
pre-gestational JJ B-NP O
diabetics NNS I-NP O
for IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP O
pregnancy NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
a DT B-NP O
stable JJ I-NP O
condition NN I-NP O
, , O O
with IN B-VP O
followup JJ B-NP O
appointments NNS I-NP O
arranged VBN O O
for IN B-VP O
the DT B-NP O
various JJ I-NP O
specialties NNS I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
without IN B-VP O
services NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
2 CD O O
Lovenox NNP B-NP B-m
subcutaneously RB O B-mo
90 CD O B-do
mg JJ O I-do
daily RB O B-f
3 CD O O
Vitamin NNP B-NP B-m
B12 NNP I-NP I-m
100 CD O B-do
mcg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Folate NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Prenatal JJ B-NP B-m
vitamins NNS I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o VB O B-mo
daily JJ O B-f
6 CD O O
Lantus NNP B-NP B-m
20 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.p.m RB O B-f
7 CD O O
Insulin NNP B-NP B-m
lispro VBD B-VP I-m
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
AC NNP B-NP B-f
, , O O
as RB O O
well RB O O
as IN B-VP O
lispro JJ O B-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
in IN B-VP O
addition NN B-NP O
a DT B-NP O
AC NNP I-NP B-f
FOLLOW-UP NNP I-NP O
APPOINTMENTS: NNP I-NP O
1 CD O O
Special NNP B-NP O
OB NNP I-NP O
on IN B-VP O
10/4/07 CD O O
2 CD O O
Dr NNP B-NP O
Lantry NNP I-NP O
, , O O
Endocrinology NNP B-NP O
on IN B-VP O
10/4/07 CD O O
3 CD O O
Dr NNP B-NP O
Nolan NNP I-NP O
Conners NNP I-NP O
, , O O
Cardiology NNP B-NP O
, , O O
on IN B-VP O
11/27/07 CD O O
4 CD O O
Dr NNP B-NP O
Winscott NNP I-NP O
, , O O
Gastroenterology NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
will MD O O
receive VB O O
letter NN B-NP O
with IN B-VP O
the DT B-NP O
appointment NN I-NP O
from IN B-VP O
GI NNP B-NP O
Clinic NNP I-NP O
eScription NN I-NP O
document: VBD B-VP O
5-4895741 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MAIOCCO NNP I-NP O
, , O O
DALLAS NNP B-NP O
Attending: NNP I-NP O
MARCOLINA NNP I-NP O
, , O O
EMMITT NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
8179861 CD O O
D: NNP B-NP O
10/30/07 CD O O
T: NNP B-NP O
10/30/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#885288 VBZ O O
974383166 CD O O
OERH NNP B-NP O
24451935 CD O O
4700934 CD O O
5/2/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
COLONIC NNP I-NP O
POLYPS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/10/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/22/2005 CD O O
ATTENDING: NNP B-NP O
POLAND NNP I-NP O
, , O O
BRODERICK NNP B-NP O
DEANGELO NNP I-NP O
MD NNP I-NP O
PRIMARY NNP I-NP O
CARE NNP I-NP O
PHYSICIAN: NNP I-NP O
Morton NNP I-NP O
Setter NNP I-NP O
, , O O
MD NNP B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Adenomatous NNP I-NP O
polyps NNS I-NP O
at IN B-VP O
the DT B-NP O
ileocecal JJ I-NP O
valve NN I-NP O
LIST NNP I-NP O
OF NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Adenomatous NNP B-NP O
polyp NN I-NP O
at IN B-VP O
the DT B-NP O
ileocecal JJ I-NP O
valve NN I-NP O
2 CD O O
Past NNP B-NP O
history NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
embolism NN I-NP O
3 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
4 CD O O
Vaginal NNP B-NP O
yeast NN I-NP O
infection NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Wentz NNP I-NP O
is VBZ O O
a DT B-NP O
51-year-old JJ I-NP O
lady NN I-NP O
who WP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
an DT B-NP O
adenomatous JJ I-NP O
polyp NN I-NP O
at IN B-VP O
the DT B-NP O
ileocecal JJ I-NP O
valve NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
not RB O O
amenable JJ O O
to TO O O
colonoscopy VB O O
resection NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
referred VBN O O
for IN B-VP O
colonoscopy NN B-NP O
after IN B-VP O
gastrointestinal JJ B-NP O
bleeding NN I-NP O
was VBD B-VP O
identified VBN O O
The DT B-NP O
patient NN I-NP O
does VBZ O O
have VB O O
a DT B-NP O
past JJ I-NP O
history NN I-NP O
of IN B-VP O
pulmonary JJ B-NP B-r
pulmonary JJ I-NP B-r
embolism NN I-NP O
that WDT O O
was VBD B-VP O
diagnosed VBN O O
in IN B-VP O
year NN B-NP O
2000 CD O O
that WDT O O
was VBD B-VP O
of IN B-VP O
unknown JJ B-NP O
origin NN I-NP O
and CC O O
has VBZ O O
since IN B-VP O
been VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
was VBD B-VP O
withheld VBN O O
a DT B-NP O
week NN I-NP O
before IN B-VP O
her PRP$ O O
operation NN B-NP O
, , O O
on IN B-VP O
6/30/05 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
metformin NN B-NP B-m
for IN B-VP O
her PRP$ O B-r
diabetes NNS B-NP I-r
mellitus VBP O I-r
This DT B-NP B-m
medication NN I-NP I-m
was VBD B-VP O
also RB O O
withheld VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
her PRP$ O O
operation NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Pulmonary NNP B-NP O
embolism NN I-NP O
in IN B-VP O
2000 CD O O
2 CD O O
Diabetes NNPS B-NP O
mellitus` VBP O O
type JJ O O
2 CD O O
3 CD O O
Obesity NN B-NP O
4 CD O O
Hypercholesterolemia NNP B-NP O
5 CD O O
Probable NNP B-NP O
COPD NNP I-NP O
6 CD O O
Hypertension NNP B-NP O
7 CD O O
Moderate NNP B-NP O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Cholecystectomy NNP B-NP O
2 CD O O
Laparoscopic NNP B-NP O
tubal JJ B-NP O
ligation NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
smoking VBG O O
She PRP O O
smoked VBD B-VP O
about IN B-VP O
35 CD O O
pack NN B-NP O
years NNS I-NP O
The DT B-NP O
patient NN I-NP O
quit NN I-NP O
five CD O O
months NNS B-NP O
ago RB O O
before IN B-VP O
her PRP$ O O
admission NN B-NP O
ALLERGIES: IN B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
allergic JJ O O
to TO O O
IV NNP B-NP O
erythromycin NN I-NP O
, , O O
which WDT O O
causes VBZ O O
rash NN B-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
2 CD O O
Metformin NNP B-NP B-m
Metformin NNP I-NP B-m
500 CD O B-do
mg NN B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
, , O O
100 CD O B-do
mg NN B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
afternoon NN I-NP I-f
3 CD O O
Coumadin NNP B-NP B-m
11 CD O B-do
mg NN B-NP I-do
4 CD O O
Tylenol NNP B-NP B-m
p.r.n NN I-NP B-f
for IN B-VP O
joint JJ B-NP B-r
pain NN I-NP I-r
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Negative NNP I-NP O
for IN B-VP O
cardiac NN B-NP O
, , O O
pulmonary JJ O O
, , O O
GI NNP B-NP O
, , O O
and CC O O
GU NNP B-NP O
symptoms NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
obese JJ O O
and CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Lung NNP I-NP O
exam NN I-NP O
revealed VBD B-VP O
no DT B-NP O
wheezing NN I-NP O
or CC O O
rhonchi VB O O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nondistended JJ O O
and CC O O
nontender JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
CBC NNP I-NP O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
6.5 CD O O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
30.7 CD O O
, , O O
platelet NN B-NP O
count NN I-NP O
was VBD B-VP O
310 CD O O
, , O O
000 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
1 CD O O
Adenomatous NNP B-NP O
polyp NN I-NP O
at IN B-VP O
ileocecal JJ O O
valve VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
laparoscopic JJ I-NP O
ileocecectomy NN I-NP O
on IN B-VP O
6/30/05 CD O O
However RB O O
, , O O
the DT B-NP O
frozen JJ I-NP O
section NN I-NP O
revealed VBD B-VP O
an DT B-NP O
invasive JJ I-NP O
adenocarcinoma NN I-NP O
The DT B-NP O
procedure NN I-NP O
was VBD B-VP O
converted VBN O O
to TO O O
an DT B-NP O
open JJ I-NP O
right NN I-NP O
hemicolectomy NN I-NP O
along IN B-VP O
with IN B-VP O
umbilical JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
Postoperative NNP I-NP O
course NN I-NP O
for IN B-VP O
the DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
rather RB O O
uneventful JJ O O
and CC O O
the DT B-NP O
pathology NN I-NP O
report NN I-NP O
revealed VBD B-VP O
that IN B-VP O
the DT B-NP O
tumor NN I-NP O
is VBZ O O
a DT B-NP O
stage NN I-NP O
T2 NNP I-NP O
, , O O
N0 NNP B-NP O
tumor NN I-NP O
with IN B-VP O
no DT B-NP O
lymph NN I-NP O
node RB O O
involvement JJ O O
2 CD O O
Past NNP B-NP O
history NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
embolism NN I-NP O
The DT B-NP O
patient's NN I-NP O
Coumadin NNP I-NP B-m
was VBD B-VP O
withheld VBN O O
a DT B-NP O
week NN I-NP O
before IN B-VP O
operation NN B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
heparin NN B-NP B-m
Her NNP I-NP O
Coumadin NNP I-NP B-m
was VBD B-VP O
restarted VBN O O
on IN B-VP O
7/3/05 CD O O
and CC O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
11 CD O B-do
mg NN B-NP I-do
Her NNP I-NP O
INR NNP I-NP O
steadily RB O O
increased VBD B-VP O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay VB O O
up IN B-VP O
to TO O O
1.7 CD O O
at IN B-VP O
her PRP O O
discharge VBP O O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
Coumadin NNP B-NP O
Clinic NNP I-NP O
and CC O O
as RB O O
well RB O O
as IN B-VP O
with IN B-VP O
PCP NNP B-NP O
to TO O O
monitor VB O O
her PRP$ O O
INR NNP B-NP O
after IN B-VP O
her PRP$ O O
discharge NN B-NP O
3 CD O O
Diabetes NNPS B-NP O
mellitus VBP O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
diabetes VBN O B-r
mellitus NNS B-NP I-r
and CC O O
her PRP$ O O
metformin NN B-NP B-m
was VBD B-VP O
withheld VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
her PRP$ O O
surgery NN B-NP O
During IN B-VP B-du
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Regular JJ B-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale NN B-NP I-do
Her NNP I-NP O
metformin NN I-NP B-m
was VBD B-VP O
restarted VBN O O
on IN B-VP O
11/16/05 CD O O
4 CD O O
Vaginal NNP B-NP O
yeast NN I-NP O
infection NN I-NP O
The DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
white JJ B-NP B-r
creamy JJ I-NP O
discharge NN I-NP O
from IN B-VP O
her PRP$ O O
vagina NN B-NP O
on IN B-VP O
9/29/05 CD O O
and CC O O
miconazole JJ B-NP B-m
suppository NN I-NP O
was VBD B-VP O
prescribed VBN O O
for IN B-VP B-du
five CD O I-du
days NNS B-NP I-du
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
her PRP$ O O
discharge NN B-NP O
from IN B-VP O
her PRP$ O O
vagina NN B-NP O
has VBZ O O
resolved VBN O O
PHYSICAL NNP B-NP O
EXAM NNP I-NP O
AT NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient's JJ I-NP O
heart NN I-NP O
exam NN I-NP O
revealed VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
and CC O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ B-NP O
Her NNP I-NP O
abdomen NN I-NP O
was VBD B-VP O
obese JJ O O
, , O O
but CC O O
soft JJ O O
and CC O O
nontender NN B-NP O
with IN B-VP O
active JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Her PRP$ O O
wound NN B-NP O
was VBD B-VP O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ B-NP O
Her NNP I-NP O
INR NNP I-NP O
was VBD B-VP O
1.7 CD O O
at IN B-VP O
discharge NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
DuoNeb NNP B-NP B-m
3/0.5 CD O B-do
mg NN B-NP I-do
q.6h NN I-NP B-f
2 CD O O
Coumadin NNP B-NP B-m
12 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
3 CD O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
4 CD O O
Metformin NNP B-NP B-m
Metformin NNP I-NP B-m
p.o NN I-NP B-mo
p.o NN I-NP B-mo
500 CD O B-do
mg NN B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
, , O O
1000 CD O B-do
mg NN B-NP I-do
in IN B-VP B-f
the DT B-NP O
afternoon NN I-NP O
5 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
p.o VBZ O B-mo
6 CD O O
Dilaudid NNP B-NP B-m
2-4 JJ B-NP B-do
mg NN I-NP I-do
q.3h NN I-NP B-f
p.o IN B-VP B-mo
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
She PRP O O
will MD O O
arrange VB O O
to TO O O
have VB O O
her PRP$ O O
INR NNP B-NP O
draw NN I-NP O
on IN B-VP O
1/1/05 CD O O
with IN B-VP O
follow-up JJ B-NP O
INRs NNP I-NP O
to TO O O
be VB O O
drain JJ O O
every DT O O
two CD O O
days NNS B-NP O
and CC O O
INR NNP B-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Afonso NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
eScription NN I-NP O
document: VBZ O O
2-6638086 JJ B-NP O
CS NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MATARESE NNP I-NP O
, , O O
HARRISON NNP B-NP O
Attending: NNP I-NP O
WRIGHTS NNP I-NP O
, , O O
JAIME NNP B-NP O
JACINTO NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1132181 CD O O
D: NNP B-NP O
11/28/05 CD O O
T: NNP B-NP O
11/28/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#892793 VBZ O O
534206895 CD O O
TGMH NNP B-NP O
71107061 CD O O
633520 CD O O
11/3/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ABD NNP I-NP O
PAIN NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/23/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/28/2000 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
33 CD O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
diet JJ O O
controlled VBN O O
diabetes NNS B-NP O
mellitus NN I-NP O
, , O O
morbid NN B-NP O
obesity NN I-NP O
, , O O
who WP O O
presents VBZ O O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
with IN B-VP O
periumbilical JJ B-NP O
pain NN I-NP O
, , O O
radiating VBG O O
to TO O O
the DT B-NP O
right NN I-NP O
lower RBR O O
quadrant NN B-NP O
In IN B-VP O
her PRP$ O O
first JJ B-NP O
trip NN I-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
her PRP$ O O
pain NN B-NP O
was VBD B-VP O
diffuse NN B-NP O
and CC O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
gastroenteritis NN B-NP O
After IN B-VP O
being VBG O O
sent VBD B-VP O
home NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
pain NN B-NP O
and CC O O
vomiting NN B-NP O
and CC O O
was VBD B-VP O
unable JJ O O
to TO O O
tolerate VB O O
p.o NN B-NP O
On IN B-VP O
her PRP$ O O
second JJ B-NP O
trip NN I-NP O
one CD O O
day NN B-NP O
later RB O O
she PRP O O
was VBD B-VP O
vomiting VBG O O
with IN B-VP O
no DT B-NP O
fever NN I-NP O
but CC O O
chills NNS B-NP O
and CC O O
no DT B-NP O
flatus NN I-NP O
The DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
take VB O O
her PRP O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
to TO O O
explore VB O O
for IN B-VP O
appendicitis NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Non NNP I-NP O
Insulin NNP I-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
diet JJ O O
controlled VBD B-VP O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
None NNP I-NP O
MEDICATION: NNP I-NP O
None NNP I-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT O O
morbidly RB O O
obese JJ B-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
She PRP O O
was VBD B-VP O
tachycardic JJ B-NP O
Chest NNP I-NP O
was VBD B-VP O
clear JJ B-NP O
Abdomen NNP I-NP O
was VBD B-VP O
soft JJ O O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
tenderness NN B-NP O
in IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
left VBD B-VP O
lower JJR B-NP O
quadrant NN I-NP O
with IN B-VP O
positive JJ B-NP O
psoas NN I-NP O
and CC O O
Rovsing's NNP B-NP O
sign NN I-NP O
Rectal NNP I-NP O
examination NN I-NP O
showed VBD B-VP O
normal JJ B-NP O
tone NN I-NP O
and CC O O
no DT B-NP O
stool NN I-NP O
Pelvic NNP I-NP O
examination NN I-NP O
showed VBD B-VP O
no DT B-NP O
cervical JJ I-NP O
motion NN I-NP O
tenderness NN I-NP O
LABORATORY: NNP I-NP O
Abdominal NNP I-NP O
CT NNP I-NP O
was VBD B-VP O
obtained VBN O O
which WDT O O
showed VBD B-VP O
5x5 CD O O
cm JJ B-NP O
cecal JJ I-NP O
thickening NN I-NP O
with IN B-VP O
extraluminal JJ B-NP O
air NN I-NP O
This DT O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
consistent JJ O O
with IN B-VP O
a DT B-NP O
perforated JJ I-NP O
appendicitis NN I-NP O
or CC O O
phlegmon NN B-NP O
CBC NNP I-NP O
showed VBD B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
count NN I-NP O
19 CD O O
, , O O
000 CD O O
Her NNP B-NP O
urine JJ B-NP O
HCG NNP I-NP O
was VBD B-VP O
negative JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
by IN B-VP O
Dr NNP B-NP O
Jenovese NNP I-NP O
, , O O
who WP O O
initially RB O O
opened VBD B-VP O
the DT B-NP O
right JJ I-NP O
lower JJR I-NP O
quadrant NN I-NP O
to TO O O
explore VB O O
for IN B-VP O
appendicitis NN B-NP O
In IN B-VP O
exploring VBG O O
the DT B-NP O
abdomen NNS I-NP O
, , O O
purulent JJ B-NP O
material NN I-NP O
was VBD B-VP O
found VBN O O
in IN B-VP O
the DT B-NP O
right NN I-NP O
lower RBR O O
quadrant NN B-NP O
, , O O
and CC O O
the DT B-NP O
appendix NN I-NP O
was VBD B-VP O
not RB O O
able JJ O O
to TO O O
be VB O O
visualized VBN O O
The DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
open VB O O
the DT B-NP O
midline NN I-NP O
incision NN I-NP O
which WDT O O
was VBD B-VP O
done VBN O O
Details NNP B-NP O
of IN B-VP O
the DT B-NP O
operation NN I-NP O
may MD O O
be VB O O
found VBN O O
in IN B-VP O
Dr NNP B-NP O
Zinsli NNP I-NP O
's POS O O
operative JJ B-NP O
report NN I-NP O
By IN B-VP O
report NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
gangrenous JJ B-NP O
portions NNS I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
colon NN I-NP O
, , O O
necessitating VBG O O
a DT B-NP O
right JJ I-NP O
colectomy NN I-NP O
This DT O O
was VBD B-VP O
performed VBN O O
, , O O
and CC O O
she PRP O O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
extubated VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
Her NNP I-NP O
immediate JJ B-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
supraventricular JJ B-NP B-r
supraventricular JJ I-NP B-r
tachycardia NN I-NP I-r
tachycardia NN I-NP I-r
to TO O O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
200 CD O O
with IN B-VP O
hypotension NN B-NP O
, , O O
requiring VBG O O
beta NN B-NP B-m
blockade NN I-NP I-m
and CC O O
adenosine NN B-NP B-m
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Surgical NNP I-NP O
ICU NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
After IN B-VP O
the DT B-NP O
use NN I-NP O
of IN B-VP O
beta NN B-NP B-m
blockade NN I-NP I-m
and CC O O
adenosine NN B-NP B-m
, , O O
her PRP$ O O
arrhythmia NN B-NP B-r
arrhythmia NN I-NP B-r
resolved VBD B-VP O
This DT O O
was VBD B-VP O
found VBN O O
to TO O O
occur VB O O
with IN B-VP O
magnesium NN B-NP B-m
of IN B-VP O
1.5 CD O B-do
which WDT O O
was VBD B-VP O
repleted VBN O O
Per NNP B-NP O
recommendations NNS I-NP O
of IN B-VP O
the DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
, , O O
an DT B-NP O
echocardiogram NN I-NP O
was VBD B-VP O
obtained VBN O O
which WDT O O
was VBD B-VP O
normal JJ O O
, , O O
and CC O O
she PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
by IN B-VP O
serial JJ B-NP O
CKs NNP I-NP O
and CC O O
electrocardiograms VB O O
An DT B-NP O
NG NNP I-NP O
tube NN I-NP O
was VBD B-VP O
in IN B-VP O
place NN B-NP O
which WDT O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
the DT B-NP O
first JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
kept VBN O O
on IN B-VP O
Zantac NNP B-NP B-m
She PRP O O
was VBD B-VP O
kept VBN O O
on IN B-VP O
ampicillin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
A NNP I-NP O
central JJ B-NP O
line NN I-NP O
was VBD B-VP O
in IN B-VP O
place NN B-NP O
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
postoperative JJ I-NP O
days NNS I-NP O
, , O O
as IN B-VP O
her PRP$ O O
NG NNP B-NP O
tube NN I-NP O
was VBD B-VP O
removed VBN O O
and CC O O
her PRP$ O O
diet JJ O O
slowly RB O O
advanced JJ O O
with IN B-VP O
sips NNS B-NP O
, , O O
she PRP O O
was VBD B-VP O
converted VBN O O
to TO O O
p.o VB O O
medication NN B-NP O
At IN B-VP O
one CD O O
point NN B-NP O
she PRP O O
developed VBD B-VP O
a DT B-NP O
second JJ I-NP O
episode NN I-NP O
of IN B-VP O
supraventricular JJ B-NP B-r
tachycardia NN I-NP O
and CC O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
either RB O O
atrial JJ B-NP O
fibrillation NN I-NP O
versus IN B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
This DT O O
did VBD B-VP O
not RB O O
respond VB O O
immediately RB O O
to TO O O
Lopressor NNP B-NP B-m
and CC O O
per IN B-VP O
Cardiology's NNP B-NP O
recommendations NNS I-NP O
, , O O
she PRP O O
was VBD B-VP O
changed VBN O O
to TO O O
diltiazem VB O B-m
followed VBN O O
by IN B-VP O
Diltiazem NNP B-NP B-m
drip NN I-NP I-m
When WRB O O
stabilized NN B-NP O
, , O O
her PRP$ O O
dose NN B-NP O
of IN B-VP O
Lopressor NNP B-NP B-m
was VBD B-VP O
increased VBN O O
, , O O
Diltiazem NNP B-NP B-m
stopped VBD B-VP O
and CC O O
she PRP O O
was VBD B-VP O
converted VBN O O
to TO O O
p.o VB O B-mo
Lopressor NNP B-NP B-m
50 CD O B-do
t.i.d NN B-NP B-f
which WDT O O
kept VBD B-VP O
her PRP O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
and CC O O
a DT B-NP O
stable JJ I-NP O
rate NN I-NP O
By IN B-VP O
the DT O O
third JJ O O
and CC O O
fourth JJ B-NP O
postoperative JJ I-NP O
day NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
, , O O
passing VBG O O
flatus NN B-NP O
and CC O O
bowel NN B-NP O
movements NNS I-NP O
and CC O O
ambulating VBG O O
independently RB O O
She PRP O O
was VBD B-VP O
weaned VBN O O
off RP O O
her PRP$ O O
oxygen NN B-NP B-m
and CC O O
her PRP$ O O
central JJ B-NP O
line NN I-NP O
was VBD B-VP O
discontinued VBN O O
She PRP O O
was VBD B-VP O
stable JJ O O
for IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
November NNP B-NP O
, , O O
2000 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
she PRP O O
will MD O O
have VB O O
completed VBN O O
a DT B-NP O
5-day JJ I-NP B-du
5-day JJ I-NP B-du
5-day JJ I-NP B-du
course NN I-NP I-du
course NN I-NP I-du
course NN I-NP I-du
of IN B-VP O
ampicillin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
She PRP O O
is VBZ O O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
, , O O
ambulating VBG O O
dependently RB O O
and CC O O
requiring VBG O O
minimal JJ B-NP B-do
amounts NNS I-NP I-do
of IN B-VP O
oral JJ B-NP B-mo
analgesics NNS I-NP B-m
She PRP O O
received VBD B-VP O
wet JJ O O
to TO O O
dry VB O O
dressing VBG O O
changes NNS B-NP O
b.i.d VBP O O
to TO O O
her PRP$ O O
wounds NNS B-NP O
, , O O
which WDT O O
will MD O O
need VB O O
to TO O O
be VB O O
continued VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
by IN B-VP O
a DT B-NP O
visiting NN I-NP O
nurse JJ B-NP O
DISCHARGE NNP I-NP O
MEDICATION: NNP I-NP O
Lopressor NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Percocet NNP B-NP B-m
1-2 JJ B-NP B-do
tabs NNS I-NP O
p.o JJ B-NP B-mo
q JJ I-NP B-f
3-4 JJ I-NP I-f
hours NNS I-NP I-f
p.r.n VBP O I-f
pain NN B-NP B-r
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP O
b.i.d NN I-NP B-f
while IN B-VP B-du
on IN B-VP I-du
Percocet NNP B-NP I-du
Percocet NNP I-NP B-m
FOLLOWUP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
instructed VBN O O
to TO O O
followup VB O O
with IN B-VP O
Dr NNP B-NP O
Goan NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
and CC O O
should MD O O
call VB O O
his PRP$ O O
office NN B-NP O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
JOEL NNP I-NP O
J NNP I-NP O
MILLIMAKI NNP I-NP O
, , O O
M.D NNP B-NP O
HE10 NNP I-NP O
Attending: NNP I-NP O
HECTOR NNP I-NP O
TRIGGS NNP I-NP O
, , O O
M.D NNP B-NP O
XO20 NNP I-NP O
IQ143/0359 NNP I-NP O
Batch: NNP I-NP O
1984 CD O O
Index NNP B-NP O
No NNP I-NP O
JPNO1I8NZQ NNP I-NP O
D: NNP I-NP O
4/2 CD O O
T: NNP B-NP O
4/2 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#893858 VBZ O O
646786895 CD O O
ICH NNP B-NP O
88612865 CD O O
620466 CD O O
5/8/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/30/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/3/1992 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
37 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
dilated VBN O O
cardiomyopathy NN B-NP O
admitted VBN O O
with IN B-VP O
positional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
associated VBN O O
with IN B-VP O
viral JJ B-NP O
prodrome NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
revealed VBD B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
dilated JJ B-NP O
cardiomyopathy NN I-NP O
in IN B-VP O
10-89 CD O O
She PRP O O
was VBD B-VP O
worked VBN O O
up RP O O
at IN B-VP O
the DT B-NP O
Ingvid's NNP I-NP O
Health NNP I-NP O
Services NNPS I-NP O
with IN B-VP O
a DT B-NP O
conclusion NN I-NP O
of IN B-VP O
idiopathic JJ O O
dilated VBN O O
cardiomyopathy NN B-NP O
, , O O
work-up JJ O O
unavailable JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
Lasix NNP B-NP B-m
, , O O
digoxin NN B-NP B-m
and CC O O
an DT B-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
In IN B-VP O
20 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
Orecross NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
after IN B-VP O
complaining VBG O O
of IN B-VP O
positional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
fatigue NN B-NP O
She PRP O O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
dilated VBN O O
cardiomyopathy NN B-NP O
and CC O O
received VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
large JJ B-NP O
ventricles NNS I-NP O
, , O O
2+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
3+ CD O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
In IN B-VP O
7 CD O O
of IN B-VP O
July NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
bicycle NN I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
and CC O O
endured VBD B-VP O
10 CD O O
minutes NNS B-NP O
and CC O O
16 CD O O
seconds NNS B-NP O
, , O O
limited VBN O O
by IN B-VP O
fatigue NN B-NP O
Peak NNP I-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
104 CD O O
, , O O
peak JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
156/80 CD O O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
few JJ I-NP O
atrial JJ I-NP O
premature NN I-NP O
beats NNS I-NP O
and CC O O
no DT B-NP O
ischemic JJ I-NP O
ST-T JJ I-NP O
changes NNS I-NP O
Her PRP$ O O
oxygen NN B-NP O
uptake NN I-NP O
was VBD B-VP O
16.2 CD O O
milliliters NNS B-NP O
per IN B-VP O
kilogram NN B-NP O
per IN B-VP O
minute NN B-NP O
In IN B-VP O
4 CD O O
of IN B-VP O
October NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
right NN I-NP O
ventriculogram NN I-NP O
which WDT O O
showed VBD B-VP O
ejection NN B-NP O
fraction NN I-NP O
24% CD O O
and CC O O
global JJ B-NP O
hypokinesis NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
on IN B-VP O
28 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
4 CD O O
days NNS B-NP O
of IN B-VP O
diarrhea NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
and CC O O
malaise NN B-NP O
, , O O
followed VBN O O
by IN B-VP O
sharp JJ B-NP O
severe JJ I-NP O
chest NN I-NP O
pain NN I-NP O
in IN B-VP O
the DT B-NP O
mid NN I-NP O
chest NN I-NP O
below IN B-VP O
the DT B-NP O
left NN I-NP O
breast NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
back NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
relieved VBN O O
by IN B-VP O
lying VBG O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
and CC O O
aggravated VBN O O
by IN B-VP O
leaning VBG O O
forward RB O O
or CC O O
lying VBG O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
, , O O
also RB O O
worsened VBN O O
by IN B-VP O
deep JJ B-NP O
breathing NN I-NP O
and CC O O
cough NN B-NP O
, , O O
and CC O O
also RB O O
with IN B-VP O
ventral JJ B-NP O
palpation NN I-NP O
The DT B-NP O
patient NN I-NP O
claimed VBD B-VP O
that IN B-VP O
the DT B-NP O
pain NN I-NP O
had VBD B-VP O
never RB O O
gone VBN O O
away RB O O
in IN B-VP O
the DT O O
past JJ O O
12 CD O O
hours NNS B-NP O
, , O O
but CC O O
again RB O O
was VBD B-VP O
aggravated VBN O O
by IN B-VP O
certain JJ B-NP O
positions NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
cardiomyopathy NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
gastritis NN B-NP O
, , O O
ex-intravenous JJ B-NP O
drug NN I-NP O
abuser NN I-NP O
for IN B-VP O
10 CD O O
years NNS B-NP O
, , O O
anemia NN B-NP O
, , O O
and CC O O
recent JJ B-NP O
crack NN I-NP O
cocaine NN I-NP O
use NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
included VBD B-VP O
Lasix NNP B-NP B-m
, , O O
Enalapril NNP B-NP B-m
and CC O O
digoxin NN B-NP B-m
ALLERGIES NNP I-NP O
were VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
black JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Blood NNP I-NP O
pressure NN I-NP O
was VBD B-VP O
162/100 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
90 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
24 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
99% CD O O
, , O O
no DT B-NP O
pulsus NN I-NP O
Eyes NNS I-NP O
were VBD B-VP O
pupils NNS B-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
extraocular JJ B-NP O
movements NNS I-NP O
intact JJ O O
, , O O
muddy JJ B-NP O
sclera NN I-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
, , O O
jugular JJ B-NP O
venous JJ I-NP O
pressure NN I-NP O
was VBD B-VP O
8 CD O O
to TO O O
10 CD O O
centimeters NNS B-NP O
, , O O
carotids NNS B-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP O
and CC O O
percussion NN B-NP O
except IN B-VP O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
bibasilar JJ I-NP O
crackles NNS I-NP O
Heart NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
rubs NN I-NP O
, , O O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ O O
, , O O
no DT B-NP O
murmurs NNS I-NP O
were VBD B-VP O
noted VBN O O
Abdomen NNP B-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
, , O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
she PRP O O
was VBD B-VP O
comfortable JJ O O
with IN B-VP O
deep JJ B-NP O
palpation NN I-NP O
diffusely RB O O
Extremities NNP B-NP O
showed VBD B-VP O
no DT B-NP O
edema NN I-NP O
Rectal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
guaiac JJ B-NP O
negative JJ I-NP O
Neurologic NNP I-NP O
examination NN I-NP O
was VBD B-VP O
nonfocal JJ B-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Sodium NNP I-NP O
was VBD B-VP O
137 CD O O
, , O O
potassium NN B-NP O
2.7 CD O O
, , O O
chloride RB O O
92 CD O O
, , O O
bicarbonate NN B-NP O
37 CD O O
, , O O
blood NN B-NP O
urea JJ B-NP O
nitrogen NN I-NP O
7 CD O O
, , O O
creatinine NN B-NP O
.9 NN I-NP O
, , O O
glucose JJ O O
159 CD O O
, , O O
AST NNP B-NP O
58 CD O O
, , O O
creatinine NN B-NP O
phosphokinase NN I-NP O
641 CD O O
, , O O
with IN B-VP O
23% CD O O
myocardial JJ B-NP O
bands NNS I-NP O
White NNP I-NP O
count NN I-NP O
was VBD B-VP O
4.6 CD O O
, , O O
hematocrit NN B-NP O
31.5 CD O O
, , O O
platelets NNS B-NP O
166 CD O O
, , O O
000 CD O O
, , O O
ESR NNP B-NP O
60 CD O O
, , O O
prothrombin JJ B-NP O
time NN I-NP O
11.3 CD O O
, , O O
partial JJ B-NP O
thromboplastin NN I-NP O
time NN I-NP O
18 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
a DT B-NP O
big JJ I-NP O
heart NN I-NP O
with IN B-VP O
mild JJ B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
The DT B-NP O
electrocardiogram NN I-NP O
showed VBD B-VP O
T-wave NNP B-NP O
inversions NNS I-NP O
in IN B-VP O
I PRP O O
, , O O
II NNP B-NP O
, , O O
F NNP B-NP O
, , O O
L NNP B-NP O
, , O O
V2 NNP B-NP O
through IN B-VP O
V6 NNP B-NP O
, , O O
consistent NN B-NP O
with IN B-VP O
a DT O O
1990 CD O O
electrocardiogram NN B-NP O
done VBN O O
when WRB O O
she PRP O O
was VBD B-VP O
complaining VBG O O
of IN B-VP O
positional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
similar JJ O O
to TO O O
the DT B-NP O
chest NN I-NP O
pain NN I-NP O
she PRP O O
is VBZ O O
having VBG O O
now RB O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
the DT B-NP O
thought NN I-NP O
that IN B-VP O
her PRP$ O O
history NN B-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
pericarditis NN B-NP O
, , O O
but CC O O
was VBD B-VP O
also RB O O
worriesome JJ O O
for IN B-VP O
ischemia NN B-NP O
given VBN O O
her PRP$ O O
elevated JJ B-NP O
creatinine NN I-NP O
phosphokinase NN I-NP O
with IN B-VP O
myocardial JJ B-NP O
band NN I-NP O
fraction NN I-NP O
of IN B-VP O
23 CD O O
, , O O
and CC O O
her PRP$ O O
history NN B-NP O
of IN B-VP O
cocaine NN B-NP O
abuse IN B-VP O
Her NNP B-NP O
hospital NN I-NP O
course NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
continuation NN B-NP O
of IN B-VP O
her PRP$ O O
pain NN B-NP B-r
through IN B-VP O
the DT B-NP O
first JJ I-NP O
day NN I-NP O
of IN B-VP O
hospitalization NN B-NP O
despite IN B-VP O
and CC O O
aggressive JJ B-NP O
anti-ischemic JJ I-NP B-m
regimen NNS I-NP I-m
It PRP O O
was VBD B-VP O
found VBN O O
that IN B-VP O
hermyocardial JJ B-NP O
band NN I-NP O
electrophoresis NN I-NP O
showed VBD B-VP O
no DT B-NP O
myocardial JJ I-NP O
band NN I-NP O
fraction NN I-NP O
detected VBN O O
, , O O
and CC O O
it PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
we PRP O O
would MD O O
shift VB O O
our PRP$ O O
therapy NN B-NP O
to TO O O
a DT O O
more RBR O O
anti-inflammatory JJ B-NP B-m
regimen NNS I-NP I-m
to TO O O
control VB O O
her PRP$ O B-r
pericarditis NN B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
Indocin NNP B-NP B-m
was VBD B-VP O
started VBN O O
and CC O O
the DT B-NP B-r
chest NN I-NP I-r
pain NN I-NP I-r
resolved VBD B-VP O
With IN B-VP O
the DT B-NP O
resolution NN I-NP O
of IN B-VP O
her PRP$ O O
chest NN B-NP O
pain NN I-NP O
, , O O
the DT B-NP O
T-wave NNP I-NP O
inversions NNS I-NP O
corrected VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transerred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
Indocin NNP B-NP B-m
50 CD O B-do
milligrams NNS B-NP I-do
3 CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
aspirin NN B-NP B-m
, , O O
Bactrim NNP B-NP B-m
, , O O
Enalapril NNP B-NP B-m
and CC O O
Carafate NNP B-NP B-m
and CC O O
remained VBD B-VP O
without IN B-VP O
chest JJS B-NP O
pain NN I-NP O
for IN B-VP O
the DT O O
next JJ O O
2 CD O O
days NNS B-NP O
She PRP O O
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
the DT B-NP O
ACE NNP I-NP O
team NN I-NP O
in IN B-VP O
consultation NN B-NP O
about IN B-VP O
her PRP$ O O
drug NN B-NP O
and CC O O
alcohol NN B-NP O
problem NN I-NP O
, , O O
and CC O O
it PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
she PRP O O
would MD O O
be VB O O
discharged VBN O O
on IN B-VP O
28 CD O O
of IN B-VP O
September NNP B-NP O
, , O O
after IN B-VP O
arrangement NN B-NP O
for IN B-VP O
follow-up NN B-NP O
with IN B-VP O
the DT B-NP O
ACE NNP I-NP O
team NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
included VBD B-VP O
aspirin NN B-NP B-m
, , O O
Indocin NNP B-NP B-m
50 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth NN B-NP O
3 CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Enalapril NNP B-NP B-m
10 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth JJ O I-mo
each DT B-NP B-f
day NN I-NP I-f
, , O O
Carafate NNP B-NP B-m
1 CD O B-do
gram NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
4 CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
FOLLOW-UP JJ O O
with IN B-VP O
Dr NNP B-NP O
Dewitt NNP I-NP O
A NNP I-NP O
Sisler NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MIRELES NNP I-NP O
Attending: NNP I-NP O
BERNARDO NNP I-NP O
R NNP I-NP O
MOULD NNP I-NP O
, , O O
M.D NNP B-NP O
KR27 NNP I-NP O
AB563/1658 NNP I-NP O
Batch: NNP I-NP O
3411 CD O O
Index NNP B-NP O
No NNP I-NP O
UXU068574 NNP I-NP O
D: NNP I-NP O
7/22/92 CD O O
T: NNP B-NP O
6/1/92 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#895892 VBZ O O
121670578 CD O O
SHAHC NNP B-NP O
33200811 CD O O
049559 CD O O
8/10/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
PANCREATITIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/26/1998 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/12/1998 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
65 CD O O
year NN B-NP O
old JJ B-NP O
African-American JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP O
pancreatitis NN I-NP O
who WP O O
was VBD B-VP O
recently RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Staho NNP I-NP O
Health NNP I-NP O
10 CD O O
of IN B-VP O
November NNP B-NP O
to TO O O
3 CD O O
of IN B-VP O
May NNP B-NP O
for IN B-VP O
her PRP$ O O
chronic JJ B-NP O
pancreatitis NN I-NP O
who WP O O
returned VBD B-VP O
on IN B-VP O
the DT O O
24 CD O O
of IN B-VP O
January NNP B-NP O
with IN B-VP O
recurrent JJ B-NP O
abdominal JJ I-NP O
pain NN I-NP O
and CC O O
symptoms NNS B-NP O
consistent JJ O O
with IN B-VP O
her PRP$ O O
chronic JJ B-NP O
pancreatitis NN I-NP O
Prior NNP I-NP O
studies NNS I-NP O
by IN B-VP O
abdominal JJ B-NP O
CT NNP I-NP O
scan NN I-NP O
had VBD B-VP O
showed VBN O O
findings NNS B-NP O
consistent JJ O O
with IN B-VP O
chronic JJ B-NP O
pancreatitis NN I-NP O
, , O O
such JJ O O
as IN B-VP O
multiple JJ B-NP O
calcifications NNS I-NP O
and CC O O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
swelling VBG O O
and CC O O
peripancreatic JJ O O
increased VBN O O
attenuation NN B-NP O
Findings NNP I-NP O
consistent NN I-NP O
with IN B-VP O
acute JJ B-NP O
pancreatitis NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
initially RB O O
to TO O O
the DT B-NP O
medical JJ I-NP O
service NN I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
low JJ I-NP O
grade NN I-NP O
temperature NN I-NP O
of IN B-VP O
100.2 CD O O
, , O O
was VBD B-VP O
tachycardic JJ O O
with IN B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
131 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
132/80 CD O O
Her NNP B-NP O
exam NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
decreased JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
base NN I-NP O
and CC O O
a DT B-NP O
few JJ I-NP O
scattered JJ I-NP O
rhonchi NNS I-NP O
Cardiac NNP I-NP O
exam NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
tachycardia NN B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
appreciated VBN O O
Abdominal NNP B-NP O
exam NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
decreased JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
She PRP O O
had VBD B-VP O
abdominal JJ B-NP O
tenderness NN I-NP O
in IN B-VP O
the DT B-NP O
midepigastric JJ I-NP O
region NN I-NP O
with IN B-VP O
guarding VBG O O
Rectal NNP B-NP O
exam NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
128 CD O O
, , O O
potassium NN B-NP O
4.1 CD O O
, , O O
chloride RB O O
95 CD O O
, , O O
bicarb NN B-NP O
26 CD O O
, , O O
BUN NNP B-NP O
23 CD O O
, , O O
creatinine NN B-NP O
0.8 CD O O
, , O O
glucose RB O O
433 CD O O
, , O O
WBC NNP B-NP O
17.8 CD O O
, , O O
hematocrit NN B-NP O
33 CD O O
, , O O
platelets NNS B-NP O
370 CD O O
Liver NNP B-NP O
function NN I-NP O
tests NNS I-NP O
had VBD B-VP O
an DT B-NP O
alk JJ I-NP O
level NN I-NP O
of IN B-VP O
434 CD O O
, , O O
T-bili NNP B-NP O
was VBD B-VP O
0.6 CD O O
, , O O
D-bili NNP B-NP O
was VBD B-VP O
0.2 CD O O
, , O O
lipase NN B-NP O
was VBD B-VP O
123 CD O O
, , O O
amylase NN B-NP O
was VBD B-VP O
37 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
ultrasound NN I-NP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
which WDT O O
showed VBD B-VP O
no DT B-NP O
gallstones NNS I-NP O
Gallbladder NNP I-NP O
that WDT O O
was VBD B-VP O
mildly RB O O
distended VBD B-VP O
A NNP B-NP O
common JJ B-NP O
bile NN I-NP O
duct NN I-NP O
that WDT O O
was VBD B-VP O
dilated VBN O O
to TO O O
7 CD O O
mm NN B-NP O
as RB O O
well RB O O
as IN B-VP O
intrahepatic JJ B-NP O
duct NN I-NP O
dilatation NN I-NP O
In IN B-VP O
addition NN B-NP O
a DT O O
6 CD O O
cm NN B-NP O
cyst NN I-NP O
was VBD B-VP O
identified VBN O O
in IN B-VP O
the DT B-NP O
region NN I-NP O
of IN B-VP O
the DT B-NP O
pancreatic JJ I-NP O
head NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
her PRP$ O O
to TO O O
be VB O O
in IN B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
with IN B-VP O
the DT B-NP O
rate NN I-NP O
of IN B-VP O
122 CD O O
She PRP O O
had VBD B-VP O
a DT O O
left VBN O O
axis NN B-NP O
deviation NN I-NP O
in IN B-VP O
Qs NNP B-NP O
and CC O O
V1 NNP B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
pancreatitis NN B-NP O
, , O O
asthma NN B-NP O
, , O O
insulin NN B-NP O
dependent JJ O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
vascular JJ B-NP O
necrosis NN I-NP O
of IN B-VP O
both DT B-NP O
hips NNS I-NP O
, , O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
total JJ I-NP O
hip NN I-NP O
replacement NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
total JJ I-NP O
hip NN I-NP O
replacement NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
She PRP O O
has VBZ O O
known VBN O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
chronic JJ B-NP O
obstructive JJ I-NP O
pulmonary JJ I-NP O
disease NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
GI NNP B-NP O
bleed NN I-NP O
Status NNP I-NP O
post NN I-NP O
a DT B-NP O
Nissen NNP I-NP O
fundoplication NN I-NP O
with IN B-VP O
redo JJ B-NP O
Hypertension NNP I-NP O
Alpha NNP I-NP O
thalassemia JJ B-NP O
History NNP I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
Chronic NNP I-NP O
low NN I-NP O
back RB O O
pain NN B-NP O
secondary JJ O O
to TO O O
spinal JJ B-NP O
stenosis NN I-NP O
MEDICATIONS: NNP I-NP O
Metformin NNP I-NP B-m
, , O O
Atrovent NNP B-NP B-m
, , O O
Albuterol NNP B-NP B-m
, , O O
Flovent NNP B-NP B-m
, , O O
Elavil NNP B-NP B-m
, , O O
Cisapride NNP B-NP B-m
, , O O
Flexeril NNP B-NP B-m
, , O O
Axid NNP B-NP B-m
, , O O
NPH NNP B-NP B-m
insulin NN I-NP I-m
, , O O
Cardizem NNP B-NP B-m
CD NNP I-NP I-m
, , O O
lisinopril NN B-NP B-m
, , O O
Lasix NNP B-NP B-m
, , O O
magnesium NN B-NP B-m
oxide NN I-NP I-m
, , O O
Percocet NNP B-NP B-m
, , O O
Premarin NNP B-NP B-m
, , O O
Provera NNP B-NP B-m
, , O O
Prilosec NNP B-NP B-m
, , O O
Lipitor NNP B-NP B-m
, , O O
Tums NNP B-NP B-m
and CC O O
multi-vitamins NNS B-NP B-m
ALLERGIES: NNP I-NP O
Aspirin NNP I-NP O
causes VBZ O O
facial JJ B-NP O
swelling NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
reactive JJ B-NP O
airway NN I-NP O
disease NN I-NP O
Ibuprofen NNP I-NP O
causing VBG O O
GI NNP B-NP O
bleed NN I-NP O
meperidine NN I-NP O
causing VBG O O
itching NN B-NP O
, , O O
prednisone NN B-NP O
causing NN I-NP O
myalgias NN I-NP O
, , O O
arthralgias NN B-NP O
, , O O
osteoporosis NN B-NP O
Penicillin NNP I-NP O
causes VBZ O O
edema JJ B-NP O
Fophonomide NNP I-NP O
causes VBZ O O
itching VBG O O
Codeine NNP B-NP O
causes VBZ O O
itching VBG O O
Morphine NNP B-NP O
causes VBZ O O
itching VBG O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
She PRP O O
does VBZ O O
not RB O O
drink VB O O
or CC O O
use VB O O
tobacco NN B-NP O
She PRP O O
has VBZ O O
two CD O O
children NNS B-NP O
She PRP O O
lives VBZ O O
alone RB O O
After IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
medical JJ I-NP O
service NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
surgical JJ I-NP O
service NN I-NP O
in IN B-VP O
consultation NN B-NP O
Based VBN O O
on IN B-VP O
clinical JJ B-NP O
findings NNS I-NP O
and CC O O
laboratory NN B-NP O
values NNS I-NP O
, , O O
a DT B-NP O
repeat NN I-NP O
abdominal JJ B-NP O
CT NNP I-NP O
study NN I-NP O
was VBD B-VP O
ordered VBN O O
with IN B-VP O
a DT B-NP O
plan NN I-NP O
for IN B-VP O
CT NNP B-NP O
guided VBD B-VP O
drainage NN B-NP O
to TO O O
rule VB O O
out RP O O
a DT B-NP O
pancreatic JJ I-NP O
abscess NN I-NP O
The DT B-NP O
CT NNP I-NP O
guided VBD B-VP O
aspirate NN B-NP O
appeared VBD B-VP O
purulent NN B-NP O
and CC O O
was VBD B-VP O
sent VBN O O
for IN B-VP O
gram NN B-NP O
and CC O O
cultures NNS B-NP O
Gram NNP I-NP O
stain NN I-NP O
was VBD B-VP O
positive JJ O O
for IN B-VP O
gram JJ B-NP O
negative JJ I-NP O
rods NNS I-NP O
and CC O O
gram JJ B-NP O
positive JJ I-NP O
cocci NN I-NP O
in IN B-VP O
pairs NNS B-NP O
actually RB O O
growing VBG O O
out RP O O
Strep NNP B-NP O
viridans NNS I-NP O
and CC O O
Klebsiella NNP B-NP O
While IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
also RB O O
developed VBD B-VP O
a DT B-NP B-r
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
with IN B-VP O
yeast NN B-NP O
, , O O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
fluconazole NN B-NP B-m
This DT O O
too RB O O
, , O O
she PRP O O
will MD O O
be VB O O
discharged VBN O O
with IN B-VP O
, , O O
to TO O O
complete VB O O
a DT B-NP B-du
seven-day JJ I-NP I-du
course NN I-NP I-du
As NNP I-NP O
well RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
peptic JJ B-NP B-r
peptic JJ I-NP B-r
ulcer NN I-NP I-r
ulcer JJ B-NP I-r
disease NN I-NP I-r
disease NN I-NP I-r
, , O O
and CC O O
was VBD B-VP O
begun VBN O O
on IN B-VP O
H NNP B-NP O
pylori JJ B-NP O
therapy NN I-NP O
of IN B-VP O
Biaxin NNP B-NP B-m
and CC O O
bismuth NN B-NP B-m
, , O O
both DT O O
of IN B-VP O
which WDT O O
she PRP O O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
to TO O O
complete VB O O
a DT O B-du
a DT B-NP B-du
seven-day JJ I-NP I-du
seven-day JJ I-NP I-du
course NN I-NP I-du
course NN I-NP I-du
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
relatively RB O O
pain-free JJ O O
, , O O
tolerating VBG O O
a DT B-NP O
p.o NN I-NP O
diet NN I-NP O
, , O O
and CC O O
afebrile IN B-VP O
The DT B-NP O
plan NN I-NP O
is VBZ O O
to TO O O
discharge VB O O
her PRP O O
to TO O O
the DT B-NP O
Triadnockum NNP I-NP O
for IN B-VP O
rehabilitation NN B-NP O
on IN B-VP O
her PRP$ O O
usual JJ B-NP O
medications NNS I-NP O
, , O O
plus CC O O
the DT B-NP O
above-mentioned JJ I-NP O
antibiotics NNS I-NP B-m
She PRP O O
will MD O O
follow VB O O
up RP O O
in IN B-VP O
the DT B-NP O
Gug NNP I-NP O
University NNP I-NP O
in IN B-VP O
the DT O O
next JJ O O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
, , O O
and CC O O
will MD O O
in IN B-VP O
addition NN B-NP O
be VB O O
followed VBN O O
by IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Lorenzo NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
COLEMAN NNP I-NP O
D NNP I-NP O
HONES NNP I-NP O
, , O O
M.D NNP B-NP O
AM50 NNP I-NP O
Attending: NNP I-NP O
STERLING NNP I-NP O
W NNP I-NP O
DONSON NNP I-NP O
, , O O
M.D NNP B-NP O
MS98 NNP I-NP O
XC841/6428 NNP I-NP O
Batch: NNP I-NP O
4574 CD O O
Index NNP B-NP O
No NNP I-NP O
MLULD48NDM NNP I-NP O
D: NNP I-NP O
1/15/98 CD O O
T: NNP B-NP O
1/15/98 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#898277 VBZ O O
696082464 CD O O
WOMH NNP B-NP O
78090082 CD O O
896867 CD O O
4/25/1996 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/29/1996 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/18/1996 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
Pulmonary NNP I-NP O
edema NN I-NP O
This DT O O
is VBZ O O
a DT O O
51 CD O O
year-old JJ B-NP O
female NN I-NP O
with IN B-VP O
fibromyalgia NN B-NP O
, , O O
hypertension NN B-NP O
and CC O O
migraine NN B-NP O
headaches NNS I-NP O
She PRP O O
reports VBZ O O
two CD O O
months NNS B-NP O
of IN B-VP O
dyspnea NN B-NP O
at IN B-VP O
night NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
and CC O O
orthopnea NN B-NP O
Over IN B-VP O
the DT O O
past JJ O O
two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
episodes NNS I-NP O
have VBP O O
been VBN O O
becoming VBG O O
worse RBR O O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
severe JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pressure NN I-NP O
associated VBN O O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
after IN B-VP O
carrying VBG O O
water NN B-NP O
bottles NNS I-NP O
from IN B-VP O
her PRP$ O O
car NN B-NP O
She PRP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
V/Q NNP B-NP O
scan NN I-NP O
was VBD B-VP O
very RB O O
low JJ B-NP O
probability NN I-NP O
She PRP O O
had VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
noninvasive JJ B-NP O
studies NNS I-NP O
which WDT O O
were VBD B-VP O
also RB O O
unremarkable JJ B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Fibromyalgia NNP I-NP O
, , O O
hypertension NN B-NP O
, , O O
mild JJ B-NP O
asthma NN I-NP O
, , O O
osteoarthritis NN B-NP O
of IN B-VP O
the DT B-NP O
knee NN I-NP O
, , O O
migraines NNS B-NP O
, , O O
total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
, , O O
bilateral JJ B-NP O
salpingo-oophorectomy NN I-NP O
, , O O
chronic JJ B-NP O
fatigue NN I-NP O
syndrome NN I-NP O
, , O O
deep RB O O
venous JJ B-NP O
thrombosis NN I-NP O
in IN B-VP O
the DT B-NP O
right NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
gallstones NNS B-NP O
Medications NNS I-NP O
on IN B-VP O
admission NN B-NP O
included VBD B-VP O
Nortriptyline NNP B-NP B-m
, , O O
methyldopa NN B-NP B-m
, , O O
hydrochlorothiazide NN B-NP B-m
, , O O
Zantac NNP B-NP B-m
, , O O
estrogen NN B-NP B-m
, , O O
Advil NNP B-NP B-m
, , O O
ALternaGEL NNP B-NP B-m
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
works VBZ O O
as IN B-VP O
a DT B-NP O
supervisor NN I-NP O
to TO O O
home NN B-NP O
health NN I-NP O
aides NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
smokes VBZ O O
one CD O O
and CC O O
one-half JJ B-NP O
packs NNS I-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
30 CD O O
years NNS B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
97.4 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
22 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
100 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
150/90 CD O O
HEENT: NNP B-NP O
Anicteric NNP I-NP O
LUNGS: NNP I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
bibasilar JJ B-NP O
crackles NNS I-NP O
about IN B-VP O
one-quarter NN B-NP O
of IN B-VP O
the DT B-NP O
way NN I-NP O
up RP O O
CARDIOVASCULAR: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
II/VI NNP I-NP O
systolic JJ B-NP O
murmur NN I-NP O
No NNP I-NP O
rubs NN I-NP O
or CC O O
gallops NNS B-NP O
ABDOMEN: NNP I-NP O
Benign NNP I-NP O
RECTAL: NNP I-NP O
Guaiac NNP I-NP O
negative NN I-NP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
EXTREMITIES: NNP I-NP O
1+ CD O O
pedal NN B-NP O
edema NN I-NP O
bilaterally RB O O
, , O O
right RB O O
greater JJR O O
than IN B-VP O
left VBD B-VP O
NEUROLOGICAL: NNP B-NP O
Nonfocal NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
hematocrit NN B-NP O
41.6 CD O O
, , O O
BUN NNP B-NP O
13 CD O O
, , O O
creatinine NN B-NP O
0.6 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
mild JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
Electrocardiogram NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
91 CD O O
, , O O
no DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
She PRP O O
had VBD B-VP O
serial JJ B-NP O
CPKs NNP I-NP O
which WDT O O
were VBD B-VP O
all DT O O
negative JJ O O
At IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
her PRP$ O O
monitor NN B-NP O
was VBD B-VP O
then RB O O
discontinued VBN O O
The DT B-NP O
patient's NN I-NP O
pulmonary JJ B-NP B-r
edema NN I-NP I-r
was VBD B-VP O
treated VBN O O
with IN B-VP O
two CD O B-du
doses NNS B-NP O
of IN B-VP O
intravenous JJ B-NP B-mo
Lasix NNP I-NP B-m
( ( O O
20 CD O B-do
milligrams NNS B-NP I-do
each DT O O
) ) O O
This DT O O
resulted VBN O O
in IN B-VP O
a DT B-NP O
moderate JJ I-NP O
diuresis NN I-NP O
and CC O O
resolution NN B-NP O
of IN B-VP O
her PRP$ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
symptoms NNS I-NP O
She PRP O O
then RB O O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
test NN I-NP O
This DT O O
was VBD B-VP O
done VBN O O
with IN B-VP O
arm NN B-NP O
ergometry NN I-NP O
( ( O O
30 CD O O
watts NN B-NP O
) ) O O
She PRP O O
went VBD B-VP O
ten JJ B-NP O
minutes NNS I-NP O
, , O O
stopped VBD B-VP O
secondary JJ O O
to TO O O
arm VB O O
fatigue NN B-NP O
Her NNP I-NP O
heart NN I-NP O
rate NN I-NP O
went VBD B-VP O
from IN B-VP O
100 CD O O
to TO O O
129 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
went VBD B-VP O
from IN B-VP O
130 CD O O
systolic JJ O O
to TO O O
172 CD O O
Electrocardiogram NNP B-NP O
showed VBD B-VP O
no DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
chest JJS I-NP O
pain NN I-NP O
or CC O O
chest VB O O
pressure NN B-NP O
with IN B-VP O
this DT O O
and CC O O
this DT O O
was VBD B-VP O
deemed VBN O O
a DT B-NP O
negative JJ I-NP O
test NN I-NP O
She PRP O O
then RB O O
underwent VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
showed VBD B-VP O
vigorous JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
of IN B-VP O
86% CD O O
, , O O
no DT B-NP O
valvular JJ I-NP O
lesions NNS I-NP O
, , O O
no DT B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
There EX O O
was VBD B-VP O
evidence NN B-NP O
of IN B-VP O
thickening VBG O O
in IN B-VP O
her PRP$ O O
ventricular JJ B-NP O
walls NNS I-NP O
Given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT O B-r
elevated VBN O I-r
diastolic JJ B-NP I-r
pressure NN I-NP I-r
and CC O O
did VBD B-VP O
show VB O O
some DT B-NP O
early JJ I-NP O
evidence NN I-NP O
of IN B-VP O
thickening VBG O O
in IN B-VP O
her PRP$ O O
ventricular JJ B-NP O
walls NNS I-NP O
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
then RB O O
made VBN O O
to TO O O
begin VB O O
her PRP$ O O
on IN B-VP O
a DT B-NP O
calcium NN I-NP B-m
channel NN I-NP O
blocker NN I-NP O
Verapamil NNP I-NP B-m
240 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
q.d NN B-NP B-f
was VBD B-VP O
initiated VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
this DT O O
prior JJ O O
to TO O O
discharge VB O O
This DT O O
was VBD B-VP O
added VBN O O
in IN B-VP O
addition NN B-NP O
to TO O O
all DT O O
her PRP$ O O
usual JJ B-NP O
medications NNS I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Verapamil NNP I-NP B-m
SR NNP I-NP I-m
240 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
q.d.; JJ B-NP B-f
Zantac NNP I-NP B-m
300 CD O B-do
milligrams NNS B-NP I-do
q.d.; VBP O B-f
estrogen RB O B-m
1.25 CD O B-do
milligrams NNS B-NP O
q.d.; VBP O B-f
Advil NNP B-NP B-m
800 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
b.i.d JJ B-NP B-f
p.r.n.; NN I-NP I-f
hydrochlorothiazide NN I-NP B-m
25 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
q.d.; JJ B-NP B-f
methyldopa NN I-NP B-m
250 CD O B-do
milligrams NNS B-NP O
q.d.; VBP O B-f
Nortriptyline NNP B-NP B-m
125 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
q.h.s PDT O B-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
scheduled VBN O O
an DT B-NP O
appointment NN I-NP O
to TO O O
see VB O O
a DT B-NP O
new JJ I-NP O
primary JJ I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Kenneth NNP I-NP O
Finneran NNP I-NP O
at IN B-VP O
Dowsna NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
She PRP O O
states VBZ O O
that IN B-VP O
appointment NN B-NP O
is VBZ O O
scheduled VBN O O
for IN B-VP O
May NNP B-NP O
, , O O
1996 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
HOUSTON NNP I-NP O
N NNP I-NP O
MONSALVE NNP I-NP O
, , O O
M.D NNP B-NP O
HE93 NNP I-NP O
Attending: NNP I-NP O
ARCHIE NNP I-NP O
J NNP I-NP O
SOLINAS NNP I-NP O
, , O O
M.D NNP B-NP O
YO28 NNP I-NP O
SY476/6632 NNP I-NP O
Batch: NNP I-NP O
0874 CD O O
Index NNP B-NP O
No NNP I-NP O
Z5HYF120UB NNP I-NP O
D: NNP I-NP O
11/28/96 CD O O
T: NNP B-NP O
11/28/96 CD O O
CC: NNP B-NP O
1 CD O O
ELTON NNP B-NP O
D NNP I-NP O
LEHNER NNP I-NP O
, , O O
M.D NNP B-NP O
HM16 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#898807 VBZ O O
199067318 CD O O
LCSMC NNP B-NP O
97187933 CD O O
8546667 CD O O
10/4/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
hereditary JJ B-NP O
angioedema NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/6/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/17/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BRUNSCHEEN NNP I-NP O
, , O O
GARTH NNP B-NP O
H NNP I-NP O
657-64-55-6 JJ B-NP O
Co NNP I-NP O
Room: NNP I-NP O
Jack NNP I-NP O
, , O O
Texas NNP B-NP O
78463 CD O O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/5/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
FLEMISTER NNP I-NP O
, , O O
RUEBEN NNP B-NP O
RANDELL NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
VIT NNP I-NP B-m
C NNP I-NP I-m
( ( O I-m
ASCORBIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ATENOLOL NNP I-NP B-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 NN I-NP O
, , O O
hr&lt;60 NN B-NP O
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP O
Instructions: NNP I-NP O
Sun NNP I-NP O
, , O O
Tues NNP B-NP O
, , O O
Thurs NNP B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/6/05 CD O O
by IN B-VP O
LEEMING NNP B-NP O
, , O O
ARMANDO NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
SYNTHROID NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
66804792 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
DIGOXIN NNP B-NP B-m
0.1875 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP O
Instructions: NNP I-NP O
On IN B-VP O
M NNP B-NP O
, , O O
W NNP B-NP O
, , O O
F NNP B-NP O
, , O O
Sat NNP B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/6/05 CD O O
by IN B-VP O
BRUNFIELD NNP B-NP O
, , O O
BEAU NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
DIGOXIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
COLACE NNP B-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
PEPCID NNP I-NP B-m
( ( O I-m
FAMOTIDINE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Instructions: NNP I-NP O
therapeutic JJ B-NP O
interchange NN I-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/6/05 CD O O
by IN B-VP O
HOEPPNER NNP B-NP O
, , O O
ARCHIE NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LASIX NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
91042032 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Sulfa; NNP B-NP O
reaction NN I-NP O
is VBZ O O
RASH NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
at IN B-VP O
home NN B-NP O
SYNTHROID NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
50 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/6/05 CD O O
by IN B-VP O
FELVER NNP B-NP O
, , O O
BERNARDO NNP B-NP O
T NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DIGOXIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
41989730 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
DIGOXIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/6/05 CD O O
by IN B-VP O
SAAR NNP B-NP O
, , O O
HERSCHEL NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
SENNA NNP B-NP B-m
TABLETS NNP I-NP I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
STANOZOLOL NNP I-NP B-m
4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP I-f
IN NNP I-NP I-f
AM NNP I-NP I-f
( ( O O
1/10 CD O O
) ) O O
VIT NNP B-NP B-m
E NNP I-NP I-m
( ( O I-m
TOCOPHEROL-DL-ALPHA NNP B-NP I-m
) ) O I-m
400 CD O B-do
UNITS NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
KEFLEX NNP I-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
X NNP I-NP B-du
28 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
1/6 CD O O
) ) O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/6/05 CD O O
by IN B-VP O
MCWELLS NNP B-NP O
, , O O
COURTNEY NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KEFLEX NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
63524947 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Penicillins; NNP B-NP O
reaction NN I-NP O
is VBZ O O
RASH NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
patient NN I-NP O
has VBZ O O
tolerated VBN O O
in IN B-VP O
past JJ B-NP O
ok JJ I-NP O
RHINOCORT NNP I-NP B-m
( ( O I-m
BUDESONIDE NNP B-NP I-m
NASAL NNP I-NP I-m
INHALER NNP I-NP I-m
) ) O I-m
2 CD O B-do
SPRAY NNP B-NP I-do
NA NNP I-NP B-mo
BID NNP I-NP B-f
ALLEGRA NNP I-NP B-m
( ( O I-m
FEXOFENADINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Morrell NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Guadagnolo NNP I-NP O
or CC O O
Dr NNP B-NP O
Yoes NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
IV NNP I-NP O
Contrast NNP I-NP O
, , O O
Sulfa NNP B-NP O
, , O O
Penicillins NNP B-NP O
, , O O
QUINIDINE NNP B-NP O
SULFATE NNP I-NP O
, , O O
LEVOFLOXACIN NNP B-NP O
, , O O
LISINOPRIL NNP B-NP O
, , O O
NITROFURANTOIN NNP B-NP O
, , O O
STANAZOL NNP B-NP O
, , O O
PROCAINE NNP B-NP O
HCL NNP I-NP O
, , O O
Dairy NNP B-NP O
Products NNPS I-NP O
, , O O
WHEAT/GLUTEN NNP B-NP O
, , O O
NITROFURANTOIN NNP B-NP O
MACROCRYSTAL NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
hereditary JJ B-NP O
angioedema NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
hereditary VBP O O
angioedema IN B-VP O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HEREDITARY NNP I-NP B-r
HEREDITARY NNP I-NP B-r
ANGIOEDEMA NNP I-NP I-r
ANGIOEDEMA NNP I-NP I-r
AFIB NNP I-NP I-r
AFIB NNP I-NP I-r
- : O O
lodose JJ B-NP O
Coum/ASA NNP I-NP B-m
HYPOTHY NNP I-NP O
H/O NNP I-NP O
SUBDURAL NNP I-NP O
ON NNP I-NP O
COUM NNP I-NP B-m
S/P NNP I-NP O
APPY NNP I-NP O
, , O O
TAH NNP B-NP O
tracheostomies VBZ O O
x $ O O
3 CD O O
multiple JJ B-NP O
intubations NNS I-NP O
DVT NNP I-NP O
, , O O
ivc JJ B-NP O
filter NN I-NP O
in IN B-VP O
place NN B-NP O
GERD NNP I-NP O
polycythemia NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
83 CD O O
yo NN B-NP O
F NNP I-NP O
with IN B-VP O
hereditary JJ B-NP O
angioedema NN I-NP O
presents NNS I-NP O
with IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
Pt NNP I-NP O
had VBD B-VP O
URI NNP B-NP O
one CD O O
week NN B-NP O
ago RB O O
, , O O
which WDT O O
resolved VBD B-VP O
, , O O
but CC O O
then RB O O
woke VBD B-VP O
up RP O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
admission NN B-NP O
with IN B-VP O
severe JJ B-NP O
abd NN I-NP O
pain NN I-NP O
Pt NNP I-NP O
has VBZ O O
had VBN O O
multiple JJ B-NP O
admits NNS I-NP O
in IN B-VP O
past NN B-NP O
for IN B-VP O
GI NNP B-NP O
sx VBD B-VP O
2/2 CD O O
hereditary JJ B-NP O
angioedema NN I-NP O
, , O O
and CC O O
pain NN B-NP B-r
on IN B-VP O
day NN B-NP O
of IN B-VP O
admit NN B-NP O
same JJ O O
as IN B-VP O
these DT B-NP O
episodes NNS I-NP O
Was VBD B-VP O
not RB O O
relieved VBN O O
by IN B-VP O
stanazolol NN B-NP B-m
Also RB O O
had VBD B-VP O
diarrhea NNS B-NP O
, , O O
N/V NNP B-NP O
, , O O
sweats NNS B-NP O
and CC O O
decreased VBN O O
POs NNP B-NP O
Admitted NNP I-NP O
for IN B-VP O
FFP NNP B-NP O
rx NN I-NP O
, , O O
which WDT O O
usually RB O O
resolves VBZ O O
her PRP O O
sx JJ B-NP O
Baseline NNP I-NP O
PE: NNP I-NP O
98.1 CD O O
85 CD O O
94/80 CD O O
20 CD O O
94% CD O O
RA NNP B-NP O
Very NNP I-NP O
distended VBD B-VP O
, , O O
tender NN B-NP O
abdomen NNS I-NP O
and CC O O
decreased VBD B-VP O
bowel NN B-NP O
sounds NNS I-NP O
Impression: NNP I-NP O
Hereditary NNP I-NP O
angioedema NN I-NP O
flare NN I-NP O
with IN B-VP O
GI NNP B-NP O
manifestations NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
ALLERGY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
6 CD O O
units NNS B-NP O
FFP NNP I-NP O
with IN B-VP O
premedication NN B-NP O
with IN B-VP O
IV NNP B-NP B-mo
Benadryl NNP I-NP B-m
on IN B-VP O
the DT B-NP O
first JJ I-NP O
night NN I-NP O
of IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
She PRP O O
was VBD B-VP O
also RB O O
given VBN O O
Stanazolol NNP B-NP B-m
Stanazolol NNP I-NP B-m
4 CD O B-do
4 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
q4h NN I-NP B-f
overnight NN I-NP B-du
, , O O
wh NN B-NP O
ich NN I-NP O
was VBD B-VP O
changed VBN O O
to TO O O
bid VB O B-f
on IN B-VP O
the DT B-NP O
second JJ I-NP O
hospital NN I-NP O
day NN I-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
outpatient NN B-NP O
dose NN I-NP O
of IN B-VP O
rhinocort NN B-NP B-m
and CC O O
allegra NN B-NP B-m
PAIN: NNP I-NP O
The DT B-NP B-r
patient's NN I-NP O
pain NN I-NP O
was VBD B-VP O
controlled VBN O O
with IN B-VP O
Dilaudid NNP B-NP B-m
CV: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
c JJ O O
ontinued VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
cardiac NN I-NP B-m
meds NNS I-NP I-m
, , O O
no DT B-NP O
changes NNS I-NP O
ENDO: VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
synthroid NN B-NP B-m
for IN B-VP O
hypothyroid NN B-NP B-r
GI: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
Zantac NNP B-NP B-m
and CC O O
Stanazolol NNP B-NP B-m
PPX: NNP I-NP O
Lovenox NNP I-NP B-m
FULL NNP I-NP O
CODE NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
instructions NNS B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
allergy JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
doctor NN B-NP O
right RB O O
away RB O O
if IN B-VP O
you PRP O O
develop VBP O O
fevers NNS B-NP O
, , O O
worsening VBG O O
of IN B-VP O
your PRP$ O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
or CC O O
other JJ O O
concerning VBG O O
symptoms NNS B-NP O
Please NNP I-NP O
call VB O O
Dr NNP B-NP O
Zaspel NNP I-NP O
and CC O O
Dr NNP B-NP O
Muskopf NNP I-NP O
's POS O O
offices NNS B-NP O
tomorrow NN I-NP O
to TO O O
make VB O O
follow JJ B-NP O
u JJ I-NP O
p NN I-NP O
appointments NNS I-NP O
for IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
WINGENTER NNP I-NP O
, , O O
DARIO NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
XB735 NNP B-NP O
) ) O O
8/5/05 CD O O
@ $ O O
09 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#901540 VBZ O O
029231694 CD O O
GH NNP B-NP O
84870418 CD O O
7244648 CD O O
10/6/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/6/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
RANDELL NNP I-NP O
SOUPHOM NNP I-NP O
M.D NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Dilated NNP I-NP O
cardiomyopathy JJ B-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
Right NNP I-NP O
foot NN I-NP O
osteomylitis NN I-NP O
, , O O
left VBD B-VP O
calf JJ B-NP O
ulcer NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
nonsustained VBD B-VP O
VT NNP B-NP O
, , O O
gout NN B-NP O
, , O O
occipital JJ B-NP O
CVA NNP I-NP O
, , O O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
left VBD B-VP O
vocal JJ B-NP O
cord NN I-NP O
paralysis NN I-NP O
, , O O
and CC O O
renal JJ B-NP O
failure NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
54-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
nonischemic JJ O O
dilated VBN O O
cardiomyopathy NN B-NP O
who WP O O
presents VBZ O O
with IN B-VP O
weight JJ B-NP O
gain NN I-NP O
, , O O
weakness NN B-NP O
, , O O
and CC O O
azotemia VBZ O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
known VBN O O
cardiomyopathy JJ B-NP O
thought NN I-NP O
to TO O O
be VB O O
secondary JJ O O
to TO O O
alcohol VB O O
with IN B-VP O
incomplete JJ B-NP O
cardiology NN I-NP O
follow VBP O O
up RP O O
Cardiac NNP B-NP O
catheterization NN I-NP O
performed VBD B-VP O
in IN B-VP O
1998 CD O O
showed VBD B-VP O
a DT B-NP O
right JJ I-NP O
atrial JJ I-NP O
pressure NN I-NP O
of IN B-VP O
16 CD O O
, , O O
PA NNP B-NP O
pressure NN I-NP O
49 CD O O
of IN B-VP O
28 CD O O
, , O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
of IN B-VP O
26 CD O O
, , O O
cardiac JJ B-NP O
output NN I-NP O
of IN B-VP O
4 CD O O
, , O O
cardiac JJ B-NP O
stress NN I-NP O
done VBN O O
in IN B-VP O
2002 CD O O
, , O O
he PRP O O
lasted VBD B-VP O
5 CD O O
minutes NNS B-NP O
30 CD O O
seconds NNS B-NP O
did VBD B-VP O
not RB O O
read VB O O
anaerobic JJ B-NP O
threshold NN I-NP O
with IN B-VP O
a DT B-NP O
ZO2 NNP I-NP O
of IN B-VP O
11.1 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
in IN B-VP O
February NNP B-NP O
2003 CD O O
with IN B-VP O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
An DT B-NP O
echo NN I-NP O
showed VBD B-VP O
LV NNP B-NP O
EDD NNP I-NP O
of IN B-VP O
65 CD O O
and CC O O
ejection JJ B-NP O
fraction NN I-NP O
of IN B-VP O
25% CD O O
with IN B-VP O
moderate JJ B-NP B-r
moderate JJ I-NP B-r
moderate JJ I-NP B-r
MR NNP I-NP I-r
MR NNP I-NP I-r
MR NNP I-NP I-r
and CC O O
severe RB O B-r
severe JJ B-NP B-r
severe JJ I-NP B-r
TR NNP I-NP I-r
TR NNP I-NP I-r
TR NNP I-NP I-r
treated VBD B-VP O
with IN B-VP O
dobutamine JJ B-NP B-m
dobutamine NN I-NP B-m
, , O O
seretide JJ B-NP B-m
seretide NN I-NP B-m
, , O O
and CC O O
diuretics NNS B-NP B-m
diuretics NNS I-NP B-m
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
Course NNP I-NP O
complicated VBN O O
by IN B-VP O
left JJ B-NP O
leg NN I-NP O
cellulitis NN I-NP O
and CC O O
worsening VBG O O
renal JJ B-NP O
functioning NN I-NP O
on IN B-VP O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
Two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
presentation NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
in IN B-VP O
clinic JJ O O
with IN B-VP O
fluid JJ B-NP B-r
retention NN I-NP I-r
, , O O
diuretics NNS B-NP B-m
were VBD B-VP O
increased VBN O O
, , O O
then RB O O
had VBD B-VP O
worsening VBG O O
renal JJ B-NP O
function NN I-NP O
, , O O
so IN B-VP O
diuretics NNS B-NP B-m
was VBD B-VP O
held VBN O O
and CC O O
now RB O O
presented VBN O O
with IN B-VP O
fatigue NN B-NP O
, , O O
leg NN B-NP O
edema NN I-NP O
, , O O
and CC O O
draining VBG O O
foot NN B-NP O
wound NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
diabetes VBZ O O
, , O O
peripheral JJ B-NP O
vasculare NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
transmetatarsal NN I-NP O
amputations NNS I-NP O
, , O O
osteomyelitis NN B-NP O
, , O O
and CC O O
VT NNP B-NP O
The DT B-NP O
patient NN I-NP O
declined VBD B-VP O
ICD NNP B-NP O
, , O O
gout NN B-NP O
, , O O
occipital JJ B-NP O
CVA NNP I-NP O
, , O O
and CC O O
atrial JJ B-NP O
fibrillation NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Digoxin NNP I-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
q.o.d NN I-NP B-f
, , O O
Imdur NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
hydralazine VBP O B-m
25 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
torsemide NN B-NP B-m
was VBD B-VP O
being VBG O O
held VBN O O
, , O O
Coumadin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
carvedilol VBP O B-m
3.125 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
allopurinol RB O B-m
100 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Glucophage NNP B-NP B-m
, , O O
and CC O O
glyburide JJ B-NP B-m
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Father NNP I-NP O
with IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
in IN B-VP O
80s CD O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
He PRP O O
currently RB O O
lives VBZ O O
with IN B-VP O
a DT B-NP O
roommate NN I-NP O
Family NNP I-NP O
is VBZ O O
somewhat RB O O
strange JJ O O
, , O O
although IN B-VP O
recently RB O O
more RBR O O
involved JJ O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
No NNP I-NP O
tobacco NN I-NP O
use NN I-NP O
and CC O O
moderate JJ B-NP O
alcohol NN I-NP O
consumption NN I-NP O
per IN B-VP O
patient NN B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
A NNP I-NP O
tired JJ B-NP O
older JJR I-NP O
man NN I-NP O
lying VBG O O
at IN B-VP O
30 CD O O
degrees NNS B-NP O
with IN B-VP O
profound JJ B-NP O
fatigue NN I-NP O
Blood NNP I-NP O
pressure NN I-NP O
84/60 CD O O
, , O O
pulse RB O O
100 CD O O
and CC O O
regular JJ O O
, , O O
weight VBD B-VP O
102.4 CD O O
kg NN B-NP O
, , O O
and CC O O
temperature NN B-NP O
99.4 CD O O
Mild NNP B-NP O
pallor NN I-NP O
No NNP I-NP O
scleral JJ B-NP O
icterus NN I-NP O
JVP NNP I-NP O
to TO O O
the DT B-NP O
angle NN I-NP O
of IN B-VP O
jaw NN B-NP O
Coarse NNP I-NP O
breath NN I-NP O
sounds VBZ O O
bilaterally RB O O
without IN B-VP O
wheeze NN B-NP O
Cardiac NNP I-NP O
irregular NN I-NP O
and CC O O
soft JJ B-NP O
systolic JJ I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
No NNP I-NP O
S3 NNP I-NP O
, , O O
gallop NN B-NP O
, , O O
or CC O O
rub VB O O
Abdomen NNP B-NP O
reveals NNS I-NP O
decreased VBD B-VP O
bowel NN B-NP O
sounds NNS I-NP O
Liver NNP I-NP O
- : O O
four CD O O
fingerbreadths NNS B-NP O
below RB O O
right JJ B-NP O
costal NN I-NP O
margin NN I-NP O
, , O O
nonpulsatile IN B-VP O
No DT B-NP O
guarding NN I-NP O
or CC O O
rebound NN B-NP O
Extremities: NNP I-NP O
Warm NNP I-NP O
with IN B-VP O
3+ CD O O
edema NN B-NP O
to TO O O
thighs VB O O
LABORATORY NNP B-NP O
DATA NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Sodium NNP I-NP O
129 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
BUN NNP B-NP O
133 CD O O
, , O O
creatinine NN B-NP O
1.2 CD O O
, , O O
hematocrit NN B-NP O
31.9 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
15.8 CD O O
with IN B-VP O
89% CD O O
polys NNS B-NP O
, , O O
8 CD O O
bands NNS B-NP O
, , O O
and CC O O
INR NNP B-NP O
4.6 CD O O
, , O O
albumin RB O O
2.7 CD O O
and CC O O
total JJ B-NP O
bilirubin NN I-NP O
3.4 CD O O
, , O O
and CC O O
normal JJ B-NP O
transaminases NNS I-NP O
ECG NNP I-NP O
showed VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
at IN B-VP O
90 CD O O
per IN B-VP O
minute NN B-NP O
, , O O
low JJ B-NP O
voltage NN I-NP O
, , O O
poor JJ B-NP O
R-wave JJ I-NP O
progression NN I-NP O
with IN B-VP O
QRS NNP B-NP O
widening NN I-NP O
, , O O
and CC O O
nonspecific JJ B-NP O
T-wave NNP I-NP O
abnormality NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
Cardiology NNP B-NP O
Service NNP I-NP O
for IN B-VP O
continued JJ B-NP O
management NN I-NP O
of IN B-VP O
his PRP$ O O
volume NN B-NP O
overload NN I-NP O
, , O O
dilated VBN O O
cardiomyopathy NN B-NP O
, , O O
and CC O O
lower JJR B-NP O
extremity NN I-NP O
infections NNS I-NP O
This DT B-NP O
hospital NN I-NP O
course NN I-NP O
will MD O O
be VB O O
summarized VBN O O
briefly NN B-NP O
by IN B-VP O
dates NNS B-NP O
1 CD O O
On IN B-VP O
4/13/03 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
progression NN B-NP O
of IN B-VP O
his PRP$ O O
right NN B-NP O
lower RBR O O
extremity NN B-NP O
infection NN I-NP O
and CC O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
OR NNP I-NP O
for IN B-VP O
debridement JJ O O
2 CD O O
On IN B-VP O
2/19/03 CD O O
, , O O
Diuril NNP B-NP B-m
was VBD B-VP O
added VBN O O
to TO O O
his PRP$ O O
regimen NNS B-NP O
and CC O O
his PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
noted VBN O O
to TO O O
increase VB O O
from IN B-VP O
2.6 CD O O
to TO O O
3.6 CD O O
and CC O O
diuretics NNS B-NP B-m
were VBD B-VP O
subsequently RB O O
held VBN O O
3 CD O O
On IN B-VP O
11/30/03 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
retuned VBD B-VP O
to TO O O
the DT B-NP O
OR NNP I-NP O
for IN B-VP O
revision NN B-NP O
of IN B-VP O
right NN B-NP O
wound NN I-NP O
infection NN I-NP O
and CC O O
underwent VB O O
a DT B-NP O
further JJ I-NP O
transmetatarsal NN I-NP O
amputation NN I-NP O
4 CD O O
On IN B-VP O
4/12/03 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
nausea NN B-NP O
, , O O
fatigue NN B-NP O
, , O O
and CC O O
malaise VB O O
coincident NN B-NP O
with IN B-VP O
20-beat JJ B-NP O
run NN I-NP O
of IN B-VP O
VT NNP B-NP O
followed VBN O O
by IN B-VP O
syncope NN B-NP O
in IN B-VP O
the DT B-NP O
stetting NN I-NP O
of IN B-VP O
dobutamine NN B-NP B-m
The DT B-NP O
VT NNP I-NP O
terminated VBD B-VP O
spontaneously RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
loaded VBN O O
on IN B-VP O
amiodarone NN B-NP B-m
, , O O
unfortunately RB O O
still RB O O
required VBN O O
low JJ B-NP B-do
dose JJ I-NP I-do
dobutamine NN I-NP B-m
to TO O O
maintain VB O O
his PRP$ O O
cardiac JJ B-NP B-r
output NN I-NP I-r
5 CD O O
On IN B-VP O
3/15/03 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
returned VBD B-VP O
to TO O O
the DT B-NP O
OR NNP I-NP O
for IN B-VP O
debridement NN B-NP O
and CC O O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
hypotensive JJ O O
with IN B-VP O
baseline JJ B-NP O
systolic JJ I-NP O
blood NN I-NP O
pressures NNS I-NP O
of IN B-VP O
80s CD O O
going VBG O O
to TO O O
60s CD O O
over IN B-VP O
palp NN B-NP O
with IN B-VP O
decrease NN B-NP O
urine NN I-NP O
output NN I-NP O
He PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
briefly NN I-NP O
and CC O O
did VBD B-VP O
well RB O O
on IN B-VP O
ionotropes NNS B-NP B-m
and CC O O
diuretics NNS B-NP B-m
He PRP O O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
floor NN I-NP O
and CC O O
continued VBD B-VP O
to TO O O
have VB O O
decrease NN B-NP O
urine JJ B-NP O
output NN I-NP O
on IN B-VP O
maximal JJ B-NP B-do
diuretic JJ I-NP B-m
doses NNS I-NP O
and CC O O
ionotropes VBZ O B-m
6 CD O O
On IN B-VP O
6/8/03 CD O O
, , O O
the DT B-NP O
renal JJ I-NP O
surgery NN I-NP O
recommended VBD B-VP O
that IN B-VP O
the DT B-NP O
dobutamine NN I-NP B-m
be VB O O
stopped VBN O O
in IN B-VP O
order NN B-NP O
to TO O O
enhance VB O B-r
renal JJ B-NP I-r
perfusion NN I-NP I-r
and CC O O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
be VB O O
increased VBN O O
to TO O O
80 CD O B-do
mg NNS B-NP I-do
per IN B-VP B-f
hour NN B-NP I-f
The DT B-NP O
patient NN I-NP O
promptly RB O O
developed VBD B-VP O
cardiogenic JJ B-NP O
shock NN I-NP O
with IN B-VP O
discontinuation NN B-NP O
of IN B-VP O
dobutamine NN B-NP B-m
and CC O O
was VBD B-VP O
again RB O O
transferred VBN O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
with IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
in IN B-VP O
the DT B-NP O
60s NNS I-NP O
He PRP O O
was VBD B-VP O
ashen RB O O
and CC O O
cold VB O O
Subsequently RB O O
, , O O
he PRP O O
has VBZ O O
required VBN O O
dobutamine NN B-NP B-m
between IN B-VP B-do
1 CD O I-do
and CC O I-do
2.5 CD O I-do
mcg/kg/minute NN B-NP I-do
to TO O O
maintain VB O O
his PRP$ O O
cardiac JJ B-NP B-r
output NN I-NP I-r
as RB O O
well RB O O
as IN B-VP O
CVVH NNP B-NP O
for IN B-VP O
volume NN B-NP O
management NN I-NP O
He PRP O O
has VBZ O O
tolerated VBN O O
the DT B-NP O
FL NNP I-NP O
rates NNS I-NP O
between IN B-VP O
15 CD O O
and CC O O
200 CD O O
7 CD O O
On IN B-VP O
7/0/03 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
hoarseness JJ B-NP O
Otolaryngology NNP I-NP O
evaluation NN I-NP O
demonstrated VBD B-VP O
paralyzed JJ B-NP O
left JJ I-NP O
vocal JJ I-NP O
cords NNS I-NP O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
left VB O O
atrial JJ B-NP O
enlargement NN I-NP O
or CC O O
potentially RB O O
the DT B-NP O
placement NN I-NP O
of IN B-VP O
a DT B-NP O
left JJ I-NP O
IJ NNP I-NP O
catheter NN I-NP O
8 CD O O
On IN B-VP O
2/11/03 CD O O
, , O O
a DT B-NP O
tunneled JJ I-NP O
catheter NN I-NP O
was VBD B-VP O
placed VBN O O
for IN B-VP O
hemodialysis NN B-NP O
and CC O O
CVVH NNP B-NP O
access NN I-NP O
with IN B-VP O
plan NN B-NP O
initiation NN I-NP O
of IN B-VP O
hemodialysis NN B-NP O
9 CD O O
On IN B-VP O
11/26/03 CD O O
, , O O
he PRP O O
had VBD B-VP O
first JJ B-NP O
course NN I-NP O
of IN B-VP O
hemodialysis NN B-NP O
and CC O O
he PRP O O
tolerated VBD B-VP O
this DT B-NP O
procedure NN I-NP O
well RB O O
A NNP B-NP O
PICC NNP I-NP O
line NN I-NP O
was VBD B-VP O
placed VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
a DT B-NP O
pneumococcal JJ I-NP O
vaccine NN I-NP O
10 CD O O
Cardiovascular: NNP B-NP O
a DT B-NP O
Pump: NNP I-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
advanced JJ O O
dilated VBN O O
cardiomyopathy NN B-NP O
with IN B-VP O
poor JJ B-NP O
overall JJ I-NP O
prognosis NN I-NP O
, , O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
in IN B-VP O
order NN B-NP O
to TO O O
improve VB O O
his PRP$ O O
position NN B-NP O
on IN B-VP O
the DT B-NP O
?? NNP I-NP O
?? NNP I-NP O
curve NN I-NP O
This DT O O
was VBD B-VP O
performed VBN O O
by IN B-VP O
CVVH NNP B-NP O
and CC O O
is VBZ O O
now RB O O
being VBG O O
transitioned VBN O O
to TO O O
hemodialysis NN B-NP O
He PRP O O
has VBZ O O
beyond IN B-VP O
less RBR O O
invasive JJ B-NP O
measures NNS I-NP O
such JJ O O
as IN B-VP O
digoxin NN B-NP B-m
and CC O O
ACE NNP B-NP B-m
inhibitors NNS I-NP O
, , O O
and CC O O
he PRP O O
is VBZ O O
now RB O O
dobutamine JJ B-NP B-m
dependent NN I-NP O
b NN I-NP O
Ischemia: NNP I-NP O
The DT B-NP O
patient NN I-NP O
without IN B-VP O
any DT B-NP O
history NN I-NP O
of IN B-VP O
ischemic JJ B-NP O
heart NN I-NP O
disease NN I-NP O
and CC O O
no DT B-NP O
symptoms NNS I-NP O
suggestive CD O O
of IN B-VP O
any DT B-NP O
incorporate JJ I-NP O
lesions NNS I-NP O
c VBP O O
Rhythm: NNP B-NP O
Chronic NNP I-NP B-r
AF NNP I-NP I-r
and CC O O
occasional JJ B-NP B-r
ectopy NN I-NP I-r
and CC O O
VT NNP B-NP B-r
on IN B-VP O
dobutamine NN B-NP B-m
dobutamine NN I-NP B-m
dobutamine NN I-NP B-m
, , O O
currently RB O O
loaded VBN O O
on IN B-VP O
amiodarone NN B-NP B-m
without IN B-VP O
any DT B-NP O
further JJ I-NP O
events NNS I-NP O
11 CD O O
Infectious NNP B-NP O
Disease: NNP I-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
chronic JJ B-NP O
osteomylitis NN I-NP O
, , O O
currently RB O O
in IN B-VP O
a DT B-NP O
six-week JJ I-NP B-du
six-week JJ I-NP B-du
six-week JJ I-NP B-du
six-week JJ I-NP B-du
course NN I-NP I-du
course NN I-NP I-du
course NN I-NP I-du
course NN I-NP I-du
of IN B-VP O
ceftazidime NN B-NP B-m
, , O O
vancomycin NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
, , O O
and CC O O
Diflucan NNP B-NP B-m
for IN B-VP O
complicated VBN O B-r
complicated VBN O B-r
complicated VBN O B-r
complicated JJ B-NP B-r
osteomyelitis NN I-NP I-r
osteomyelitis NN I-NP I-r
osteomyelitis NN I-NP I-r
osteomyelitis NN I-NP I-r
, , O O
end NN B-NP O
date NN I-NP O
is VBZ O O
on IN B-VP O
2/30/03 CD O O
He PRP O O
was VBD B-VP O
given VBN O O
pneumococcal JJ B-NP O
vaccine NN I-NP O
He PRP O O
is VBZ O O
up-to-date JJ O O
on IN B-VP O
his PRP$ O O
flu NN B-NP O
vaccine NN I-NP O
12 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
progressive JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
likely JJ O O
secondary JJ O O
to TO O O
low JJ B-NP O
flow NN I-NP O
to TO O O
the DT B-NP O
kidneys NN I-NP O
This DT O O
has VBZ O O
been VBN O O
exacerbated VBN O O
by IN B-VP O
ACE NNP B-NP B-m
inhibitors NNS I-NP I-m
in IN B-VP O
the DT B-NP O
past NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
increasing VBG O O
doses NNS B-NP O
of IN B-VP O
diuretics NNS B-NP B-m
have VBP O O
been VBN O O
ineffective JJ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
is VBZ O O
able JJ O O
to TO O O
obtain VB O O
increased JJ B-NP O
amounts NNS I-NP O
of IN B-VP O
cardiac JJ B-NP O
output NN I-NP O
As IN B-VP O
he PRP O O
comes VBZ O O
on IN B-VP O
strongly RB O O
through IN B-VP O
, , O O
he PRP O O
may MD O O
regain VB O O
some DT B-NP O
renal JJ I-NP O
function NN I-NP O
, , O O
however RB O O
, , O O
it PRP O O
is VBZ O O
predicted VBN O O
that IN B-VP O
he PRP O O
will MD O O
require VB O O
hemodialysis NN B-NP O
for IN B-VP O
remainder NN B-NP O
of IN B-VP O
the DT B-NP O
life NN I-NP O
He PRP O O
has VBZ O O
tolerated VBN O O
this DT B-NP O
A NNP I-NP O
tunneled VBD B-VP O
catheter NN B-NP O
was VBD B-VP O
placed VBN O O
for IN B-VP O
access NN B-NP O
on IN B-VP O
9/2/03 CD O O
13 CD O O
Vascular: NNP B-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
now RB O O
status NN B-NP O
post NN I-NP O
transmetatarsal NN I-NP O
amputation NN I-NP O
He PRP O O
remains VBZ O O
with IN B-VP O
a DT B-NP O
open JJ I-NP O
wound NN I-NP O
in IN B-VP O
his PRP$ O O
left JJ B-NP O
foot NN I-NP O
and CC O O
a DT B-NP O
calf NN I-NP O
ulcer IN B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
planned VBN O O
to TO O O
be VB O O
evaluated VBN O O
by IN B-VP O
Plastic NNP B-NP O
Surgery NNP I-NP O
prior RB O O
to TO O O
discharge VB O O
for IN B-VP O
final JJ B-NP O
plans NNS I-NP O
whether IN B-VP O
a DT B-NP O
flap NN I-NP O
or CC O O
healing NN B-NP O
by IN B-VP O
secondary JJ B-NP O
retention NN I-NP O
14 CD O O
Psychiatry: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
depressed VBN O O
with IN B-VP O
frequent JJ B-NP O
periods NNS I-NP O
of IN B-VP O
anxiety NN B-NP O
, , O O
exceedingly RB O O
fearful JJ O O
of IN B-VP O
dying VBG O O
, , O O
and CC O O
unable JJ O O
to TO O O
sleep VB O O
with IN B-VP O
light JJ O O
off RP O O
or CC O O
with IN B-VP O
drapes NNS B-NP O
pole JJ O O
secondary JJ O O
to TO O O
believe VB O O
that IN B-VP O
if IN B-VP O
he PRP O O
falls VBZ O O
asleep RB O O
, , O O
he PRP O O
will MD O O
no RB O O
longer RB O O
wake VB O O
up RP O O
He PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Psychiatry NNP B-NP O
, , O O
who WP O O
suggested VBD B-VP O
starting VBG O O
low JJ B-NP B-do
dose NN I-NP I-do
of IN B-VP O
Zyprexa NNP B-NP B-m
in IN B-VP B-f
the DT B-NP O
evening NN I-NP O
This DT O O
has VBZ O O
greatly RB O O
improved VBN O O
his PRP$ O O
mood NN B-NP O
and CC O O
he PRP O O
is VBZ O O
doing VBG O O
well RB O O
from IN B-VP O
this DT B-NP O
regard NN I-NP O
15 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
failed VBD B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
stimulation NN B-NP O
test NN I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
hydrocortisone NN B-NP B-m
hydrocortisone NN I-NP B-m
When WRB O O
this DT O O
was VBD B-VP O
tapered VBN O O
down RB O O
, , O O
he PRP O O
had VBD B-VP O
some DT B-NP O
periods NNS I-NP O
of IN B-VP O
hypotension NN B-NP B-r
and CC O O
this DT O O
was VBD B-VP O
increased VBN O O
again RB O O
He PRP O O
remains VBZ O O
on IN B-VP O
maintenance NN B-NP B-do
maintenance NN I-NP B-do
doses VBZ O I-do
doses NNS B-NP I-do
of IN B-VP O
hydrocortisone NN B-NP B-m
hydrocortisone NN I-NP B-m
Etiology NNP I-NP O
of IN B-VP O
his PRP$ O O
adrenal JJ B-NP O
insufficieny NN I-NP O
is VBZ O O
unclear JJ O O
Additionally RB O O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
diabetes VBN O B-r
diabetes NNS B-NP B-r
diabetes VBZ O B-r
diabetes NNS B-NP B-r
He PRP O O
was VBD B-VP O
on IN B-VP O
oral JJ B-NP B-mo
hypoglycemic NN I-NP B-m
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
however RB O O
, , O O
now RB O O
this DT B-NP O
renal JJ I-NP O
function NN I-NP O
, , O O
he PRP O O
has VBZ O O
been VBN O O
transitioned VBN O O
over IN B-VP O
to TO O O
insulin VB O B-m
with IN B-VP O
his PRP$ O O
standing VBG O B-do
doses NNS B-NP I-do
of IN B-VP O
Lantus NNP B-NP B-m
with IN B-VP O
a DT O O
lispro JJ O B-m
sliding VBG O B-do
scale JJ O I-do
16 CD O O
FEN: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
TPN NNP B-NP B-m
for IN B-VP O
quite RB O B-r
severe JJ B-NP O
malnutrition NN I-NP O
He PRP O O
now RB O O
has VBZ O O
increasing VBG O O
albumin RP O O
with IN B-VP O
increased JJ B-NP O
appetite NN I-NP O
, , O O
and CC O O
he PRP O O
is VBZ O O
tolerating VBG O O
more RBR O O
food NN B-NP O
He PRP O O
has VBZ O O
been VBN O O
placed VBN O O
on IN B-VP O
nectar NN B-NP O
thick NN I-NP O
liquids NNS I-NP O
for IN B-VP O
secondary JJ O O
to TO O O
left VB O O
vocal JJ B-NP O
cord NN I-NP O
paralysis NN I-NP O
and CC O O
visualized JJ B-NP O
aspiration NN I-NP O
on IN B-VP O
barium NN B-NP O
swallow NN I-NP O
by IN B-VP O
ENT NNP B-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
currently RB O O
is VBZ O O
stable JJ B-NP O
PLAN: NNP I-NP O
At IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
would MD O O
be VB O O
discharge VBN O O
with IN B-VP O
home NN B-NP O
dobutamine NN I-NP B-m
and CC O O
frequent JJ O O
and CC O O
careful JJ O O
follow VB O O
up RP O O
by IN B-VP O
his PRP$ O O
primary JJ B-NP O
cardiologist NN I-NP O
Dr NNP I-NP O
Mongiovi NNP I-NP O
eScription NN I-NP O
document: VBD B-VP O
9-3711468 CD O O
EMS NNP B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
KAEDING NNP I-NP O
, , O O
DAMIAN NNP B-NP O
Attending: NNP I-NP O
ROTHBERG NNP I-NP O
, , O O
CLETUS NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
4865660 CD O O
D: NNP B-NP O
11/26/03 CD O O
T: NNP B-NP O
8/4/03 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#903921 VBZ O O
390336468 CD O O
BMH NNP B-NP O
27343781 CD O O
4801760 CD O O
1/9/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CELLULITIS NNP I-NP O
RIGHT NNP I-NP O
FOOT NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/4/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/5/2006 CD O O
ATTENDING: NNP B-NP O
GLANDEN NNP I-NP O
, , O O
MODESTO NNP B-NP O
HAL NNP I-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Chronic NNP I-NP O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
complicated VBN O O
by IN B-VP O
atheroemboli NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
cardiac JJ B-NP O
catheterization NN I-NP O
PROCEDURES: NNP I-NP O
1 CD O O
10/30/2006 CD O O
, , O O
aortogram RB O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
runoff NN I-NP O
Dr NNP I-NP O
Zumstein NNP I-NP O
2 CD O O
0/25/2006 CD O O
left VBD B-VP O
femoral JJ O O
to TO O O
dorsalis VB O O
pedis JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
, , O O
Dr NNP B-NP O
Saltzberg NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
75-year-old JJ I-NP O
former JJ I-NP O
smoker NN I-NP O
with IN B-VP O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
, , O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
coronary JJ B-NP O
catheterization NN I-NP O
in IN B-VP O
March NNP B-NP O
2006 CD O O
and CC O O
March NNP B-NP O
2006 CD O O
who WP O O
presented VBD B-VP O
in IN B-VP O
clinic NN B-NP O
with IN B-VP O
progressively RB O O
worsening VBG O O
bilateral JJ B-NP O
foot NN I-NP O
pain NN I-NP O
, , O O
foot NN B-NP O
mottling NN I-NP O
and CC O O
new JJ B-NP O
ulcerations NNS I-NP O
Concern NNP I-NP O
for IN B-VP O
atheroembolization NN B-NP O
was VBD B-VP O
raised VBN O O
following VBG O O
cardiac JJ B-NP O
catheterization NN I-NP O
In IN B-VP O
followup NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
appeared VBD B-VP O
to TO O O
have VB O O
persistent JJ B-NP O
ulcerations NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
erythema NN B-NP O
Pedal NNP I-NP O
signals NNS I-NP O
by IN B-VP O
Doppler NNP B-NP O
, , O O
however RB O O
, , O O
were VBD B-VP O
present JJ O O
She PRP O O
was VBD B-VP O
admitted VBN O O
from IN B-VP O
clinic NN B-NP O
for IN B-VP O
cellulitis NN B-NP O
and CC O O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
her PRP$ O O
vascular JJ B-NP O
anatomy NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O O
denied VBD B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
fever NN B-NP O
, , O O
chills VBZ O O
She PRP O O
described VBD B-VP O
the DT B-NP O
pain NN I-NP O
as IN B-VP O
burning NN B-NP O
in IN B-VP O
both DT O O
her PRP$ O O
feet NNS B-NP O
with IN B-VP O
some DT B-NP O
relief NN I-NP O
obtained VBN O O
when WRB O O
dangling VBG O O
the DT B-NP O
feet NNS I-NP O
off IN B-VP O
the DT B-NP O
bed NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
End-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
Monday NNP I-NP O
, , O O
Wednesday NNP B-NP O
, , O O
Friday NNP B-NP O
a DT O O
7/6/2004 CD O O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
radiocephalic JJ B-NP O
AV NNP I-NP O
fistula NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Mcbroom NNP I-NP O
b NN I-NP O
2/1/2005 CD O O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
AV NNP B-NP O
fistula VBZ O O
cephalic JJ B-NP O
transposition NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Roskovensky NNP I-NP O
c VBD B-VP O
11/28/2006 CD O O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
AVF NNP B-NP O
revision NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Espinel NNP I-NP O
d VBZ O O
6/21/2006 CD O O
, , O O
status NN B-NP O
post NN I-NP O
right RB O O
IJ NNP B-NP O
tunneled VBD B-VP O
hemodialysis NN B-NP O
catheter NN I-NP O
2 CD O O
CAD NNP B-NP O
a DT B-NP O
History NNP I-NP O
of IN B-VP O
non-ST JJ B-NP O
elevation NN I-NP O
MI NNP I-NP O
b NN I-NP O
status NN I-NP O
post NN I-NP O
catheterization NN I-NP O
on IN B-VP O
11/28/2006 CD O O
with IN B-VP O
80% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
stenosis NN I-NP O
status NN I-NP O
post NN I-NP O
drug-eluting JJ B-NP O
stent NN I-NP O
of IN B-VP O
the DT B-NP O
LAD NNP I-NP O
c NN I-NP O
Status NNP I-NP O
post NN I-NP O
catheterization NN I-NP O
0/12/2006 CD O O
with IN B-VP O
left VBN O O
circumflex NN B-NP O
and CC O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
noncritical JJ O O
3 CD O O
CHF NNP B-NP O
with IN B-VP O
diastolic JJ B-NP O
dysfunction NN I-NP O
a DT O O
3/7/2006 CD O O
, , O O
Echo NNP B-NP O
showing VBG O O
concentric JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
, , O O
EF NNP B-NP O
of IN B-VP O
45-50% CD O O
which WDT O O
was VBD B-VP O
reduced VBN O O
from IN B-VP O
2004 CD O O
Septal NNP B-NP O
and CC O O
inferior JJ B-NP O
wall NN I-NP O
hypokinesis NN I-NP O
, , O O
mild JJ O O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
, , O O
moderate VB O O
to TO O O
severe VB O O
MR NNP B-NP O
, , O O
mild JJ B-NP O
TR NNP I-NP O
4 CD O O
COPD NNP B-NP O
, , O O
on IN B-VP O
intermittent JJ B-NP O
home NN I-NP O
oxygen NN I-NP O
5 CD O O
Obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
6 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
7 CD O O
Hypertension NNP B-NP O
8 CD O O
Dyslipidemia NNP B-NP O
9 CD O O
Gout NNP B-NP O
10 CD O O
GERD NNP B-NP O
11 CD O O
History NNP B-NP O
of IN B-VP O
right JJ B-NP O
pleural JJ I-NP O
effusion NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
2 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Cardizem NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
4 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
5 CD O O
Atrovent JJ O B-m
2 CD O B-do
puffs NNS B-NP I-do
four CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
6 CD O O
Albuterol NNP B-NP B-m
2 CD O B-do
puffs NNS B-NP I-do
b.i.d VBD B-VP B-f
7 CD O O
Renagel NNP B-NP B-m
806 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT B-NP B-f
meal NN I-NP I-f
8 CD O O
Allopurinol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Zaroxylyn NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
p.r.n NN I-NP I-f
overload NN I-NP B-r
10 CD O O
Lantus NNP B-NP B-m
10 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
nightly RB O B-f
11 CD O O
Regular JJ B-NP B-m
insulin NN I-NP I-m
sliding VBG O B-do
scale JJ O I-do
12 CD O O
Valium NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP I-f
13 CD O O
Isordil NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
14 CD O O
Hydralazine NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
15 CD O O
Lopressor NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
16 CD O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
17 CD O O
Aciphex NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
18 CD O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o VBD B-VP B-mo
post-dialysis NN B-NP O
19 CD O O
Metamucil NNP B-NP B-m
20 CD O O
Nitroglycerine NNP B-NP B-m
p.r.n NN I-NP B-f
21 CD O O
Procrit NNP B-NP B-m
40 CD O B-do
, , O I-do
000 CD O I-do
units NNS B-NP I-do
subcutaneously RB O B-mo
every DT B-NP B-f
week NN I-NP I-f
22 CD O O
Lilly NNP B-NP B-m
Lilly NNP I-NP B-m
insulin JJ B-NP I-m
insulin NN I-NP I-m
pen JJ B-NP I-m
pen NN I-NP I-m
, , O O
unknown JJ B-NP O
dosage NN I-NP O
20 CD O B-do
units NNS B-NP I-do
every DT B-NP B-f
morning NN I-NP I-f
and CC O O
10 CD O B-do
units NNS B-NP I-do
every DT B-NP B-f
evening NN I-NP I-f
23 CD O O
Loperamide NNP B-NP B-m
2 CD O B-do
tabs NNS B-NP I-do
p.o RB O B-mo
four CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
24 CD O O
Ambien NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
p.r.n VBZ O I-f
ALLERGIES: NNP B-NP O
1 CD O O
Penicillin NNP B-NP O
causing VBG O O
tongue NN B-NP O
swelling VBG O O
2 CD O O
Morphine NNP B-NP O
causing VBG O O
mental JJ B-NP O
status NN I-NP O
changes NNS I-NP O
3 CD O O
Codeine NNP B-NP O
causing VBG O O
mental JJ B-NP O
status NN I-NP O
change NN I-NP O
4 CD O O
Dilaudid NNP B-NP O
causing VBG O O
mental JJ B-NP O
status NN I-NP O
change NN I-NP O
, , O O
added VBD B-VP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Tobacco NNP B-NP O
, , O O
80-pack-year JJ B-NP O
history NN I-NP O
, , O O
quit NN B-NP O
in IN B-VP O
1990 CD O O
2 CD O O
No DT B-NP O
alcohol NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
temperature NN B-NP O
of IN B-VP O
99.2 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
121 CD O O
in IN B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
, , O O
blood NN B-NP O
pressure NN I-NP O
116/60 CD O O
, , O O
saturating VBG O O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT O O
2/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
apex JJ I-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
bilaterally RB O O
Pulse NNP B-NP O
exam NN I-NP O
showed VBD B-VP O
no DT B-NP O
palpable JJ I-NP O
femoral JJ I-NP O
pulses NNS I-NP O
and CC O O
biphasic JJ B-NP O
dopplerable JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
, , O O
DP NNP B-NP O
and CC O O
PT NNP B-NP O
Extremities NNP I-NP O
showed VBD B-VP O
bilateral JJ B-NP O
mottling NN I-NP O
of IN B-VP O
all DT B-NP O
toes NNS I-NP O
and CC O O
an DT O O
open JJ O O
0.5 CD O O
cm JJ B-NP O
ulceration NN I-NP O
at IN B-VP O
the DT B-NP O
base NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
fourth JJ I-NP O
toe NN I-NP O
All DT B-NP O
toes NNS I-NP O
are VBP O O
exquisitely RB O O
tender NN B-NP O
to TO O O
palpation NN B-NP O
Sensation NNP I-NP O
is VBZ O O
decreased VBN O O
but CC O O
equal JJ O O
bilaterally RB O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
This DT B-NP O
75-year-old JJ I-NP O
female JJ I-NP O
vasculopath NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
her PRP$ O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
which WDT O O
was VBD B-VP O
suspected VBN O O
to TO O O
be VB O O
contributing VBG O O
to TO O O
her PRP$ O O
new JJ B-NP O
ulcerations NNS I-NP O
and CC O O
progressively RB O O
worsening VBG O O
wrist NN B-NP O
pain NN I-NP O
as IN B-VP O
an DT O O
exacerbating VBG O O
factor NN B-NP O
to TO O O
likely JJ B-NP O
atheroembolic JJ I-NP O
phenomenon NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
catheterizations NNS I-NP O
earlier RBR O O
in IN B-VP O
the DT B-NP O
year NN I-NP O
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
broad-spectrum JJ B-NP O
antibiotics NNS I-NP B-m
and CC O O
plan NN B-NP O
was VBD B-VP O
made VBN O O
for IN B-VP O
an DT B-NP O
MRA NNP I-NP O
to TO O O
evaluate VB O O
her PRP$ O O
anatomy NN B-NP O
Unfortunately RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
tolerate VB O O
the DT B-NP O
MR NNP I-NP O
and CC O O
did VBD B-VP O
experience VB O O
some DT B-NP O
mental JJ I-NP O
status NN I-NP O
changes NNS I-NP O
that WDT O O
prevented VBD B-VP O
further RBR O O
noninvasive JJ B-NP O
imaging NN I-NP O
, , O O
when WRB O O
she PRP O O
received VBD B-VP O
some DT O O
narcotic JJ O B-m
following VBG O O
her PRP$ O O
hemodialysis NN B-NP O
round NN I-NP O
Over IN B-VP O
the DT B-NP O
ensuing JJ I-NP O
days NNS I-NP O
she PRP O O
required VBD B-VP O
rather RB O O
significant JJ B-NP B-do
significant JJ I-NP B-do
doses NNS I-NP I-do
doses NNS I-NP I-do
of IN B-VP O
Zyprexa NNP B-NP B-m
Zyprexa NNP I-NP B-m
and CC O O
Haldol NNP B-NP B-m
Haldol NNP I-NP B-m
to TO O O
contain VB O O
agitation NN B-NP B-r
agitation NN I-NP B-r
and CC O O
delirium NN B-NP B-r
delirium NN I-NP B-r
, , O O
as IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
also RB O O
get VB O O
physical JJ O O
and CC O O
violent JJ O O
This DT O O
appeared VBD B-VP O
to TO O O
sedate VB O O
her PRP$ O O
sufficiently RB O O
and CC O O
over IN B-VP O
the DT B-NP O
following JJ I-NP O
days NNS I-NP O
, , O O
she PRP O O
did VBD B-VP O
manage VB O O
to TO O O
calm VB O O
significantly RB O O
and CC O O
returned VBD B-VP O
to TO O O
her PRP$ O O
baseline NN B-NP O
mental NN I-NP O
status NN I-NP O
She PRP O O
did VBD B-VP O
appear VB O O
very RB O O
emotionally RB O O
labile JJ O O
throughout IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
her PRP$ O O
stay NN B-NP O
and CC O O
incredibly RB O O
remorseful VB O O
for IN B-VP O
previous JJ B-NP O
events NNS I-NP O
On IN B-VP O
10/30/2006 CD O O
, , O O
she PRP O O
was VBD B-VP O
offered VBN O O
an DT B-NP O
angiogram NN I-NP O
to TO O O
delineate VB O O
aortic JJ O O
and CC O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
runoff NN I-NP O
anatomy IN B-VP O
She PRP O O
did VBD B-VP O
tolerate VB O O
this DT B-NP O
well NN I-NP O
under IN B-VP O
simple JJ B-NP O
IV NNP I-NP O
conscious JJ B-NP O
sedation NN I-NP O
This DT O O
showed VBD B-VP O
chronic JJ B-NP O
disease NN I-NP O
with IN B-VP O
collateralization NN B-NP O
and CC O O
very RB O O
poor JJ B-NP O
inflow NN I-NP O
to TO O O
the DT B-NP O
bilateral JJ I-NP O
feet NNS I-NP O
with IN B-VP O
essentially RB O O
one CD O O
vessel NN B-NP O
run VB O O
off RP O O
on IN B-VP O
either DT B-NP O
side NN I-NP O
After IN B-VP O
extensive JJ B-NP O
discussions NNS I-NP O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
the DT B-NP O
patient's JJ I-NP O
family NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
agree VB O O
to TO O O
a DT O O
left JJ O O
femoral JJ O O
to TO O O
dorsalis VB O O
pedis JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
which WDT O O
was VBD B-VP O
performed VBN O O
on IN B-VP O
0/25/2006 CD O O
without IN B-VP O
complication NN B-NP O
Please NNP I-NP O
see VB O O
the DT B-NP O
operative JJ I-NP O
note NN I-NP O
for IN B-VP O
further JJ B-NP O
details NNS I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
tolerate VB O O
the DT B-NP O
procedure NN I-NP O
well RB O O
By IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
and CC O O
ambulating VBG O O
at IN B-VP O
baseline NN B-NP O
with IN B-VP O
her PRP$ O O
rolling VBG O O
walker NN B-NP O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
well RB O O
controlled VBN O O
with IN B-VP O
minimal JJ B-NP O
analgesics NNS I-NP O
that WDT O O
were VBD B-VP O
not RB O O
narcotic JJ O O
based VBN O O
Cardiology NNP B-NP O
was VBD B-VP O
consulted VBN O O
during IN B-VP O
this DT B-NP O
time NN I-NP O
to TO O O
optimize VB O O
her PRP$ O O
prior JJ O O
to TO O O
the DT B-NP O
OR NNP I-NP O
Her NNP I-NP O
primary JJ B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Fugle NNP I-NP O
did VBD B-VP O
make VB O O
some DT B-NP O
recommendations NNS I-NP O
including VBG O O
an DT B-NP O
echocardiogram NN I-NP O
that WDT O O
showed VBD B-VP O
preserved VBN O O
ejection NN B-NP O
fraction NN I-NP O
and CC O O
no DT B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities VBZ O O
Her NNP B-NP O
beta NN I-NP B-m
blockade NN I-NP I-m
was VBD B-VP O
titrated VBN O B-do
up RP O I-do
and CC O O
she PRP O O
was VBD B-VP O
instructed VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
cardiology NN B-NP O
She PRP O O
did VBD B-VP O
tolerate VB O O
hemodialysis NN B-NP O
throughout IN B-VP O
this DT B-NP O
time NN I-NP O
without IN B-VP O
undue JJ B-NP O
difficulty NN I-NP O
She PRP O O
did VBD B-VP O
on IN B-VP O
one CD O O
occasion NN B-NP O
experience NN I-NP O
dyspnea NN I-NP O
following VBG O O
hemodialysis NN B-NP O
that WDT O O
resolved VBD B-VP O
of IN B-VP O
its PRP$ O O
own JJ B-NP O
accord NN I-NP O
, , O O
no DT B-NP O
cardiac JJ I-NP O
events NNS I-NP O
or CC O O
in IN B-VP O
evidence NN B-NP O
by IN B-VP O
EKG NNP B-NP O
or CC O O
by IN B-VP O
following VBG O O
cardiac JJ B-NP O
enzymes NNS I-NP O
As IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
and CC O O
back RB O O
to TO O O
her PRP$ O O
baseline JJ B-NP O
level NN I-NP O
of IN B-VP O
activity NN B-NP O
with IN B-VP O
very RB O O
strong JJ B-NP O
support NN I-NP O
at IN B-VP O
home NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
for IN B-VP O
wound NN B-NP O
checks NNS I-NP O
and CC O O
home NN B-NP O
safety NN I-NP O
evaluation NN I-NP O
She PRP O O
was VBD B-VP O
instructed VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Sedlachek NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
1 CD O O
Touchdown NNP B-NP O
weightbearing VBG O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
heel VBZ O O
The DT B-NP O
patient NN I-NP O
should MD O O
not RB O O
keep VB O O
legs NNS B-NP O
in IN B-VP O
dependent JJ B-NP O
position NN I-NP O
for IN B-VP O
more JJR O O
than IN B-VP O
10 CD O O
minutes NNS B-NP O
at IN B-VP O
a DT B-NP O
time NN I-NP O
She PRP O O
was VBD B-VP O
to TO O O
use VB O O
the DT B-NP O
walker NN I-NP O
and CC O O
a DT B-NP O
cane NN I-NP O
as IN B-VP O
instructed VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
2 CD O O
Legs NNP B-NP O
are VBP O O
to TO O O
be VB O O
elevated VBN O O
as RB O O
much JJ O O
as IN B-VP O
possible JJ O O
while IN B-VP O
sitting VBG O O
or CC O O
lying VBG O O
down RP O O
3 CD O O
All DT B-NP O
home NN I-NP B-m
medications NNS I-NP I-m
were VBD B-VP O
to TO O O
be VB O O
resumed VBN O O
except IN B-VP O
for IN B-VP O
Lopressor NNP B-NP B-m
, , O O
the DT B-NP O
dose NN I-NP O
of IN B-VP O
which WDT O O
had VBD B-VP O
been VBN O O
changed VBN O O
by IN B-VP O
Dr NNP B-NP O
Huggins NNP I-NP O
to TO O O
50 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
t.i.d VBP O B-f
4 CD O O
VNA NNP B-NP O
was VBD B-VP O
ordered VBN O O
to TO O O
assist VB O O
with IN B-VP O
wound NN B-NP B-r
care NN I-NP I-r
including VBG O O
Betadine NNP B-NP B-m
paint NN I-NP O
to TO O O
incisions NNS B-NP B-mo
daily RB O B-f
5 CD O O
Showering VBG O O
only RB O O
, , O O
no DT B-NP O
bathing NN I-NP O
or CC O O
immersion NN B-NP O
in IN B-VP O
water NN B-NP O
for IN B-VP O
prolonged JJ B-NP O
periods NNS I-NP O
of IN B-VP O
time NN B-NP O
6 CD O O
Follow-up JJ B-NP O
visit NN I-NP O
to TO O O
be VB O O
scheduled VBN O O
with IN B-VP O
Dr NNP B-NP O
Amorose NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
and CC O O
Dr NNP B-NP O
Morici NNP I-NP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Tylenol NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT O B-f
four CD O I-f
hours NNS B-NP I-f
p.r.n VBP O I-f
pain VBP O B-r
2 CD O O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
2 CD O B-do
puffs NNS B-NP I-do
b.i.d VBD B-VP B-f
3 CD O O
Allopurinol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Calcitriol NNP B-NP B-m
Calcitriol NNP I-NP B-m
1.5 CD O B-do
1.5 CD O B-do
mcg NN B-NP I-do
mcg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
every DT O B-f
every DT B-NP B-f
Monday NNP I-NP I-f
Monday NNP I-NP I-f
and CC O I-f
every DT B-NP I-f
Friday NNP I-NP I-f
6 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
7 CD O O
Darbepoetin NNP B-NP B-m
alfa NN I-NP I-m
100 CD O B-do
mcg NN B-NP I-do
subcutaneous JJ O B-mo
every DT B-NP B-f
week NN I-NP I-f
8 CD O O
Ferrous JJ B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
9 CD O O
Prozac NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
10 CD O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o VBD B-VP B-mo
post-dialysis NN B-NP O
11 CD O O
Motrin NNP B-NP B-m
400 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT O B-f
eight CD O I-f
hours NNS B-NP I-f
p.r.n VBP O I-f
pain VBP O B-r
12 CD O O
Lantus NNP B-NP B-m
10 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
nightly RB O B-f
13 CD O O
Insulin NNP B-NP B-m
regular JJ O I-m
sliding VBG O B-do
scale NN B-NP I-do
See NNP I-NP O
discharge NN I-NP O
order NN I-NP O
for IN B-VP O
scale NN B-NP O
14 CD O O
Atrovent NNP B-NP B-m
2 CD O B-do
puffs NNS B-NP I-do
four CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
15 CD O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
Do NNP I-NP O
not RB O O
take VB O O
with IN B-VP O
lightheadedness NN B-NP O
or CC O O
dizziness NN B-NP O
16 CD O O
Metamucil NNP B-NP B-m
1 CD O B-do
packet NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
17 CD O O
Sevelamer NNP B-NP B-m
800 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
18 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
eScription JJ O O
document: IN B-VP O
5-4188453 JJ B-NP O
HFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BODE NNP I-NP O
, , O O
NED NNP B-NP O
Attending: NNP I-NP O
STENT NNP I-NP O
, , O O
PABLO NNP B-NP O
JARRED NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5557264 CD O O
D: NNP B-NP O
5/1/06 CD O O
T: NNP B-NP O
5/1/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#904835 VBZ O O
546608017 CD O O
HH NNP B-NP O
85716261 CD O O
546508 CD O O
0/3/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
STROKE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/3/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/30/1999 CD O O
CHIEF NNP B-NP O
COMPLAINT: NNP I-NP O
This DT B-NP O
patient NN I-NP O
presented VBD B-VP O
with IN B-VP O
an DT B-NP O
acute JJ I-NP O
stroke NN I-NP O
and CC O O
was VBD B-VP O
brought VBN O O
in IN B-VP O
by IN B-VP O
her PRP$ O O
daughter JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Sixty-six NNP I-NP O
year NN I-NP O
old JJ B-NP O
obese JJ I-NP O
African JJ I-NP O
American NNP I-NP O
woman NN I-NP O
of IN B-VP O
previous JJ B-NP O
CVA NNP I-NP O
of IN B-VP O
unclear JJ B-NP O
etiology NN I-NP O
and CC O O
unclear JJ B-NP O
clinical JJ I-NP O
sequelae NN I-NP O
She PRP O O
was VBD B-VP O
driving VBG O O
as IN B-VP O
a DT B-NP O
passenger NN I-NP O
in IN B-VP O
a DT B-NP O
car NN I-NP O
around RB O O
11:00 CD O O
o'clock NN B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
and CC O O
experienced VBD B-VP O
a DT B-NP O
sudden JJ I-NP O
speech NN I-NP O
arrest NN I-NP O
which WDT O O
was VBD B-VP O
witnessed VBN O O
by IN B-VP O
her PRP$ O O
daughter-in-law NN B-NP O
She PRP O O
has VBZ O O
also RB O O
difficulty NN B-NP O
moving VBG O O
her PRP$ O O
right JJ B-NP O
arm NN I-NP O
and CC O O
she PRP O O
had VBD B-VP O
some DT B-NP O
tearing NN I-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
eye NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
skewed JJ I-NP O
look NN I-NP O
on IN B-VP O
her PRP$ O O
face NN B-NP O
By IN B-VP O
11:40 CD O O
a.m NNS B-NP O
, , O O
the DT B-NP O
ambulance NN I-NP O
had VBD B-VP O
arrived VBN O O
and CC O O
she PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Koote NNP I-NP O
Hospital NNP I-NP O
emergency NN I-NP O
department NN I-NP O
where WRB O O
the DT B-NP O
protocol NN I-NP O
for IN B-VP O
acute JJ B-NP O
stroke NN I-NP O
was VBD B-VP O
instituted VBN O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
CTA NNP I-NP O
done VBN O O
which WDT O O
showed VBD B-VP O
questionable JJ B-NP O
luminal JJ I-NP O
narrowing NN I-NP O
of IN B-VP O
the DT O O
distal JJ O O
left VBD B-VP O
middle JJ B-NP O
cerebral JJ I-NP O
artery NN I-NP O
CT NNP I-NP O
scan NN I-NP O
was VBD B-VP O
normal JJ O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
intravenous JJ B-NP B-mo
TPA NNP I-NP B-m
at IN B-VP O
1323 CD O O
p.m NN B-NP O
She PRP O O
was VBD B-VP O
given VBN O O
a DT O O
9 CD O B-do
9 CD O B-do
mg NN B-NP O
bolus NN I-NP B-m
bolus JJ O B-m
bolus CC O B-m
dose JJ O O
over IN B-VP B-du
two CD O I-du
two CD O B-du
minutes NNS B-NP I-du
minutes NNS I-NP I-du
and CC O O
81 CD O B-do
mg NN B-NP I-do
given VBN O O
over IN B-VP O
the DT B-NP B-du
following JJ I-NP O
hour NN I-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
neuro JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
of IN B-VP O
Ham NNP B-NP O
Tertnough NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY; NNP I-NP O
Diet NNP I-NP O
controlled VBD B-VP O
diabetes NNS B-NP O
, , O O
obesity NN B-NP O
, , O O
hypertension NN B-NP O
as IN B-VP O
per IN B-VP O
the DT B-NP O
Rinn NNP I-NP O
Maield NNP I-NP O
Pinessi NNP I-NP O
Hospital NNP I-NP O
internal JJ B-NP O
medicine NN I-NP O
associate NN I-NP O
records NNS I-NP O
She PRP O O
also RB O O
has VBZ O O
history NN B-NP O
of IN B-VP O
ulcerative JJ B-NP O
colitis NN I-NP O
and CC O O
is VBZ O O
on IN B-VP O
treatment NN B-NP O
She PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
MI NNP I-NP O
in IN B-VP O
1988 CD O O
and CC O O
there EX O O
is VBZ O O
question NN B-NP O
of IN B-VP O
an DT B-NP O
old JJ I-NP O
stroke NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
There EX O O
is VBZ O O
also RB O O
question NN B-NP O
of IN B-VP O
asthma JJ B-NP O
MEDICATIONS: NNP I-NP O
Currently NNP I-NP O
is VBZ O O
aspirin JJ O B-m
325 CD O B-do
mg NN B-NP I-do
and CC O O
Asacol NNP B-NP B-m
although IN B-VP O
she PRP O O
wasn't VBZ O O
sure JJ O O
of IN B-VP O
the DT B-NP O
dose JJ I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Nonsmoker NNP I-NP O
, , O O
married VBD B-VP O
with IN B-VP O
several JJ B-NP O
children NNS I-NP O
At IN B-VP O
baseline NN B-NP O
, , O O
she PRP O O
is VBZ O O
wheelchair JJ O O
dependent JJ O O
due JJ O O
to TO O O
chronic JJ B-NP O
hip NN I-NP O
and CC O O
back RB O O
pain NN B-NP O
although IN B-VP O
she PRP O O
ambulates VBZ O O
at IN B-VP O
home NN B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Revealed NNP I-NP O
chronic JJ B-NP O
mild NN I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
significant JJ I-NP O
other JJ I-NP O
family NN I-NP O
history NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION; NNP I-NP O
Blood NNP I-NP O
pressure NN I-NP O
is VBZ O O
138/76 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
80 CD O O
and CC O O
paced VBD B-VP O
She PRP O O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
lady NN I-NP O
lying VBG O O
on IN B-VP O
her PRP O O
back RB O O
HEAD NNP B-NP O
AND NNP I-NP O
NECK: NNP I-NP O
Revealed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
trauma NN B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
bruits NNS I-NP O
in IN B-VP O
the DT B-NP O
neck NN I-NP O
CHEST: NNP I-NP O
Clear NNP I-NP O
There EX O O
were VBD B-VP O
bilateral JJ B-NP O
wheezes NNS I-NP O
ABDOMEN: NNP I-NP O
Soft NNP I-NP O
, , O O
non-tender JJ B-NP O
EXTREMITIES: NNP I-NP O
Normal NNP I-NP O
, , O O
obese JJ O O
with IN B-VP O
no DT B-NP O
edema NN I-NP O
NEURO: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
awake JJ O O
and CC O O
alert JJ O O
, , O O
looking VBG O O
around IN B-VP O
She PRP O O
was VBD B-VP O
mute JJ O O
however RB O O
She PRP O O
was VBD B-VP O
able JJ O O
to TO O O
follow VB O O
one CD O O
step NN B-NP O
commands VBZ O O
She PRP O O
had VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP O
right JJ I-NP O
field NN I-NP O
compromise NN I-NP O
difficulty NN I-NP O
crossing VBG O O
the DT B-NP O
midline NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
upper JJ I-NP O
motor NN I-NP O
neuron IN B-VP O
seventh JJ B-NP O
weakness NN I-NP O
with IN B-VP O
decreased JJ B-NP O
power NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
of IN B-VP O
the DT B-NP O
face NN I-NP O
She PRP O O
had VBD B-VP O
flaccid VBN O O
right JJ B-NP O
arm NN I-NP O
Her PRP$ O O
right JJ B-NP O
leg NN I-NP O
had VBD B-VP O
some DT B-NP O
power NN I-NP O
with IN B-VP O
flexion NN B-NP O
at IN B-VP O
the DT B-NP O
knee NN I-NP O
but CC O O
was VBD B-VP O
generally RB O O
weak JJ O O
She PRP O O
had VBD B-VP O
optimum JJ B-NP O
coordination NN I-NP O
and CC O O
absent NN B-NP O
pinprick NN I-NP O
and CC O O
proprioception NN B-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
All NNP I-NP O
of IN B-VP O
this DT O O
was VBD B-VP O
documented VBN O O
at IN B-VP O
12:30 CD O O
a.m NN B-NP O
By IN B-VP O
14;30 CD O O
a.m NNS B-NP O
, , O O
after IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
intravenous JJ B-NP B-mo
TPA NNP I-NP B-m
, , O O
the DT B-NP O
patient's NN I-NP O
language NN I-NP O
had VBD B-VP O
returned VBN O O
completely RB O O
to TO O O
normal JJ O O
She PRP O O
had VBD B-VP O
normal JJ B-NP O
speech NN I-NP O
including VBG O O
comprehension NN B-NP O
and CC O O
naming VBG O O
Her PRP$ O O
ability NN B-NP O
to TO O O
distinguish VB O O
left VBN O O
from IN B-VP O
right NN B-NP O
was VBD B-VP O
intact JJ B-NP O
Her NNP I-NP O
repetition NN I-NP O
was VBD B-VP O
intact JJ B-NP O
SHe NNP I-NP O
had VBD B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
movement NN B-NP O
of IN B-VP O
the DT B-NP O
eyes NNS I-NP O
with IN B-VP O
full JJ B-NP O
fields NNS I-NP O
of IN B-VP O
confrontation NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
mild JJ I-NP O
right JJ I-NP O
arm NN I-NP O
drift NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
but CC O O
her PRP$ O O
strength NN B-NP O
was VBD B-VP O
4+/5 CD O O
distally RB O O
and CC O O
proximally RB O O
There EX O O
was VBD B-VP O
normal JJ B-NP O
power NN I-NP O
in IN B-VP O
the DT B-NP O
right NN I-NP O
lower JJR B-NP O
lobe NN I-NP O
and CC O O
the DT B-NP O
plantars NNS I-NP O
were VBD B-VP O
normal JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
increase NN I-NP O
in IN B-VP O
reflexes NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
for IN B-VP O
the DT B-NP O
neurological JJ I-NP O
service NN I-NP O
of IN B-VP O
Teaspell NNP B-NP O
Diee NNP I-NP O
Hospital NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Blood NNP I-NP O
pressure NN I-NP O
monitoring NN I-NP O
was VBD B-VP O
instituted VBN O O
per IN B-VP O
protocol NN B-NP O
, , O O
nasal JJ B-NP B-mo
oxygen NN I-NP B-m
was VBD B-VP O
given VBN O O
and CC O O
no DT B-NP O
antiplatelet NN I-NP O
therapy NN I-NP O
was VBD B-VP O
given VBN O O
for IN B-VP B-du
24 CD O I-du
hours NNS B-NP I-du
Head NNP I-NP O
of IN B-VP O
bed NN B-NP O
was VBD B-VP O
raised VBN O O
to TO O O
30 CD O O
degrees NNS B-NP O
Head NNP I-NP O
CT NNP I-NP O
was VBD B-VP O
repeated VBN O O
the DT O O
following VBG O O
morning NN B-NP O
, , O O
the DT B-NP O
results NNS I-NP O
of IN B-VP O
which WDT O O
show VBP O O
that IN B-VP O
there EX O O
is VBZ O O
slight JJ B-NP O
left JJ I-NP O
basal NN I-NP O
ganglion NN I-NP O
internal JJ B-NP O
capsule NN I-NP O
, , O O
acute NN B-NP O
and CC O O
subacute NN B-NP O
infarct NN I-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
middle JJ B-NP O
cerebral JJ I-NP O
artery NN I-NP O
distribution NN I-NP O
which WDT O O
was VBD B-VP O
evolving VBG O O
from IN B-VP O
the DT B-NP O
previous JJ I-NP O
study NN I-NP O
THere NNP I-NP O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
intracranial JJ B-NP O
hemorrhage NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
further JJ B-NP O
investigations NNS I-NP O
to TO O O
look VB O O
for IN B-VP O
a DT B-NP O
cause NN I-NP O
of IN B-VP O
this DT B-NP O
presumed JJ I-NP O
embolic JJ I-NP O
stroke NN I-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
done VBN O O
which WDT O O
showed VBD B-VP O
the DT B-NP O
aortic JJ I-NP O
root NN I-NP O
at IN B-VP O
3.5 CD O O
cm NN B-NP O
, , O O
the DT B-NP O
atrium NN I-NP O
at IN B-VP O
3.2 CD O O
which WDT O O
is VBZ O O
slightly RB O O
dilated VBN O O
There EX O O
was VBD B-VP O
normal JJ B-NP O
ventricular JJ I-NP O
size NN I-NP O
and CC O O
overall JJ O O
preserved VBN O O
systolic JJ B-NP O
function NN I-NP O
, , O O
trace NN B-NP O
aortic JJ B-NP O
insufficiency NN I-NP O
, , O O
1+ CD O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
, , O O
trace NN B-NP O
mitral JJ B-NP O
regurgitation NN I-NP O
Holter NNP I-NP O
monitor NN I-NP O
was VBD B-VP O
done VBN O O
which WDT O O
showed VBD B-VP O
persistent JJ B-NP O
atrial JJ I-NP O
flutter NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
coumadinized VBN O O
and CC O O
some DT B-NP O
discussion NN I-NP O
pertaining VBG O O
to TO O O
cardioversion NN B-NP O
was VBD B-VP O
entertained VBN O O
by IN B-VP O
the DT B-NP O
electrophysiology NN I-NP O
service NN I-NP O
However RB O O
, , O O
this DT O O
was VBD B-VP O
not RB O O
done VBN O O
as IN B-VP O
an DT B-NP O
inpatient NN I-NP O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
do VB O O
remarkably RB O O
well RB O O
after IN B-VP O
her PRP$ O O
intravenous JJ B-NP B-mo
thrombolysis NN I-NP B-m
over IN B-VP B-du
the DT B-NP I-du
next JJ I-NP I-du
couple NN I-NP I-du
of IN B-VP I-du
days NNS B-NP I-du
She PRP O O
had VBD B-VP O
persistent JJ B-NP O
drift NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
arm; NN I-NP O
however RB O O
, , O O
her PRP O O
speech NN B-NP O
remained VBD B-VP O
completely RB O O
normal JJ B-NP O
SHe NNP I-NP O
was VBD B-VP O
reviewed VBN O O
by IN B-VP O
the DT B-NP O
chronic JJ I-NP O
pain NN I-NP O
service NN I-NP O
on IN B-VP O
several JJ B-NP O
occasions NNS I-NP O
for IN B-VP O
chronic JJ B-NP O
back NN I-NP O
and CC O O
leg NN B-NP O
pain NN I-NP O
She PRP O O
reached VBD B-VP O
normal JJ B-NP O
levels NNS I-NP O
of IN B-VP O
Coumadin NNP B-NP B-m
within IN B-VP O
several JJ B-NP B-du
days NNS I-NP I-du
and CC O O
was VBD B-VP O
discharged VBN O O
without IN B-VP O
rehabilitation NN B-NP O
She PRP O O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
service NN I-NP O
and CC O O
a DT B-NP O
plan NN I-NP O
for IN B-VP O
complete JJ B-NP O
cardioversion NN I-NP O
was VBD B-VP O
instituted VBN O O
within IN B-VP O
one CD O O
month NN B-NP O
The DT B-NP O
patient NN I-NP O
went VBD B-VP O
home NN B-NP O
on IN B-VP O
Coumadin NNP B-NP B-m
She PRP O O
was VBD B-VP O
finally RB O O
discharged VBN O O
on IN B-VP O
0/21/99 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
HAROLD NNP I-NP O
ULLMANN NNP I-NP O
, , O O
M.D NNP B-NP O
HQ91 NNP I-NP O
Attending: NNP I-NP O
IAN NNP I-NP O
M NNP I-NP O
LAJEUNESSE NNP I-NP O
, , O O
M.D NNP B-NP O
IX83 NNP I-NP O
RO255/5843 NNP I-NP O
Batch: NNP I-NP O
74024 CD O O
Index NNP B-NP O
No NNP I-NP O
B7NM1543EG NNP I-NP O
D: NNP I-NP O
6/6/99 CD O O
T: NNP B-NP O
6/6/99 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#910475 VBZ O O
138430825 CD O O
OHAHC NNP B-NP O
06084114 CD O O
488437 CD O O
10/29/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/6/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/20/1995 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
CHEST NNP B-NP O
PAIN NNP I-NP O
, , O O
FOR NNP B-NP O
RULE NNP I-NP O
OUT NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
2 CD O O
INSULIN NNP B-NP O
DEPENDENT NNP I-NP O
DIABETES NNP I-NP O
3 CD O O
CHRONIC NNP B-NP O
ATRIAL NNP I-NP O
FIBRILLATION NNP I-NP O
4 CD O O
HYPERTENSION NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
60 CD O O
year NN B-NP O
old JJ O O
, , O O
Spanish JJ O O
speaking VBG O O
woman NN B-NP O
with IN B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
who WP O O
presented VBD B-VP O
complaining NN B-NP O
of IN B-VP O
unstable JJ B-NP O
chest NN I-NP O
pain NN I-NP O
The DT B-NP O
patient's NN I-NP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
adult JJ B-NP O
onset NN I-NP O
diabetes NNS I-NP O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
a DT B-NP O
positive JJ I-NP O
family NN I-NP O
history NN I-NP O
, , O O
previous JJ B-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
as RB O O
well RB O O
as IN B-VP O
postmenopausal NN B-NP O
state NN I-NP O
secondary JJ O O
to TO O O
hysterectomy VB O O
21 CD O O
years NNS B-NP O
ago RB O O
and CC O O
not RB O O
on IN B-VP O
estrogen NN B-NP O
replacement NN I-NP O
therapy IN B-VP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT O O
two CD O O
to TO O O
three CD O O
year NN B-NP O
history NN I-NP O
of IN B-VP O
exertional JJ B-NP O
angina NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
approximately RB O O
one CD O O
year NN B-NP O
ago IN B-VP O
she PRP O O
began VBD B-VP O
to TO O O
have VB O O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
at IN B-VP O
rest NN B-NP O
The DT B-NP O
patient NN I-NP O
states VBZ O O
that IN B-VP O
currently RB O O
she PRP O O
is VBZ O O
having VBG O O
approximately RB O O
three CD O O
episodes NNS B-NP O
a DT B-NP O
day NN I-NP O
on IN B-VP O
average NN B-NP O
She PRP O O
describes VBZ O O
these DT O O
as IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
which WDT O O
radiates VBZ O O
to TO O O
her PRP$ O O
bilateral JJ B-NP O
arms NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
jaw NN B-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
associated JJ I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
but CC O O
does VBZ O O
occasionally RB O O
note VB O O
diaphoresis NN B-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
nausea NN I-NP O
or CC O O
vomiting NN B-NP O
or CC O O
palpitations NNS B-NP O
In IN B-VP O
July NNP B-NP O
of IN B-VP O
1994 CD O O
the DT B-NP O
patient NN I-NP O
underwent VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
showed VBD B-VP O
a DT B-NP O
left JJ I-NP O
atrial JJ I-NP O
size NN I-NP O
of IN B-VP O
4.0 CD O O
cm NN B-NP O
and CC O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
approximately RB O O
60% CD O O
with IN B-VP O
mild JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
and CC O O
mild JJ B-NP O
tricuspid JJ I-NP O
regurgitation NN I-NP O
Since IN B-VP O
this DT B-NP O
time NN I-NP O
she PRP O O
has VBZ O O
been VBN O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Maximo NNP I-NP O
Bryum NNP I-NP O
in IN B-VP O
C&O NNP B-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
Clinic NNP I-NP O
who WP O O
initiated VBD B-VP O
an DT B-NP O
antianginal JJ I-NP B-m
regimen NNS I-NP I-m
which WDT O O
resulted VBD B-VP O
in IN B-VP O
decreased JJ B-NP O
frequency NN I-NP O
of IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
Of IN B-VP O
note VBP O O
the DT B-NP O
patient NN I-NP O
recently RB O O
stopped VBD B-VP O
taking VBG O O
Aspirin NNP B-NP B-m
Her NNP I-NP O
symptoms NNS I-NP O
then RB O O
recurred VBD B-VP O
On IN B-VP O
the DT O O
27 CD O O
of IN B-VP O
January NNP B-NP O
, , O O
1995 CD O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
Dobutamine NNP I-NP B-m
MIBBE NNP I-NP O
on IN B-VP O
which WDT O O
she PRP O O
went VBD B-VP O
6 CD O O
minutes NNS B-NP O
and CC O O
48 CD O O
seconds NNS B-NP O
reaching VBG O O
a DT B-NP O
maximal JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
154 CD O O
, , O O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
172/82 CD O O
The DT B-NP O
test NN I-NP O
showed VBD B-VP O
2 CD O O
mm NNS B-NP O
ST NNP I-NP O
depressions NNS I-NP O
diffusely RB O O
The DT B-NP O
MIBBE NNP I-NP O
showed VBD B-VP O
moderate JJ O O
to TO O O
severe VB O O
reversible JJ O O
anterior JJ O O
and CC O O
anteroseptal JJ B-NP O
wall NN I-NP O
ischemia NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
her PRP$ O O
VNA NNP B-NP O
During IN B-VP O
her PRP$ O O
VNA's NNP B-NP O
visit NN I-NP O
the DT B-NP O
patient NN I-NP O
began VBD B-VP O
to TO O O
have VB O O
her PRP$ O B-r
typical JJ B-NP I-r
anginal JJ I-NP I-r
symptoms NNS I-NP I-r
with IN B-VP O
radiation NN B-NP O
to TO O O
her PRP$ O O
arms NNS B-NP O
and CC O O
jaw NN B-NP O
as RB O O
well RB O O
as IN B-VP O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
She PRP O O
denied VBD B-VP O
any DT B-NP O
diaphoresis NN I-NP O
or CC O O
nausea VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
three CD O B-do
three CD O B-do
three CD O B-do
sublingual JJ B-NP B-mo
sublingual JJ I-NP B-mo
sublingual JJ I-NP B-mo
Nitroglycerins NNP I-NP B-m
Nitroglycerins NNP I-NP B-m
Nitroglycerins NNP I-NP B-m
after IN B-VP O
her PRP$ O O
primary JJ B-NP O
M.D NNP I-NP O
was VBD B-VP O
called VBN O O
and CC O O
her PRP$ O B-r
pain NN B-NP I-r
resolved VBD B-VP O
after IN B-VP O
approximately RB O O
15 CD O O
minutes NNS B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Remarkable NNP I-NP O
for IN B-VP O
a DT O O
10 CD O O
year NN B-NP O
history NN I-NP O
of IN B-VP O
Insulin NNP B-NP O
dependent NN I-NP O
diabetes VBZ O O
with IN B-VP O
complications NNS B-NP O
including VBG O O
neuropathy JJ O O
and CC O O
retinopathy JJ B-NP O
Chronic NNP I-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
included VBD B-VP O
a DT B-NP O
normal JJ I-NP O
TSH NNP I-NP O
Hypertension NNP I-NP O
Degenerative NNP I-NP O
joint JJ B-NP O
disease NN I-NP O
Gastroesophageal NNP I-NP O
reflux NN I-NP O
Status NNP I-NP O
post NN I-NP O
hysterectomy NN I-NP O
approximately RB O O
21 CD O O
years NNS B-NP O
ago RB O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Atenolol NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Enteric NNP B-NP B-m
Coated NNP I-NP I-m
Aspirin NNP I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
which WDT O O
the DT B-NP O
patient NN I-NP O
recently RB O O
stopped VBD B-VP O
, , O O
Coumadin NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Diltiazem NNP B-NP B-m
240 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lisinopril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lopipd NNP B-NP B-m
600 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Insulin NNP B-NP B-m
Insulin NNP I-NP B-m
, , O I-m
, , O I-m
NPH NNP B-NP I-m
NPH NNP I-NP I-m
, , O O
75 CD O B-do
units NNS B-NP I-do
sub-q JJ B-NP B-mo
q.a.m NN I-NP B-f
, , O O
50 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
, , O O
Insulin NNP B-NP B-m
Regular NNP I-NP I-m
25 CD O B-do
units NNS B-NP I-do
sub-q JJ B-NP B-mo
q.a.m NN I-NP B-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Her NNP I-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
58 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
141/73 CD O O
, , O O
O-2 NNP B-NP O
saturation NN I-NP O
97% CD O O
on IN B-VP O
2 CD O O
liters NNS B-NP O
, , O O
respiratory NN B-NP O
rate NN I-NP O
16 CD O O
and CC O O
unlabored JJ B-NP O
HEENT NNP I-NP O
exam NN I-NP O
showed VBD B-VP O
pupils NNS B-NP O
equal JJ B-NP O
round NN I-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Extraocular JJ I-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Oropharynx NNP I-NP O
was VBD B-VP O
clear JJ B-NP O
Mucous JJ I-NP O
membranes NNS I-NP O
were VBD B-VP O
moist JJ B-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
Jugular NNP I-NP O
venous JJ B-NP O
pressure NN I-NP O
was VBD B-VP O
difficult JJ O O
to TO O O
assess VB O O
secondary JJ O O
to TO O O
increased VBN O O
soft JJ B-NP O
tissue NN I-NP O
around IN B-VP O
the DT B-NP O
neck NN I-NP O
Carotids NNP I-NP O
were VBD B-VP O
2+ CD O O
and CC O O
without IN B-VP O
bruits NNS B-NP O
Cardiac NNP I-NP O
exam NN I-NP O
showed VBD B-VP O
an DT B-NP O
irregularly JJ I-NP O
irregular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
a DT O O
normal JJ O O
S-1 JJ O O
and CC O O
S-2 NNP B-NP O
, , O O
a DT B-NP O
I/VI NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
noted VBD B-VP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP O
and CC O O
percussion NN B-NP O
Abdomen NNP I-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
obese JJ O O
with IN B-VP O
active JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities NNS B-NP O
showed VBD B-VP O
a DT B-NP O
right JJ I-NP O
shin NN I-NP O
scar NN I-NP O
which WDT O O
was VBD B-VP O
healing VBG O O
well RB O O
There EX O O
was VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
or CC O O
cyanosis NN B-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
femoral JJ I-NP O
bruits NNS I-NP O
Rectal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
On IN B-VP O
neurologic JJ B-NP O
examination NN I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
x $ O O
2 CD O O
Cranial JJ B-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
were VBD B-VP O
intact JJ B-NP O
Strength NNP I-NP O
was VBD B-VP O
5/5 CD O O
bilaterally RB O O
There EX O O
was VBD B-VP O
decreased VBN O O
sensation NN B-NP O
to TO O O
light JJ B-NP O
touch NN I-NP O
bilaterally RB O O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
admission NN B-NP O
Sodium NNP I-NP O
134 CD O O
, , O O
Potassium NNP B-NP O
4.7 CD O O
, , O O
Chloride NNP B-NP O
96 CD O O
, , O O
Bicarb NNP B-NP O
22 CD O O
, , O O
BUN NNP B-NP O
28 CD O O
, , O O
Creatinine NNP B-NP O
1.3 CD O O
, , O O
Blood NNP B-NP O
Glucose NNP I-NP O
472 CD O O
, , O O
Digoxin NNP B-NP O
level VBZ O O
1.0 CD O O
PT NNP B-NP O
14.5 CD O O
, , O O
PTT NNP B-NP O
26 CD O O
Urinalysis NNP B-NP O
was VBD B-VP O
negative JJ B-NP O
EKG NNP I-NP O
showed VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
60 CD O O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
axis NN I-NP O
T NNP I-NP O
wave VBP O O
inversions NNS B-NP O
were VBD B-VP O
noted VBN O O
in IN B-VP O
both DT B-NP O
leads NNS I-NP O
3 CD O O
and CC O O
F NNP B-NP O
and CC O O
Q NNP B-NP O
waves NNS I-NP O
were VBD B-VP O
noted VBN O O
in IN B-VP O
V-1 NNP B-NP O
through IN B-VP O
V-3 NNP B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
infiltrates NNS B-NP O
or CC O O
effusions NNS B-NP O
There EX O O
was VBD B-VP O
borderline NN B-NP O
cardiomegaly NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
Medicine NNP B-NP O
Team NNP I-NP O
Voone NNP I-NP O
Parkway NNP I-NP O
, , O O
Ainggo NNP B-NP O
Ra NNP I-NP O
I PRP O O
, , O O
Alaska $ O O
89772 CD O O
She PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
with IN B-VP O
serial JJ B-NP O
CK NNP I-NP O
, , O O
MB NNP B-NP O
and CC O O
EKG's NNP B-NP O
Heparin NNP I-NP B-m
was VBD B-VP O
initially RB O O
started VBN O O
given VBN O O
the DT B-NP O
possibility NN I-NP O
that IN B-VP O
this DT O O
was VBD B-VP O
unstable JJ O B-r
angina IN B-VP I-r
The DT B-NP O
Cardiology NNP I-NP O
Team NNP I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
recommendations NNS B-NP O
on IN B-VP O
possible JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
On IN B-VP O
further JJ B-NP O
review NN I-NP O
of IN B-VP O
her PRP$ O O
history NN B-NP O
the DT B-NP O
Cardiology NNP I-NP O
Team NNP I-NP O
decided VBD B-VP O
to TO O O
schedule VB O O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
This DT O O
was VBD B-VP O
performed VBN O O
on IN B-VP O
the DT O O
4 CD O O
of IN B-VP O
June NNP B-NP O
and CC O O
showed VBD B-VP O
mildly RB O O
elevated VBN O O
right RB O O
sided JJ B-NP O
pressure NN I-NP O
including VBG O O
a DT B-NP O
right JJ I-NP O
atrial JJ I-NP O
pressure NN I-NP O
of IN B-VP O
15 CD O O
, , O O
an DT B-NP O
RV NNP I-NP O
pressure NN I-NP O
of IN B-VP O
50/16 CD O O
with IN B-VP O
a DT B-NP O
mean JJ I-NP O
PA NNP I-NP O
pressure NN I-NP O
of IN B-VP O
32 CD O O
, , O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
of IN B-VP O
22 CD O O
The DT B-NP O
coronary JJ I-NP O
arteries NNS I-NP O
were VBD B-VP O
noted VBN O O
to TO O O
be VB O O
normal JJ O O
and CC O O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
was VBD B-VP O
also RB O O
assessed VBN O O
as IN B-VP O
normal JJ O O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
this DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
without IN B-VP O
complications NNS B-NP O
Given VBP O O
the DT B-NP O
confluence NN I-NP O
of IN B-VP O
her PRP$ O O
data NNS B-NP O
, , O O
two CD O O
possible JJ B-NP O
explanations NNS I-NP O
were VBD B-VP O
postulated VBN O O
including VBG O O
either CC O O
syndrome JJ B-NP O
X NN I-NP O
or CC O O
small JJ B-NP O
vessel NN I-NP O
disease NN I-NP O
, , O O
not RB O O
noted VBN O O
on IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
stable JJ O O
, , O O
status NN B-NP O
post NN I-NP O
cardiac JJ B-NP O
catheterization NN I-NP O
and CC O O
was VBD B-VP O
prepared VBN O O
for IN B-VP O
discharge NN B-NP O
Also RB O O
during IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
the DT B-NP O
patient's JJ I-NP O
Insulin NNP I-NP B-m
dosages NNS I-NP O
were VBD B-VP O
adjusted VBN O O
in IN B-VP O
the DT B-NP O
manner NN I-NP O
to TO O O
keep VB O O
her PRP$ O B-r
blood NN B-NP O
sugars NNS I-NP O
in IN B-VP O
the DT O O
approximately RB O O
200 CD O O
range NN B-NP O
DISPOSITION: NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Enteric NNP I-NP B-m
Coated NNP I-NP I-m
Aspirin NNP I-NP I-m
325 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Lasix NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Lopid NNP I-NP B-m
600 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; JJ B-NP B-f
Insulin NNP I-NP B-m
Insulin NNP I-NP B-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
100 CD O B-do
units NNS B-NP I-do
sub-q JJ B-NP B-mo
q.a.m NN I-NP B-f
, , O O
70 CD O B-do
units NNS B-NP I-do
sub-q JJ B-NP B-mo
q.h.s NN I-NP B-f
, , O O
Insulin NNP B-NP B-m
Regular NNP I-NP I-m
25 CD O B-do
units NNS B-NP I-do
sub-q JJ B-NP B-mo
q.a.m.; JJ I-NP B-f
Lisinopril NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Nitroglycerin NNP I-NP B-m
1/150th CD O I-m
one CD O B-do
tablet NN B-NP I-do
sublingual JJ B-NP B-mo
q NN I-NP B-f
5 CD O O
minutes NNS B-NP O
x VBP O O
3 CD O O
p.r.n JJ B-NP O
chest NN I-NP B-r
pain; NN I-NP I-r
Omeprazole NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Coumadin NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s.; NN I-NP B-f
Diltiazem NNP I-NP B-m
CD NN I-NP I-m
240 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d JJ B-NP B-f
FOLLOW-UP NNP I-NP O
CARE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow-up VB O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
M.D NNP I-NP O
, , O O
Dr NNP B-NP O
Jarvis NNP I-NP O
Needy NNP I-NP O
in IN B-VP O
the DT B-NP O
RINGBURG NNP I-NP O
RITA'S NNP I-NP O
PROPRES NNP I-NP O
MEMORIAL NNP I-NP O
HOSPITAL NNP I-NP O
Clinic NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
DARRON NNP I-NP O
MCCLARIN NNP I-NP O
, , O O
M.D NNP B-NP O
BV80 NNP I-NP O
Attending: NNP I-NP O
IGNACIO NNP I-NP O
W NNP I-NP O
DITTER NNP I-NP O
, , O O
M.D NNP B-NP O
OC31 NNP I-NP O
CQ254/6623 NNP I-NP O
Batch: NNP I-NP O
7060 CD O O
Index NNP B-NP O
No NNP I-NP O
F5QNED61F1 NNP I-NP O
D: NNP I-NP O
11/10/95 CD O O
T: NNP B-NP O
2/12/95 CD O O
CC: NNP B-NP O
1 CD O O
CLARENCE NNP B-NP O
L NNP I-NP O
BRABANT NNP I-NP O
, , O O
M.D NNP B-NP O
EZ23 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#912444 VBZ O O
992808716 CD O O
IMC NNP B-NP O
44368736 CD O O
638469 CD O O
4/17/1996 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/5/1996 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/18/1996 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Hora NNP I-NP O
is VBZ O O
a DT O O
45 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
hypertensive JJ B-NP O
disease NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
diabetes NNS B-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
sustained JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
long RB O O
standing JJ B-NP O
obesity NN I-NP O
with IN B-VP O
moderate JJ O O
to TO O O
severe VB O O
hypertension NN B-NP O
which WDT O O
has VBZ O O
been VBN O O
fairly RB O O
well RB O O
controlled VBN O O
and CC O O
poorly RB O O
controlled VBN O O
diabetes NNS B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
asthma NN B-NP O
Over IN B-VP O
the DT O O
last JJ O O
four CD O O
days NNS B-NP O
she PRP O O
has VBZ O O
had VBD B-VP O
increased VBN O O
episodes NNS B-NP O
of IN B-VP O
rather RB O O
persistent JJ B-NP O
chest JJS I-NP O
discomfort NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
She PRP O O
generally RB O O
describes VBZ O O
it PRP O O
in IN B-VP O
her PRP$ O O
anterior JJ B-NP O
chest NN I-NP O
wall NN I-NP O
as IN B-VP O
pressure NN B-NP O
, , O O
but CC O O
there EX O O
is VBZ O O
also RB O O
some DT B-NP O
sharp JJ I-NP O
qualities NNS I-NP O
as IN B-VP O
well RB O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
also RB O O
noted VBN O O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
dyspnea NN B-NP O
without IN B-VP O
subjective JJ B-NP O
wheezing NN I-NP O
and CC O O
there EX O O
has VBZ O O
been VBN O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
orthopnea NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
unsure JJ O O
of IN B-VP O
whether IN B-VP O
her PRP$ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
correlates NNS I-NP O
with IN B-VP O
her PRP$ O O
chest NN B-NP O
pressure NN I-NP O
Previous NNP I-NP O
evaluation NN I-NP O
has VBZ O O
included VBN O O
several JJ B-NP O
negative JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
tests NNS I-NP O
, , O O
but CC O O
there RB O O
was VBD B-VP O
in IN B-VP O
1981 CD O O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
with IN B-VP O
Thallium NN B-NP O
that WDT O O
showed VBD B-VP O
a DT B-NP O
fixed JJ I-NP O
anterior JJ I-NP O
profusion NN I-NP O
defect NN I-NP O
and CC O O
an DT B-NP O
EKG NNP I-NP O
has VBZ O O
chronic JJ B-NP O
anterolateral JJ I-NP O
Q NNP I-NP O
wave NN I-NP O
to TO O O
poor JJ B-NP O
R NNP I-NP O
wave NN I-NP O
progression NN I-NP O
An DT B-NP O
echo NN I-NP O
in IN B-VP O
1991 CD O O
showed VBD B-VP O
LVH NNP B-NP O
with IN B-VP O
no DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
MI NNP B-NP O
three CD O O
months NNS B-NP O
prior RB O O
to TO O O
this DT B-NP O
admission NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Asthma NNP B-NP O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
4 CD O O
Obesity NNP B-NP O
5 CD O O
Sleep NNP B-NP O
apnea NN I-NP O
6 CD O O
Peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
Codeine NNP B-NP O
which WDT O O
produces VBZ O O
nausea NN B-NP O
CARDIAC NNP I-NP O
RISK NNP I-NP O
FACTORS: NNP I-NP O
1 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Family NNP B-NP O
history NN I-NP O
of IN B-VP O
CAD NNP B-NP O
4 CD O O
No NNP B-NP O
tobacco NN I-NP O
5 CD O O
No NNP B-NP O
hypercholesterolemia NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for: VBD B-VP O
1 CD O O
Hysterectomy NNP B-NP O
vaginally RB O O
2 CD O O
Status NNP B-NP O
post NN I-NP O
an DT B-NP O
umbilical JJ I-NP O
hernia NN I-NP O
repair NN I-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Azmacort NNP I-NP B-m
, , O O
Proventil NNP B-NP B-m
, , O O
Tagamet NNP B-NP B-m
, , O O
Cardizem NNP B-NP B-m
300 CD O B-do
q.day NN B-NP B-f
, , O O
insulin JJ B-NP B-m
insulin NN I-NP B-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
40 CD O B-do
units NNS B-NP I-do
q.AM RB O B-f
and CC O O
55 CD O B-do
units NNS B-NP O
q.PM RB O B-f
, , O O
aspirin NN B-NP B-m
, , O O
Motrin NNP B-NP B-m
, , O O
Maxide NNP B-NP B-m
1 CD O B-do
per IN B-VP B-f
day NN B-NP I-f
, , O O
Lisinopril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day JJ B-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile RB O O
, , O O
heart NN B-NP O
rate NN I-NP O
100 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
140/80 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
was VBD B-VP O
99% CD O O
on IN B-VP O
2 CD O O
liters NNS B-NP O
She PRP O O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
black JJ I-NP O
female NN I-NP O
lying NN I-NP O
in IN B-VP O
the DT B-NP O
bed NN I-NP O
at IN B-VP O
45 CD O O
degrees NNS B-NP O
with IN B-VP O
nasal JJ B-NP O
cannula NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Her PRP$ O O
head NN B-NP O
was VBD B-VP O
normocephalic JJ B-NP O
atraumatic JJ I-NP O
Pupils NNS I-NP O
were VBD B-VP O
equal JJ O O
and CC O O
round NN B-NP O
to TO O O
light NN B-NP O
and CC O O
accommodation NN B-NP O
Her NNP I-NP O
extraocular NN I-NP O
movements NNS I-NP O
were VBD B-VP O
full JJ B-NP O
Cranial JJ I-NP O
nerves NNS I-NP O
were VBD B-VP O
intact JJ O O
There EX O O
were VBD B-VP O
no DT B-NP O
oral JJ I-NP O
lesions NNS I-NP O
There EX O O
was VBD B-VP O
minimal JJ B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
Chest NNP I-NP O
was VBD B-VP O
clear JJ B-NP O
Heart NNP I-NP O
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
, , O O
or CC O O
gallops NNS B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
CVA NNP I-NP O
tenderness NN I-NP O
There EX O O
was VBD B-VP O
some DT B-NP O
chest JJS I-NP O
wall NN I-NP O
tenderness NN I-NP O
on IN B-VP O
the DT O O
left VBN O O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
obese JJ O O
and CC O O
non-tender JJ O O
, , O O
with IN B-VP O
bowel NN B-NP O
sounds NNS I-NP O
present JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
cyanosis NN I-NP O
, , O O
clubbing VBG O O
, , O O
or CC O O
edema VB O O
There EX O O
was VBD B-VP O
no DT B-NP O
proprioceptive JJ I-NP O
defects NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Laboratories NNPS I-NP O
on IN B-VP O
admission NN B-NP O
showed VBD B-VP O
her PRP O O
to TO O O
have VB O O
a DT B-NP O
potassium NN I-NP O
of IN B-VP O
3.7 CD O O
, , O O
BUN NNP B-NP O
and CC O O
creatinine NN B-NP O
of IN B-VP O
11/1.2 CD O O
, , O O
creatinine JJ B-NP O
kinase NN I-NP O
of IN B-VP O
148 CD O O
, , O O
troponin NN B-NP O
of IN B-VP O
0.0 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
was VBD B-VP O
clear JJ O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
left JJ B-NP O
ventricular JJ I-NP O
failure NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
90 CD O O
with IN B-VP O
Q NNP B-NP O
waves/poor NN I-NP O
R NNP I-NP O
wave VBP O O
progression NN B-NP O
in IN B-VP O
I PRP O O
, , O O
III NNP B-NP O
, , O O
IV NNP B-NP O
, , O O
which WDT O O
was VBD B-VP O
no DT B-NP O
acute JJ I-NP O
change NN I-NP O
from IN B-VP O
the DT O O
most RBS O O
recent JJ B-NP O
EKG NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
and CC O O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
with IN B-VP O
serial JJ B-NP O
CPK NNP I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
serial JJ B-NP O
troponin NN I-NP O
, , O O
both DT O O
of IN B-VP O
which WDT O O
showed VBD B-VP O
0.0 CD O O
The DT B-NP O
patient NN I-NP O
also RB O O
underwent VBD B-VP O
a DT B-NP O
VQ NNP I-NP O
scan JJ O O
given VBN O O
her PRP$ O O
sedentary JJ B-NP O
life NN I-NP O
style NN I-NP O
to TO O O
rule VB O O
out RP O O
pulmonary JJ B-NP O
embolus NN I-NP O
, , O O
and CC O O
in IN B-VP O
fact NN B-NP O
it PRP O O
was VBD B-VP O
very RB O O
low JJ B-NP O
probability NN I-NP O
The DT B-NP O
patient NN I-NP O
at IN B-VP O
that DT B-NP O
point NN I-NP O
was VBD B-VP O
managed VBN O O
by IN B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
a DT B-NP O
gastrointestinal JJ I-NP O
regimen NN I-NP O
of IN B-VP O
Prilosec NNP B-NP B-m
and CC O O
Cisapride NNP B-NP B-m
as IN B-VP O
she PRP O O
had VBD B-VP O
complained VBN O O
of IN B-VP O
some DT B-NP O
worsening NN I-NP O
of IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
chest NN B-NP I-r
chest NN I-NP I-r
pressure NN I-NP I-r
pressure NN I-NP I-r
when WRB O O
she PRP O O
laid VBD B-VP O
back RB O O
flat JJ O O
and CC O O
some DT B-NP O
sour JJ I-NP O
taste NN I-NP O
in IN B-VP O
her PRP$ O O
mouth NN B-NP O
The DT B-NP O
patient NN I-NP O
reported VBD B-VP O
that IN B-VP O
this DT B-NP O
combination NN I-NP O
of IN B-VP O
medications NNS B-NP O
made VBD B-VP O
her PRP$ O O
feel NN B-NP O
somewhat RB O O
better VBD B-VP O
The DT B-NP O
patient NN I-NP O
finally RB O O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
with IN B-VP O
MIBI NNP B-NP O
1/9/96 CD O O
She PRP O O
went VBD B-VP O
5 CD O O
minutes NNS B-NP O
and CC O O
0 CD O O
seconds NNS B-NP O
on IN B-VP O
a DT B-NP O
Bruce NNP I-NP O
protocol NN I-NP O
, , O O
stopped VBD B-VP O
secondary JJ O O
to TO O O
chest VB O O
pain NN B-NP O
Her NNP I-NP O
peak JJ B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
140 CD O O
, , O O
which WDT O O
is VBZ O O
85% CD O O
of IN B-VP O
predicted VBN O O
Her NNP B-NP O
systolic JJ B-NP O
maximum NN I-NP O
was VBD B-VP O
120 CD O O
The DT B-NP O
chest NN I-NP O
pressure NN I-NP O
was VBD B-VP O
similar JJ O O
to TO O O
that DT O O
on IN B-VP O
admission NN B-NP O
and CC O O
it PRP O O
was VBD B-VP O
somewhat RB O O
atypical JJ O O
and CC O O
ill JJ O O
defined VBD B-VP O
The DT B-NP O
patient NN I-NP O
then RB O O
had VBD B-VP O
MIBI NNP B-NP O
images NNS I-NP O
which WDT O O
showed VBD B-VP O
a DT B-NP O
borderline NN I-NP O
to TO O O
minimal VB O O
anterior JJ B-NP O
reversible JJ I-NP O
defect NN I-NP O
, , O O
but CC O O
that DT O O
was VBD B-VP O
as IN B-VP O
said VBD B-VP O
borderline IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
deemed VBN O O
suitable JJ O O
for IN B-VP O
discharge NN B-NP O
after IN B-VP O
conversation NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Dubin NNP I-NP O
of IN B-VP O
the DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
following VBG O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
The DT B-NP O
medication NN I-NP O
changes NNS I-NP O
will MD O O
be VB O O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
Prilosec NNP B-NP B-m
and CC O O
Cisapride NNP B-NP B-m
in IN B-VP O
the DT B-NP O
place NN I-NP O
of IN B-VP O
Axid NNP B-NP O
AND CC O O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
isordil NN B-NP B-m
10mg CD O B-do
po NN B-NP B-mo
tid NN I-NP B-f
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Proventil NNP I-NP B-m
2 CD O B-do
puffs NNS B-NP I-do
inhaler JJ B-NP B-mo
q.i.d NN I-NP B-f
, , O O
enteric RB O B-m
coated VBD B-VP O
aspirin JJ O O
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
40 CD O B-do
units NNS B-NP O
q.AM RB O B-f
and CC O O
55 CD O B-do
units NNS B-NP I-do
subcu JJ B-NP B-mo
q.PM NN I-NP B-f
, , O O
Lisinopril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
Maxide NNP B-NP B-m
1 CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
nitroglycerin RB O B-m
1/150 CD O I-m
1 CD O B-do
tablet NN B-NP I-do
sublingual JJ B-NP B-mo
q.5 NN I-NP B-f
minutes NNS I-NP I-f
times NNS I-NP I-f
three CD O I-f
p.r.n NN B-NP I-f
chest NN I-NP B-r
pain NN I-NP I-r
, , O O
Prilosec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
Azmacort NNP B-NP B-m
4 CD O B-do
puffs NNS B-NP I-do
inhaler JJ B-NP B-mo
b.i.d NN I-NP B-f
, , O O
Cardizem NNP B-NP B-m
CD NNP I-NP I-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
Cisapride NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
and CC O O
isordil RB O B-m
10 CD O B-do
mg NNS B-NP I-do
po JJ O B-mo
tid RB O B-f
Dictated NNP B-NP O
By: NNP I-NP O
SHELTON NNP I-NP O
BUEL NNP I-NP O
, , O O
M.D NNP B-NP O
RV15 NNP I-NP O
Attending: NNP I-NP O
JAMEY NNP I-NP O
L NNP I-NP O
GOLOMBECKI NNP I-NP O
, , O O
M.D NNP B-NP O
DH5 NNP I-NP O
NT789/8157 NNP I-NP O
Batch: NNP I-NP O
93753 CD O O
Index NNP B-NP O
No NNP I-NP O
B3HMCL54Z3 NNP I-NP O
D: NNP I-NP O
0/9/96 CD O O
T: NNP B-NP O
4/25/96 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#915973 VBZ O O
741191636 CD O O
LWMMC NNP B-NP O
76526432 CD O O
5688336 CD O O
2/4/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
DEHYDRATION NNP I-NP O
, , O O
NEUTROPENIC NNP B-NP O
, , O O
LUNG NNP B-NP O
CANCER NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/19/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/18/2005 CD O O
ATTENDING: NNP B-NP O
LAFUENTE NNP I-NP O
, , O O
NATHANIAL NNP B-NP O
ROOSEVELT NNP I-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Urosepsis NNP I-NP O
LIST NNP I-NP O
OF NNP I-NP O
PROBLEMS NNP I-NP O
AND NNP I-NP O
DIAGNOSES: NNP I-NP O
Diabetes NNP I-NP O
, , O O
obesity NN B-NP O
, , O O
severe JJ B-NP O
COPD NNP I-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
anemia NN B-NP O
, , O O
colonic JJ B-NP O
polyps NNS I-NP O
, , O O
uterine JJ B-NP O
fibroids NNS I-NP O
, , O O
gastrointestinal JJ O O
bled VBD B-VP O
, , O O
neutropenic JJ B-NP O
enteritis NN I-NP O
, , O O
nonsmall DT B-NP O
cell NN I-NP O
lung NN I-NP O
cancer NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
appendectomy NN I-NP O
, , O O
gout NN B-NP O
, , O O
and CC O O
osteoarthritis JJ B-NP O
BRIEF NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
For IN B-VP O
further JJ B-NP O
details NNS I-NP O
please VB O O
see VB O O
the DT B-NP O
chart NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
multiple JJ B-NP O
medical JJ I-NP O
problems NNS I-NP O
including VBG O O
severe JJ B-NP B-r
COPD NNP I-NP I-r
, , O O
( ( O O
on IN B-VP O
home NN B-NP B-m
O2 NNP I-NP I-m
2 CD O B-do
liters NNS B-NP I-do
baseline VBP O O
sat VBN O O
below IN B-VP O
90s CD O O
) ) O O
, , O O
nonsmall RB O B-r
cell NN B-NP I-r
lung NN I-NP I-r
cancer NN I-NP I-r
, , O O
diagnosed VBN O O
in IN B-VP O
1999 CD O O
status NN B-NP O
post NN I-NP O
multiple JJ B-NP O
chemotherapy NN I-NP B-m
regimens NNS I-NP I-m
, , O O
most JJS O O
recently RB O O
ALIMTA NNP B-NP B-m
from IN B-VP B-du
1/29/2005 CD O I-du
to TO O I-du
09 CD O I-du
, , O O
diabetes NNS B-NP O
, , O O
obesity NN B-NP O
, , O O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
who WP O O
was VBD B-VP O
admitted VBN O O
to TO O O
MICU NNP B-NP O
on IN B-VP O
2/19/2005 CD O O
for IN B-VP O
neutropenia NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
requiring VBG O O
intubation NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
prerenal JJ B-NP O
azotemia NN I-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
2.9; CD O O
all DT O O
of IN B-VP O
which WDT O O
are VBP O O
believed VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
sepsis VB O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Included NNP I-NP O
Avapro NNP I-NP B-m
, , O O
Lipitor NNP B-NP B-m
, , O O
Decadron NNP B-NP B-m
, , O O
ranitidine NN B-NP B-m
, , O O
Humalog NNP B-NP B-m
, , O O
allopurinol NN B-NP B-m
, , O O
Alimta NNP B-NP B-m
, , O O
Flonase NNP B-NP B-m
, , O O
vitamin NN B-NP B-m
D NNP I-NP I-m
, , O O
B12 NNP B-NP B-m
, , O O
and CC O O
Colace NNP B-NP B-m
ALLERGIES: NNP I-NP O
Bactrim NNP I-NP O
, , O O
resulting VBG O O
in IN B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
hyperkalemic NN B-NP O
, , O O
and CC O O
penicillin NN B-NP O
resulting VBG O O
in IN B-VP O
anaphylaxis JJ B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Pertinent NNP I-NP O
for IN B-VP O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
she PRP O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
remote JJ I-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
, , O O
quit VBP O O
15 CD O O
years NNS B-NP O
ago RB O O
, , O O
and CC O O
denies VBZ O O
alcohol VBP O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Pertinent NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
stroke NN B-NP O
, , O O
thyroid JJ B-NP O
cancer NN I-NP O
, , O O
and CC O O
cervical JJ B-NP O
cancer NN I-NP O
FINDINGS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Shows VBZ O O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
98.9 CD O O
pulse NN B-NP O
of IN B-VP O
116 CD O O
, , O O
and CC O O
blood NN B-NP O
pressure NN I-NP O
84/47 CD O O
, , O O
and CC O O
96% CD O O
on IN B-VP O
ventilation NN B-NP O
General NNP I-NP O
exam: NN I-NP O
She PRP O O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
female NN I-NP O
, , O O
intubated VBN O O
and CC O O
awake VB O O
, , O O
motioning VBG O O
to TO O O
take VB O O
her PRP$ O O
tube NN B-NP O
out IN B-VP O
Skin NNP B-NP O
exam NN I-NP O
showed VBD B-VP O
scattered JJ B-NP O
group NN I-NP O
petechial JJ B-NP O
areas NNS I-NP O
over IN B-VP O
the DT B-NP O
torso NN I-NP O
, , O O
abdomen NNS B-NP O
, , O O
and CC O O
under IN B-VP O
the DT B-NP O
right JJ I-NP O
breast NN I-NP O
HEENT NNP I-NP O
Exam NNP I-NP O
shows VBZ O O
pupils NNS B-NP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
and CC O O
anicteric JJ O O
, , O O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
JVP NNP I-NP O
Pulmonary NNP I-NP O
exam NN I-NP O
shows NNS I-NP O
decreased VBD B-VP O
mildly RB O O
decreased VBN O O
breath NN B-NP O
sounds NNS I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
base NN I-NP O
No NNP I-NP O
crackles NNS I-NP O
, , O O
increase NN B-NP O
in IN B-VP O
expiratory JJ B-NP O
phase NN I-NP O
, , O O
few JJ O O
scattered VBD B-VP O
rales NNS B-NP O
Cardiac NNP I-NP O
exam NN I-NP O
shows VBZ O O
tachycardia JJ O O
otherwise RB O O
regular JJ O O
rhythm VB O O
A DT O O
2/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
across IN B-VP O
precordium NN B-NP O
Abdomen NNP I-NP O
is VBZ O O
soft JJ O O
, , O O
obese JJ O O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
with IN B-VP O
chronic JJ B-NP O
skin NN I-NP O
changes NNS I-NP O
below IN B-VP O
the DT B-NP O
pannus NN I-NP O
Extremities NNP I-NP O
show VBP O O
trace NN B-NP O
to TO O O
1+ CD O O
edema NN B-NP O
to TO O O
the DT B-NP O
shins NNS I-NP O
, , O O
with IN B-VP O
2+ CD O O
dorsalis NNS B-NP O
pedis JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
Neurologic NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
awake; JJ O O
however RB O O
, , O O
the DT B-NP O
exam NN I-NP O
is VBZ O O
otherwise RB O O
difficult JJ O O
to TO O O
perform VB O O
secondary JJ O O
to TO O O
the DT B-NP O
patient NN I-NP O
being VBG O O
intubated VBN O O
PERTINENT NNP B-NP O
LABS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Show NNP I-NP O
a DT B-NP O
white JJ I-NP O
count NN I-NP O
of IN B-VP O
0.74 CD O O
with IN B-VP O
46% CD O O
polys NNS B-NP O
and CC O O
6% CD O O
bands NNS B-NP O
, , O O
resulting VBG O O
in IN B-VP O
an DT B-NP O
absolute JJ I-NP O
neutrophil NN I-NP O
count NN I-NP O
of IN B-VP O
340 CD O O
, , O O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
26.2 CD O O
, , O O
and CC O O
platelets NNS B-NP O
of IN B-VP O
37 CD O O
Creatinine NNP B-NP O
of IN B-VP O
3.1 CD O O
, , O O
a DT B-NP O
PTT NNP I-NP O
of IN B-VP O
83.5 CD O O
and CC O O
INR NNP B-NP O
of IN B-VP O
1.4 CD O O
, , O O
and CC O O
lactic JJ B-NP O
acid NN I-NP O
of IN B-VP O
1.4 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
on IN B-VP O
admission NN B-NP O
shows NNS I-NP O
right RB O O
infrahilar JJ B-NP O
mass NN I-NP O
, , O O
bibasilar JJ B-NP O
opacities NNS I-NP O
, , O O
with IN B-VP O
chronic JJ B-NP O
alveolar JJ I-NP O
disease NN I-NP O
versus IN B-VP O
new JJ B-NP O
fusions NNS I-NP O
, , O O
I PRP O O
cannot VBP O O
rule VB O O
out RP O O
infiltrate JJ B-NP O
Abdominal NNP I-NP O
CT NNP I-NP O
shows VBZ O O
small JJ B-NP O
bowel NN I-NP O
wall NN I-NP O
thickening NN I-NP O
and CC O O
left-sided JJ B-NP O
atelectasis NN I-NP O
versus NN I-NP O
pneumonia NN I-NP O
PROCEDURES: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
intubation NN I-NP O
and CC O O
extubation NN B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Infectious NNP B-NP O
disease: NN I-NP O
Ms NNP I-NP O
Dozois NNP I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
fever NN B-NP O
and CC O O
hypertension NN B-NP O
, , O O
and CC O O
I PRP O O
was VBD B-VP O
concerned VBN O O
for IN B-VP O
sepsis NN B-NP O
, , O O
I PRP O O
initially RB O O
thought VBD B-VP O
nosocomial JJ B-NP O
pneumonia NN I-NP O
versus NN I-NP O
GI NNP I-NP O
as IN B-VP O
the DT B-NP O
primary JJ I-NP O
source NN I-NP O
She PRP O O
required VBD B-VP O
intubation NN B-NP O
and CC O O
pressors NNS B-NP O
, , O O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-m
, , O O
Levaquin NNP B-NP B-m
, , O O
and CC O O
aztreonam RB O B-m
along IN B-VP O
with IN B-VP O
Flagyl NNP B-NP B-m
empirically RB O O
Her PRP$ O O
urine NN B-NP O
grew VBD B-VP O
Enterococcus NNP B-NP O
and CC O O
she PRP O O
was VBD B-VP O
changed VBN O O
to TO O O
Levaquin NNP B-NP B-m
Levaquin NNP I-NP B-m
only RB O O
on IN B-VP O
10/25/2005 CD O O
to TO O O
treat VB O O
an DT B-NP B-r
enterococcal JJ I-NP I-r
UTI NNP I-NP I-r
and CC O O
possible JJ B-NP B-r
nosocomial JJ I-NP O
pneumonia NN I-NP O
An DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
which WDT O O
shows VBZ O O
small JJ B-NP O
bowel NN I-NP O
wall NN I-NP O
thickening NN I-NP O
and CC O O
injection NN B-NP O
of IN B-VP O
the DT B-NP O
SMA NNP I-NP O
territory NN I-NP O
concerning VBG O O
for IN B-VP O
a DT B-NP B-r
neutropenic JJ I-NP I-r
enteritis NN I-NP I-r
Surgery NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
she PRP O O
was VBD B-VP O
managed VBN O O
conservatively RB O O
with IN B-VP O
antibiotics NNS B-NP B-m
initially RB O O
and CC O O
then RB O O
with IN B-VP O
bowel NN B-NP O
rest NN I-NP O
She PRP O O
is VBZ O O
no RB O O
longer JJR O O
neutropenic JJ O O
and CC O O
was VBD B-VP O
off RB O O
Neupogen NNP B-NP B-m
over IN B-VP O
a DT B-NP O
week NN I-NP O
prior RB O O
to TO O O
discharge VB O O
She PRP O O
was VBD B-VP O
afebrile RB O O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
and CC O O
will MD O O
stay VB O O
and CC O O
finish VB O O
the DT B-NP O
14-day JJ I-NP B-du
course NN I-NP I-du
of IN B-VP O
Levaquin NNP B-NP B-m
for IN B-VP O
UTI NNP B-NP B-r
2 CD O O
GI: NNP B-NP O
Ms NNP I-NP O
Lorts NNP I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
bowel NN B-NP O
rest NN I-NP O
for IN B-VP O
her PRP$ O O
neutropenic JJ B-NP O
enteritis NN I-NP O
and CC O O
once RB O O
she PRP O O
was VBD B-VP O
no RB O O
longer JJR O O
neutropenic JJ O O
without IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
clear JJ B-NP O
liquid NN I-NP O
diet NN I-NP O
However RB O O
, , O O
she PRP O O
developed VBD B-VP O
intermittent JJ B-NP O
GI NNP I-NP O
bleed NN I-NP O
, , O O
secondary JJ O O
to TO O O
likely JJ B-NP O
sloughing NN I-NP O
of IN B-VP O
her PRP$ O O
mucosa NN B-NP O
status NN I-NP O
post NN I-NP O
neutropenic JJ B-NP O
enteritis NN I-NP O
GI NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
she PRP O O
was VBD B-VP O
again RB O O
placed VBN O O
on IN B-VP O
bowel NN B-NP O
rest NN I-NP O
Though IN B-VP O
, , O O
she PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
colonic JJ B-NP O
polyps NNS I-NP O
, , O O
GI NNP B-NP O
also RB O O
felt VBD B-VP O
that IN B-VP O
the DT B-NP O
culprit NN I-NP O
of IN B-VP O
her PRP$ O O
GI NNP B-NP O
bleed NN I-NP O
is VBZ O O
mucosal JJ O O
sloughing VBG O O
as RB O O
well RB O O
She PRP O O
continued VBD B-VP O
to TO O O
have VB O O
intermittent JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
bloody NN B-NP O
diarrhea NN I-NP O
whenever WRB O O
she PRP O O
was VBD B-VP O
re VBG O O
challenged VBN O O
with IN B-VP O
p.o JJ O O
intake VB O O
Her PRP$ O O
C-diff NNP B-NP O
is VBZ O O
negative JJ B-NP O
Colonoscopy NNP I-NP O
was VBD B-VP O
deferred VBN O O
secondary JJ O O
to TO O O
thrombocytopenia VB O O
She PRP O O
required JJ B-NP O
multiple JJ I-NP B-do
red JJ I-NP B-m
blood NN I-NP I-m
transfusions NNS I-NP I-m
to TO O O
maintain VB O O
her PRP$ O B-r
hematocrit NN B-NP I-r
greater JJR O O
than IN B-VP O
26 CD O O
, , O O
though IN B-VP O
she PRP O O
was VBD B-VP O
never RB O O
hemodynamically RB O O
unstable JJ B-NP O
Finally NNP I-NP O
, , O O
after IN B-VP O
given VBN O O
sustained VBD B-VP O
bowel JJ B-NP O
rest NN I-NP O
, , O O
her PRP$ O O
blood NN B-NP O
stools NNS I-NP O
resolved VBD B-VP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
able JJ O O
to TO O O
tolerate VB O O
oral JJ B-NP O
contrast NN I-NP O
and CC O O
an DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
on IN B-VP O
6/30/2005 CD O O
showed VBD B-VP O
no DT B-NP O
small JJ I-NP O
bowel NN I-NP O
wall NN I-NP O
thickening NN I-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
intraabdominal JJ I-NP O
process NN I-NP O
causing VBG O O
her PRP$ O O
symptoms NNS B-NP O
Her PRP$ O O
diet NN B-NP O
was VBD B-VP O
advanced VBN O O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
regular JJ B-NP O
diet NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
without IN B-VP O
problems NNS B-NP O
3 CD O O
COPD: NNP B-NP O
On IN B-VP O
home NN B-NP O
O2 NNP I-NP O
, , O O
typically RB O O
requiring VBG O O
2 CD O O
liters NNS B-NP O
with IN B-VP O
baseline NN B-NP O
sat VBD B-VP O
over IN B-VP O
90s CD O O
Ms NNP B-NP O
Shubrick NNP I-NP O
was VBD B-VP O
intubated VBN O O
on IN B-VP O
admission NN B-NP O
for IN B-VP O
increased JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
hypoxia NN B-NP O
She PRP O O
was VBD B-VP O
extubated VBN O O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
on IN B-VP O
4/16/2005 CD O O
She PRP O O
requires VBZ O O
BiPAP NNP B-NP O
nightly RB O O
, , O O
now RB O O
stable JJ O O
on IN B-VP O
2 CD O O
to TO O O
4 CD O O
liters NNS B-NP O
nasal JJ B-NP O
cannula NN I-NP O
during IN B-VP O
the DT B-NP O
day NN I-NP O
4 CD O O
Heme: NNP B-NP O
On IN B-VP O
chemotherapy NN B-NP B-m
induced VBN O O
anemia IN B-VP B-r
with IN B-VP O
hematocrit JJ B-NP O
drop NN I-NP O
on IN B-VP O
admission NN B-NP O
to TO O O
21 CD O O
from IN B-VP O
the DT B-NP O
baseline NN I-NP O
of IN B-VP O
around IN B-VP O
26 CD O O
She PRP O O
responded VBD B-VP O
well RB O O
initially RB O O
to TO O O
three CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
over IN B-VP O
7/28/2005 CD O O
and CC O O
09 CD O O
However RB O O
, , O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
her PRP$ O O
GI NNP B-NP O
bleed NN I-NP O
from IN B-VP O
a DT O O
sloughing VBG O O
mucosa NN B-NP O
secondary JJ O O
to TO O O
resolving VBG O O
neutropenic JJ B-NP O
enteritis NN I-NP O
and CC O O
recent JJ B-NP O
chemo NN I-NP B-m
, , O O
she PRP O O
required VBD B-VP O
multiple RB O B-do
further JJ B-NP O
RBC NNP I-NP B-m
transfusions NNS I-NP O
to TO O O
keep VB O O
her PRP$ O O
hematocrit NN B-NP B-r
greater JJR O O
than IN B-VP O
30 CD O O
She PRP O O
was VBD B-VP O
also RB O O
thrombocytopenic JJ O O
, , O O
status NN B-NP O
post NN I-NP O
chemo NN I-NP O
and CC O O
required VBN O O
multiple JJ B-NP B-do
platelet NN I-NP B-m
transfusions NNS I-NP I-m
to TO O O
keep VB O O
her PRP$ O O
platelets NNS B-NP O
greater JJR O O
than IN B-VP O
30 CD O O
, , O O
000 CD O O
Hematology NNP B-NP O
was VBD B-VP O
consulted VBN O O
secondary JJ O O
to TO O O
suboptimal VB O O
busted JJ B-NP O
platelet NN I-NP O
levels NNS I-NP O
status NN I-NP O
post NN I-NP O
transfusions NNS I-NP O
, , O O
which WDT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
poor JJ B-NP O
marrow NN I-NP O
response NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
recent JJ B-NP O
chemo NN I-NP B-m
( ( O O
workup NN B-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
other JJ B-NP O
possible JJ I-NP O
causes NNS I-NP O
refractory JJ B-NP O
thrombocytopenia NN I-NP O
, , O O
nystatin NN B-NP B-m
, , O O
allopurinol NN B-NP B-m
, , O O
were VBD B-VP O
held VBN O O
given VBN O O
possible JJ B-NP O
worsening NN I-NP O
of IN B-VP O
her PRP$ O O
thrombocytopenia NN B-NP B-r
thrombocytopenia NN I-NP B-r
) ) O O
On IN B-VP O
discharge NN B-NP O
her PRP$ O O
hematocrit NN B-NP O
and CC O O
platelets NNS B-NP O
were VBD B-VP O
stable JJ O O
respectively RB O O
at IN B-VP O
29.8 CD O O
and CC O O
46 CD O O
, , O O
000 CD O O
and CC O O
she PRP O O
had VBD B-VP O
not RB O O
required VBN O O
a DT B-NP O
transfusion NN I-NP O
in IN B-VP O
greater JJR O O
than IN B-VP O
24 CD O O
hours NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
5 CD O O
Acute NNP B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure: NN I-NP O
The DT B-NP O
patient's NN I-NP O
baseline NN I-NP O
creatine NN I-NP O
is VBZ O O
1.7; CD O O
however RB O O
, , O O
on IN B-VP O
admission NN B-NP O
it PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
3 CD O O
, , O O
likely RB O O
secondary JJ O O
to TO O O
hypovolemia VB O O
from IN B-VP O
vomiting VBG O O
and CC O O
diarrhea NN B-NP O
( ( O O
FENa NNP B-NP O
was VBD B-VP O
0.22% CD O O
) ) O O
Her PRP$ O O
creatinine NN B-NP O
is VBZ O O
now RB O O
back RB O O
to TO O O
baseline VB O O
with IN B-VP O
hydration NN B-NP O
Her NNP I-NP O
creatinine NN I-NP O
was VBD B-VP O
1.1 CD O O
prior RB O O
to TO O O
discharge VB O O
6 CD O O
Nonsmall NNP B-NP O
cell NN I-NP O
lung NN I-NP O
cancer: VBP O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
Alimta NNP B-NP B-m
started VBD B-VP O
for IN B-VP O
her PRP$ O B-r
neutropenia NN B-NP I-r
, , O O
which WDT O O
has VBZ O O
since IN B-VP O
resolved VBN O O
She PRP O O
will MD O O
follow VB O O
with IN B-VP O
her PRP O O
oncologist JJ B-NP O
Dr NNP I-NP O
Ervin NNP I-NP O
Tonrey NNP I-NP O
for IN B-VP O
further JJ B-NP O
therapy NN I-NP O
7 CD O O
Endocrine: NNP B-NP O
Because IN B-VP O
of IN B-VP O
her PRP$ O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
portland NN B-NP O
protocol NN I-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
stress NN I-NP O
dose JJ B-NP O
Steroids NNP I-NP B-m
were VBD B-VP O
discontinued VBN O O
on IN B-VP O
10/25/2005 CD O O
and CC O O
she PRP O O
passed VBD B-VP O
a DT B-NP O
cortisol JJ I-NP B-m
stimulation NN I-NP O
test NN I-NP O
on IN B-VP O
10/25/2005 CD O O
as RB O O
well RB O O
She PRP O O
was VBD B-VP O
changed VBN O O
to TO O O
standing VBG O O
insulin NN B-NP B-m
on IN B-VP O
10/25/2005 CD O O
and CC O O
her PRP$ O O
Lantus NN B-NP B-m
was VBD B-VP O
up RB O B-do
titrated VBN O I-do
along IN B-VP O
with IN B-VP O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
to TO O O
maintain VB O O
blood NN B-NP B-r
blood NN I-NP B-r
blood NN I-NP B-r
sugars NNS I-NP I-r
sugars VBZ O I-r
sugars NNS B-NP I-r
in IN B-VP O
the DT O O
80s CD O O
to TO O O
120s CD O O
She PRP O O
will MD O O
return VB O O
home NN B-NP O
on IN B-VP O
her PRP$ O O
home NN B-NP B-m
regimen NNS I-NP I-m
8 CD O O
FEN: NNP B-NP O
TPN NNP I-NP B-m
was VBD B-VP O
started VBN O O
on IN B-VP O
4/21/2005 CD O O
, , O O
given VBN O O
her PRP$ O B-r
bowel NN B-NP I-r
rest NN I-NP I-r
for IN B-VP O
possible JJ B-NP O
neutropenic JJ I-NP O
enteritis NN I-NP O
She PRP O O
restarted VBD B-VP O
p.o JJ B-NP O
intake NN I-NP O
on IN B-VP O
9/2/2005 CD O O
and CC O O
tolerated VBD B-VP O
advancement NN B-NP O
to TO O O
diabetic JJ B-NP O
diet NN I-NP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
weaned VBN O O
off RP O O
her PRP$ O O
TPN NNP B-NP B-m
prior NN I-NP O
to TO O O
discharge VB O O
CONSULTANTS: NNP B-NP O
General NNP I-NP O
Surgery NNP I-NP O
, , O O
Hematology NNP B-NP O
, , O O
and CC O O
Gastroenterology NNP B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
AT NNP I-NP O
DISCHARGE: NNP I-NP O
Vital NNP I-NP O
signs: VBD B-VP O
T NNP B-NP O
max NN I-NP O
98 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
120/60 CD O O
, , O O
pulse RB O O
88 CD O O
, , O O
and CC O O
respirations NNS B-NP O
20 CD O O
sating VBG O O
at IN B-VP O
95% CD O O
on IN B-VP O
3.5 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
General NNP I-NP O
exam NN I-NP O
shows VBZ O O
an DT B-NP O
obese JJ I-NP O
female NN I-NP O
resting NN I-NP O
and CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Nasal NNP I-NP O
cannula NN I-NP O
in IN B-VP O
place NN B-NP O
HEENT NNP I-NP O
Exam NNP I-NP O
was VBD B-VP O
normocephalic JJ O O
, , O O
atraumatic JJ B-NP O
Pulmonary NNP I-NP O
exam NN I-NP O
showed VBD B-VP O
decreased JJ B-NP O
air NN I-NP O
entry NN I-NP O
, , O O
decreased VBN O O
breath NN B-NP O
sounds NNS I-NP O
, , O O
but CC O O
otherwise RB O O
no DT B-NP O
obvious JJ I-NP O
wheezes NNS I-NP O
or CC O O
rhonchi VB O O
Cardiovascular JJ B-NP O
exam NN I-NP O
shows NNS I-NP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
, , O O
or CC O O
gallops NNS B-NP O
, , O O
but CC O O
decreased VBD B-VP O
heart NN B-NP O
sounds VBZ O O
Abdominal NNP B-NP O
exam NN I-NP O
shows VBZ O O
an DT B-NP O
obese JJ I-NP O
abdomen NNS I-NP O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities NNP B-NP O
show VBP O O
1 CD O O
to TO O O
2+ CD O O
edema NNS B-NP O
bilaterally RB O O
to TO O O
the DT B-NP O
knee NN I-NP O
Skin NNP I-NP O
exam NN I-NP O
shows VBZ O O
a DT B-NP O
area NN I-NP O
where WRB O O
left VBD B-VP O
internal JJ B-NP O
jugular JJ I-NP O
line NN I-NP O
was VBD B-VP O
removed VBN O O
and CC O O
the DT B-NP O
site NN I-NP O
is VBZ O O
intact JJ O O
and CC O O
dressed JJ B-NP O
Improved NNP I-NP O
erythema NN I-NP O
in IN B-VP O
her PRP$ O O
intertriginous JJ B-NP O
areas NNS I-NP O
Neurologic NNP I-NP O
exam NN I-NP O
shows VBZ O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
without IN B-VP O
any DT B-NP O
focal JJ I-NP O
neurologic NN I-NP O
deficits VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
and CC O O
she PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Marco NNP I-NP O
Derosset NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Tylenol NNP I-NP B-m
Tylenol NNP I-NP B-m
Tylenol NNP I-NP B-m
650 CD O B-do
650 CD O B-do
650 CD O B-do
to TO O I-do
to TO O I-do
to TO O I-do
1000 CD O I-do
1000 CD O I-do
1000 CD O I-do
mg NN B-NP I-do
mg NN I-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
p.o NN I-NP B-mo
q NN I-NP B-f
q NN I-NP B-f
q VBD B-VP B-f
6h CD O I-f
6h CD O I-f
6h CD O I-f
p.r.n NN B-NP I-f
p.r.n NN I-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
headache NN B-NP B-r
, , O O
if IN B-VP O
fever NN B-NP B-r
is VBZ O O
greater JJR O O
than IN B-VP O
101 CD O O
, , O O
Peridex NNP B-NP B-m
mouth VBD B-VP I-m
wash JJ O I-m
10 CD O B-do
mL NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
nystatin RB O B-m
mouth JJ B-NP I-m
wash NN I-NP I-m
10 CD O B-do
mL NN B-NP I-do
swish NN I-NP B-mo
and CC O I-mo
swallow VB O I-mo
4 CD O B-f
x JJ B-NP O
day NN I-NP O
as IN B-VP O
needed VBN O O
, , O O
oxycodone PRP O B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
6h CD O I-f
p.r.n NN B-NP I-f
pain NN I-NP B-r
, , O O
simethicone NN B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
p.r.n NN I-NP I-f
gaseousness NN I-NP B-r
, , O O
trazodone NN B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
miconazole JJ B-NP B-m
nitrate NN I-NP I-m
2% CD O I-m
powder NN B-NP I-m
topical JJ B-NP B-mo
b.i.d NN I-NP B-f
to TO O O
areas NNS B-NP O
between IN B-VP O
skin NN B-NP O
folds NNS I-NP O
including VBG O O
under IN B-VP O
the DT B-NP O
right JJ I-NP O
breast NN I-NP O
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lantus NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
subcutaneous JJ O B-mo
daily RB O B-f
, , O O
DuoNeb NNP B-NP B-m
3/0.5 CD O B-do
mg NN B-NP O
Nebs NNP I-NP B-mo
q VBZ O B-f
3 CD O I-f
h NN B-NP I-f
p.r.n NN I-NP I-f
shortness NN I-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
, , O O
aspart RB O B-m
4 CD O B-do
units NNS B-NP I-do
before IN B-VP B-f
each DT B-NP O
meal NN I-NP O
subcutaneously RB O B-mo
, , O O
folate VB O B-m
3 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Avapro NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
meclizine PRP O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Combivent NNP B-NP B-m
2 CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d NN B-NP B-f
, , O O
vitamin NN B-NP B-m
D NNP I-NP I-m
125 CD O I-m
0.25 CD O B-do
mcg NNS B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
eScription NN I-NP O
document: VBZ O O
5-0185679 JJ B-NP O
AFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SPAHN NNP I-NP O
, , O O
LELAND NNP B-NP O
Attending: NNP I-NP O
SCHEURING NNP I-NP O
, , O O
WILLY NNP B-NP O
LYMAN NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
2453716 CD O O
D: NNP B-NP O
6/13/05 CD O O
T: NNP B-NP O
10/30/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#916765 VBZ O O
970021603 CD O O
ALEH NNP B-NP O
38063617 CD O O
188368 CD O O
11/10/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
AORTIC NNP I-NP O
VALVE NNP I-NP O
DISEASE NNP I-NP O
, , O O
MITRAL NNP B-NP O
VALVE NNP I-NP O
DISEASE NNP I-NP O
, , O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/10/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/10/1997 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Vendetti NNP I-NP O
is VBZ O O
a DT O O
61 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
surgical JJ I-NP O
service NN I-NP O
on IN B-VP O
0/14/97 CD O O
for IN B-VP O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
, , O O
mitral JJ O O
valve FW O O
replacement NN B-NP O
He PRP O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
that WDT O O
demonstrated VBD B-VP O
a DT B-NP O
dilated JJ I-NP O
left NN I-NP O
ventricle NN I-NP O
and CC O O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
with IN B-VP O
moderate JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
with IN B-VP O
moderate JJ O O
to TO O O
severe VB O O
aortic JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
peak JJ I-NP O
gradient NN I-NP O
of IN B-VP O
35 CD O O
millimeters NNS B-NP O
of IN B-VP O
mercury NN B-NP O
, , O O
mild NN B-NP O
to TO O O
moderate VB O O
mitral JJ B-NP O
stenosis NN I-NP O
and CC O O
moderate JJ B-NP O
mitral JJ I-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
mitral JJ I-NP O
valve JJ I-NP O
area NN I-NP O
of IN B-VP O
1.1 CD O O
cm NN B-NP O
squared VBD B-VP O
He PRP O O
has VBZ O O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
rheumatic JJ B-NP O
heart NN I-NP O
disease VB O O
His PRP$ O O
cardiac JJ B-NP O
catheterization NN I-NP O
on IN B-VP O
4/21/97 CD O O
demonstrated VBD B-VP O
a DT O O
95% CD O O
proximal JJ B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
lesion NN I-NP O
and CC O O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
50% CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Included NNP I-NP O
rheumatic JJ B-NP O
heart NN I-NP O
disease NN I-NP O
and CC O O
hypertension NN B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Is VBZ O O
none JJ B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Former NNP I-NP O
smoker; VBD B-VP O
twenty NN B-NP O
pack NN I-NP O
year NN I-NP O
history NN I-NP O
MEDICATIONS: NNP I-NP O
On IN B-VP O
admission NN B-NP O
are VBP O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
50 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
aspirin NN B-NP B-m
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
and CC O O
Zocor NNP B-NP B-m
50 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
Unremarkable NNP I-NP O
except IN B-VP O
for IN B-VP O
a DT O O
3/6 CD O O
diastolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
and CC O O
a DT O O
3 CD O O
to TO O O
4/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT O O
lower JJR O O
left VBD B-VP O
sternal JJ B-NP O
border NN I-NP O
LABORATORY: NNP I-NP O
Were NNP I-NP O
all DT O O
normal JJ O O
, , O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
He PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
5/16/97 CD O O
where WRB O O
he PRP O O
had VBD B-VP O
a DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
replacement NN I-NP O
with IN B-VP O
a DT B-NP O
#31 JJ I-NP O
St NNP I-NP O
Jude NNP I-NP O
mechanical JJ B-NP O
prosthesis NN I-NP O
and CC O O
an DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
replacement NN I-NP O
with IN B-VP O
a DT B-NP O
#25 JJ I-NP O
St NNP I-NP O
Jude NNP I-NP O
mechanical JJ B-NP O
prosthesis NN I-NP O
and CC O O
a DT B-NP O
right JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
to TO O O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
complications NNS I-NP O
He PRP O O
is VBZ O O
being VBG O O
discharged VBN O O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
four CD O O
without IN B-VP O
complications NNS B-NP O
He PRP O O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
for IN B-VP B-du
two CD O I-du
days NNS B-NP I-du
with IN B-VP O
potassium NN B-NP B-m
, , O O
K-Dur NNP B-NP B-m
tabs VBZ O I-m
10 CD O B-do
mEq NN B-NP I-do
once RB O B-f
a DT B-NP O
day NN I-NP O
for IN B-VP B-du
two CD O I-du
days NNS B-NP I-du
with IN B-VP O
Lasix NNP B-NP B-m
, , O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
one CD O I-do
tab NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
or CC O O
as IN B-VP O
directed VBN O O
The DT B-NP O
Coumadin NNP I-NP B-m
has VBZ O O
been VBN O O
restarted VBN O O
for IN B-VP O
right JJ B-NP B-r
leg NN I-NP I-r
DVT NNP I-NP I-r
that WDT O O
was VBD B-VP O
discovered VBN O O
post NN B-NP O
cardiac JJ B-NP O
catheterization NN I-NP O
and CC O O
is VBZ O O
to TO O O
be VB O O
continued VBN O O
for IN B-VP B-du
a DT B-NP I-du
total NN I-NP I-du
of IN B-VP I-du
three CD O I-du
months NNS B-NP I-du
Percocet NNP I-NP B-m
is VBZ O O
one CD O B-do
tab NN B-NP I-do
q.4h NN I-NP B-f
prn NN I-NP I-f
for IN B-VP O
pain NN B-NP B-r
and CC O O
he PRP O O
is VBZ O O
being VBG O O
discharged VBN O O
to TO O O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Sterling NNP I-NP O
Goodson NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CLIFFORD NNP I-NP O
GASCOIGNE NNP I-NP O
, , O O
P.A NNP B-NP O
Attending: NNP I-NP O
LUIS NNP I-NP O
O NNP I-NP O
HEMPE NNP I-NP O
, , O O
M.D NNP B-NP O
OQ0 NNP I-NP O
GF827/5167 NNP I-NP O
Batch: NNP I-NP O
14692 CD O O
Index NNP B-NP O
No NNP I-NP O
A7KPYH929V NNP I-NP O
D: NNP I-NP O
10/22/97 CD O O
T: NNP B-NP O
9/15/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#916948 VBZ O O
976430219 CD O O
TMMC NNP B-NP O
90625216 CD O O
905629 CD O O
9/15/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
ATRIAL NNP I-NP O
FIBRILLATION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/23/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/12/2002 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
CONGESTIVE NNP B-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
2 CD O O
ATRIAL NNP B-NP O
FIBRILLATION NNP I-NP O
3 CD O O
URINARY NNP B-NP O
TRACT NNP I-NP O
INFECTION NNP I-NP O
4 CD O O
DIABETES NNP B-NP O
MELLITUS NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
70-year-old JJ I-NP O
woman NN I-NP O
who WP O O
was VBD B-VP O
followed VBN O O
in IN B-VP O
cardiology NN B-NP O
by IN B-VP O
Dr NNP B-NP O
Pikula NNP I-NP O
who WP O O
has VBZ O O
presumed VBN O O
diastolic JJ B-NP O
dysfunction NN I-NP O
, , O O
who WP O O
was VBD B-VP O
in IN B-VP O
her PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
5/12 CD O O
, , O O
when WRB O O
she PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Dobubay NNP I-NP O
Naicent NNP I-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
with IN B-VP O
a DT B-NP O
flare NN I-NP O
of IN B-VP O
Crohn's NNP B-NP O
ileitis NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
discharge NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
not RB O O
restarted VBN O O
on IN B-VP O
her PRP$ O O
Lasix NNP B-NP O
and CC O O
subsequently RB O O
developed VBD B-VP O
fluid JJ B-NP O
retention NN I-NP O
with IN B-VP O
gradual JJ B-NP O
worsening NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
lower JJR B-NP O
extremity NN I-NP O
edema VBP O O
The DT B-NP O
patient NN I-NP O
noted VBD B-VP O
a DT O O
20 CD O O
lb NN B-NP O
weight VBD B-VP O
gain NN B-NP O
during IN B-VP O
this DT B-NP O
period NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
increasing VBG O O
orthopnea NN B-NP O
and CC O O
increasing VBG O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
when WRB O O
getting VBG O O
dressed VBN O O
or CC O O
doing VBG O O
any DT B-NP O
different JJ I-NP O
movements NNS I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
cardiology NN B-NP O
clinic NN I-NP O
on IN B-VP O
4/7/02 CD O O
and CC O O
found VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
much JJ B-NP O
worse JJR I-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
new JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
then RB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
here RB O O
at IN B-VP O
the DT B-NP O
Peresvillee NNP I-NP O
Nawvine NNP I-NP O
University NNP I-NP O
Of IN B-VP O
Hospitals NNP B-NP O
And CC O O
Clinics NNP B-NP O
Her NNP I-NP O
most RBS O O
recent JJ B-NP O
echocardiogram NN I-NP O
on IN B-VP O
11/18/01 CD O O
revealed VBD B-VP O
mild NN B-NP O
to TO O O
moderate VB O O
left JJ B-NP O
ventricular JJ I-NP O
hypertrophy NN I-NP O
without IN B-VP O
any DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities VBZ O O
Her NNP B-NP O
systolic JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
was VBD B-VP O
estimated VBN O O
to TO O O
be VB O O
60% CD O O
suggesting VBG O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
diastolic JJ B-NP O
dysfunction NN I-NP O
and CC O O
heart NN B-NP O
failure NN I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
volume NN B-NP O
overload NN I-NP O
for IN B-VP O
diuresis NN B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
review NN I-NP O
of IN B-VP O
symptoms NNS B-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
chest JJS B-NP O
tightness NN I-NP O
with IN B-VP O
occasional JJ B-NP O
palpitations NNS I-NP O
She PRP O O
experienced VBD B-VP O
no DT B-NP O
dizziness NN I-NP O
, , O O
no DT B-NP O
syncope NN I-NP O
and CC O O
no DT B-NP O
recent JJ I-NP O
diarrhea NN I-NP O
, , O O
no DT B-NP O
abdominal JJ I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
nausea NN I-NP O
or CC O O
vomiting VBG O O
She PRP O O
did VBD B-VP O
report VB O O
chronic NN B-NP O
arthritis IN B-VP O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
( ( O O
1 CD O O
) ) O O
Significant NN B-NP O
for IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
due JJ O O
to TO O O
diastolic JJ B-NP O
dysfunction NN I-NP O
, , O O
( ( O O
2 CD O O
) ) O O
Crohn's NNP B-NP O
colitis NN I-NP O
diagnosed VBD B-VP O
in IN B-VP O
1963 CD O O
, , O O
( ( O O
3 CD O O
) ) O O
Right NNP B-NP O
breast NN I-NP O
carcinoma NN I-NP O
stage NN I-NP O
II NNP I-NP O
previously RB O O
treated VBD B-VP O
, , O O
not RB O O
currently RB O O
active JJ O O
, , O O
( ( O O
4 CD O O
) ) O O
Diabetes NNPS B-NP O
mellitus NN I-NP O
, , O O
( ( O O
5 CD O O
) ) O O
Obstructive CD O O
sleep JJ B-NP O
apnea NN I-NP O
, , O O
( ( O O
6 CD O O
) ) O O
Gastroesophageal NNP B-NP O
reflux NN I-NP O
disease NN I-NP O
, , O O
( ( O O
7 CD O O
) ) O O
Hypercholesterolemia NN B-NP O
, , O O
( ( O O
8 CD O O
) ) O O
Osteoarthritis NNP B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
prior JJ I-NP O
tobacco NN I-NP O
smoker NN I-NP O
, , O O
having VBG O O
smoked VBN O O
two CD O O
packs NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
38 CD O O
years NNS B-NP O
, , O O
but CC O O
has VBZ O O
quit VBN O O
She PRP O O
does VBZ O O
not RB O O
drink VB O O
alcohol NN B-NP O
and CC O O
does VBZ O O
not RB O O
use VB O O
any DT B-NP O
recreational JJ I-NP O
drugs NNS I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
in IN B-VP O
Di NNP B-NP O
with IN B-VP O
a DT B-NP O
friend NN I-NP O
and CC O O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
x-ray JJ I-NP O
technician JJ I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
medical JJ B-NP O
allergies NNS I-NP O
include VBP O O
penicillin NN B-NP O
, , O O
which WDT O O
causes VBZ O O
a DT B-NP O
rash NN I-NP O
, , O O
Demerol NNP B-NP O
and CC O O
Dilaudid NNP B-NP O
causing VBG O O
nausea NN B-NP O
, , O O
and CC O O
Macrodantin NNP B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
VITAL NNP I-NP O
SIGNS: NNP I-NP O
Included VBD B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
97 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
76 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
90/60 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
28 CD O O
, , O O
and CC O O
a DT B-NP O
saturation NN I-NP O
of IN B-VP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
GENERAL: NNP I-NP O
Physical NNP I-NP O
examination NN I-NP O
showed VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
, , O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
, , O O
having VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
while IN B-VP O
sitting VBG O O
up RP O O
in IN B-VP O
bed NN B-NP O
HEENT: NNP I-NP O
Normocephalic NNP I-NP O
, , O O
atraumatic JJ O O
, , O O
pupils JJ O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
, , O O
extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
NECK: NNP I-NP O
Showed NNP I-NP O
jugular JJ B-NP O
venous JJ I-NP O
distention NN I-NP O
to TO O O
at IN B-VP O
least JJS O O
20 CD O O
cm NN B-NP O
CHEST: NNP I-NP O
Showed NNP I-NP O
crackles VBZ O O
posteriorly RB O O
approximately RB O O
half NN B-NP O
of IN B-VP O
the DT B-NP O
way NN I-NP O
up RP O O
CARDIOVASCULAR: NNP B-NP O
Showed NNP I-NP O
an DT B-NP O
irregular JJ I-NP O
rhythm NN I-NP O
and CC O O
a DT B-NP O
systolic JJ I-NP O
ejection NN I-NP O
murmur FW O O
consistent NN B-NP O
with IN B-VP O
the DT B-NP O
prior JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
aortic JJ B-NP O
stenosis NN I-NP O
ABDOMEN: NNP I-NP O
Showed NNP I-NP O
profound IN B-VP O
obesity NN B-NP O
EXTREMITIES: NNP I-NP O
Showed NNP I-NP O
significant JJ O O
pitting VBG O O
edema NN B-NP O
bilaterally RB O O
over IN B-VP O
the DT B-NP O
calves NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Showed VBD B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
7 CD O O
, , O O
hematocrit NN B-NP O
31 CD O O
, , O O
platelets NNS B-NP O
of IN B-VP O
148 CD O O
Sodium NNP B-NP O
was VBD B-VP O
142 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
BUN NNP B-NP O
56 CD O O
, , O O
creatinine NN B-NP O
1.3 CD O O
, , O O
with IN B-VP O
a DT B-NP O
glucose NN I-NP O
of IN B-VP O
75 CD O O
Liver NNP B-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
normal JJ B-NP O
CK NNP I-NP O
was VBD B-VP O
44 CD O O
and CC O O
troponin NN B-NP O
was VBD B-VP O
0.02 CD O O
A NNP B-NP O
chest NN I-NP O
x-ray NN I-NP O
showed VBD B-VP O
mild JJ B-NP O
pulmonary JJ I-NP O
vascular JJ I-NP O
congestion NN I-NP O
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
infiltrates NNS B-NP O
EKG NNP I-NP O
showed VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
72 CD O O
, , O O
otherwise RB O O
no DT B-NP O
abnormalities NNS I-NP O
beside VBP O O
some DT B-NP O
nonspecific JJ I-NP O
ST-T JJ I-NP O
wave NN I-NP O
changes NNS I-NP O
Urinalysis NNP I-NP O
showed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
an DT B-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
with IN B-VP O
20-30 JJ B-NP O
white JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
and CC O O
was VBD B-VP O
leukocyte JJ B-NP O
esterase NN I-NP O
positive JJ B-NP O
Urine NNP I-NP O
culture NN I-NP O
was VBD B-VP O
sent VBN O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Congestive NNP B-NP B-r
Congestive NNP I-NP B-r
heart NN I-NP I-r
heart NN I-NP I-r
failure NN I-NP I-r
failure NN I-NP I-r
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
along IN B-VP O
with IN B-VP O
Zaroxolyn NNP B-NP B-m
and CC O O
responded VBD B-VP O
with IN B-VP O
a DT B-NP O
brisk JJ I-NP O
diuresis NN I-NP O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
the DT B-NP O
admission NN I-NP O
The DT B-NP O
patient's NN I-NP O
weight NN I-NP O
declined VBN O O
by IN B-VP O
approximately RB O O
5.2 CD O O
kg VBD B-VP O
It PRP O O
was VBD B-VP O
estimated VBN O O
that IN B-VP O
the DT B-NP O
total JJ I-NP O
volume NN I-NP O
of IN B-VP O
fluid NN B-NP O
removed VBN O O
was VBD B-VP O
approximately RB O O
15 CD O O
liters NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
reported VBN O O
great JJ B-NP O
improvement NN I-NP O
in IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
, , O O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
without IN B-VP O
requiring VBG O O
supplemental JJ B-NP O
oxygen NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
switched VBN O O
to TO O O
oral JJ B-NP B-mo
Lasix NNP I-NP B-m
and CC O O
continued VBD B-VP O
her PRP O B-r
diuresis NN B-NP O
The DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
switched VBN O O
to TO O O
oral JJ B-NP B-mo
torsemide NN I-NP B-m
, , O O
and CC O O
she PRP O O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
that DT B-NP B-m
medication NN I-NP I-m
2 CD O O
Atrial NNP B-NP O
fibrillation NN I-NP O
- : O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
new JJ O O
onset VBN O O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
while IN B-VP O
being VBG O O
seen VBN O O
in IN B-VP O
cardiology NN B-NP O
clinic NN I-NP O
on IN B-VP O
4/7/02 CD O O
Since IN B-VP O
it PRP O O
was VBD B-VP O
not RB O O
known VBN O O
how WRB O O
long JJ O O
the DT B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
had VBD B-VP O
been VBN O O
going VBG O O
on IN B-VP O
, , O O
a DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
anticoagulate VB O O
the DT B-NP O
patient NN I-NP O
She PRP O O
was VBD B-VP O
initially RB O O
started VBN O O
on IN B-VP O
intravenous JJ B-NP B-mo
unfractionated JJ I-NP O
heparin NN I-NP B-m
while IN B-VP O
starting VBG O O
anticoagulation NN B-NP B-r
with IN B-VP O
Coumadin NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
reached VBD B-VP O
a DT B-NP O
therapeutic JJ I-NP O
INR NNP I-NP O
of IN B-VP O
2.5 CD O O
within IN B-VP O
approximately RB O O
4-5 JJ B-NP O
days NNS I-NP O
and CC O O
the DT B-NP O
IV NNP I-NP B-mo
heparin NN I-NP B-m
was VBD B-VP O
discontinued VBN O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
INR NNP I-NP O
was VBD B-VP O
3.2 CD O O
She PRP O O
will MD O O
have VB O O
INR NNP B-NP O
follow VB O O
up RP O O
through IN B-VP O
her PRP$ O O
primary JJ B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Janousek NNP I-NP O
Currently NNP I-NP O
, , O O
the DT B-NP O
decision NN I-NP O
to TO O O
cardiovert VB O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
left VBN O O
in IN B-VP O
the DT B-NP O
hands NNS I-NP O
of IN B-VP O
her PRP$ O O
outpatient JJ B-NP O
cardiologist NN I-NP O
3 CD O O
Urinary NNP B-NP O
tract NN I-NP O
infection NN I-NP O
- : O O
The DT B-NP O
patient's JJ I-NP O
initial JJ I-NP O
urinalysis NN I-NP O
indicated VBD B-VP O
a DT B-NP B-r
bacterial JJ I-NP I-r
urinary JJ I-NP I-r
tract NN I-NP I-r
infection NN I-NP I-r
Subsequent NNP I-NP O
urine NN I-NP O
culture NN I-NP O
grew VBD B-VP O
out RP O O
E NNP B-NP O
coli NNS I-NP O
, , O O
which WDT O O
was VBD B-VP O
subsequently RB O O
determined VBN O O
to TO O O
be VB O O
resistant JJ O O
to TO O O
levofloxacin VB O B-m
Initially NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
started VBN O O
on IN B-VP O
IV NNP B-NP B-mo
levofloxacin NN I-NP B-m
, , O O
which WDT O O
was VBD B-VP O
subsequently RB O O
changed VBN O O
to TO O O
p.o VB O B-mo
cefixime VB O B-m
The DT B-NP O
patient NN I-NP O
completed VBD B-VP O
a DT B-NP B-du
five-day JJ I-NP I-du
course NN I-NP I-du
of IN B-VP O
p.o JJ B-NP B-mo
cefixime NN I-NP B-m
while IN B-VP O
here RB O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
and CC O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
that DT B-NP B-m
medicine NN I-NP I-m
to TO O O
complete VB O O
a DT B-NP B-du
10-day JJ I-NP I-du
course NN I-NP I-du
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
initial JJ I-NP O
symptoms NNS I-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
including VBG O O
hematuria NN B-NP O
, , O O
resolved VBN O O
by IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
4 CD O O
Diabetes NNPS B-NP B-r
mellitus SYM O I-r
- : O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
requiring VBG O O
insulin NN B-NP B-m
treatment NN I-NP O
She PRP O O
is VBZ O O
followed VBN O O
by IN B-VP O
endocrinologist NN B-NP O
at IN B-VP O
the DT B-NP O
Kingnix NNP I-NP O
Lowemar NNP I-NP O
W.kell NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
During IN B-VP I-du
this DT B-NP I-du
hospitalization NN I-NP O
, , O O
her PRP$ O B-r
blood NN B-NP O
sugars NNS I-NP O
were VBD B-VP O
maintained VBN O O
with IN B-VP O
insulin NN B-NP B-m
subcutaneous JJ B-NP B-mo
injections NNS I-NP I-mo
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
continue VB O O
the DT B-NP O
management NN I-NP O
of IN B-VP O
her PRP$ O O
diabetes NNS B-NP O
per IN B-VP O
her PRP$ O O
endocrinologist NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
( ( O O
1 CD O O
) ) O O
Vitamin NNP B-NP B-m
C NNP I-NP I-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
2 CD O O
) ) O O
ferrous JJ B-NP B-m
sulfate NN I-NP O
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
3 CD O O
) ) O O
insulin NN B-NP B-m
Lente NNP I-NP I-m
subcutaneous JJ O B-mo
30 CD O B-do
U NNP B-NP I-do
q.h.s NN I-NP B-f
, , O O
( ( O O
4 CD O O
) ) O O
insulin NN B-NP B-m
Regular NNP I-NP I-m
subcutaneous JJ O B-mo
30 CD O B-do
U NNP B-NP I-do
q.h.s NN I-NP B-f
, , O O
( ( O O
5 CD O O
) ) O O
Synthroid NNP B-NP B-m
200 CD O B-do
mcg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
6 CD O O
) ) O O
Zaroxolyn VBD B-VP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
( ( O O
7 CD O O
) ) O O
tamoxifen NN B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
( ( O O
8 CD O O
) ) O O
Vitamin NNP B-NP B-m
E NNP I-NP I-m
400 CD O B-do
U NNP B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
9 CD O O
) ) O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
( ( O O
10 CD O O
) ) O O
multivitamins VBZ O B-m
1 CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
11 CD O O
) ) O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
( ( O O
12 CD O O
) ) O O
insulin NN B-NP B-m
70/30 CD O I-m
35 CD O B-do
U NNP B-NP I-do
subcu NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
( ( O O
13 CD O O
) ) O O
Neurontin NNP B-NP B-m
Neurontin NNP I-NP B-m
Neurontin NNP I-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
2:00 CD O O
p.m NN B-NP O
, , O O
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
( ( O O
14 CD O O
) ) O O
Serevent NN B-NP B-m
inhaled VBD B-VP B-mo
1 CD O B-do
puff NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
( ( O O
15 CD O O
) ) O O
torsemide RB O B-m
100 CD O B-do
p.o NN B-NP B-mo
q.a.m NN I-NP B-f
, , O O
( ( O O
16 CD O O
) ) O O
Trusopt $ O B-m
1 CD O B-do
drop NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
( ( O O
17 CD O O
) ) O O
Flonase NNP B-NP B-m
nasal JJ B-NP B-mo
1-2 JJ I-NP B-do
sprays NNS I-NP I-do
b.i.d NN I-NP B-f
, , O O
( ( O O
18 CD O O
) ) O O
Xalatan VBD B-VP B-m
1 CD O B-do
drop NN B-NP I-do
ocular NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
( ( O O
19 CD O O
) ) O O
Pulmicort NNP B-NP B-m
inhaled VBD B-VP B-mo
1 CD O B-do
puff NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
( ( O O
20 CD O O
) ) O O
Celebrex NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
( ( O O
21 CD O O
) ) O O
Avandia NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
22 CD O O
) ) O O
Hyzaar $ O B-m
12.5 CD O I-m
mg/50 NN B-NP I-m
mg NN I-NP I-m
1 CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
23 CD O O
) ) O O
Nexium NN B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
( ( O O
24 CD O O
) ) O O
potassium NN B-NP B-m
chloride NN I-NP O
20 CD O B-do
mEq NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
( ( O O
25 CD O O
) ) O O
Suprax NNP B-NP B-m
400 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
x4 NNP I-NP B-du
days NNS I-NP I-du
, , O O
( ( O O
26 CD O O
) ) O O
albuterol NN B-NP B-m
inhaled VBD B-VP B-mo
2 CD O B-do
puffs NNS B-NP I-do
q.i.d JJ B-NP B-f
p.r.n NN I-NP I-f
wheezing NN I-NP B-r
, , O O
( ( O O
27 CD O O
) ) O O
miconazole NN B-NP B-m
2% CD O I-m
powder NN B-NP I-m
applied VBN O O
topically RB O B-mo
on IN B-VP O
skin NN B-NP O
b.i.d NN I-NP B-f
for IN B-VP O
itching VBG O B-r
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
stable JJ O O
upon IN B-VP O
discharge NN B-NP O
DISCHARGE NNP I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
the DT O O
following VBG O O
services: NN B-NP O
( ( O O
1 CD O O
) ) O O
Visiting VBG O O
nurse NN B-NP O
on IN B-VP O
Wednesday NNP B-NP O
, , O O
2/11/02 CD O O
, , O O
who WP O O
will MD O O
send VB O O
blood NN B-NP O
for IN B-VP O
INR NNP B-NP O
and CC O O
a DT O O
basic JJ O O
metabolic JJ O O
seven CD O O
panel NN B-NP O
to TO O O
be VB O O
sent VBN O O
to TO O O
Dr NNP B-NP O
Silsbee NNP I-NP O
, , O O
her PRP$ O O
primary JJ B-NP O
cardiologist NN I-NP O
( ( O O
2 CD O O
) ) O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
an DT B-NP O
appointment NN I-NP O
scheduled VBN O O
with IN B-VP O
Dr NNP B-NP O
Sedgwick NNP I-NP O
on IN B-VP O
0/10/02 CD O O
at IN B-VP O
4:00 CD O O
p.m NN B-NP O
, , O O
which WDT O O
is VBZ O O
already RB O O
scheduled VBN O O
Dictated NNP B-NP O
By: NNP I-NP O
HUGH NNP I-NP O
WRAIGHT NNP I-NP O
, , O O
M.D NNP B-NP O
MT68 NNP I-NP O
Attending: NNP I-NP O
ROMAN NNP I-NP O
B NNP I-NP O
ZAPANTA NNP I-NP O
, , O O
M.D NNP B-NP O
WX5 NNP I-NP O
GO317/880453 NNP I-NP O
Batch: NNP I-NP O
73154 CD O O
Index NNP B-NP O
No NNP I-NP O
UWORGB5W18 NNP I-NP O
D: NNP I-NP O
11/29/02 CD O O
T: NNP B-NP O
11/29/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#918321 VBZ O O
094005161 CD O O
WGH NNP B-NP O
94426176 CD O O
066618 CD O O
11/2/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/16/1991 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/13/1991 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
HYPERTENSION NNP I-NP O
HYPERCHOLESTEROLEMIA NNP I-NP O
PROCEDURES: NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
BYPASS NNP I-NP O
GRAFTING NNP I-NP O
TIMES NNP I-NP O
THREE NNP I-NP O
WITH NNP I-NP O
RIGHT NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
AND NNP I-NP O
LEFT NNP I-NP O
ANTERIOR NNP I-NP O
DESCENDING NNP I-NP O
ARTERY NNP I-NP O
ENDARTERECTOMY NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
37-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
known JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
admitted VBD B-VP O
for IN B-VP O
pre-coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
evaluation NN B-NP O
The DT B-NP O
patient's JJ I-NP O
cardiac JJ I-NP O
history NN I-NP O
dates NNS I-NP O
back RB O O
to TO O O
the DT B-NP O
fall NN I-NP O
of IN B-VP O
1989 CD O O
when WRB O O
the DT B-NP O
patient NN I-NP O
began VBD B-VP O
to TO O O
experience VB O O
exertional JJ O O
angina IN B-VP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
followed VBN O O
for IN B-VP O
his PRP$ O O
angina NN B-NP O
since IN B-VP O
that DT B-NP O
time NN I-NP O
Currently NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
experiences VBZ O O
angina RB O O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
most JJS B-NP O
work NN I-NP O
days NNS I-NP O
In IN B-VP O
light NN B-NP O
of IN B-VP O
his PRP$ O O
young JJ B-NP O
age NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
referred VBN O O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
and CC O O
probable JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
8/10/91 CD O O
This DT O O
showed VBD B-VP O
severe JJ B-NP O
triple JJ I-NP O
vessel NN I-NP O
disease NN I-NP O
with IN B-VP O
an DT O O
essentially RB O O
normal JJ B-NP O
left JJ I-NP O
ventricle NN I-NP O
Thus NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
8/26/91 CD O O
Under IN B-VP O
general JJ B-NP O
endotracheal NN I-NP O
anesthesia NN I-NP O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
times NNS B-NP O
three CD O O
with IN B-VP O
bilateral JJ B-NP O
internal JJ I-NP O
mammary JJ I-NP O
arteries NNS I-NP O
The DT B-NP O
left JJ I-NP O
internal JJ I-NP O
mammary NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT O O
left VBN O O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
the DT B-NP O
right JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
The DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
first JJ I-NP O
obtuse NN I-NP O
marginal JJ B-NP O
branch NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
extremely RB O O
pronounced JJ B-NP O
atherosclerosis NN I-NP O
of IN B-VP O
his PRP$ O O
coronary JJ B-NP O
arteries NNS I-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
apparent JJ I-NP O
complications NNS I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Postoperatively RB O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT O O
entirely RB O O
smooth JJ B-NP O
postoperative JJ I-NP O
course NN I-NP O
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
low JJ B-NP B-m
molecular JJ I-NP I-m
weight NN I-NP I-m
Dextran NNP I-NP I-m
for IN B-VP B-du
48 CD O I-du
hours NNS B-NP I-du
for IN B-VP O
his PRP$ O B-r
endarterectomy NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
enteric JJ B-NP B-m
enteric NN I-NP B-m
coated VBD B-VP I-m
coated JJ B-NP I-m
aspirin NN I-NP I-m
aspirin NN I-NP I-m
on IN B-VP O
the DT B-NP O
first JJ I-NP O
day NN I-NP O
of IN B-VP O
his PRP$ O O
operation NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
extubated VBN O O
and CC O O
all DT O O
his PRP$ O O
chest NN B-NP O
tubes NNS I-NP O
and CC O O
mediastinal JJ B-NP O
tubes NNS I-NP O
were VBD B-VP O
removed VBN O O
The DT B-NP O
patient NN I-NP O
diuresed VBD B-VP O
very RB O O
well RB O O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
beta NN B-NP B-m
blockers NNS I-NP I-m
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
and CC O O
sinus JJ B-NP O
tachycardia NN I-NP O
for IN B-VP O
the DT B-NP O
entire JJ I-NP O
postoperative JJ I-NP O
course NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
MEDICATIONS: NNP I-NP O
On IN B-VP O
discharge NN B-NP O
included VBD B-VP O
Tenormin NNP B-NP B-m
, , O O
75 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
day; NN I-NP I-f
enteric NN I-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
, , O O
one CD O B-do
po NN B-NP B-mo
q NN I-NP B-f
day; NN I-NP I-f
Carafate NNP I-NP B-m
, , O O
1 CD O B-do
gram NN B-NP I-do
po NN I-NP B-mo
q.i.d.; NN I-NP B-f
iron NN I-NP B-m
sulfate NN I-NP I-m
, , O O
325 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
day; NN I-NP I-f
Percocet NNP I-NP B-m
and CC O O
Colace NNP B-NP B-m
UI094/9465 NNP I-NP O
DORIAN NNP I-NP O
L NNP I-NP O
DUNAY NNP I-NP O
, , O O
M.D NNP B-NP O
DF5 NNP I-NP O
D: NNP I-NP O
5/9/91 CD O O
Batch: NNP B-NP O
5818 CD O O
Report: NNP B-NP O
M8839A4 NNP I-NP O
T: NNP I-NP O
7/19/91 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
REED NNP I-NP O
KIZZIE NNP I-NP O
, , O O
M.D NNP B-NP O
VS71 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#919745 VBZ O O
144441147 CD O O
PVNMH NNP B-NP O
55286769 CD O O
8657724 CD O O
1/30/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Left NNP I-NP O
globus NN I-NP O
pallidus NN I-NP O
hemorrhage NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/30/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/18/2005 CD O O
****** NNP B-NP O
INCOMPLETE NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MOLANO NNP I-NP O
, , O O
PALMER NNP B-NP O
296-21-40-4 CD O O
Ton NNP B-NP O
Blo NNP I-NP O
Day NNP I-NP O
Service: NNP I-NP O
NEU NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
0/18/05 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
SNF/rehab NNP I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SLEIGHT NNP I-NP O
, , O O
SAMUEL NNP B-NP O
ORVAL NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
Incomplete NNP I-NP O
Discharge NNP I-NP O
DISPOSITION: NNP I-NP O
Rehabilitation NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HYDRALAZINE NNP I-NP B-m
HCL NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Other:SBP&gt;160mmHg NNP I-NP O
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
Sliding VBG O B-do
Sliding VBG O B-do
Sliding VBG O B-do
Scale NNP B-NP I-do
Scale NNP I-NP I-do
Scale NNP I-NP I-do
( ( O B-mo
( ( O B-mo
subcutaneously RB O I-mo
subcutaneously RB O I-mo
) ) O I-mo
) ) O I-mo
SC NNP B-NP I-mo
SC NNP I-NP I-mo
qAC NN I-NP B-f
, , O O
qHS RB O B-f
qHS JJ O B-f
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
LISINOPRIL NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MAGNESIUM NNP I-NP B-m
GLUCONATE NNP I-NP I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
MILK NNP I-NP B-m
OF NNP I-NP I-m
MAGNESIA NNP I-NP I-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
HYDROXIDE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
PM NNP I-NP O
on IN B-VP O
0/17 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
XALATAN NNP I-NP B-m
( ( O I-m
LATANOPROST NNP B-NP I-m
) ) O I-m
1 CD O B-do
DROP NNP B-NP I-do
OU NNP I-NP B-mo
QPM NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
FLOMAX NNP B-NP B-m
( ( O I-m
TAMSULOSIN NNP B-NP I-m
) ) O I-m
0.4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Marshall NNP I-NP O
Dewilde NNP I-NP O
( ( O O
PCP NNP B-NP O
) ) O O
Next NNP B-NP O
Available NNP I-NP O
, , O O
Willie NNP B-NP O
Milbrath NNP I-NP O
( ( O O
Neurology NNP B-NP O
) ) O O
358-579-5885 CD O O
Next NNP B-NP O
Available NNP I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Left NNP I-NP O
globus NN I-NP O
pallidus NN I-NP O
hemorrhage NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Left VBD B-VP O
globus JJ B-NP O
pallidus NN I-NP O
hemorrhage NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
aortic JJ B-NP O
stenosis NN I-NP O
heart NN I-NP O
block NN I-NP O
w/ppm VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
diabetes VBZ O O
gout IN B-VP O
CAD NNP B-NP O
BPH NNP I-NP O
gout NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CT NNP B-NP O
scan NN I-NP O
of IN B-VP O
brain NN B-NP O
CXR NNP I-NP O
EKG NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
HPI: NNP I-NP O
82 CD O O
yo NN B-NP O
RHM NNP I-NP O
with IN B-VP O
h/o NN B-NP O
HTN NNP I-NP O
, , O O
DM-2 NNP B-NP O
, , O O
CAD NNP B-NP O
and CC O O
AVR NNP B-NP O
( ( O O
on IN B-VP O
coumadin NN B-NP B-m
until IN B-VP B-du
3/29 CD O I-du
) ) O O
was VBD B-VP O
last JJ O O
seen VBN O O
normal JJ O O
when WRB O O
went VBD B-VP O
to TO O O
nap VB O O
this DT B-NP O
afternoon NN I-NP O
at IN B-VP O
12:45pm CD O O
At IN B-VP O
2:30pm CD O O
he PRP O O
woke VBD B-VP O
up RP O O
somewhat RB O O
confused JJ O O
with IN B-VP O
slurred JJ B-NP O
speech NN I-NP O
, , O O
mild JJ B-NP O
RUE NNP I-NP O
weakness NN I-NP O
Initial NNP I-NP O
vitals NNS I-NP O
148/80 CD O O
, , O O
p-62 JJ B-NP O
sent NN I-NP O
to TO O O
FH NNP B-NP O
where WRB O O
coags NN B-NP O
and CC O O
platelets NNS B-NP O
WNL NNP I-NP O
, , O O
head NN B-NP O
CT NNP I-NP O
showed VBD B-VP O
right JJ B-NP O
thalamic NNS I-NP O
bleed VBD B-VP O
with IN B-VP O
3rd CD O O
ventricle NN B-NP O
extension NN I-NP O
Received NNP I-NP O
Mannitol NNP I-NP B-m
-&gt; NNP I-NP O
referred VBD B-VP O
to TO O O
WTSMC NNP B-NP O
ER NNP I-NP O
for IN B-VP O
further JJ B-NP O
w/u NN I-NP O
PMH: NNP I-NP O
Aortic NNP I-NP O
valve NN I-NP O
stenosis NN I-NP O
-s/p NNP I-NP O
AVR NNP I-NP O
+ NNP I-NP O
CABG NNP I-NP O
, , O O
with IN B-VP O
#25 JJ B-NP O
CE-MAGNA NNP I-NP O
PERICARDIAL NNP I-NP O
BIOPROSTHESIS NNP I-NP O
AVB NNP I-NP O
s/p NN I-NP O
Pacemaker NNP I-NP O
placement NN I-NP O
( ( O O
and CC O O
a-fib JJ B-NP O
focus NN I-NP O
ablation NN I-NP O
) ) O O
DM-2 NNP B-NP O
complicated VBN O O
by IN B-VP O
neuropathy JJ O O
and CC O O
nephropathy JJ B-NP O
Gout NNP I-NP O
Glaucoma NNP I-NP O
CHF: NNP I-NP O
last JJ B-NP O
EF: NNP I-NP O
55% CD O O
S/P NNP B-NP O
right RB O O
3rd CD O O
toe NN B-NP O
amp NN I-NP O
and CC O O
s/p NN B-NP O
left VBD B-VP O
2nd CD O O
tow NN B-NP O
amp NN I-NP O
MEDS: NNP I-NP O
BRIMONIDINE NNP I-NP B-m
0.2% CD O I-m
BID NNP B-NP B-f
LASIX NNP I-NP B-m
20 CD O B-do
PO NNP B-NP B-mo
QD NNP I-NP B-f
XALATAN NNP I-NP B-m
0.005 CD O B-do
OU NNP B-NP B-mo
QHS NNP I-NP B-f
GLIPIZIDE NNP I-NP B-m
10MG CD O B-do
PO NNP B-NP B-mo
QD NNP I-NP B-f
NEXIUM NNP I-NP B-m
20MG CD O B-do
PO NNP B-NP B-mo
QD NNP I-NP B-f
FLOMAX NNP I-NP B-m
0.4 CD O B-do
QD NNP B-NP B-f
ZOCOR NNP I-NP B-m
20MG CD O B-do
QD NNP B-NP B-f
METOPROLOL NNP I-NP B-m
50MG CD O B-do
QD NNP B-NP B-f
METFORMIN NNP I-NP B-m
1000MG CD O B-do
BID NNP B-NP B-f
LISINOPRIL NNP I-NP B-m
10MG CD O B-do
QD NNP B-NP B-f
NIFEREX NNP I-NP B-m
150 CD O B-do
BID NNP B-NP B-f
ASA NNP I-NP B-m
81 CD O B-do
PO NNP B-NP B-mo
QD NNP I-NP B-f
Coumadin: NNP I-NP B-m
by IN B-VP O
report NN B-NP O
held VBD B-VP O
since IN B-VP O
3/29 CD O O
, , O O
for IN B-VP O
unclear JJ B-NP O
reason NN I-NP O
ALL: NNP I-NP O
Sulfa NNP I-NP O
, , O O
amoxicillin NN B-NP O
, , O O
azithro: JJ B-NP O
unclear JJ I-NP O
reactions NNS I-NP O
SH: NNP I-NP O
Lives VBZ O O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
, , O O
retired VBN O O
from IN B-VP O
a DT B-NP O
phone NN I-NP O
company NN I-NP O
Remote NNP I-NP O
( ( O O
45y CD O O
ago RB O O
) ) O O
history NN B-NP O
of IN B-VP O
smoking NN B-NP O
, , O O
raer NN B-NP O
etoh NN I-NP O
ROS: NNP I-NP O
denied VBD B-VP O
diplopia NN B-NP O
, , O O
numbness NN B-NP O
of IN B-VP O
face NN B-NP O
, , O O
vertigo/tinnitus NN B-NP O
, , O O
dysphagia NN B-NP O
or CC O O
dysarthria NN B-NP O
( ( O O
prior JJ O O
to TO O O
this DT B-NP O
event NN I-NP O
) ) O O
, , O O
HA NNP B-NP O
F/C/N/V NNP I-NP O
, , O O
CP/pressure NNP B-NP O
, , O O
heartburn NN B-NP O
, , O O
constipation NN B-NP O
, , O O
diarrhea NN B-NP O
, , O O
dysuria NN B-NP O
, , O O
rashes NNS B-NP O
, , O O
joint JJ B-NP O
aches NNS I-NP O
Reports NNPS I-NP O
occasional JJ B-NP O
SOB NNP I-NP O
even RB O O
in IN B-VP O
mild JJ B-NP O
effort NN I-NP O
EXAM NNP I-NP O
VS: NNP I-NP O
T: NNP I-NP O
afebrile IN B-VP O
BP: NNP B-NP O
145/64 CD O O
P: NNP B-NP O
60 CD O O
RR: NNP B-NP O
18 CD O O
O2 NNP B-NP O
sat: VBD B-VP O
97%r.a CD O O
General: NNP B-NP O
WNWD NNP I-NP O
, , O O
NAD NNP B-NP O
HEENT: NNP I-NP O
Anicteric NNP I-NP O
, , O O
MMM NNP B-NP O
without IN B-VP O
lesions NNS B-NP O
, , O O
OP NNP B-NP O
clear JJ B-NP O
Neck: NNP I-NP O
Supple NNP I-NP O
, , O O
No NNP B-NP O
LAD NNP I-NP O
CV: NNP I-NP O
s1s2 NN I-NP O
paced VBD B-VP O
, , O O
pronounce NN B-NP O
S2 NNP I-NP O
, , O O
3/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
, , O O
2/6 CD O O
diastolic JJ B-NP O
Resp: NNP I-NP O
CTAB NNP I-NP O
Abd: NNP I-NP O
+BS NNP I-NP O
Soft/NT/ND NNP I-NP O
Ext: NNP I-NP O
No NNP I-NP O
C/C/E NNP I-NP O
, , O O
s/p NN B-NP O
above IN B-VP O
amputation NN B-NP O
MS: NNP I-NP O
Awake NNP I-NP O
and CC O O
alert NN B-NP O
, , O O
oriented VBN O O
to TO O O
date NN B-NP O
, , O O
place NN B-NP O
and CC O O
self NN B-NP O
Attention: NNP I-NP O
DOW NNP I-NP O
backwards NNS I-NP O
Memory: NNP I-NP O
registration NN I-NP O
3/3 CD O O
, , O O
recall NN B-NP O
2/3 CD O O
at IN B-VP O
5 CD O O
min NNS B-NP O
3/3 CD O O
with IN B-VP O
prompting VBG O O
Language: NNP B-NP O
fluent NN I-NP O
, , O O
+comprehension NN B-NP O
, , O O
+repetition NN B-NP O
, , O O
+naming VBG O O
intact JJ O O
, , O O
Nondominant: NNP B-NP O
no DT B-NP O
neglect NN I-NP O
to TO O O
DSS NNP B-NP O
, , O O
able JJ O O
to TO O O
salute/brush VB O O
teeth NNS B-NP O
, , O O
CN: NNP B-NP O
II NNP I-NP O
, , O O
III NNP B-NP O
- : O O
pupils VBZ O O
3 CD O O
` `` O O
2 CD O O
bilaterally RB O O
, , O O
VFF NNP B-NP O
by IN B-VP O
confrontation; NN B-NP O
III NNP I-NP O
, , O O
IV NNP B-NP O
, , O O
VI NNP B-NP O
- : O O
EOMI NNP B-NP O
, , O O
no DT B-NP O
ptosis NN I-NP O
, , O O
no DT B-NP O
nystagmus; JJ I-NP O
V- NNP I-NP O
sensation NN I-NP O
intact NN I-NP O
to TO O O
LT/PP NNP B-NP O
, , O O
corneal NN B-NP O
reflex JJ B-NP O
intact; NN I-NP O
VII NNP I-NP O
- : O O
mild NN B-NP O
right JJ B-NP O
facial JJ I-NP O
weakness NN I-NP O
VIII NNP I-NP O
- : O O
hears NNS B-NP O
finger VBP O O
rub VB O O
IX NNP B-NP O
, , O O
X NNP B-NP O
- : O O
voice NN B-NP O
dysarthric NN I-NP O
, , O O
palate NN B-NP O
elevates NNS I-NP O
symmetrically RB O O
, , O O
gag JJ B-NP O
intact; NN I-NP O
XI NNP I-NP O
- : O O
SCM/Trapezii NN B-NP O
5/5 CD O O
B NNP B-NP O
XII NNP I-NP O
- : O O
tongue NN B-NP O
protrudes NNS I-NP O
midline VBP O O
Motor: NNP B-NP O
Right NNP I-NP O
pronator NN I-NP O
drift NN I-NP O
No NNP I-NP O
asterixis NN I-NP O
nl RB O O
bulk NN B-NP O
and CC O O
tone NN B-NP O
, , O O
no DT B-NP O
tremor NN I-NP O
, , O O
rigidity NN B-NP O
or CC O O
bradykinesia NN B-NP O
Strength: NNP I-NP O
ShFl NNP I-NP O
ElFl NNP I-NP O
ElEx NNP I-NP O
WrFl NNP I-NP O
WrEx NNP I-NP O
FgSp NNP I-NP O
HpFl NNP I-NP O
KnEx NNP I-NP O
KnFl NNP I-NP O
Dors NNP I-NP O
Plan NNP I-NP O
R NNP I-NP O
4 CD O O
4+ CD O O
4+ CD O O
5 CD O O
4+ CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
L NNP B-NP O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
5 CD O O
DTRs:Bi NNP B-NP O
( ( O O
C56 NNP B-NP O
)BR NNP I-NP O
( ( O O
C6 NNP B-NP O
)Tri NNP I-NP O
( ( O O
C7 NNP B-NP O
)Pa NNP I-NP O
( ( O O
L34 NNP B-NP O
)Ac NNP I-NP O
( ( O O
S12 NNP B-NP O
)Plantar NNP I-NP O
L2 NNP I-NP O
2 CD O O
2 CD O O
1 CD O O
0 CD O O
amputated VBD B-VP O
R1 NNP B-NP O
1 CD O O
1 CD O O
1 CD O O
0 CD O O
up RB O O
Sensory: NNP B-NP O
significant JJ O O
for IN B-VP O
decreased JJ B-NP O
LT NNP I-NP O
, , O O
temperature NN B-NP O
, , O O
vibration NN B-NP O
distally RB O O
up IN B-VP O
to TO O O
knees NNS B-NP O
Coord: NNP I-NP O
finger NN I-NP O
tap NN I-NP O
rapid JJ B-NP O
&amp; NNP I-NP O
symm NN I-NP O
, , O O
FNF NNP B-NP O
&amp; NNP I-NP O
finger NN I-NP O
follow VB O O
intact JJ O O
( ( O O
for IN B-VP O
weakness NN B-NP O
) ) O O
foot NN B-NP O
tap NN I-NP O
rapid JJ B-NP O
&amp; NNP I-NP O
symm NN I-NP O
Gait: NNP I-NP O
deferred VBD B-VP O
LABS: NNP B-NP O
SODIUM NNP I-NP O
141 CD O O
( ( O O
136-142 JJ O O
) ) O O
mmol/L NN B-NP O
POTASSIUM $ O O
4.7 CD O O
( ( O O
3.5-5.0 CD O O
) ) O O
mmol/L NN B-NP O
CHLORIDE NNP I-NP O
103 CD O O
( ( O O
98-108 CD O O
) ) O O
mmol/L NN B-NP O
TOTAL NNP I-NP O
CO2 NNP I-NP O
29 CD O O
( ( O O
23-32 JJ O O
) ) O O
mmol/L FW O O
ANION NNP B-NP O
GAP NNP I-NP O
9 CD O O
( ( O O
3-15 CD O O
) ) O O
mmol/L NN B-NP O
CK NNP I-NP O
33 CD O O
* NNP B-NP O
( ( O O
41-266 JJ O O
) ) O O
U/L NNP B-NP O
CKMB NNP I-NP O
QUANT NNP I-NP O
1.7 CD O O
# # O O
( ( O O
0.0-5.0 JJ O O
) ) O O
ng/mL FW O O
CALCIUM $ O O
9.0 CD O O
( ( O O
8.8-10.5 CD O O
) ) O O
mg/dL NN B-NP O
MAGNESIUM NNP I-NP O
1.6 CD O O
* NNP B-NP O
( ( O O
1.8-2.5 JJ O O
) ) O O
mg/dL VBZ O O
cTn-I JJ B-NP O
See NNP I-NP O
Result NNP I-NP O
Below NNP I-NP O
( ( O O
0.00-0.10 JJ O O
) ) O O
ng/mL VBP O O
GLUCOSE $ O O
130 CD O O
* NNP B-NP O
( ( O O
54-118 JJ O O
) ) O O
mg/dL FW O O
UREA NNP B-NP O
N NNP I-NP O
20 CD O O
( ( O O
9-25 CD O O
) ) O O
mg/dL NN B-NP O
CREATININE NNP I-NP O
0.9 CD O O
( ( O O
0.7-1.3 NN B-NP O
) ) O O
mg/dL NN B-NP O
eGFR $ O O
86 CD O O
WBC NNP B-NP O
7.83 CD O O
( ( O O
4-10 JJ O O
) ) O O
K/uL NNP B-NP O
RBC NNP I-NP O
4.15 CD O O
* NNP B-NP O
( ( O O
4.5-6.4 JJ O O
) ) O O
M/uL NNP B-NP O
HGB NNP I-NP O
11.9 CD O O
* NNP B-NP O
( ( O O
13.5-18.0 JJ O O
) ) O O
g/dL NN B-NP O
HCT $ O O
35.5 CD O O
*# NNP B-NP O
( ( O O
40-54 JJ O O
) ) O O
% NN B-NP O
MCV NNP I-NP O
85.6 CD O O
# # O O
( ( O O
80-95 JJ O O
) ) O O
um3 JJ B-NP O
MCH NNP I-NP O
28.7 CD O O
( ( O O
27-32 JJ O O
) ) O O
uug JJ B-NP O
MCHC NNP I-NP O
33.6 CD O O
( ( O O
32-36 CD O O
) ) O O
g/dL NN B-NP O
RDW $ O O
13.9 CD O O
( ( O O
10-14.5 JJ O O
) ) O O
PLT NNP B-NP O
215 CD O O
# # O O
( ( O O
150-450 JJ O O
) ) O O
K/uL NNP B-NP O
LYMP NNP I-NP O
% NN I-NP O
24.2 CD O O
( ( O O
18-41 JJ O O
) ) O O
MONO NNP B-NP O
% NN I-NP O
6.7 CD O O
( ( O O
2.5-8.5 JJ O O
) ) O O
NEUT NNP B-NP O
% NN I-NP O
65.9 CD O O
( ( O O
48-76 JJ O O
) ) O O
EOS NNP B-NP O
% NN I-NP O
2.6 CD O O
( ( O O
0-5 NN B-NP O
) ) O O
BASO NNP B-NP O
% NN I-NP O
0.6 CD O O
( ( O O
0-1.5 NN B-NP O
) ) O O
LYMP NNP B-NP O
# # O O
1.89 CD O O
( ( O O
0.8-4.1 NN B-NP O
) ) O O
K/uL NNP B-NP O
MONO NNP I-NP O
# # O O
0.52 CD O O
( ( O O
.10-0.8 JJ O O
) ) O O
K/uL NNP B-NP O
NEUT NNP I-NP O
# # O O
5.16 CD O O
( ( O O
1.9-7.6 JJ O O
) ) O O
K/uL NNP B-NP O
EOS NNP I-NP O
# # O O
0.21 CD O O
( ( O O
0-0.5 NN B-NP O
) ) O O
K/uL NNP B-NP O
BASO NNP I-NP O
# # O O
0.04 CD O O
( ( O O
0.00-0.15 NN B-NP O
) ) O O
K/uL NNP B-NP O
PT NNP I-NP O
14.3 CD O O
# # O O
( ( O O
11.8-14.6 JJ O O
) ) O O
sec NN B-NP O
PTT NNP I-NP O
29.2 CD O O
# # O O
( ( O O
23.8-36.6 JJ O O
) ) O O
sec NN B-NP O
PT( NNP I-NP O
INR NNP I-NP O
) ) O O
1.1 CD O O
( ( O O
0.9-1.1 NN B-NP O
) ) O O
CT NNP B-NP O
I-: NNP I-NP O
Small NNP I-NP O
left VBD B-VP O
putamminal JJ B-NP O
bleed NN I-NP O
extending VBG O O
above IN B-VP O
l-thalamus NN B-NP O
Small NNP I-NP O
amount NN I-NP O
of IN B-VP O
blood NN B-NP O
in IN B-VP O
left JJ B-NP O
occipital JJ I-NP O
horn NN I-NP O
Stable NNP I-NP O
compared VBN O O
to TO O O
CT NNP B-NP O
at IN B-VP O
SMC NNP B-NP O
A/P: NNP I-NP O
82 CD O O
yo NN B-NP O
RHM NNP I-NP O
with IN B-VP O
h/o NN B-NP O
HTN NNP I-NP O
, , O O
DM-2 NNP B-NP O
, , O O
CAD NNP B-NP O
and CC O O
AVR NNP B-NP O
( ( O O
on IN B-VP O
coumadin NN B-NP B-m
until IN B-VP B-du
3/29 CD O I-du
) ) O O
was VBD B-VP O
last JJ O O
seen VBN O O
normal JJ O O
when WRB O O
went VBD B-VP O
to TO O O
nap VB O O
this DT B-NP O
afternoon NN I-NP O
at IN B-VP O
12:45pm CD O O
At IN B-VP O
2:30pm CD O O
woke VBD B-VP O
up RB O O
dysarthric JJ O O
, , O O
mild JJ B-NP O
RUE NNP I-NP O
weakness NN I-NP O
His PRP$ O O
wife NN B-NP O
noticed VBD B-VP O
slowing VBG O O
and CC O O
confusion NN B-NP O
Head NNP I-NP O
CT NNP I-NP O
at IN B-VP O
BMC NNP B-NP O
( ( O O
repeated VBN O O
here RB O O
) ) O O
showed VBD B-VP O
small JJ O O
left VBD B-VP O
BG NNP B-NP O
bleed NN I-NP O
, , O O
extending VBG O O
to TO O O
left JJ O O
lateral JJ O O
( ( O O
occipital JJ B-NP O
horn NN I-NP O
) ) O O
Given NNP B-NP O
location NN I-NP O
, , O O
most RBS O O
likely JJ B-NP O
hypertensive JJ I-NP O
bleed NN I-NP O
Cannot NNP I-NP O
rule NN I-NP O
out IN B-VP O
underlying VBG O O
small JJ B-NP O
stroke NN I-NP O
Given NNP I-NP O
h/o NN I-NP O
AVR NNP I-NP O
will MD O O
r/o VB O O
endocarditis NN B-NP O
as RB O O
well RB O O
Plan NNP B-NP O
1 CD O O
admit NN B-NP O
to TO O O
NICU NNP B-NP O
When WRB O O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
TAGH NNP I-NP O
2 CD O O
BP NNP B-NP O
control NN I-NP O
with IN B-VP O
home NN B-NP O
regimen NNS I-NP O
keep VB O O
SBP&lt;140 NNP B-NP O
3 CD O O
Hold NNP B-NP O
ASA NNP I-NP B-m
Continue NNP I-NP O
holding VBG O O
coumadin NN B-NP B-m
, , O O
clarify VB O O
indication NN B-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
4 CD O O
Hold NNP B-NP O
metformin NN I-NP B-m
for IN B-VP O
now RB O O
( ( O O
in IN B-VP O
case NN B-NP O
needs NNS I-NP O
CT/A NNP I-NP O
) ) O O
, , O O
add JJ B-NP O
insulin NN I-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
Brief NNP I-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
The DT B-NP O
hemorrhage NN I-NP O
was VBD B-VP O
stable JJ O O
on IN B-VP O
follow-up JJ B-NP O
imaging NN I-NP O
INR NNP I-NP O
was VBD B-VP O
1.1 CD O O
Neurologic NNP B-NP O
exam NN I-NP O
was VBD B-VP O
stable JJ O O
, , O O
with IN B-VP O
persistent JJ B-NP O
dysarthria NNS I-NP O
, , O O
right JJ B-NP O
pronator NN I-NP O
drift NN I-NP O
, , O O
and CC O O
mild VB O O
right JJ B-NP O
leg NN I-NP O
weakness NN I-NP O
Patient NNP I-NP O
evaluated VBN O O
by IN B-VP O
PT/OT NNP B-NP O
and CC O O
deemed VBN O O
appropriate JJ B-NP O
candidate NN I-NP O
for IN B-VP O
acute JJ B-NP O
rehab NN I-NP O
Cardiovascular: NNP I-NP O
Continued VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
Pacemaker NNP I-NP O
was VBD B-VP O
firing VBG O O
, , O O
but CC O O
on IN B-VP O
4/27 CD O O
pm NN B-NP O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
hr NN B-NP O
30's CD O O
x NNP B-NP O
few JJ B-NP O
seconds NNS I-NP O
, , O O
and CC O O
for IN B-VP O
rest NN B-NP O
of IN B-VP O
night NN B-NP O
hr NN I-NP O
40's CD O O
- : O O
50's CD O O
EKG NNP B-NP O
unchanged JJ O O
from IN B-VP O
admission NN B-NP O
- : O O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
left VBD B-VP O
anterior JJ B-NP O
fascicular JJ I-NP O
block NN I-NP O
, , O O
some DT B-NP O
pvc's NN I-NP O
Consulted VBD B-VP O
PH NNP B-NP O
Cardiology NNP I-NP O
, , O O
who WP O O
analyzed VBD B-VP O
the DT B-NP O
telemetry NN I-NP O
and CC O O
found VBD B-VP O
that IN B-VP O
bradycardic JJ B-NP O
readings NNS I-NP O
were VBD B-VP O
artifactual JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
EKG NNP I-NP O
obtained VBD B-VP O
during IN B-VP O
bradycardia NN B-NP O
and CC O O
no DT B-NP O
documented JJ I-NP O
physical JJ I-NP O
exam NN I-NP O
findings NNS I-NP O
to TO O O
suggest VB O O
bradycardia NN B-NP O
Cardiology NNP I-NP O
felt VBD B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
other JJ I-NP O
evidence NN I-NP O
of IN B-VP O
pacer NN B-NP O
malfunction NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Fair NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
outpatient JJ B-NP O
cardiologist NN I-NP O
, , O O
neurologist NN B-NP O
, , O O
and CC O O
PCP NNP B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MCCOLGAN NNP I-NP O
, , O O
SAM NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
IW52 NNP B-NP O
) ) O O
0/18/05 CD O O
@ $ O O
12 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#920102 VBZ O O
590629022 CD O O
SMC NNP B-NP O
89867333 CD O O
3190948 CD O O
11/27/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CARDIAC NNP I-NP O
ISCHEMIA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/6/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/10/2005 CD O O
ATTENDING: NNP B-NP O
DUSTY NNP I-NP O
GREGER NNP I-NP O
MD NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Laborn NNP I-NP O
is VBZ O O
a DT B-NP O
54-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
no DT B-NP O
significant JJ I-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
, , O O
who WP O O
presented VBD B-VP O
to TO O O
his PRP$ O O
cardiologist NN B-NP O
with IN B-VP O
complaints NNS B-NP O
of IN B-VP O
chest JJ B-NP O
pressure NN I-NP O
while IN B-VP O
he PRP O O
was VBD B-VP O
working VBG O O
out RP O O
This DT O O
was VBD B-VP O
approximately RB O O
one CD O O
month NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
Since IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
he PRP O O
has VBZ O O
been VBN O O
having VBG O O
similar JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
chest JJS B-NP O
discomfort NN I-NP O
while IN B-VP O
working VBG O O
out RP O O
Stress NNP B-NP O
test NN I-NP O
was VBD B-VP O
positive JJ O O
for IN B-VP O
anterior JJ B-NP O
lateral JJ I-NP O
ischemic JJ I-NP O
changes NNS I-NP O
, , O O
which WDT O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
showing VBG O O
diffuse NN B-NP O
LAD NNP I-NP O
disease VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
referred VBN O O
to TO O O
Dr NNP B-NP O
Pillon NNP I-NP O
for IN B-VP O
coronary JJ B-NP O
revascularization NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
COPD NNP B-NP O
, , O O
asthma VBZ O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PREOPERATIVE NNP I-NP O
MEDICATIONS: NNP I-NP O
Lisinopril NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
atorvastatin VBD B-VP B-m
40 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Xanax NNP B-NP B-m
dose VBP O O
unknown JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Temperature NNP B-NP O
97.7 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
70 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
160/100 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
arm NN I-NP O
150/100 CD O O
HEENT: NNP B-NP O
Dentition NNP I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection NN B-NP O
No NNP I-NP O
carotid NN I-NP O
bruit NN I-NP O
Chest: NNP I-NP O
No NNP I-NP O
incisions NNS I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmur JJ B-NP O
Peripheral NNP I-NP O
pulses NNS I-NP O
are VBP O O
all DT O O
2+ CD O O
include VBP O O
the DT B-NP O
carotid NN I-NP O
, , O O
radial JJ O O
, , O O
femoral JJ O O
, , O O
dorsalis JJ B-NP O
pedis NN I-NP O
, , O O
posterior JJ B-NP O
tibial JJ I-NP O
Respiratory: NNP I-NP O
Breath NNP I-NP O
sounds VBZ O O
clear JJ O O
bilaterally RB O O
Extremities: NNP B-NP O
Without IN B-VP O
scarring VBG O O
, , O O
varicosities NNS B-NP O
or CC O O
edema VB O O
Neuro: NNP B-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
with IN B-VP O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
PREOPERATIVE NNP I-NP O
LABS: NNP I-NP O
Sodium NNP I-NP O
141 CD O O
, , O O
potassium NN B-NP O
3.7 CD O O
, , O O
chloride RB O O
102 CD O O
, , O O
carbon NN B-NP O
dioxide NN I-NP O
32 CD O O
, , O O
BUN NNP B-NP O
17 CD O O
, , O O
creatinine NN B-NP O
1.2 CD O O
, , O O
glucose RB O O
95 CD O O
, , O O
magnesium NN B-NP O
2.1 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
7.37 CD O O
, , O O
hematocrit NN B-NP O
46.8 CD O O
, , O O
hemoglobin NN B-NP O
16.2 CD O O
, , O O
platelets NNS B-NP O
174 CD O O
, , O O
000 CD O O
, , O O
PT NNP B-NP O
13.7 CD O O
, , O O
INR NNP B-NP O
1 CD O O
, , O O
PTT NNP B-NP O
28.1 CD O O
CARDIAC NNP B-NP O
CATHETERIZATION NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
2/1/05 CD O O
coronary JJ B-NP O
anatomy NN I-NP O
95% CD O O
osteal NN B-NP O
LAD NNP I-NP O
, , O O
90% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
, , O O
70% CD O O
LAD NNP B-NP O
left VBD B-VP O
dominant JJ B-NP O
circulation NN I-NP O
ECG NNP I-NP O
on IN B-VP O
2/1/05 CD O O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
at IN B-VP O
61 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
on IN B-VP O
2/1/05 CD O O
was VBD B-VP O
read VBN O O
as IN B-VP O
normal JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Date NNP I-NP O
of IN B-VP O
surgery NN B-NP O
0/8/05 CD O O
PREOPERATIVE NNP B-NP O
DIAGNOSIS: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
POSTOPERATIVE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
PROCEDURE: NNP I-NP O
CABG NNP I-NP O
x2 NNP I-NP O
with IN B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
, , O O
SVG1 NNP B-NP O
to TO O O
the DT B-NP O
D1 NNP I-NP O
Bypass NNP I-NP O
time NN I-NP O
was VBD B-VP O
60 CD O O
minutes NNS B-NP O
Crossclamp NNP I-NP O
time NN I-NP O
was VBD B-VP O
41 CD O O
minutes NNS B-NP O
One CD O O
Ventricular NNP B-NP O
wire NN I-NP O
, , O O
two CD O O
pericardial JJ B-NP O
tubes NNS I-NP O
, , O O
and CC O O
one CD O O
left VBD B-VP O
pleural JJ B-NP O
tube NNS I-NP O
were VBD B-VP O
placed VBN O O
FINDINGS: NNP B-NP O
Unable JJ O O
to TO O O
perform VB O O
off RP O O
pump NN B-NP O
CABG NNP I-NP O
due JJ O O
to TO O O
the DT B-NP O
difficult JJ I-NP O
position NN I-NP O
of IN B-VP O
the DT B-NP O
D1 NNP I-NP O
target NN I-NP O
After IN B-VP O
the DT B-NP O
operation NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
under IN B-VP O
stable JJ B-NP O
condition NN I-NP O
His PRP$ O O
course NN B-NP O
was VBD B-VP O
uncomplicated VBN O O
in IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
He PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
step-down JJ I-NP O
unit NN I-NP O
All NNP I-NP O
epicardial JJ B-NP O
pacing NN I-NP O
wires NNS I-NP O
and CC O O
chest JJS B-NP O
tubes NNS I-NP O
were VBD B-VP O
removed VBN O O
without IN B-VP O
complication NN B-NP O
He PRP O O
was VBD B-VP O
weaned VBN O O
from IN B-VP O
his PRP$ O O
oxygen NN B-NP B-m
requirement NN I-NP O
and CC O O
diuresed VBD B-VP O
to TO O O
below IN B-VP O
his PRP$ O O
preoperative JJ B-NP O
weight NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
He PRP O O
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#4 NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
the DT B-NP B-m
following JJ I-NP O
medications NNS I-NP O
Aspirin VBP O B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
oxycodone RB O B-m
5 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.6h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Flovent NNP B-NP B-m
44 CD O B-do
mcg NN B-NP I-do
inhaler NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lipitor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
PLAN: NNP I-NP O
Mr NNP I-NP O
Gariety NNP I-NP O
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Delawyer NNP I-NP O
cardiac JJ B-NP O
surgeon NN I-NP O
in IN B-VP O
six CD O O
weeks NNS B-NP O
and CC O O
Dr NNP B-NP O
Eggleston NNP I-NP O
, , O O
cardiologist NN B-NP O
in IN B-VP O
two CD O O
weeks NNS B-NP O
eScription NN I-NP O
document: IN B-VP O
4-2047447 JJ B-NP O
JSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WISENER NNP I-NP O
, , O O
WILMER NNP B-NP O
Attending: NNP I-NP O
SHARON NNP I-NP O
, , O O
HUNG NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7131983 CD O O
D: NNP B-NP O
7/28/05 CD O O
T: NNP B-NP O
7/28/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#920361 VBZ O O
697378455 CD O O
HTRH NNP B-NP O
74497426 CD O O
665281 CD O O
4/12/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
BRONCHITIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/23/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/13/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
Bronchitis NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
) ) O O
Hypertension NNP B-NP O
2 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
cerebrovascular JJ B-NP O
accident NN I-NP O
in IN B-VP O
1983 CD O O
with IN B-VP O
left VBN O O
sided JJ B-NP O
involvement NN I-NP O
3 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
4 CD O O
) ) O O
Insulin NNP B-NP O
dependent JJ B-NP O
diabetes NNS I-NP O
mellitus VBP O O
5 CD O O
) ) O O
Arthritis $ O O
6 CD O O
) ) O O
Cataracts VBZ O O
7 CD O O
) ) O O
Total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
8 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
sinus NN B-NP O
problems NNS I-NP O
9 CD O O
) ) O O
Stable JJ B-NP O
angina JJ I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
69 JJ I-NP O
year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
past JJ B-NP O
hospitalizations NNS I-NP O
for IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
( ( O O
last JJ B-NP O
March NNP I-NP O
, , O O
1996 CD O O
) ) O O
and CC O O
hypertension NN B-NP O
, , O O
who WP O O
3-4 JJ B-NP O
weeks NNS I-NP O
prior RB O O
to TO O O
admission NN B-NP O
had VBD B-VP O
been VBN O O
having VBG O O
increasing VBG O O
cough NN B-NP O
Initially NNP I-NP O
she PRP O O
thought VBD B-VP O
it PRP O O
was VBD B-VP O
because IN B-VP O
of IN B-VP O
allergies NNS B-NP O
, , O O
but CC O O
it PRP O O
progressed VBD B-VP O
and CC O O
over IN B-VP O
the DT B-NP O
3-4 JJ I-NP O
days NNS I-NP O
prior RB O O
to TO O O
admission VB O O
she PRP O O
had VBD B-VP O
increasing VBG O O
cough JJ B-NP O
productive NN I-NP O
of IN B-VP O
yellow JJ B-NP O
sputum NN I-NP O
Over IN B-VP O
the DT O O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission VB O O
the DT B-NP O
patient NN I-NP O
felt VBD B-VP O
feverish JJ O O
, , O O
chills NNS B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
wheezing VBG O O
She PRP O O
had VBD B-VP O
a DT B-NP O
fever NN I-NP O
to TO O O
101 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission VB O O
She PRP O O
denied VBD B-VP O
ill JJ B-NP O
contacts NNS I-NP O
or CC O O
recent JJ B-NP O
travel NN I-NP O
Her PRP$ O O
last JJ B-NP O
pneumonia JJ I-NP O
vaccine NN I-NP O
was VBD B-VP O
in IN B-VP O
July NNP B-NP O
of IN B-VP O
1997 CD O O
She PRP O O
has VBZ O O
stable JJ O O
three CD O O
pillow JJ B-NP O
orthopnea NN I-NP O
She PRP O O
has VBZ O O
no DT B-NP O
PND NNP I-NP O
, , O O
recent JJ B-NP O
leg NN I-NP O
swelling VBG O O
She PRP O O
has VBZ O O
no DT B-NP O
recent JJ I-NP O
increase NN I-NP O
in IN B-VP O
frequency NN B-NP O
in IN B-VP O
angina NN B-NP O
and CC O O
no DT B-NP O
recent JJ I-NP O
weight NN I-NP O
gain NN I-NP O
or CC O O
increase VB O O
in IN B-VP O
abdominal JJ B-NP O
girth NN I-NP O
She PRP O O
describes VBZ O O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
when WRB O O
lying VBG O O
on IN B-VP O
her PRP$ O O
left JJ B-NP O
side NN I-NP O
which WDT O O
is VBZ O O
relieved VBN O O
by IN B-VP O
sleeping VBG O O
on IN B-VP O
her PRP O O
right JJ B-NP O
side NN I-NP O
Her NNP I-NP O
most RBS O O
recent JJ B-NP O
echocardiogram NN I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1996 CD O O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
40% CD O O
with IN B-VP O
1 CD O O
plus CC O O
mitral JJ B-NP O
regurgitation NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
Persantine NNP I-NP B-m
MIBI NNP I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1996 CD O O
, , O O
on IN B-VP O
which WDT O O
she PRP O O
had VBD B-VP O
no DT O O
fixed VBN O O
or CC O O
reversible JJ B-NP O
ischemia NN I-NP O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
the DT B-NP O
Mashard NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
and CC O O
she PRP O O
was VBD B-VP O
afebrile JJ B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
) ) O O
Hypertension NNP B-NP O
2 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
cerebrovascular JJ B-NP O
accident NN I-NP O
in IN B-VP O
1983 CD O O
with IN B-VP O
left VBN O O
sided JJ B-NP O
involvement NN I-NP O
but CC O O
no DT B-NP O
residual JJ I-NP O
symptoms NNS I-NP O
3 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure: NN I-NP O
Echocardiogram NNP I-NP O
- : O O
March NNP B-NP O
of IN B-VP O
1996 CD O O
revealing VBG O O
1+ CD O O
mitral JJ B-NP O
regurge NN I-NP O
, , O O
1+ CD O O
tricuspid JJ B-NP O
regurge NN I-NP O
, , O O
normal JJ O O
left VBD B-VP O
ventricular JJ B-NP O
size NN I-NP O
with IN B-VP O
mild JJ B-NP O
decrease NN I-NP O
in IN B-VP O
systolic JJ B-NP O
function NN I-NP O
, , O O
mild JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
with IN B-VP O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
40% CD O O
, , O O
inferior JJ B-NP O
wall NN I-NP O
with IN B-VP O
slight JJ B-NP O
hypokinesis NN I-NP O
and CC O O
apex NN B-NP O
mildly RB O O
abnormal JJ O O
, , O O
with IN B-VP O
bi-atrial JJ O O
enlargement JJ O O
4 CD O O
) ) O O
Persantine NNP B-NP B-m
MIBI NNP I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1996 CD O O
with IN B-VP O
maximum JJ B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
89 CD O O
, , O O
maximum JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
180/120 CD O O
with IN B-VP O
no DT O O
fixed JJ O O
or CC O O
reversible JJ B-NP O
perfusion NN I-NP O
abnormalities NNS I-NP O
Catheterization NNP I-NP O
in IN B-VP O
May NNP B-NP O
of IN B-VP O
1992 CD O O
showed VBD B-VP O
normal JJ B-NP O
coronaries NNS I-NP O
5 CD O O
) ) O O
Insulin NNP B-NP O
dependent JJ B-NP O
diabetes NNS I-NP O
mellitus VBP O O
- : O O
hemoglobin NN B-NP O
A1C NNP I-NP O
of IN B-VP O
7.6 CD O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1997 CD O O
6 CD O O
) ) O O
Arthritis $ O O
7 CD O O
) ) O O
Cataracts NNPS B-NP O
- : O O
status NN B-NP O
post NN I-NP O
right RB O O
sided VBD B-VP O
cataract JJ B-NP O
surgery NN I-NP O
in IN B-VP O
1993 CD O O
8 CD O O
) ) O O
Total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
9 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
sinus NN B-NP O
problems NNS I-NP O
10 CD O O
) ) O O
Stable JJ O O
angina SYM O O
- : O O
"chest JJS B-NP B-r
heaviness" NN I-NP I-r
after IN B-VP O
climbing VBG O O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
, , O O
relieved VBN O O
by IN B-VP O
rest NN B-NP O
and CC O O
one CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NNS B-NP I-do
per IN B-VP B-f
day NN B-NP I-f
2 CD O O
) ) O O
Insulin NNP B-NP B-m
Insulin NNP I-NP B-m
70/30 CD O O
28 CD O B-do
units NNS B-NP I-do
q JJ B-NP B-f
a.m NN I-NP I-f
and CC O O
5 CD O B-do
units NNS B-NP I-do
q RB O B-f
p.m RB O I-f
3 CD O O
) ) O O
Verapamil NNP B-NP B-m
SR NNP I-NP I-m
120 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
b.i.d VBZ O B-f
4 CD O O
) ) O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
KCL NNP B-NP B-m
10 CD O B-do
mEq NN B-NP I-do
PO NNP I-NP B-mo
q NNP I-NP B-f
day NN I-NP I-f
6 CD O O
) ) O O
Premarin VBD B-VP B-m
0.625 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
q NNP I-NP B-f
day NN I-NP I-f
7 CD O O
) ) O O
Zestril VBD B-VP B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
8 CD O O
) ) O O
Atenolol NNP B-NP B-m
, , O O
recently RB O O
discontinued VBD B-VP O
9 CD O O
) ) O O
Tofranil $ O B-m
75 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
q NN I-NP B-f
HS NNP I-NP I-f
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Mother NNP I-NP O
died VBD B-VP O
at IN B-VP O
age NN B-NP O
82 CD O O
from IN B-VP O
kidney NN B-NP O
failure NN I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
or CC O O
hypertension NN B-NP O
in IN B-VP O
the DT B-NP O
family NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
with IN B-VP O
her PRP O O
two CD O O
grandchildren NN B-NP O
and CC O O
her PRP$ O O
daughter NN B-NP O
She PRP O O
does VBZ O O
not RB O O
use VB O O
tobacco NN B-NP O
and CC O O
does VBZ O O
not RB O O
drink VB O O
alcohol IN B-VP O
She PRP O O
is VBZ O O
originally RB O O
from IN B-VP O
Sco NNP B-NP O
Oale NNP I-NP O
Fran NNP I-NP O
where WRB O O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
her PRP$ O O
family NN B-NP O
currently RB O O
lives VBZ O O
She PRP O O
left VBD B-VP O
there EX O O
several JJ B-NP O
months NNS I-NP O
ago RB O O
PHYSICAL NNP B-NP O
EXAM: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT B-NP O
pleasant JJ I-NP O
woman NN I-NP O
lying VBG O O
comfortably RB O O
in IN B-VP O
bed NN B-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Her PRP$ O O
temperature NN B-NP O
was VBD B-VP O
98.4 CD O O
, , O O
pulse RB O O
106 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
150/70 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
, , O O
saturation NN B-NP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
HEENT: NNP I-NP O
Surgical NNP I-NP O
right NN I-NP O
pupil NN I-NP O
, , O O
anicteric JJ B-NP O
sclera NN I-NP O
, , O O
no DT B-NP O
nasal JJ I-NP O
discharge NN I-NP O
, , O O
moist NN B-NP O
oropharynx NN I-NP O
Neck: NNP I-NP O
Supple NNP I-NP O
No NNP I-NP O
jugular NN I-NP O
venous JJ B-NP O
distention NN I-NP O
and CC O O
no DT B-NP O
lymphadenopathy NN I-NP O
, , O O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
Lungs: NNP I-NP O
Diffusely NNP I-NP O
rigorous JJ O O
, , O O
no DT B-NP O
crackles NNS I-NP O
or CC O O
wheezes VBZ O O
bilaterally RB O O
Cardiovascular: NNP B-NP O
Distant NNP I-NP O
heart NN I-NP O
sounds VBZ O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
S3 NNP I-NP O
and CC O O
no DT B-NP O
S4 NNP I-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
Abdomen: NNP I-NP O
Normal NNP I-NP O
active JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Soft JJ O O
, , O O
non-tender JJ O O
, , O O
non-distended JJ O O
and CC O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
Extremities: NNP I-NP O
No NNP I-NP O
edema NN I-NP O
Dorsalis NNP I-NP O
pedis NN I-NP O
pulses VBZ O O
2+ CD O O
bilaterally RB O O
Neurological: NNP B-NP O
Mild NNP I-NP O
decreased VBD B-VP O
sensation NN B-NP O
left VBD B-VP O
side NN B-NP O
of IN B-VP O
face NN B-NP O
, , O O
otherwise RB O O
cranial JJ B-NP O
nerves NNS I-NP O
III-XII NNP I-NP O
are VBP O O
grossly RB O O
intact JJ B-NP O
Reflexes NNP I-NP O
in IN B-VP O
upper JJ B-NP O
extremities NNS I-NP O
were VBD B-VP O
1 CD O O
plus CC O O
, , O O
no DT B-NP O
reflexes NNS I-NP O
elicited VBN O O
in IN B-VP O
lower JJR B-NP O
extremities NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
White NNP I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
9.3 CD O O
, , O O
hematocrit NN B-NP O
43 CD O O
, , O O
platelet NN B-NP O
count NN I-NP O
312 CD O O
BUN NNP B-NP O
20 CD O O
, , O O
creatinine NN B-NP O
1.4 CD O O
, , O O
glucose RB O O
377 CD O O
, , O O
LDH NNP B-NP O
220 CD O O
Sputum NNP B-NP O
revealed VBD B-VP O
4+ CD O O
polys NN B-NP O
, , O O
4+ CD O O
epithelial JJ B-NP O
cells NNS I-NP O
, , O O
gram JJ O O
negative JJ O O
and CC O O
gram JJ B-NP O
positive JJ I-NP O
cocci NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
revealed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
no DT B-NP O
infiltrates NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
69 JJ I-NP O
year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
hypertension NN B-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
a DT B-NP O
productive JJ I-NP O
cough NN I-NP O
which WDT O O
was VBD B-VP O
worsening VBG O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
3-4 JJ I-NP O
days NNS I-NP O
and CC O O
fever NN B-NP O
to TO O O
101 CD O O
with IN B-VP O
chills NNS B-NP O
and CC O O
shakes NNS B-NP O
and CC O O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
She PRP O O
was VBD B-VP O
afebrile JJ O O
however RB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
Her NNP I-NP O
exam NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
diffuse NN B-NP O
rhonchi NN I-NP O
and CC O O
moderate JJ B-NP O
jugular NN I-NP O
venous JJ B-NP O
distention NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
9.3 CD O O
with IN B-VP O
54% CD O O
polys NNS B-NP O
and CC O O
9.6 CD O O
% NN B-NP O
eosinophils JJ B-NP O
Blood NNP I-NP O
glucose NN I-NP O
of IN B-VP O
377 CD O O
and CC O O
a DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
or CC O O
infiltrate NN B-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
with IN B-VP O
Albuterol NNP B-NP B-m
nebulizer NN I-NP I-m
and CC O O
plans NNS B-NP O
were VBD B-VP O
to TO O O
discharge VB O O
her PRP$ O O
to TO O O
home NN B-NP O
, , O O
however RB O O
, , O O
her PRP O O
saturations NNS B-NP O
dropped VBD B-VP O
to TO O O
89% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
with IN B-VP O
exercise NN B-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
further JJ B-NP O
observation NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
intravenous JJ B-NP B-mo
intravenous JJ I-NP B-mo
Cefuroxime NNP I-NP B-m
Cefuroxime NNP I-NP B-m
, , O O
and CC O O
initially RB O O
improved VBN O O
with IN B-VP O
decrease NN B-NP O
in IN B-VP O
cough NN B-NP B-r
and CC O O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
however RB O O
, , O O
the DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
desat VB O O
with IN B-VP O
exercise NN B-NP O
A NNP I-NP O
repeat NN I-NP O
chest NN I-NP O
x-ray NN I-NP O
was VBD B-VP O
performed VBN O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
change NN I-NP O
when WRB O O
compared VBN O O
to TO O O
the DT B-NP O
admission NN I-NP O
film NN I-NP O
Her NNP I-NP O
sputum NN I-NP O
culture NN I-NP O
grew VBD B-VP O
out RP O O
Pen-sensitive JJ B-NP B-r
E-coli NN I-NP I-r
and CC O O
she PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
intravenous JJ O B-mo
and CC O O
then RB O O
PO NNP B-NP B-mo
antibiotics NNS I-NP B-m
antibiotics NNS I-NP B-m
She PRP O O
continued VBD B-VP O
to TO O O
desat VB O O
with IN B-VP O
exercise NN B-NP O
, , O O
however RB O O
, , O O
and CC O O
her PRP$ O O
cough NN B-NP O
persisted VBN O O
although IN B-VP O
she PRP O O
remained VBD B-VP O
afebrile JJ O O
with IN B-VP O
a DT O O
slightly RB O O
elevated VBN O O
white JJ B-NP O
count NN I-NP O
and CC O O
moderate JJ O O
peripheral JJ O O
eosinophilia FW O O
Her PRP$ O O
chest NN B-NP O
exam NN I-NP O
remained VBD B-VP O
rancorous JJ O O
and CC O O
the DT B-NP O
reason NN I-NP O
for IN B-VP O
this DT O O
remained JJ O O
unclear JJ O O
Given VBN O O
the DT B-NP O
finding NN I-NP O
of IN B-VP O
E-coli NNP B-NP O
in IN B-VP O
the DT B-NP O
sputum NN I-NP O
sample NN I-NP O
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
the DT O O
elevated VBN O O
eosinophilia NN B-NP O
and CC O O
lack NN B-NP O
of IN B-VP O
finding VBG O O
on IN B-VP O
chest JJS O O
x-ray JJ O O
despite IN B-VP O
significant JJ B-NP O
findings NNS I-NP O
on IN B-VP O
chest NN B-NP O
exam NN I-NP O
, , O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
a DT B-NP O
worm NN I-NP O
or CC O O
parasitic JJ B-NP O
disease NN I-NP O
was VBD B-VP O
raised VBN O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
from IN B-VP O
Pa NNP B-NP O
but CC O O
had VBD B-VP O
not RB O O
been VBN O O
there RB O O
in IN B-VP O
8 CD O O
years NNS B-NP O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diarrhea NN B-NP O
for IN B-VP O
several JJ B-NP O
weeks NNS I-NP O
a DT B-NP O
few JJ I-NP O
months NNS I-NP O
prior RB O O
to TO O O
this DT B-NP O
admission NN I-NP O
Stool NNP I-NP O
specimen NNS I-NP O
was VBD B-VP O
sent VBN O O
but CC O O
was VBD B-VP O
rejected VBN O O
by IN B-VP O
the DT B-NP O
laboratory NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
produce VB O O
another DT B-NP O
stool NN I-NP O
specimen NNS I-NP O
before IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
and CC O O
instructions NNS B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
physician NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
plans NNS B-NP O
were VBD B-VP O
made VBN O O
for IN B-VP O
her PRP$ O O
to TO O O
have VB O O
PFTs NNP B-NP O
done VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
plan NN B-NP O
for IN B-VP O
chest NN B-NP O
CT NN I-NP O
if IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
continued VBN O O
without IN B-VP O
other JJ B-NP O
etiology NN I-NP O
being VBG O O
discovered VBN O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
po JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
2 CD O O
) ) O O
Cefuroxime NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
b.i.d VBZ O B-f
3 CD O O
) ) O O
Premarin VBD B-VP B-m
0.625 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
q NNP I-NP B-f
day NN I-NP I-f
4 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
q NNP I-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Tofranil $ O B-m
75 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
q NN I-NP B-f
HS NNP I-NP I-f
6 CD O O
) ) O O
Zestril VBD B-VP B-m
20 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
b.i.d VBZ O B-f
7 CD O O
) ) O O
Verapamil NNP B-NP B-m
SR NNP I-NP O
120 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
b.i.d VBZ O B-f
8 CD O O
) ) O O
Insulin NNP B-NP B-m
Insulin NNP I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
28 CD O B-do
units NNS B-NP I-do
q JJ B-NP B-f
a.m NN I-NP I-f
and CC O O
5 CD O B-do
units NNS B-NP I-do
q RB O B-f
p.m VBP O I-f
subcue JJ O B-mo
9 CD O O
) ) O O
Potassium NN B-NP B-m
slow JJ B-NP I-m
release NN I-NP I-m
10 CD O B-do
mEq NN B-NP I-do
PO NNP I-NP B-mo
q NNP I-NP B-f
day NN I-NP I-f
10 CD O O
) ) O O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
two CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d JJ B-NP B-f
DISPOSITION: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
the DT B-NP O
patient's NN I-NP O
saturation NN I-NP O
was VBD B-VP O
92 CD O O
to TO O O
93% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
dropping VBG O O
slightly RB O O
to TO O O
90 CD O O
to TO O O
91% CD O O
with IN B-VP O
exercise NN B-NP O
, , O O
however RB O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
this DT B-NP O
well NN I-NP O
and CC O O
was VBD B-VP O
getting VBG O O
relief NN B-NP O
from IN B-VP O
her PRP$ O O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
She PRP O O
was VBD B-VP O
to TO O O
finish VB O O
a DT B-NP O
full JJ I-NP O
ten JJ I-NP B-du
day NN I-NP I-du
course NN I-NP I-du
of IN B-VP O
antibiotics NNS B-NP B-m
for IN B-VP O
presumed JJ B-NP B-r
bronchitis NN I-NP I-r
and CC O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
physician NN I-NP O
in IN B-VP O
clinic NN B-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
including VBG O O
PFTs NNP B-NP O
and CC O O
possible JJ B-NP O
chest NN I-NP O
CT NNP I-NP O
if IN B-VP O
symptoms NNS B-NP O
did VBD B-VP O
not RB O O
abate VB O O
Dictated NNP B-NP O
By: NNP I-NP O
RICKEY NNP I-NP O
HAWS NNP I-NP O
, , O O
M.D NNP B-NP O
ZW08 NNP I-NP O
Attending: NNP I-NP O
ANDREA NNP I-NP O
E NNP I-NP O
LEETH NNP I-NP O
, , O O
M.D NNP B-NP O
KO9 NNP I-NP O
TG420/6864 NNP I-NP O
Batch: NNP I-NP O
52134 CD O O
Index NNP B-NP O
No NNP I-NP O
DXRA899I31 NNP I-NP O
D: NNP I-NP O
10/6/97 CD O O
T: NNP B-NP O
2/30/97 CD O O
CC: NNP B-NP O
1 CD O O
CLEVELAND NNP B-NP O
MAYR NNP I-NP O
, , O O
M.D NNP B-NP O
ZW08 NNP I-NP O
2 CD O O
FRANKLIN NNP B-NP O
H NNP I-NP O
KUKAHIKO NNP I-NP O
, , O O
M.D NNP B-NP O
KO9 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#921741 VBZ O O
024934655 CD O O
GTMHO NNP B-NP O
75482269 CD O O
7544011 CD O O
11/4/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
, , O O
CARDIOMYOPATHY NNP B-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/4/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/19/2004 CD O O
ATTENDING: NNP B-NP O
MILFORD NNP I-NP O
WIZWER NNP I-NP O
M.D NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
36-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP O
familial JJ I-NP O
cardiomyopathy NN I-NP O
, , O O
ejection NN B-NP O
fraction NN I-NP O
estimated VBN O O
at IN B-VP O
around IN B-VP O
15% CD O O
with IN B-VP O
marked VBN O O
left NN B-NP O
and CC O O
right JJ B-NP O
chamber NN I-NP O
enlargement NN I-NP O
, , O O
severe JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
, , O O
and CC O O
PA NNP B-NP O
pressures NNS I-NP O
of IN B-VP O
51 CD O O
plus CC O O
right JJ B-NP O
atrium NN I-NP O
, , O O
as IN B-VP O
per IN B-VP O
an DT B-NP O
echo NN I-NP O
in IN B-VP O
2003 CD O O
He PRP O O
was VBD B-VP O
also RB O O
status NN B-NP O
post NN I-NP O
ICD NNP I-NP O
placement NN I-NP O
in IN B-VP O
2001 CD O O
At IN B-VP O
baseline NN B-NP O
, , O O
he PRP O O
has VBZ O O
a DT O O
one CD O O
staircase NN B-NP O
exercise NN I-NP O
tolerance NN I-NP O
before IN B-VP O
becoming VBG O O
short JJ O O
of IN B-VP O
breath NN B-NP O
He PRP O O
also RB O O
admits VBZ O O
that IN B-VP O
he PRP O O
has VBZ O O
been VBN O O
having VBG O O
increasing VBG O O
orthopnea NN B-NP O
and CC O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
He PRP O O
denies VBZ O O
, , O O
chest JJS B-NP O
pain NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
peripheral JJ B-NP O
edema NN I-NP O
He PRP O O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
dietary JJ B-NP O
fluid NNS I-NP O
intake NN I-NP O
and CC O O
medications NNS B-NP O
noncompliance RB O O
leading VBG O O
to TO O O
heart NN B-NP O
failure NN I-NP O
exacerbations NNS I-NP O
Currently RB O O
, , O O
he PRP O O
states VBZ O O
that IN B-VP O
he PRP O O
has VBZ O O
been VBN O O
eating VBG O O
"salty NN B-NP O
foods NNS I-NP O
, , O O
" NN B-NP O
and CC O O
has VBZ O O
been VBN O O
drinking VBG O O
a DT B-NP O
lot NN I-NP O
of IN B-VP O
extra JJ B-NP O
fluids NNS I-NP O
because IN B-VP O
he PRP O O
has VBZ O O
been VBN O O
feeling VBG O O
dry JJ O O
and CC O O
is VBZ O O
not RB O O
always RB O O
taking VBG O O
his PRP$ O O
medications NNS B-NP O
Consequently RB O O
, , O O
he PRP O O
has VBZ O O
noticed VBN O O
a DT B-NP O
worsening NN I-NP O
in IN B-VP O
his PRP$ O O
exercise NN B-NP O
tolerance NN I-NP O
, , O O
worsening VBG O O
orthopnea NN B-NP O
, , O O
and CC O O
most JJS O O
notably RB O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
abdominal JJ B-NP O
girth NN I-NP O
Because IN B-VP O
of IN B-VP O
these DT B-NP O
symptoms NNS I-NP O
consistent VBP O O
with IN B-VP O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
his PRP$ O O
physicians NNS B-NP O
suggested VBD B-VP O
that IN B-VP O
he PRP O O
be VB O O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
for IN B-VP O
management NN B-NP O
of IN B-VP O
his PRP$ O O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O O
has VBZ O O
been VBN O O
previously RB O O
on IN B-VP O
a DT B-NP O
transplant JJ I-NP O
list NN I-NP O
, , O O
but CC O O
has VBZ O O
been VBN O O
delisted VBN O O
given VBN O O
his PRP$ O O
noncompliance NN B-NP O
and CC O O
continuation NN B-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
In IN B-VP O
addition NN B-NP O
to TO O O
the DT B-NP O
cardiomyopathy NN I-NP O
is VBZ O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
with IN B-VP O
the DT B-NP O
creatinine NN I-NP O
ranging VBG O O
from IN B-VP O
1.2 CD O O
to TO O O
3.5 CD O O
at IN B-VP O
times NNS B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Aldactone NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
K-Dur NNP B-NP B-m
40 CD O B-do
mEq NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
lisinopril VBZ O B-m
2.5 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Isordil NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
digoxin NN B-NP B-m
0.125 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
torsemide RB O B-m
200 CD O B-do
mg NN B-NP I-do
twice RB O B-f
, , O O
and CC O O
metolazone NN B-NP B-m
p.r.n NN I-NP B-f
for IN B-VP O
volume NN B-NP B-r
overload NN I-NP I-r
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
As NNP I-NP O
mentioned VBD B-VP O
, , O O
he PRP O O
is VBZ O O
smoking VBG O O
one-half JJ O O
per IN B-VP O
day NN B-NP O
of IN B-VP O
cigarettes NNS B-NP O
, , O O
occasional JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
, , O O
no DT B-NP O
IV NNP I-NP O
drug NN I-NP O
use NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
His PRP$ O O
mother NN B-NP O
, , O O
his PRP$ O O
brother NN B-NP O
, , O O
and CC O O
his PRP$ O O
cousin NN B-NP O
and CC O O
nephew RB O O
all DT O O
have VBP O O
the DT B-NP O
familial JJ I-NP O
cardiomyopathy JJ I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
he PRP O O
presented VBD B-VP O
with IN B-VP O
the DT B-NP O
JVP NNP I-NP O
in IN B-VP O
the DT O O
18 CD O O
to TO O O
20 CD O O
range NN B-NP O
on IN B-VP O
the DT B-NP O
physical JJ I-NP O
examination NN I-NP O
with IN B-VP O
positive JJ B-NP O
HJR NNP I-NP O
His PRP$ O O
cardiac NN B-NP O
exam NN I-NP O
had VBD B-VP O
a DT B-NP O
positive JJ I-NP O
S3 NNP I-NP O
of IN B-VP O
laterally RB O O
displaced VBN O O
PMI NNP B-NP O
with IN B-VP O
the DT B-NP O
right JJ I-NP O
ventricular NN I-NP O
heave NN I-NP O
He PRP O O
also RB O O
had VBD B-VP O
a DT O O
2/6 CD O O
systolic JJ O O
murmur FW O O
His PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
distended VBN O O
, , O O
nontender NN B-NP O
, , O O
but CC O O
likely RB O O
with IN B-VP O
ascites NNS B-NP O
and CC O O
palpable JJ B-NP O
liver NN I-NP O
edge VB O O
His PRP$ O O
extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
without IN B-VP O
edema JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
From IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
standpoint NN I-NP O
, , O O
we PRP O O
initially RB O O
attempted VBD B-VP O
to TO O O
diurese VB O O
him PRP O O
IV NNP B-NP B-mo
torsemide RB O B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
However RB O O
, , O O
he PRP O O
did VBD B-VP O
not RB O O
respond VB O O
well RB O O
enough RB O O
to TO O O
this DT B-NP O
regimen NNS I-NP O
, , O O
and CC O O
therefore RB O O
we PRP O O
started VBD B-VP O
drip NN B-NP B-mo
with IN B-VP O
Zaroxolyn NNP B-NP B-m
p.r.n NN I-NP B-f
We PRP O O
also RB O O
stopped VBD B-VP O
his PRP$ O O
Isordil NNP B-NP B-m
and CC O O
ACE NNP B-NP B-m
inhibitor VBP O I-m
early RB O O
on IN B-VP O
because IN B-VP O
of IN B-VP O
blood NN B-NP B-r
pressures NNS I-NP I-r
in IN B-VP O
the DT O O
80s CD O O
On IN B-VP O
admission NN B-NP O
, , O O
his PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
2.0 CD O O
and CC O O
on IN B-VP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
2.2 CD O O
with IN B-VP O
low JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
, , O O
at IN B-VP O
which WDT O O
point NN B-NP O
, , O O
we PRP O O
decided VBD B-VP O
to TO O O
start VB O O
a DT B-NP O
low-dose JJ I-NP O
dopamine NN I-NP B-m
drips NNS I-NP B-mo
at IN B-VP O
2 CD O O
mcg NNS B-NP O
per IN B-VP B-f
hour NN B-NP I-f
However RB O O
, , O O
his PRP$ O O
urine JJ B-NP O
output NN I-NP O
was VBD B-VP O
only RB O O
about RB O O
500 CD O O
cc NNS B-NP O
negative JJ O O
, , O O
so IN B-VP O
we PRP O O
further VBP O O
increased VBD B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
drip NN I-NP I-m
drip NN I-NP I-m
from IN B-VP O
10 CD O B-do
10 CD O B-do
mg NN B-NP I-do
mg VBD B-VP I-do
an DT B-NP B-f
hour NN I-NP I-f
to TO O O
20 CD O O
mg NNS B-NP O
an DT B-NP B-du
hour NN I-NP I-du
after IN B-VP O
200 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
Lasix NNP I-NP B-m
bolus NN I-NP I-m
On IN B-VP O
this DT B-NP O
combination NN I-NP O
of IN B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP I-m
at IN B-VP O
20 CD O B-do
an DT B-NP B-f
hour NN I-NP O
and CC O O
dopamine NN B-NP B-m
at IN B-VP O
2 CD O B-do
mcg NNS B-NP I-do
per IN B-VP B-f
hour NN B-NP I-f
, , O O
he PRP O O
began VBD B-VP O
to TO O O
have VB O O
very RB O O
good JJ O O
and CC O O
effective JJ B-NP O
urine NN I-NP O
output NN I-NP O
at IN B-VP O
approximately RB O O
2-3 JJ B-NP O
liters NNS I-NP O
per IN B-VP O
day NN B-NP O
, , O O
negative JJ O O
, , O O
also RB O O
reflected VBN O O
in IN B-VP O
his PRP$ O O
total JJ B-NP O
weight NN I-NP O
, , O O
and CC O O
came VBD B-VP O
in IN B-VP O
with IN B-VP O
admission NN B-NP O
weight NN I-NP O
of IN B-VP O
around IN B-VP O
90 CD O O
kg NNS B-NP O
On IN B-VP O
each DT B-NP O
day NN I-NP O
, , O O
he PRP O O
diuresed VBD B-VP O
about IN B-VP O
an DT B-NP O
half NN I-NP O
to TO O O
kilo VB O O
off RP O O
until IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
at IN B-VP O
which WDT O O
point NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
less JJR O O
than IN B-VP O
86 CD O O
kg NN B-NP O
We PRP O O
monitored VBD B-VP O
strict JJ B-NP O
I's NNP I-NP O
and CC O O
O's NNP B-NP O
, , O O
checked VBD B-VP O
daily JJ B-NP O
weight NN I-NP O
During IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
his PRP$ O O
diuresis NN B-NP O
, , O O
his PRP$ O O
sodium NN B-NP O
levels NNS I-NP O
were VBD B-VP O
decreasing VBG O O
mostly RB O O
secondary JJ O O
to TO O O
the DT B-NP O
patient NN I-NP O
drinking VBG O O
a DT B-NP O
lot NN I-NP O
of IN B-VP O
free JJ B-NP O
water NN I-NP O
The DT B-NP O
combination NN I-NP O
of IN B-VP O
free JJ B-NP O
water NN I-NP O
intake NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
natriuresis NN B-NP O
resulted VBN O O
in IN B-VP O
further JJ B-NP O
worsening NN I-NP O
of IN B-VP O
his PRP$ O O
hyponatremia NN B-NP O
from IN B-VP O
an DT B-NP O
admission NN I-NP O
sodium NN I-NP O
of IN B-VP O
128 CD O O
to TO O O
124 CD O O
, , O O
eventually RB O O
to TO O O
122 CD O O
We PRP O O
strictly RB O O
reinforce VBP O O
the DT B-NP O
need NN I-NP O
to TO O O
limit VB O O
his PRP$ O O
fluid NN B-NP O
intake NN I-NP O
to TO O O
less JJR O O
than IN B-VP O
2 CD O O
liters NNS B-NP O
per IN B-VP O
day NN B-NP O
, , O O
and CC O O
at IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
his PRP$ O O
sodium NN B-NP O
levels NNS I-NP O
than IN B-VP O
rebounded VBD B-VP O
to TO O O
124 CD O O
and CC O O
also RB O O
128 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
We PRP O O
monitored VBD B-VP O
the DT B-NP O
b.i.d NN I-NP O
lytes VBZ O O
Eventually RB O O
, , O O
his PRP$ O O
blood NN B-NP O
pressures NNS I-NP O
remained VBD B-VP O
stable JJ O O
His PRP$ O O
JVP NNP B-NP O
decreased VBD B-VP O
from IN B-VP O
18 CD O O
to TO O O
20 CD O O
on IN B-VP O
admission NN B-NP O
to TO O O
about RB O O
10 CD O O
to TO O O
12 CD O O
and CC O O
continued VBD B-VP O
to TO O O
have VB O O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
, , O O
thus RB O O
we PRP O O
weaned VBD B-VP O
off RP O O
the DT B-NP O
dopamine NN I-NP B-m
, , O O
but CC O O
continued VBD B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP O
for IN B-VP B-du
one CD O I-du
more JJR B-NP I-du
day NN I-NP I-du
We PRP O O
then RB O O
discontinued VBD B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP B-mo
and CC O O
transitioned VBD B-VP O
him PRP O O
back RB O O
over IN B-VP O
to TO O O
torsemide VB O B-m
200 CD O B-do
b.i.d NN B-NP B-f
p.o NN I-NP B-mo
, , O O
which WDT O O
was VBD B-VP O
his PRP$ O O
home NN B-NP O
regimen NNS I-NP O
and CC O O
watch VBP O O
him PRP O O
for IN B-VP O
another DT O O
24 CD O O
hours NNS B-NP O
He PRP O O
continued VBD B-VP O
to TO O O
diurese VB O O
at IN B-VP O
this DT B-NP O
dose NN I-NP O
, , O O
but CC O O
then RB O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
his PRP$ O O
I's NNP B-NP O
and CC O O
O's NNP B-NP O
were VBD B-VP O
finally RB O O
about IN B-VP O
500 CD O O
cc NNS B-NP O
negative JJ O O
, , O O
which WDT O O
is VBZ O O
a DT B-NP O
change NN I-NP O
from IN B-VP O
about IN B-VP O
1 CD O O
to TO O O
2 CD O O
liters NNS B-NP O
negative JJ O O
per IN B-VP O
day NN B-NP O
His PRP$ O O
JVP NNP B-NP O
was VBD B-VP O
about RB O O
9 CD O O
to TO O O
10 CD O O
and CC O O
his PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
stable JJ O O
at IN B-VP O
1.7 CD O O
We PRP O O
re-added VBD B-VP O
his PRP$ O O
Isordil NN B-NP B-m
at IN B-VP O
10 CD O B-do
mg NNS B-NP I-do
t.i.d NN I-NP B-f
for IN B-VP B-du
the DT O I-du
last JJ O I-du
24 CD O I-du
hours NNS B-NP I-du
and CC O O
his PRP$ O O
blood NN B-NP B-r
pressures NNS I-NP I-r
were VBD B-VP O
stable JJ O O
in IN B-VP O
the DT O O
90s CD O O
Given NNP B-NP O
his PRP$ O B-r
potassium NN B-NP B-m
potassium NN I-NP I-r
, , O O
which WDT O O
was VBD B-VP O
always RB O O
borderline JJ O O
low JJ O O
in IN B-VP O
the DT O O
33 CD O O
or CC O O
35 CD O O
range NN B-NP O
, , O O
we PRP O O
decided VBD B-VP O
to TO O O
increase VB O O
his PRP$ O O
Aldactone NNP B-NP B-m
Aldactone NNP I-NP B-m
dose VBD B-VP O
to TO O O
25 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
but CC O O
given VBN O O
his PRP$ O O
underlying JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
we PRP O O
have VBP O O
decreased VBN O O
his PRP$ O O
standing VBG O O
K-Dur NNP B-NP B-m
K-Dur NNP I-NP B-m
from IN B-VP O
40 CD O B-do
mEq NNS B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
to TO O O
20 CD O B-do
mEq NNS B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
An DT B-NP O
echo NN I-NP O
was VBD B-VP O
done VBN O O
, , O O
which WDT O O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
20% CD O O
and CC O O
4+ CD O O
MR NNP B-NP O
They PRP O O
did VBD B-VP O
not RB O O
comment VB O O
on IN B-VP O
the DT B-NP O
synchrony NN I-NP O
on IN B-VP O
the DT B-NP O
preliminary JJ I-NP O
report NN I-NP O
However RB O O
, , O O
he PRP O O
is VBZ O O
a DT B-NP O
candidate NN I-NP O
for IN B-VP O
Bi-V NNP B-NP O
pacing VBG O O
given VBN O O
his PRP$ O O
mildly RB O O
widened VBD B-VP O
QRS NNP B-NP O
complex JJ B-NP O
stage NN I-NP O
III NNP I-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
having VBG O O
been VBN O O
on IN B-VP O
a DT O O
very RB O O
good JJ B-NP O
heart NN I-NP O
failure NN I-NP O
regimen VBZ O O
up RP O O
until IN B-VP O
this DT B-NP O
point NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
At IN B-VP O
discharge NN B-NP O
, , O O
his PRP$ O O
medical JJ B-NP O
regimen NNS I-NP O
consisted VBN O O
of IN B-VP O
digoxin NN B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
torsemide RB O B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Aldactone NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
and CC O O
K-Dur NNP B-NP B-m
20 CD O B-do
mEq NN B-NP I-do
We PRP O O
also RB O O
added VBD B-VP O
folate JJ O B-m
5 CD O B-do
mg NN B-NP O
to TO O O
his PRP$ O O
regimen NNS B-NP O
because IN B-VP O
he PRP O O
had VBD B-VP O
an DT B-NP O
elevated JJ I-NP B-r
homocystine NN I-NP I-r
level NN I-NP O
He PRP O O
also RB O O
takes VBZ O O
Ambien NNP B-NP B-m
at IN B-VP B-f
night NN B-NP I-f
p.r.n NN I-NP I-f
for IN B-VP O
insomnia NN B-NP B-r
DISPOSITION: NNP I-NP O
He PRP O O
is VBZ O O
being VBG O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
plan NN B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Grassi NNP I-NP O
in IN B-VP O
her PRP$ O O
Thyroid NNP B-NP O
Clinic NNP I-NP O
on IN B-VP O
2/11/05 CD O O
He PRP O O
has VBZ O O
been VBN O O
again RB O O
urged VBN O O
to TO O O
stop VB O O
smoking NN B-NP O
and CC O O
to TO O O
be VB O O
complaint NN B-NP O
with IN B-VP O
his PRP$ O O
regimen NNS B-NP O
because IN B-VP O
he PRP O O
is VBZ O O
a DT B-NP O
good JJ I-NP O
heart NN I-NP O
transplant NN I-NP O
candidate NN I-NP O
and CC O O
for IN B-VP O
the DT B-NP O
current JJ I-NP O
time NN I-NP O
, , O O
he PRP O O
is VBZ O O
not RB O O
listed VBN O O
given VBN O O
the DT B-NP O
aforementioned JJ I-NP O
reasons NNS I-NP O
Overall NNP I-NP O
, , O O
Mr NNP B-NP O
Plagmann NNP I-NP O
states VBZ O O
that IN B-VP O
his PRP$ O O
symptoms NNS B-NP O
have VBP O O
drastically RB O O
improved VBN O O
He PRP O O
no RB O O
longer RBR O O
has VBZ O O
orthopnea NN B-NP O
He PRP O O
is VBZ O O
able JJ O O
to TO O O
exert VB O O
himself PRP O O
much RB O O
more RBR O O
without IN B-VP O
symptoms NNS B-NP O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
lightheadedness NN B-NP O
, , O O
and CC O O
he PRP O O
is VBZ O O
eager JJ O O
to TO O O
go VB O O
home NN B-NP O
eScription NN I-NP O
document: VBD B-VP O
3-1999936 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BURK NNP I-NP O
, , O O
MARIANO NNP B-NP O
Attending: NNP I-NP O
MIRICLE NNP I-NP O
, , O O
BRENDAN NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
9252376 CD O O
D: NNP B-NP O
9/28/04 CD O O
T: NNP B-NP O
9/28/04 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#922618 VBZ O O
399346117 CD O O
RH NNP B-NP O
54171890 CD O O
497574 CD O O
5/24/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/12/1991 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/21/1991 CD O O
DISCHARGE NNP B-NP O
DIAGNOSIS: NNP I-NP O
CHOLECYSTITIS NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
65 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
the DT B-NP O
sudden JJ I-NP O
onset NN I-NP O
of IN B-VP O
right JJ B-NP O
upper JJ I-NP O
quadrant NN I-NP O
and CC O O
epigastric JJ B-NP O
abdominal JJ I-NP O
pain NN I-NP O
The DT B-NP O
pain NN I-NP O
had VBD B-VP O
awoken VBN O O
her PRP$ O O
from IN B-VP O
sleep NN B-NP O
and CC O O
radiated VBD B-VP O
to TO O O
her PRP$ O O
right NN B-NP O
back RB O O
She PRP O O
had VBD B-VP O
an DT O O
ultrasound JJ O O
two CD O O
years NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
which WDT O O
showed VBD B-VP O
sludge NN B-NP O
in IN B-VP O
her PRP$ O O
gallbladder NN B-NP O
with IN B-VP O
no DT B-NP O
other JJ I-NP O
abnormalities NNS I-NP O
noted VBD B-VP O
She PRP O O
had VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
bilious JJ O O
vomiting VBG O O
with IN B-VP O
nausea NN B-NP O
prior RB O O
to TO O O
presentation VB O O
Patient NNP B-NP O
had VBD B-VP O
been VBN O O
given VBN O O
some DT B-NP O
Demerol NNP I-NP B-m
with IN B-VP O
some DT B-NP O
relief NN I-NP O
but CC O O
she PRP O O
had VBD B-VP O
persistent JJ B-NP O
pain NN I-NP O
The DT B-NP O
last JJ I-NP O
bowel NN I-NP O
movement NN I-NP O
was VBD B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
and CC O O
she PRP O O
had VBD B-VP O
an DT B-NP O
ultrasound NN I-NP O
on IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
admission NN B-NP O
which WDT O O
showed VBD B-VP O
multiple IN B-VP O
small JJ B-NP O
stones NNS I-NP O
and CC O O
a DT B-NP O
gallbladder NN I-NP O
with IN B-VP O
sludge NN B-NP O
and CC O O
thickening NN B-NP O
of IN B-VP O
the DT B-NP O
gallbladder NN I-NP O
wall NN I-NP O
HIDA NNP I-NP O
scan NN I-NP O
showed VBD B-VP O
no DT B-NP O
filling NN I-NP O
of IN B-VP O
the DT B-NP O
gallbladder NN I-NP O
consistent NN I-NP O
with IN B-VP O
cholecystitis NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
and CC O O
morbid NN B-NP O
obesity NN I-NP O
CURRENT NNP I-NP O
MEDICATIONS: NNP I-NP O
Vistaril NNP I-NP B-m
, , O O
Premarin NNP B-NP B-m
, , O O
and CC O O
Clinoril NNP B-NP B-m
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
an DT B-NP O
uncomfortable JJ I-NP O
obese JJ I-NP O
white JJ I-NP O
female NN I-NP O
in IN B-VP O
moderate JJ B-NP O
distress NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
were VBD B-VP O
stable JJ O O
and CC O O
her PRP$ O O
temperature NN B-NP O
was VBD B-VP O
98.6 CD O O
SKIN: NNP B-NP O
Normal NNP I-NP O
HEENT: NNP I-NP O
Normocephalic NNP I-NP O
and CC O O
atraumatic JJ B-NP O
CHEST: NNP I-NP O
Clear NNP I-NP O
bilaterally RB O O
CARDIAC: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
Sl NNP I-NP O
and CC O O
S2 NNP B-NP O
with IN B-VP O
a DT B-NP O
grade NN I-NP O
II/VI NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
ABDOMEN: NNP I-NP O
Soft NNP I-NP O
, , O O
non-tender NN B-NP O
, , O O
and CC O O
non-distended JJ B-NP O
except NN I-NP O
for IN B-VP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
upper NN I-NP O
quadrant NN I-NP O
where WRB O O
she PRP O O
had VBD B-VP O
right JJ B-NP O
upper JJ I-NP O
quadrant NN I-NP O
pain NN I-NP O
and CC O O
a DT B-NP O
positive JJ I-NP O
Murphy's NNP I-NP O
but CC O O
no DT B-NP O
peritoneal JJ I-NP O
signs NNS I-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
a DT B-NP O
white JJ I-NP O
count NN I-NP O
of IN B-VP O
7.2 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
40.5 CD O O
, , O O
and CC O O
a DT B-NP O
normal JJ I-NP O
set NN I-NP O
of IN B-VP O
liver JJ B-NP O
function NN I-NP O
tests NNS I-NP O
with IN B-VP O
an DT B-NP O
amylase NN I-NP O
of IN B-VP O
63 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Teeleah NNP I-NP O
Valley NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
given VBN O O
triple RB O O
intravenous JJ B-NP B-mo
antibiotics NNS I-NP B-m
, , O O
kept VBD B-VP O
NPO NNP B-NP O
, , O O
and CC O O
placed VBD B-VP O
on IN B-VP O
intravenous JJ B-NP B-mo
hydration NN I-NP B-m
On IN B-VP O
10 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
she PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
where WRB O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
esophagogastroduodenoscopy NN I-NP O
, , O O
a DT B-NP O
cholecystectomy NN I-NP O
with IN B-VP O
an DT B-NP O
intraoperative JJ I-NP O
cholangiogram NN I-NP O
, , O O
and CC O O
common JJ B-NP O
bile NN I-NP O
duct NN I-NP O
exploration NN I-NP O
with IN B-VP O
T-Tube NNP B-NP O
placement NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Karsh NNP I-NP O
, , O O
Dr NNP B-NP O
Karty NNP I-NP O
, , O O
and CC O O
Dr NNP B-NP O
Noorani NNP I-NP O
Intraoperatively NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
large JJ I-NP O
inflamed JJ I-NP O
gallbladder NN I-NP O
with IN B-VP O
multiple JJ B-NP O
small JJ I-NP O
cholesterol NN I-NP O
stones NNS I-NP O
in IN B-VP O
her PRP$ O O
gallbladder NN B-NP O
and CC O O
two CD O O
stones NNS B-NP O
in IN B-VP O
her PRP$ O O
common JJ B-NP O
duct NN I-NP O
Intraoperatively RB O O
, , O O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
short JJ I-NP O
run NN I-NP O
of IN B-VP O
an DT B-NP O
abnormal JJ I-NP O
rhythm NN I-NP O
with IN B-VP O
a DT B-NP O
rate NN I-NP O
in IN B-VP O
the DT B-NP O
seventies NNS I-NP O
which WDT O O
quickly RB O O
resolved VBD B-VP O
Post-operatively RB O O
, , O O
she PRP O O
continued VBD B-VP O
to TO O O
remain VB O O
stable JJ O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Recovery NNP I-NP O
Room NNP I-NP O
and CC O O
eventually RB O O
back RB O O
to TO O O
the DT B-NP O
floor NN I-NP O
She PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
On IN B-VP O
0/30/9l CD O O
, , O O
she PRP O O
was VBD B-VP O
doing VBG O O
well RB O O
, , O O
had VBD B-VP O
been VBN O O
started VBN O O
on IN B-VP O
sips NNS B-NP O
of IN B-VP O
clear JJ B-NP O
fluids NNS I-NP O
, , O O
and CC O O
was VBD B-VP O
up RB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
voiding VBG O O
on IN B-VP O
her PRP$ O O
own JJ O O
By IN B-VP O
10/19/9l CD O O
, , O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
Her PRP$ O O
wound NN B-NP O
showed VBD B-VP O
some DT B-NP O
erythema NN I-NP O
but CC O O
continued VBD B-VP O
to TO O O
heal VB O O
well RB O O
On IN B-VP O
1/12/9l CD O O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
T-Tube JJ I-NP O
cholangiogram NN I-NP O
and CC O O
was VBD B-VP O
clamped VBN O O
DISPOSITION: NNP B-NP O
She PRP O O
remained VBD B-VP O
afebrile JJ O O
with IN B-VP O
no DT B-NP O
abdominal JJ I-NP O
tenderness NN I-NP O
and CC O O
is VBZ O O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
1/9/9l CD O O
to TO O O
be VB O O
followed VBN O O
up RP O O
by IN B-VP O
Dr NNP B-NP O
Tendick NNP I-NP O
in IN B-VP O
Clinic NNP B-NP O
BT272/5455 NNP I-NP O
RICKIE NNP I-NP O
S NNP I-NP O
SANGH NNP I-NP O
, , O O
M.D NNP B-NP O
NQ6 NNP I-NP O
D: NNP I-NP O
11/1/91 CD O O
Batch: NNP B-NP O
9763 CD O O
Report: NNP B-NP O
N6056S64 NNP I-NP O
T: NNP I-NP O
3/5/91 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
ELISHA NNP I-NP O
H NNP I-NP O
DOLFAY NNP I-NP O
, , O O
M.D NNP B-NP O
BI41 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#924060 VBZ O O
666197546 CD O O
TRH NNP B-NP O
10577072 CD O O
8354947 CD O O
1/18/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Right NNP I-NP O
Shoulder NNP I-NP O
Pain NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/18/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/18/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
NESSPOR NNP I-NP O
, , O O
JEROME NNP B-NP O
171-12-68-8 CD O O
Hend NNP B-NP O
Service: NNP I-NP O
ORT NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/0/06 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SZUFAT NNP I-NP O
, , O O
JERRELL NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DILAUDID NNP I-NP B-m
( ( O I-m
HYDROMORPHONE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
2-6 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
ATROVENT NNP I-NP B-m
HFA NNP I-NP I-m
INHALER NNP I-NP I-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
INHALER NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Contraindicated NNP I-NP O
in IN B-VP O
Patients NNP B-NP O
with IN B-VP O
Peanut NNP B-NP O
, , O O
Soya NNP B-NP O
or CC O O
Soyabean NNP B-NP O
Allergy NNP I-NP O
LOPRESSOR NNP I-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;110 NNP I-NP O
, , O O
HR&lt;60 NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
MS NNP I-NP B-m
CONTIN NNP I-NP I-m
( ( O I-m
MORPHINE NNP B-NP I-m
CONTROLLED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
45 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
MS NNP I-NP B-m
CONTIN NNP I-NP I-m
( ( O I-m
MORPHINE NNP B-NP I-m
CONTROLLED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
SIMVASTATIN NNP I-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
TERAZOSIN NNP B-NP B-m
HCL NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
DIET: NNP B-NP O
No NNP I-NP O
Restrictions NNP I-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Hally NNP I-NP O
3/18/06 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
IV NNP I-NP O
Contrast NNP I-NP O
, , O O
Tape NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Right NNP I-NP O
Shoulder NNP I-NP O
Pain NNP I-NP O
?Infection NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Right NNP B-NP O
Shoulder NNP I-NP O
Pain NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
asthma JJ B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
8/18/2006 CD O O
: : O O
CT NN B-NP O
guided VBD B-VP O
aspiration NN B-NP O
of IN B-VP O
R NNP B-NP O
shoulder NN I-NP O
joint NN I-NP O
fluid NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Pain NNP B-NP O
Control NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Notari NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Orthopaedic NNP I-NP O
Hand NNP I-NP O
Service NNP I-NP O
on IN B-VP O
1/18/2006 CD O O
w/ NN B-NP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
increased JJ B-NP O
R NNP I-NP O
shoulder NN I-NP O
pain NN I-NP O
following VBG O O
a DT B-NP O
cellulitis NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
hand NN I-NP O
An DT B-NP O
ESR NNP I-NP O
was VBD B-VP O
checked VBN O O
on IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
slightly RB O O
elevated VBN O O
at IN B-VP O
18 CD O O
He PRP O O
was VBD B-VP O
afebrile JJ O O
and CC O O
non-toxic JJ O O
, , O O
therefore RB O O
was VBD B-VP O
not RB O O
started VBN O O
on IN B-VP O
antibiotics NNS B-NP O
Dilaudid NNP I-NP B-m
was VBD B-VP O
added VBN O O
to TO O O
his PRP$ O O
pain NN B-NP O
regimen NNS I-NP O
for IN B-VP O
his PRP$ O B-r
increased JJ B-NP O
discomfort NN I-NP O
On IN B-VP O
9/25/2006 CD O O
a DT B-NP O
CT NNP I-NP O
guided VBD B-VP O
R NNP B-NP O
shoulder NN I-NP O
joint NN I-NP O
fluid NN I-NP O
aspiration NN I-NP O
was VBD B-VP O
performed VBN O O
by IN B-VP O
Radiology NNP B-NP O
Analysis NNP I-NP O
of IN B-VP O
this DT B-NP O
fluid NN I-NP O
was VBD B-VP O
not RB O O
consistant JJ O O
with IN B-VP O
joint JJ B-NP O
infection NN I-NP O
He PRP O O
received VBD B-VP O
Lovenox NNP B-NP B-m
for IN B-VP O
DVT NNP B-NP B-r
prophylaxis NN I-NP I-r
during IN B-VP B-du
his PRP$ O I-du
admission NN B-NP I-du
On IN B-VP O
HD#4 NNP B-NP O
he PRP O O
was VBD B-VP O
awake RB O O
, , O O
alert NN B-NP O
, , O O
appropriate JJ O O
and CC O O
afebrile JJ O O
with IN B-VP O
stable JJ B-NP O
vitals NNS I-NP O
signs NNS I-NP O
His PRP$ O B-r
pain NN B-NP O
was VBD B-VP O
well RB O O
controlled VBN O O
on IN B-VP O
oral JJ B-NP B-m
medications NNS I-NP I-m
He PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
and CC O O
instructed VBD B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Rumler NNP I-NP O
at IN B-VP O
his PRP$ O O
previously RB O O
scheduled VBN O O
appointment NN B-NP O
on IN B-VP O
4/13/2006 CD O O
His PRP$ O O
final JJ B-NP O
joint NN I-NP O
fluid NN I-NP O
cultures NNS I-NP O
were VBD B-VP O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
he PRP O O
will MD O O
be VB O O
contacted VBN O O
at IN B-VP O
home NN B-NP O
if IN B-VP O
these DT O O
turn VBP O O
positivie JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
Do NNP B-NP O
pendulum NN I-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
exercises VBZ O O
regularly RB O O
This DT O O
is VBZ O O
very RB O O
important JJ O O
in IN B-VP O
maintaining VBG O O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
You PRP O O
should MD O O
not RB O O
add VB O O
any DT B-NP O
additional JJ I-NP O
exercises NNS I-NP O
until IN B-VP O
cleared VBN O O
to TO O O
do VB O O
so RB O O
by IN B-VP O
Dr NNP B-NP O
Stupka NNP I-NP O
2 CD O O
You PRP O O
have VBP O O
been VBN O O
given VBN O O
a DT B-NP O
prescription NN I-NP O
for IN B-VP O
a DT O O
narcotic JJ O B-m
for IN B-VP O
pain NN B-NP B-r
control NN I-NP I-r
Do NNP I-NP O
not RB O O
drive VB O O
a DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
, , O O
drink VB O O
any DT B-NP O
alcohol NN I-NP O
or CC O O
operate VB O O
machinery NN B-NP O
while IN B-VP O
taking VBG O O
this DT B-NP B-m
medication NN I-NP I-m
As IN B-VP O
your PRP$ O O
pain NN B-NP O
allows NNS I-NP O
, , O O
you PRP O O
should MD O O
reduce VB O O
the DT B-NP O
amount NN I-NP O
of IN B-VP O
this DT B-NP B-m
medication NN I-NP I-m
accordingly RB O O
Narcotic NNP B-NP B-m
pain NN I-NP I-m
medications NNS I-NP I-m
can MD O O
cause VB O O
constipation NN B-NP B-r
constipation NN I-NP B-r
, , O O
so IN B-VP O
you PRP O O
should MD O O
drink VB O O
plenty NN B-NP O
of IN B-VP O
water NN B-NP O
and CC O O
take VB O O
a DT B-NP O
stool NN I-NP B-m
softener NN I-NP O
( ( O O
Colace NNP B-NP O
) ) O O
to TO O O
help VB O O
prevent VB O O
this DT B-NP O
side NN I-NP O
effect NN I-NP O
3 CD O O
Call NNP B-NP O
Dr NNP I-NP O
Camelo NNP I-NP O
at IN B-VP O
the DT B-NP O
number NN I-NP O
above IN B-VP O
, , O O
or CC O O
your PRP$ O O
Primary JJ B-NP O
Care NNP I-NP O
Physician NNP I-NP O
, , O O
or CC O O
go VB O O
to TO O O
a DT B-NP O
local JJ I-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
develop VBP O O
fevers/chills NNS B-NP O
, , O O
redness NN B-NP O
around IN B-VP O
your PRP$ O O
incision NN B-NP O
that DT O O
is VBZ O O
warm JJ O O
to TO O O
the DT B-NP O
touch NN I-NP O
, , O O
pus-like JJ B-NP O
drainage NN I-NP O
from IN B-VP O
the DT B-NP O
wound NN I-NP O
, , O O
loss NN B-NP O
of IN B-VP O
function NN B-NP O
( ( O O
either CC O O
strength NN B-NP O
or CC O O
sensation NN B-NP O
) ) O O
in IN B-VP O
your PRP$ O O
hand NN B-NP O
, , O O
return NN B-NP O
to TO O O
your PRP$ O O
original JJ B-NP O
symptoms NNS I-NP O
, , O O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
concerning NN I-NP O
symptoms NNS I-NP O
4 CD O O
You PRP O O
may MD O O
not RB O O
drive VB O O
a DT B-NP O
car NN I-NP O
until IN B-VP O
cleared VBN O O
to TO O O
do VB O O
so RB O O
by IN B-VP O
Dr NNP B-NP O
Boys NNP I-NP O
5 CD O O
Resume NNP B-NP O
home NN I-NP B-m
medications NNS I-NP I-m
unless IN B-VP O
specifically RB O O
instructed VBN O O
otherwise RB O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GRDINA NNP I-NP O
, , O O
EDDY NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
ZL34 NNP B-NP O
) ) O O
11/0/06 CD O O
@ $ O O
09 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#937042 VBZ O O
774927831 CD O O
LCH NNP B-NP O
62092282 CD O O
8782800 CD O O
0/12/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/12/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/12/2007 CD O O
ATTENDING: NNP B-NP O
PAAVOLA NNP I-NP O
, , O O
OMAR NNP B-NP O
MD NNP I-NP O
ADMITTING NNP I-NP O
DIAGNOSIS: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
BRIEF NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
an DT B-NP O
81-year-old JJ I-NP O
Italian-speaking JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
and CC O O
COPD NNP B-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
rise NN B-NP O
in IN B-VP O
his PRP$ O O
chest NN B-NP O
pain NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
there EX O O
were VBD B-VP O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
and CC O O
the DT B-NP O
chest JJS I-NP O
CT NNP I-NP O
PE NNP I-NP O
protocol NN I-NP O
was VBD B-VP O
reportedly RB O O
negative JJ B-NP O
Several JJ I-NP O
hours NNS I-NP O
later RB O O
, , O O
the DT B-NP O
patient NN I-NP O
developed VBD B-VP O
left-sided JJ B-NP O
chest NN I-NP O
pain NN I-NP O
with IN B-VP O
ST NNP B-NP O
elevations NNS I-NP O
in IN B-VP O
V2 NNP B-NP O
, , O O
V4 NNP B-NP O
and CC O O
enzyme JJ B-NP O
leak NN I-NP O
On IN B-VP O
11/5/06 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
M NNP B-NP O
Valley NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
where WRB O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
three-vessel JJ B-NP O
disease NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Hypertension NNP B-NP O
2 CD O O
Diabetes VBZ O O
3 CD O O
Hyperglyceridemia NNP B-NP O
4 CD O O
COPD NNP B-NP O
5 CD O O
BPH NNP B-NP O
6 CD O O
Seizures NNP B-NP O
7 CD O O
Blindness NNP B-NP O
in IN B-VP O
the DT B-NP O
right NN I-NP O
eye NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Bilateral NNP B-NP O
knee NN I-NP O
replacement NN I-NP O
2 CD O O
Right NNP B-NP O
knee NN I-NP O
re-operated JJ O O
for IN B-VP O
infection NN B-NP O
3 CD O O
Bilateral NNP B-NP O
inguinal JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
4 CD O O
Right NNP B-NP O
eye NN I-NP O
enucleation NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Italian JJ B-NP O
speaking NN I-NP O
, , O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
, , O O
is VBZ O O
accompanied VBN O O
with IN B-VP O
his PRP$ O O
son NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
farm NN I-NP O
worker NN I-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
allergic JJ O O
to TO O O
Ciprofloxacin NNP B-NP O
, , O O
Ceftin NNP B-NP O
, , O O
and CC O O
Singulair NNP B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Lopressor NNP B-NP B-m
25 CD O B-do
orally RB O B-mo
every DT O B-f
6 CD O I-f
hours NNS B-NP I-f
2 CD O O
Diltiazem NNP B-NP B-m
125 CD O B-do
mg NNS B-NP I-do
orally RB O B-mo
daily RB O B-f
3 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NNS B-NP I-do
orally RB O B-mo
daily RB O B-f
4 CD O O
Furosemide NNP B-NP B-m
20 CD O B-do
mg NNS B-NP I-do
orally RB O B-mo
daily RB O B-f
5 CD O O
Methylprednisolone NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
every DT O B-f
8 CD O I-f
hours NNS B-NP I-f
6 CD O O
Atorvastatin NNP B-NP B-m
80 CD O B-do
mg NNS B-NP I-do
orally RB O B-mo
daily RB O B-f
7 CD O O
Allopurinol NNP B-NP B-m
100 CD O B-do
mg NNS B-NP I-do
orally RB O B-mo
daily RB O B-f
8 CD O O
Ativan NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
orally RB O B-mo
at IN B-VP B-f
bedtime RB O I-f
9 CD O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NNS B-NP I-do
orally RB O B-mo
daily RB O B-f
10 CD O O
Proscar NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
orally RB O B-mo
every DT B-NP B-f
night NN I-NP I-f
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
were VBD B-VP O
as IN B-VP O
follows VBZ O O
Temperature NNP B-NP O
97.1 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
73 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
108/59 CD O O
, , O O
and CC O O
oxygen NN B-NP O
saturation NN I-NP O
98% CD O O
HEENT NNP B-NP O
, , O O
PERRLA NNP B-NP O
, , O O
dentition NN B-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection NN B-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits VBZ O O
On IN B-VP O
chest JJS B-NP O
examination NN I-NP O
, , O O
no DT B-NP O
incisions NNS I-NP O
Cardiovascular NNP I-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmurs NNS B-NP O
Respiratory NNP I-NP O
, , O O
breath NN B-NP O
sounds NNS I-NP O
are VBP O O
clear JJ O O
bilaterally RB O O
On IN B-VP O
abdominal JJ B-NP O
exam NN I-NP O
, , O O
bilateral JJ B-NP O
inguinal JJ I-NP O
hernia NN I-NP O
incisions NNS I-NP O
and CC O O
enlarged VBD B-VP O
right JJ B-NP O
groin NN I-NP O
hematoma NN I-NP O
from IN B-VP O
previous JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
On IN B-VP O
extremities NNS B-NP O
, , O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
varicosities NNS I-NP O
Neuro NNP I-NP O
exam NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
without IN B-VP O
focal JJ B-NP O
deficits NNS I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
performed VBD B-VP O
at IN B-VP O
An DT O O
on IN B-VP O
10/28/06 CD O O
revealed VBD B-VP O
30% CD O O
mid NN B-NP O
RCA NNP I-NP O
occlusion NN I-NP O
, , O O
40% CD O O
distal JJ B-NP O
RCA NNP I-NP O
, , O O
90% CD O O
ostial JJ B-NP O
OM1 NNP I-NP O
, , O O
90% CD O O
mid NN B-NP O
CX NNP I-NP O
, , O O
80% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
, , O O
99% CD O O
mid NN B-NP O
LAD NNP I-NP O
, , O O
and CC O O
60% CD O O
mid NN B-NP O
LM NNP I-NP O
EKG NNP I-NP O
on IN B-VP O
2/5/06 CD O O
showed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
76 CD O O
and CC O O
an DT B-NP O
incomplete JJ I-NP O
right JJ I-NP O
bundle-branch NN I-NP O
block NN I-NP O
A NNP I-NP O
chest NN I-NP O
x-ray NN I-NP O
on IN B-VP O
10/28/06 CD O O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient's JJ I-NP O
hospital NN I-NP O
course NN I-NP O
is VBZ O O
as IN B-VP O
follows VBZ O O
by IN B-VP O
systems NNS B-NP O
1 CD O O
Neurologic: NNP B-NP O
Agitation NNP I-NP O
and CC O O
delirium NN B-NP O
In IN B-VP O
the DT B-NP O
immediate JJ I-NP O
postoperative JJ I-NP O
period NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
alcohol NN B-NP B-m
drip NN I-NP B-mo
, , O O
given VBN O O
a DT B-NP O
preop JJ I-NP O
history NN I-NP O
of IN B-VP O
alcohol NN B-NP B-r
use IN B-VP I-r
The DT B-NP O
patient's NN I-NP O
neurologic JJ B-NP O
status NN I-NP O
improved VBN O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
being VBG O O
more JJR B-NP O
alert NN I-NP O
during IN B-VP O
the DT B-NP O
day NN I-NP O
, , O O
particularly RB O O
with IN B-VP O
family NN B-NP O
members NNS I-NP O
present JJ B-NP O
Haldol NNP I-NP B-m
was VBD B-VP O
used VBN O O
p.r.n NN B-NP B-f
for IN B-VP O
agitation NN B-NP B-r
during IN B-VP B-du
the DT B-NP I-du
hospital JJ I-NP I-du
course NN I-NP I-du
2 CD O O
Cardiovascular: NNP B-NP O
On IN B-VP O
11/5/06 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
and CC O O
underwent JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
x1 NN B-NP O
with IN B-VP O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
, , O O
with IN B-VP O
incomplete JJ B-NP O
revascularization NN I-NP O
due JJ O O
to TO O O
inadequate VB O O
conduit NN B-NP O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well NN I-NP O
and CC O O
after IN B-VP O
a DT B-NP O
period NN I-NP O
of IN B-VP O
observation NN B-NP O
, , O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
Subsequently NNP I-NP O
, , O O
during IN B-VP O
the DT B-NP O
hospital NN I-NP O
stay NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
beta-blockers NNS B-NP B-m
and CC O O
statins NNS B-NP B-m
Later NNP I-NP O
during IN B-VP O
the DT B-NP O
hospital NN I-NP O
stay NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
became VBD B-VP O
hypotensive JJ B-NP B-r
hypotensive NN I-NP B-r
, , O O
requiring VBG O O
fluid NN B-NP B-m
resuscitation NN I-NP O
and CC O O
vasopressor NN B-NP B-m
administration NN I-NP O
3 CD O O
Respiratory: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
extubated VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
, , O O
but CC O O
he PRP O O
was VBD B-VP O
reintubated VBN O O
for IN B-VP O
acute JJ B-NP O
respiratory NN I-NP O
failure NN I-NP O
later RBR O O
during IN B-VP O
the DT B-NP O
day NN I-NP O
with IN B-VP O
subsequent JJ B-NP O
re-extubation NN I-NP O
on IN B-VP O
1/14/07 CD O O
During IN B-VP O
the DT B-NP O
hospital NN I-NP O
stay NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
two CD O O
additional JJ B-NP O
re-intubations NNS I-NP O
for IN B-VP O
acute JJ B-NP O
respiratory JJ I-NP O
failure NN I-NP O
events NNS I-NP O
, , O O
one CD O O
on IN B-VP O
0/7/07 CD O O
followed VBN O O
by IN B-VP O
extubation NN B-NP O
on IN B-VP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
, , O O
on IN B-VP O
0/14/07 CD O O
and CC O O
the DT B-NP O
second JJ I-NP O
one NN I-NP O
on IN B-VP O
9/26/07 CD O O
followed VBN O O
by IN B-VP O
extubation NN B-NP O
on IN B-VP O
6/24/07 CD O O
4 CD O O
GI: NNP B-NP O
It PRP O O
was VBD B-VP O
characterized VBN O O
by IN B-VP O
nutrition NN B-NP O
deficiency NN I-NP O
, , O O
although IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
tolerate VB O O
soft JJ B-NP O
mechanical JJ I-NP O
diet NN I-NP O
, , O O
the DT B-NP O
intake NN I-NP O
was VBD B-VP O
limited VBN O O
The DT B-NP O
puff NN I-NP O
tubes NNS I-NP O
were VBD B-VP O
placed VBN O O
multiple JJ B-NP O
times NNS I-NP O
for IN B-VP O
additional JJ B-NP O
nutrition NN I-NP O
, , O O
but CC O O
were VBD B-VP O
frequently RB O O
removed VBN O O
by IN B-VP O
the DT B-NP O
patient NN I-NP O
, , O O
given VBN O O
the DT B-NP O
delirium NN I-NP O
and CC O O
agitation NN B-NP O
5 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
and CC O O
the DT B-NP O
electrolyte NN I-NP O
and CC O O
creatinine NN B-NP O
levels NNS I-NP O
were VBD B-VP O
closely RB O O
monitored JJ O O
6 CD O O
Endocrine: NNP B-NP O
Tight NNP I-NP B-r
glycemic FW O I-r
control NN B-NP I-r
was VBD B-VP O
maintained VBN O O
with IN B-VP O
Portland NNP B-NP O
protocol NN I-NP O
in IN B-VP O
the DT B-NP O
immediate JJ I-NP O
postop JJ I-NP O
period NN I-NP O
and CC O O
subsequently RB O O
with IN B-VP O
subcu JJ B-NP B-mo
insulin NN I-NP B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
on IN B-VP O
prednisone NN B-NP B-m
prednisone NN I-NP B-m
with IN B-VP O
the DT B-NP O
preop NN I-NP O
indications NNS I-NP O
for IN B-VP O
COPD NNP B-NP B-r
and CC O O
given VBN O O
his PRP$ O B-r
postop JJ B-NP O
frequent JJ I-NP O
bronchospastic JJ I-NP O
events NNS I-NP O
7 CD O O
Hematologic: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
also RB O O
on IN B-VP O
Plavix NNP B-NP B-m
, , O O
given VBN O O
the DT B-NP O
incomplete JJ I-NP B-r
incomplete JJ I-NP B-r
coronary JJ I-NP I-r
coronary JJ I-NP I-r
vascularization NN I-NP I-r
vascularization NN I-NP I-r
Hematocrit NNP I-NP O
and CC O O
platelets NNS B-NP O
were VBD B-VP O
stable JJ O O
8 CD O O
Infectious JJ B-NP O
disease: NN I-NP O
The DT B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by: IN B-VP O
A NNP B-NP O
) ) O O
Sternal NNP B-NP O
wound NN I-NP O
infection NN I-NP O
for IN B-VP O
which WDT O O
the DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
pericardial JJ I-NP O
strip NN I-NP O
advancement NN I-NP O
on IN B-VP O
0/7/07 CD O O
and CC O O
omental JJ B-NP O
flap NN I-NP O
and CC O O
wound JJ B-NP O
closure NN I-NP O
on IN B-VP O
10/13/07 CD O O
The DT B-NP O
wound NN I-NP O
was VBD B-VP O
reopened VBN O O
at IN B-VP O
the DT B-NP O
bedside NN I-NP O
on IN B-VP O
10/30/07 CD O O
by IN B-VP O
Plastic NN B-NP O
Surgery NNP I-NP O
due JJ O O
to TO O O
increased VBN O O
drainage NN B-NP O
and CC O O
a DT B-NP O
VAC NNP I-NP O
sponge NN I-NP O
was VBD B-VP O
placed VBN O O
Wound IN B-VP O
cultures NNS B-NP O
were VBD B-VP O
sent VBN O O
and CC O O
appropriate JJ B-NP O
antibiotic JJ I-NP B-m
treatment NN I-NP O
was VBD B-VP O
instituted VBN O O
B NNP B-NP O
) ) O O
Pneumonias NNP B-NP B-r
Treated NNP I-NP O
initially RB O O
empirically RB O O
and CC O O
subsequently RB O O
with IN B-VP O
specific JJ B-NP O
antibiotics NNS I-NP B-m
after IN B-VP O
culture NN B-NP O
results NNS I-NP O
became VBD B-VP O
available JJ B-NP O
C NNP I-NP O
) ) O O
Fever NNP B-NP O
, , O O
later RB O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
experienced VBD B-VP O
fever RB O O
without IN B-VP O
leukocytosis NN B-NP O
despite IN B-VP O
negative JJ B-NP O
cultures NNS I-NP O
Throughout IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
Infectious NNP B-NP O
Disease NNP I-NP O
Service NNP I-NP O
and CC O O
Pulmonary NNP B-NP O
Service NNP I-NP O
were VBD B-VP O
consulted VBN O O
and CC O O
they PRP O O
followed VBD B-VP O
the DT B-NP O
patient NN I-NP O
continuously RB O O
9 CD O O
Other: NNP B-NP O
Incidental NNP I-NP O
radiologic VBD B-VP O
finding NN B-NP O
of IN B-VP O
a DT B-NP O
renal JJ I-NP O
mass NN I-NP O
consistent NN I-NP O
with IN B-VP O
renal JJ B-NP O
cell NN I-NP O
carcinoma NN I-NP O
Urology NNP I-NP O
Service NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
the DT B-NP O
recommendations NNS I-NP O
were VBD B-VP O
made VBN O O
for IN B-VP O
no DT B-NP O
intervention NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
After IN B-VP O
excessive JJ B-NP O
discussion NN I-NP O
with IN B-VP O
the DT O O
very RB O O
supportive JJ B-NP O
patient's NNS I-NP O
family NN I-NP O
with IN B-VP O
regards NNS B-NP O
to TO O O
the DT B-NP O
patient's NN I-NP O
prognosis NN I-NP O
, , O O
family NN B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
withdraw VB O O
medical JJ B-NP O
care NN I-NP O
and CC O O
discharge VB O O
the DT B-NP O
patient NN I-NP O
to TO O O
home NN B-NP O
with IN B-VP O
hospice NN B-NP O
services NNS I-NP O
Thus RB O O
, , O O
on IN B-VP O
9/26/07 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
after IN B-VP O
hospice NN B-NP O
services NNS I-NP O
were VBD B-VP O
arranged VBN O O
MEDICATIONS NNP B-NP O
AT NNP I-NP O
DISCHARGE: NNP I-NP O
Were NNP I-NP O
the DT O O
following VBG O O
1 CD O O
Tylenol NNP B-NP B-m
suppository NN I-NP I-m
650 CD O B-do
mg NN B-NP I-do
every DT O B-f
6 CD O I-f
hours NNS B-NP I-f
2 CD O O
Toradol NNP B-NP B-m
orally RB O B-mo
10 CD O B-do
mg NN B-NP I-do
every DT O B-f
4 CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
3 CD O O
Haldol NNP B-NP B-m
liquid VBD B-VP I-m
1 CD O B-do
to TO O I-do
3 CD O I-do
mg NNS B-NP I-do
orally RB O B-mo
every DT O B-f
4 CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
agitation NN B-NP B-r
4 CD O O
Nexium NN B-NP B-m
20 CD O B-do
mg NN B-NP I-do
everyday JJ O B-f
5 CD O O
Morphine NNP B-NP B-m
Morphine NNP I-NP B-m
liquid NN I-NP I-m
liquid VBD B-VP I-m
5 CD O B-do
5 CD O B-do
to TO O I-do
to TO O I-do
20 CD O I-do
20 CD O I-do
mg NN B-NP I-do
mg NN I-NP I-do
orally RB O B-mo
orally RB O B-mo
every DT O B-f
every DT O B-f
2 CD O I-f
2 CD O I-f
hours NNS B-NP I-f
hours NNS I-NP I-f
as IN B-VP I-f
as IN B-VP I-f
needed VBN O I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
and CC O O
for IN B-VP O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
Support NNP I-NP O
for IN B-VP O
the DT B-NP O
patient's JJ I-NP O
family NN I-NP O
was VBD B-VP O
provided VBN O O
throughout IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
and CC O O
the DT B-NP O
patient's JJ I-NP O
family NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
call VB O O
house NN B-NP O
officer NN I-NP O
on IN B-VP O
call NN B-NP O
if IN B-VP O
any DT B-NP O
question NN I-NP O
might MD O O
arise VB O O
eScription NN B-NP O
document: IN B-VP O
9-8603383 CD O O
CSSten NNP B-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SPAHN NNP I-NP O
, , O O
NEWTON NNP B-NP O
Attending: NNP I-NP O
MUDRICK NNP I-NP O
, , O O
JAMEY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
2086227 CD O O
D: NNP B-NP O
2/5/07 CD O O
T: NNP B-NP O
2/5/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#939003 VBZ O O
979128258 CD O O
DAMC NNP B-NP O
19635378 CD O O
745862 CD O O
10/15/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
sob NN I-NP O
of IN B-VP O
unknown JJ B-NP O
etiology NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/15/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/16/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DIOMEDE NNP I-NP O
, , O O
DAVID NNP B-NP O
572-07-61-6 CD O O
U NNP B-NP O
Ertna NNP I-NP O
Leigh NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/2/01 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CONER NNP I-NP O
, , O O
LEN NNP B-NP O
DOMINGO NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
KLONOPIN NNP I-NP B-m
( ( O I-m
CLONAZEPAM NNP B-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/20/01 CD O O
by IN B-VP O
FRIEDRICHS NNP B-NP O
, , O O
ERIK NNP B-NP O
JIM NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
AZITHROMYCIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
63922816 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/20/01 CD O O
by IN B-VP O
RESSEGUIE NNP B-NP O
, , O O
COLUMBUS NNP B-NP O
DARELL NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
AZITHROMYCIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
78776952 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PROZAC NNP I-NP B-m
( ( O I-m
FLUOXETINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZESTRIL NNP I-NP B-m
( ( O I-m
LISINOPRIL NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NIFEREX-150 NNP I-NP B-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PERCOCET NNP I-NP B-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP O
X NNP I-NP B-du
7 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
6/1 CD O O
) ) O O
PRN NNP B-NP O
pain VBP O B-r
AZITHROMYCIN NNP B-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
4 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
IN NNP B-NP O
AM NNP I-NP O
( ( O O
6/1 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/20/01 CD O O
by IN B-VP O
HUNZIKER NNP B-NP O
, , O O
BARTON NNP B-NP O
ELDON NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
ATROVENT NNP I-NP B-m
INHALER NNP I-NP I-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
INHALER NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
Taper NNP I-NP O
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
Give NNP I-NP O
60 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
0/22/01-09 JJ O O
) ) O O
, , O O
then RB O O
---done CD O O
Give NNP B-NP O
50 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
2/26/01-09 JJ O O
) ) O O
, , O O
then RB O O
---done CD O O
Give NNP B-NP O
40 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
9/28/01-09 CD O O
) ) O O
, , O O
then RB O O
---done CD O O
Give NNP B-NP O
30 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
4/0/01-09 JJ O O
) ) O O
, , O O
then RB O O
---done CD O O
Give NNP B-NP O
20 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
8/26/01-09 JJ O O
) ) O O
, , O O
then RB O O
---done CD O O
Give NNP B-NP O
10 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
2/20/01-10 JJ O O
) ) O O
, , O O
then RB O O
---done CD O O
Give NNP B-NP O
5 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
day( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
( ( O O
3/6/01-10 JJ O O
) ) O O
, , O O
then RB O O
---done CD O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician JJ I-NP O
No NNP I-NP O
Known NNP I-NP O
Allergies NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
sob NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
sob NN B-NP O
of IN B-VP O
unknown JJ B-NP O
etiology NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Borderline NNP I-NP O
HTN NNP I-NP O
Anxiety NNP I-NP O
D/O NNP I-NP O
PPD NNP I-NP O
+ NNP I-NP O
s/p VBD B-VP O
INH NNP B-NP O
G5P4TAB1 NNP I-NP O
morbid NN I-NP O
obesity NN I-NP O
( ( O O
obesity NN B-NP O
) ) O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
psoriasis NN B-NP O
( ( O O
psoriasis NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
37 CD O O
yo NN B-NP O
multiple JJ B-NP O
admissions NNS I-NP O
for IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
morbid NN B-NP O
obesity NN I-NP O
, , O O
restrictive JJ B-NP O
lung NN I-NP O
dz NN I-NP O
by IN B-VP O
PFTs NNP B-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
, , O O
borderline NN B-NP O
HTN NNP I-NP O
Had NNP I-NP O
cath NN I-NP O
last JJ B-NP O
admission NN I-NP O
and CC O O
showed VBD B-VP O
clean JJ B-NP O
coronaries NNS I-NP O
Now RB O O
comes VBZ O O
in IN B-VP O
complaining VBG O O
of IN B-VP O
SOB NNP B-NP O
and CC O O
"asthma NNP B-NP O
attack" NN I-NP O
and CC O O
anxiety NN B-NP B-r
Responded NNP I-NP O
well RB O O
to TO O O
Nebs NNP B-NP O
and CC O O
Ativan NNP B-NP B-m
in IN B-VP O
ED NNP B-NP O
Will NNP I-NP O
d/c VB O O
to TO O O
complete VB O O
course NN B-NP O
of IN B-VP O
Macrolide NNP B-NP B-m
antibio RB O O
tic JJ O O
to TO O O
cover VB O O
atypicals NNS B-NP O
for IN B-VP O
tracheobronchitis NN B-NP B-r
at IN B-VP O
home NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
JAY NNP I-NP O
, , O O
LAMAR NNP B-NP O
KRIS NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
TD84 NNP B-NP O
) ) O O
6/2/01 CD O O
@ $ O O
10:58 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#939531 VBZ O O
214850753 CD O O
RVHC NNP B-NP O
17622865 CD O O
943010 CD O O
7/21/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/15/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/29/1995 CD O O
PRELIMINARY NNP B-NP O
DIAGNOSIS: NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
62-year-old JJ I-NP O
white JJ I-NP O
male NN I-NP O
status NN I-NP O
post NN I-NP O
anterior RB O O
wall JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
TPA NNP I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
post-infarct JJ B-NP O
angina NNS I-NP O
and CC O O
three-vessel JJ B-NP O
disease NN I-NP O
by IN B-VP O
catheterization NN B-NP O
The DT B-NP O
patient's NN I-NP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
and CC O O
positive JJ B-NP O
family NN I-NP O
history NN I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
cigarettes VBZ O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
very RB O O
noncooperative JJ B-NP O
historian NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
diabetes NNS B-NP B-r
of IN B-VP O
20 CD O O
years NNS B-NP O
without IN B-VP O
neurological JJ O O
or CC O O
retinopathy JJ O O
treated VBN O O
with IN B-VP O
oral JJ B-NP B-mo
hypoglycemics NNS I-NP B-m
The DT B-NP O
patient NN I-NP O
has VBZ O O
long-standing JJ B-NP O
hypotension NN I-NP O
of IN B-VP O
30 CD O O
to TO O O
40 CD O O
years NNS B-NP O
The DT B-NP O
patient NN I-NP O
, , O O
in IN B-VP O
1985 CD O O
, , O O
had VBD B-VP O
a DT B-NP O
percutaneous JJ I-NP O
transluminal JJ I-NP O
coronary JJ I-NP O
angioplasty NN I-NP O
at IN B-VP O
the DT B-NP O
Ribush NNP I-NP O
Bassta NNP I-NP O
Syark NNP I-NP O
Hospital NNP I-NP O
and CC O O
has VBZ O O
had VBN O O
rule NN B-NP O
outs NNS I-NP O
since IN B-VP O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
with IN B-VP O
the DT O O
last JJ O O
one CD O O
approximately RB O O
in IN B-VP O
1990 CD O O
at IN B-VP O
Dormro NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
The DT B-NP O
patient NN I-NP O
, , O O
however RB O O
, , O O
has VBZ O O
been VBN O O
able JJ O O
to TO O O
work VB O O
and CC O O
climb VB O O
stairs NNS B-NP O
and CC O O
walk VBP O O
about IN B-VP O
a DT B-NP O
mile NN I-NP O
without IN B-VP O
difficulty NN B-NP O
Several JJ B-NP O
days NNS I-NP O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
reports NNS I-NP O
pain NN I-NP O
and CC O O
ache NN B-NP O
over IN B-VP O
the DT B-NP O
lower JJR I-NP O
back NN I-NP O
and CC O O
flanks NNS B-NP O
as RB O O
well RB O O
as IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
with IN B-VP O
radiation NN B-NP O
to TO O O
the DT B-NP O
upper JJ I-NP O
left NN I-NP O
arm VBZ O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
unable JJ O O
to TO O O
describe VB O O
any DT B-NP O
further JJ I-NP O
symptoms NNS I-NP O
The DT B-NP O
patient NN I-NP O
denied VBD B-VP O
nausea NN B-NP O
or CC O O
vomiting NN B-NP O
but CC O O
says VBZ O O
he PRP O O
was VBD B-VP O
diaphoretic JJ O O
The DT B-NP O
patient NN I-NP O
took VBD B-VP O
four CD O B-do
to TO O I-do
five CD O I-do
Nitroglycerins NNS B-NP B-m
without IN B-VP O
relief NN B-NP O
The DT B-NP O
patient NN I-NP O
subsequently RB O O
was VBD B-VP O
admitted VBN O O
to TO O O
Agrit NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
and CC O O
had VBD B-VP O
at IN B-VP O
least JJS O O
3 CD O O
hours NNS B-NP O
of IN B-VP O
pain NN B-NP O
at IN B-VP O
Pari NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
ruled VBN O O
in IN B-VP O
for IN B-VP O
anterior JJ B-NP O
wall NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
with IN B-VP O
ST NNP B-NP O
elevations NNS I-NP O
4 CD O O
to TO O O
5 CD O O
mm NNS B-NP O
in IN B-VP O
V1 NNP B-NP O
Blood NNP I-NP O
pressure NN I-NP O
was VBD B-VP O
152/95 CD O O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
front-loaded JJ B-NP B-m
TPA NNP I-NP I-m
, , O O
Heparin NNP B-NP B-m
, , O O
Aspirin NNP B-NP B-m
, , O O
Morphine NNP B-NP B-m
sulfate NN I-NP I-m
and CC O O
Nifedipine NNP B-NP B-m
At IN B-VP O
1:00 CD O O
a.m NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
recurrent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
with IN B-VP O
elevations NNS B-NP O
in IN B-VP O
V1 NNP B-NP O
through IN B-VP O
6 CD O O
, , O O
Lead NNP B-NP O
, , O O
1 CD O O
, , O O
AVL NNP B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
Pepor NNP I-NP O
El NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Of IN B-VP O
At IN B-VP O
the DT B-NP O
Hitchter NNP I-NP O
University NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
cathed VBN O O
and CC O O
had VBD B-VP O
100% CD O O
stenotic JJ B-NP O
mid NN I-NP O
left VBD B-VP O
anterior JJ B-NP O
descending NN I-NP O
, , O O
90% CD O O
ulcerated JJ O O
obtuse IN B-VP O
marginal JJ B-NP O
first JJ I-NP O
branch NN I-NP O
, , O O
60 CD O O
to TO O O
70% CD O O
stenotic JJ O O
right RB O O
coronary JJ B-NP O
artery NN I-NP O
and CC O O
anterior JJ B-NP O
apical JJ I-NP O
aneurysm NN I-NP O
was VBD B-VP O
noted VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
an DT B-NP O
intra-aortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
in IN B-VP O
preparation NN B-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
surgery NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
inclusive JJ O O
of IN B-VP O
status NN B-NP O
post NN I-NP O
percutaneous JJ B-NP O
transluminal JJ I-NP O
coronary NN I-NP O
angioplasty NN I-NP O
in IN B-VP O
'85 NN B-NP O
at IN B-VP O
Ason NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
hypertension NN B-NP O
and CC O O
ruptured VBD B-VP O
appendectomy RB O O
25 CD O O
years NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications: NN I-NP O
Diltiazem NNP I-NP B-m
60 CD O B-do
t.i.d NN B-NP B-f
, , O O
Glyburide NNP B-NP B-m
, , O O
Lisinopril NNP B-NP B-m
20 CD O B-do
PO NNP B-NP B-mo
q.day NN I-NP B-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
temperature NN I-NP O
is VBZ O O
98.1 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
66 CD O O
, , O O
sinus VBD B-VP O
137/57 CD O O
, , O O
saturating VBG O O
at IN B-VP O
97% CD O O
and CC O O
100% CD O O
face NN B-NP O
mask NN I-NP O
who WP O O
is VBZ O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
lying VBG O O
in IN B-VP O
bed NN B-NP O
with IN B-VP O
an DT B-NP O
intra-aortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
HEENT: NNP I-NP O
Pupils NNP I-NP O
are VBP O O
equal JJ O O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
Intraocular NNP I-NP O
muscles NNS I-NP O
intact JJ B-NP O
Oropharynx NNP I-NP O
clear JJ B-NP O
Neck: NNP I-NP O
Jugular NNP I-NP O
venous JJ B-NP O
pressure NN I-NP O
was VBD B-VP O
about IN B-VP O
8 CD O O
cm NN B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
hepatojugular JJ I-NP O
reflux NN I-NP O
No NNP I-NP O
thyromegaly NN I-NP O
No NNP I-NP O
lymphadenopathy JJ B-NP O
Carotids NNP I-NP O
were VBD B-VP O
2+ CD O O
without IN B-VP O
bruits NNS B-NP O
Heart: NNP I-NP O
A NNP I-NP O
balloon NN I-NP O
pump NN I-NP O
was VBD B-VP O
in IN B-VP O
place NN B-NP O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Normal NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
No NNP I-NP O
murmurs NN I-NP O
appreciated VBD B-VP O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities: NNP B-NP O
No NNP I-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema VB O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
2+ CD O O
dorsalis NNS B-NP O
and CC O O
posterior JJ B-NP O
tibial JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
and CC O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
intra-aortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
in IN B-VP O
place NN B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
varices NNS I-NP O
noted VBD B-VP O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
went VBD B-VP O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
11/23 CD O O
, , O O
had VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
x NNP I-NP O
three CD O O
with IN B-VP O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
, , O O
first JJ B-NP O
branch NN I-NP O
of IN B-VP O
the DT B-NP O
obtuse NN I-NP O
marginal JJ O O
and CC O O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
artery IN B-VP O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
the DT O O
patient JJ O O
self-extubated JJ O O
himself PRP O O
and CC O O
resultantly RB O O
had VBD B-VP O
an DT B-NP O
adequate JJ I-NP O
arterial JJ I-NP O
blood NN I-NP O
gas NN I-NP O
, , O O
thus RB O O
not RB O O
requiring VBG O O
emergent JJ B-NP O
intubation NN I-NP O
The DT B-NP O
patient's JJ I-NP O
intra-aortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
was VBD B-VP O
subsequently RB O O
removed VBN O O
without IN B-VP O
further JJ B-NP O
incident NN I-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
which WDT O O
was VBD B-VP O
treated VBN O O
and CC O O
controlled VBN O O
pharmacologically RB O O
, , O O
and CC O O
also RB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
prophylactic JJ B-NP B-r
anticoagulation NN I-NP I-r
with IN B-VP O
Coumadin NNP B-NP B-m
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP O
hospital NN I-NP O
stay NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
afebrile JJ O O
, , O O
tolerated VBD B-VP O
his PRP$ O O
diet NN B-NP O
, , O O
was VBD B-VP O
ambulatory JJ O O
, , O O
had VBD B-VP O
his PRP$ O O
chest NN B-NP O
tube NN I-NP O
and CC O O
cordis NN B-NP O
and CC O O
Foley NNP B-NP O
catheters NNS I-NP O
removed VBD B-VP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#6 NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
converted VBD B-VP O
to TO O O
sinus VB O O
rhythm NN B-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
planned VBN O O
discharge NN B-NP O
for IN B-VP O
24 CD O O
hours NNS B-NP O
after IN B-VP O
that DT O O
which WDT O O
would MD O O
have VB O O
been VBN O O
on IN B-VP O
6/10 CD O O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
requested VBD B-VP O
to TO O O
be VB O O
discharged VBN O O
to TO O O
home VB O O
The DT B-NP O
condition NN I-NP O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
the DT B-NP O
patient's NN I-NP O
wife NN I-NP O
which WDT O O
required VBD B-VP O
continued JJ B-NP O
observation NN I-NP O
until IN B-VP O
the DT B-NP O
morning NN I-NP O
for IN B-VP O
removal NN B-NP O
of IN B-VP O
epicardial JJ B-NP O
wires NNS I-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
refused VBD B-VP O
to TO O O
stay VB O O
He PRP O O
experienced VBD B-VP O
a DT B-NP O
desire NN I-NP O
to TO O O
go VB O O
home NN B-NP O
stating NN I-NP O
that IN B-VP O
he PRP O O
does VBZ O O
not RB O O
like IN B-VP O
the DT B-NP O
food NN I-NP O
here RB O O
and CC O O
is VBZ O O
unable JJ O O
to TO O O
sleep VB O O
and CC O O
does VBZ O O
not RB O O
want VB O O
further RBR O O
medical JJ B-NP O
intervention NN I-NP O
The DT B-NP O
risks NNS I-NP O
of IN B-VP O
the DT B-NP O
discharge NN I-NP O
including VBG O O
rhythm NN B-NP O
, , O O
abnormalities NNS B-NP O
and CC O O
complications NNS B-NP O
related VBN O O
to TO O O
pacing VBG O O
wires NNS B-NP O
were VBD B-VP O
reviewed VBN O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
his PRP$ O O
wife NN B-NP O
DISPOSITION: NNP I-NP O
Despite IN B-VP O
understanding VBG O O
potential JJ B-NP O
risks NNS I-NP O
for IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
expressed VBD B-VP O
desire NN B-NP O
for IN B-VP O
leaving VBG O O
against IN B-VP O
medical JJ B-NP O
advice NN I-NP O
The DT B-NP O
above JJ I-NP O
condition NN I-NP O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
Dr NNP B-NP O
Poore NNP I-NP O
, , O O
the DT O O
attending VBG O O
surgeon NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
subsequently RB O O
found VBN O O
to TO O O
have VB O O
left VBN O O
the DT B-NP O
hospital NN I-NP O
by IN B-VP O
taxi NN B-NP O
with IN B-VP O
IV NNP B-NP O
Heplocks NNP I-NP O
, , O O
wires NNS B-NP O
and CC O O
Telemetry NNP B-NP O
intact VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
called VBN O O
at IN B-VP O
home NN B-NP O
, , O O
and CC O O
condition NN B-NP O
of IN B-VP O
his PRP$ O O
discharge NN B-NP O
and CC O O
recommendations NNS B-NP O
were VBD B-VP O
given VBN O O
which WDT O O
were VBD B-VP O
to TO O O
return VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
to TO O O
have VB O O
IV's NNP B-NP O
, , O O
wires NNS B-NP O
and CC O O
Telemetry NNP B-NP O
removed VBD B-VP O
The DT B-NP O
patient NN I-NP O
refused VBD B-VP O
, , O O
however RB O O
He PRP O O
refused VBD B-VP O
to TO O O
have VB O O
the DT B-NP O
Visiting NNP I-NP O
Nurse NNP I-NP O
Association NNP I-NP O
to TO O O
come VB O O
in IN B-VP O
to TO O O
remove VB O O
his PRP$ O O
IV's NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
encouraged VBN O O
to TO O O
return VB O O
for IN B-VP O
clipping NN B-NP O
of IN B-VP O
the DT B-NP O
epicardial JJ I-NP O
pacing NN I-NP O
wires; NN I-NP O
however RB O O
, , O O
he PRP O O
refused VBD B-VP O
The DT B-NP O
patient's JJ I-NP O
wife NN I-NP O
was VBD B-VP O
sent VBN O O
with IN B-VP O
prescriptions NNS B-NP O
and CC O O
risk NN B-NP O
management NN I-NP O
was VBD B-VP O
also RB O O
informed VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
requested VBN O O
to TO O O
return VB O O
today NN B-NP O
, , O O
the DT O O
7 CD O O
of IN B-VP O
August NNP B-NP O
, , O O
to TO O O
have VB O O
pacing NN B-NP O
wires NNS I-NP O
and CC O O
Telemetry NNP B-NP O
removed VBD B-VP O
as RB O O
well RB O O
as IN B-VP O
IV's NNP B-NP O
The DT B-NP O
patient NN I-NP O
returned VBD B-VP O
for IN B-VP O
an DT B-NP O
hour NN I-NP O
, , O O
had VBD B-VP O
pacing NN B-NP O
wires NNS I-NP O
removed VBD B-VP O
and CC O O
Telemetry NNP B-NP O
box NN I-NP O
also RB O O
removed VBD B-VP O
The DT B-NP O
patient NN I-NP O
just RB O O
left VBN O O
on IN B-VP O
his PRP$ O O
own JJ B-NP O
accord NN I-NP O
The DT B-NP O
patient NN I-NP O
requested VBD B-VP O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Schoening NNP I-NP O
in IN B-VP O
6 CD O O
weeks NNS B-NP O
and CC O O
his PRP$ O O
cardiologist NN B-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
Dictated VBN O O
By: NNP B-NP O
MYLES NNP I-NP O
VELASQUEZ NNP I-NP O
, , O O
M.D NNP B-NP O
TV19 NNP I-NP O
Attending: NNP I-NP O
ARTHUR NNP I-NP O
G NNP I-NP O
SHEFFIELD NNP I-NP O
, , O O
M.D NNP B-NP O
EN0 NNP I-NP O
VA550/1873 NNP I-NP O
Batch: NNP I-NP O
0923 CD O O
Index NNP B-NP O
No NNP I-NP O
Z3WLE779PM NNP I-NP O
D: NNP I-NP O
3/28/95 CD O O
T: NNP B-NP O
3/28/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#940794 VBZ O O
750216362 CD O O
TMH NNP B-NP O
21370582 CD O O
6716015 CD O O
2/27/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Non NNP I-NP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/21/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/11/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
LANTON NNP I-NP O
, , O O
ORVAL NNP B-NP O
313-51-70-4 CD O O
Bufft NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/11/06 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BECKETT NNP I-NP O
, , O O
COLIN NNP B-NP O
WALLY NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Rehabilitation NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACEBUTOLOL NNP I-NP B-m
HCL NNP I-NP I-m
400 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
8/10 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
ALLOPURINOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
VITAMIN NNP I-NP B-m
C NNP I-NP I-m
( ( O I-m
ASCORBIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
CALCIUM NNP I-NP B-m
CARBONATE NNP I-NP I-m
( ( O I-m
500 CD O I-m
MG NNP B-NP I-m
ELEMENTAL NNP I-NP I-m
CA++ NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
CIPROFLOXACIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
X NNP I-NP B-du
4 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
